TAKAYASU ARTERITIS

Takayasu arteritis is a chronic granulomatous vasculitis of medium- and large-sized arteries,

characterized principally by involvement of the aorta, aortic arch, and major branches of the
aorta. The disease is classically known as pulseless disease because stenosis or obliteration of
the aortic arch branches may produce markedly weakened or absent peripheral pulses. It is also
referred to as aortic arch syndrome when the dominant pathological involvement affects the
aortic arch and its great vessels.

Pathologically, Takayasu arteritis is a fibroinflammatory disease of large elastic arteries. The

defining process is granulomatous inflammation of the arterial wall followed by transmural
scarring, irregular wall thickening, intimal hyperplasia, adventitial fibrosis, and progressive
luminal narrowing. The most characteristic vascular distribution is the aortic arch and its branch
vessels, particularly the brachiocephalic, carotid, and subclavian arteries. The thoracic and
abdominal aorta, renal arteries, pulmonary arteries, and coronary ostia may also be involved.

The key structural consequences are segmental stenosis, irregular wall thickening involving
the aortic arch and its major branches, marked wall thickening, luminal narrowing, and
fibrotic changes. These macroscopic abnormalities correspond microscopically to
granulomatous transmural arteritis, medial injury, intimal fibroplasia, and adventitial scarring.

Etiology

The precise etiology of Takayasu arteritis is unknown. The most accepted concept is an
immune-mediated large-vessel vasculitis occurring in genetically susceptible individuals. The
disease is not defined by a single infectious agent, toxin, or degenerative vascular process. Its
dominant etiologic framework is autoimmune injury directed against the arterial wall of large
elastic vessels.

Genetic susceptibility is supported by associations with certain HLA alleles in some

populations. These associations are not uniform across all geographic groups and are not
diagnostic criteria, but they support the concept that host immune background influences
disease susceptibility.

Cell-mediated immunity has a central role. The aorta and its major branches appear to become
targets of an immune reaction in which T lymphocytes, macrophages, and granulomatous
inflammation dominate the lesion. This immune response injures the media and adventitia and
subsequently promotes fibrointimal proliferation and scarring.
Infectious triggers, particularly mycobacterial antigens, have been proposed because of the
granulomatous morphology of the lesion. However, no microorganism has been established as
the direct cause. If microbial antigens contribute, they are best interpreted as possible immune
triggers rather than persistent pathogens within the arterial wall.

Sex-related and hormonal factors may influence disease susceptibility, but they do not
independently explain the pathogenesis. The most appropriate etiologic formulation is
genetically influenced, T cell–mediated autoimmunity targeting large elastic arteries.

Pathogenesis

The central pathogenic process is immune-mediated granulomatous inflammation of the arterial

wall. The inflammatory reaction often begins in the adventitia and around the vasa vasorum,
then extends into the media and intima. Perivascular cuffing of the vasa vasorum is an
important early morphological feature and reflects the adventitial-centered component of the
disease.

Activated T lymphocytes and macrophages accumulate within the arterial wall. Macrophage
activation leads to granulomatous inflammation, and multinucleated giant cells may be present
in active lesions. The media undergoes injury, with patchy medial necrosis, smooth muscle
cell damage, and destruction of the normal elastic arterial architecture.

The active inflammatory stage is followed by chronic fibroproliferative remodeling. Intimal

hyperplasia progressively narrows the vascular lumen. Adventitial fibrosis and medial scarring
thicken and stiffen the arterial wall. The combined effect of medial destruction, fibrointimal
thickening, and adventitial scarring produces severe stenosis or obliteration of major arterial
branches.

The major pathological sequence is:

immune-mediated granulomatous arteritis of large elastic arteries → adventitial and vasa

vasorum-centered inflammation → transmural mononuclear inflammation and granulomatous
medial injury → patchy medial necrosis and arterial wall destruction → intimal hyperplasia and
adventitial fibrosis → severe luminal narrowing and ischemic vascular consequences.

The essential pathogenic idea is that Takayasu arteritis is not a primary intimal plaque disease.
It is a granulomatous transmural arteritis in which immune-mediated injury of the arterial wall
is followed by fibrotic remodeling and stenosis.
Macroscopic Findings

Grossly, Takayasu arteritis most characteristically involves the aortic arch and its major
branches. The affected arteries show segmental stenosis, irregular wall thickening, firmness,
fibrosis, and marked reduction of the vascular lumen. The arterial wall may become rigid and
scarred, and the lumen may be narrowed to a slit-like channel or completely obliterated.

The origins of the great vessels are particularly important. The brachiocephalic, carotid, and
subclavian artery ostia may show severe narrowing or obliteration. This gross pattern explains
the classical designation pulseless disease.

In advanced disease, the aortic arch and major arterial branches demonstrate marked wall
thickening, luminal narrowing, and fibrotic changes. The intimal surface may appear
wrinkled, irregular, or thickened. Chronic lesions are dominated by fibrosis and scarring.

The thoracic aorta, abdominal aorta, renal arteries, pulmonary arteries, and coronary ostia may
also be involved. Renal artery involvement may show ostial or proximal stenosis. Pulmonary
artery involvement may produce thickened and narrowed pulmonary arterial branches.
Coronary ostial involvement may be associated with ischemic myocardial injury.

Although stenosis and occlusion are the dominant gross patterns, aneurysmal dilatation can
occur when medial destruction weakens the arterial wall. Nevertheless, the classical
macroscopic picture is a thickened, fibrotic aortic arch with narrowed or obliterated major
branch vessel origins.

Histopathological Findings

Histopathologically, Takayasu arteritis shows a spectrum of lesions depending on activity and

chronicity. The characteristic lesion is granulomatous transmural arteritis of large elastic
arteries.

The key diagnostic histopathological phrase is Transmural giant cell–rich granulomatous

arteritis.

In early or active lesions, the adventitia contains mononuclear inflammatory infiltrates, often
accentuated around the vasa vasorum. Perivascular cuffing of the vasa vasorum is a
characteristic feature. The inflammatory process may extend through the vessel wall and
produce intense transmural mononuclear inflammation.
The infiltrate is composed predominantly of lymphocytes and macrophages. Granulomatous
inflammation may be prominent, with epithelioid histiocytes and multinucleated giant cells.
Giant cells may be foreign body type or Langhans type. Active lesions may show patchy
medial necrosis and destruction of the arterial media. The media may show smooth muscle cell
loss and disruption of the normal elastic arterial architecture.

Elastic tissue stains are useful for evaluating injury to the elastic framework of the involved
artery. Verhoeff–Van Gieson elastic staining may reveal prominent fragmentation and
disruption of the internal elastic fibers. This finding supports the diagnosis by demonstrating
structural damage to the elastic arterial wall.

As the lesion evolves, chronic repair produces fibrointimal thickening, intimal hyperplasia,
medial fibrosis, and adventitial fibrosis. These changes are responsible for severe luminal
narrowing. In late disease, inflammation may become less conspicuous, while scarring
dominates. The artery may appear as a thickened, fibrotic, stenotic vessel with residual medial
destruction and chronic inflammatory cells.

The essential microscopic constellation is Transmural giant cell–rich granulomatous

arteritis, adventitial mononuclear inflammation, vasa vasorum cuffing, patchy medial
necrosis, medial destruction, intimal hyperplasia, adventitial fibrosis, luminal narrowing,
and fragmentation and disruption of the internal elastic fibers on Verhoeff–Van Gieson
elastic staining.

Immunohistochemistry is not the principal diagnostic basis, but it may characterize the
inflammatory infiltrate. CD3 highlights T lymphocytes, CD68 highlights macrophages and
histiocytes, and smooth muscle actin may help assess medial smooth muscle loss or reactive
myointimal proliferation. The primary diagnostic assessment remains the light microscopic
evaluation of the arterial wall architecture, inflammation, fibrosis, and elastic tissue injury.

Electron Microscopic Findings

No disease-defining ultrastructural alteration has been established for Takayasu arteritis.

Reported ultrastructural findings mainly reflect nonspecific vascular injury, including
endothelial damage, smooth muscle cell degeneration, extracellular matrix remodeling,
collagen deposition, and disruption of elastic fibers.

The decisive morphological abnormalities are demonstrated by gross examination, routine

histology, and elastic tissue staining: large-vessel wall thickening, granulomatous
transmural arteritis, medial destruction, fibrointimal thickening, adventitial fibrosis,
luminal stenosis, and elastic fiber fragmentation on Verhoeff–Van Gieson elastic staining.

Differential Diagnosis

The most important differential diagnosis is giant cell arteritis. Both Takayasu arteritis and giant
cell arteritis are granulomatous large-vessel vasculitides and may show giant cells, medial
inflammation, arterial wall scarring, elastic tissue injury, and luminal narrowing. Giant cell
arteritis more characteristically involves cranial branches of the carotid artery, especially the
temporal artery, whereas Takayasu arteritis predominantly involves the aorta, aortic arch, and
major branches of the aorta. In pathology teaching, the most reliable distinction is the
vascular distribution together with the overall clinicopathological setting.

Polyarteritis nodosa may enter the differential diagnosis because it is a systemic necrotizing
arteritis. However, it primarily involves small- to medium-sized muscular arteries rather than
large elastic arteries. Histologically, it shows segmental transmural necrotizing inflammation
with fibrinoid necrosis and thrombosis. It does not primarily produce granulomatous aortitis
with aortic arch branch stenosis.

Kawasaki disease is a vasculitis of medium-sized arteries, especially coronary arteries. Its

pathology is centered on coronary arteritis and aneurysm formation. The coronary-predominant
distribution and pediatric mucocutaneous disease pattern distinguish it from Takayasu arteritis.

Granulomatosis with polyangiitis is a necrotizing granulomatous vasculitis that predominantly

affects small- to medium-sized vessels of the respiratory tract and kidney. It may show
necrotizing granulomas and pauci-immune crescentic glomerulonephritis. The respiratory-renal
distribution and ANCA association distinguish it from the aortic arch-centered large-vessel
lesion of Takayasu arteritis.

Atherosclerosis may produce large-artery stenosis, but it is an intimal lipid-driven degenerative

disease rather than a granulomatous transmural arteritis. Atherosclerotic plaques contain fibrous
caps, lipid cores, foam cells, cholesterol clefts, calcification, and plaque complications. They
lack Transmural giant cell–rich granulomatous arteritis, vasa vasorum cuffing, patchy
medial necrosis, and granulomatous medial destruction.

Syphilitic aortitis may involve the thoracic aorta and cause aortic wall scarring, but its
characteristic lesion is obliterative endarteritis of the vasa vasorum with ischemic medial
damage. It classically produces wrinkling of the aortic intima and aortic root dilatation. This
differs from the stenosing granulomatous arteritis of the aortic arch and great vessels seen in
Takayasu arteritis.

Infectious aortitis may cause destructive inflammation of the aortic wall, sometimes with
abscess formation or mycotic aneurysm. Neutrophil-rich suppurative inflammation, organisms,
bacteremia, adjacent infection, or an infected aneurysm favors infectious aortitis over Takayasu
arteritis.
 Gross /
Main Vessel Key Histopathological Distinguishing
Disease Structural
Involvement Finding Feature
Pattern

Transmural giant cell–

Segmental rich granulomatous
Aorta, aortic stenosis, arteritis with vasa
arch, major irregular wall vasorum cuffing, Large-vessel
branches; thickening, patchy medial necrosis, granulomatous
Takayasu may involve marked wall intimal hyperplasia, stenosing
arteritis renal, thickening, adventitial fibrosis, and arteritis centered
pulmonary, luminal Verhoeff–Van Gieson on the aortic arch
and coronary narrowing, evidence of internal and its branches
arteries fibrotic elastic fiber
changes fragmentation and
disruption

Temporal
artery and other Segmental Granulomatous arteritis
Cranial artery-
cranial arterial with giant cells, medial
Giant cell predominant
branches of thickening and inflammation, elastic
arteritis granulomatous
carotid artery; luminal lamina damage, and
arteritis
may involve narrowing intimal thickening
aorta

Segmental Medium-vessel
Small- to vascular lesions necrotizing
Transmural necrotizing
Polyarteritis medium-sized with possible arteritis; not a
arteritis with fibrinoid
nodosa muscular thrombosis and primary
necrosis and thrombosis
arteries aneurysmal granulomatous
change aortitis

Medium-sized Coronary Coronary-

Kawasaki Transmural arteritis of
arteries, arteritis, predominant
disease coronary arteries with
especially dilatation, vasculitis
 Gross /
Main Vessel Key Histopathological Distinguishing
Disease Structural
Involvement Finding Feature
Pattern

coronary aneurysm, wall damage and

arteries thrombosis aneurysm risk

Small- to
Necrotizing Necrotizing
medium-sized Respiratory-
Granulomatosis respiratory granulomatous
vessels of renal
with lesions and renal inflammation and pauci-
respiratory granulomatous
polyangiitis small-vessel immune necrotizing
tract and vasculitis
injury vasculitis
kidney

Degenerative
Large and Fibrofatty intimal plaque
Lipid core, fibrous cap,
medium plaques causing rather than
Atherosclerosis foam cells, cholesterol
arteries, mainly luminal granulomatous
clefts, calcification
intima narrowing transmural
arteritis

Vasa vasorum
Ascending Aortic root Obliterative endarteritis
Syphilitic endarteritis with
thoracic aorta dilatation and of vasa vasorum with
aortitis aortic root
and aortic root wrinkled intima medial ischemic scarring
involvement

Infectious
Destructive destructive
Suppurative
Focal or diffuse aortic aortitis rather
Infectious inflammation,
aortic inflammation, than immune
aortitis organisms, abscess
involvement possible mycotic granulomatous
formation
aneurysm stenosing
arteritis
CROHN DISEASE

Crohn disease is a chronic idiopathic inflammatory bowel disease characterized by

discontinuous, transmural inflammation that may involve any segment of the gastrointestinal
tract from the oral cavity to the anus. The most frequently affected sites are the terminal ileum,
ileocecal valve, cecum, and colon. Because of its frequent ileal involvement, it has historically
been called regional enteritis.

The defining pathological identity of Crohn disease is segmental transmural chronic

inflammation with skip lesions, deep ulceration, mural thickening, fibrosis, stricture
formation, and granulomatous inflammation. Unlike ulcerative colitis, which is limited to the
colon and primarily affects the mucosa and submucosa in a continuous pattern, Crohn disease
typically produces full-thickness bowel wall injury and discontinuous involvement.

The most characteristic structural consequences are skip lesions, transmural inflammation,
deep fissuring ulcers, thickened bowel wall, strictures, creeping fat, and cobblestone
appearance. The most characteristic microscopic teaching phrase is transmural chronic
inflammation with noncaseating granulomas. Granulomas are highly supportive when
present, but their absence does not exclude Crohn disease.

Etiology

The precise etiology of Crohn disease is not fully established. It is best understood as a
multifactorial inflammatory disorder resulting from interaction between genetic susceptibility,
altered intestinal microbiota, epithelial barrier dysfunction, dysregulated mucosal immunity,
and environmental influences.

Genetic susceptibility is important. Crohn disease is associated with variants affecting innate
immune responses, microbial recognition, autophagy, epithelial barrier integrity, and immune
regulation. NOD2 is one of the best-known susceptibility genes, especially in ileal Crohn
disease. NOD2 participates in recognition of bacterial peptidoglycan-derived muramyl
dipeptide and influences mucosal immune responses to intestinal bacteria. Other genes involved
in autophagy and immune regulation, including ATG16L1 and IL23R-related pathways, support
the concept that Crohn disease develops when mucosal handling of intestinal microbes becomes
abnormal.

The intestinal microbiota is central to disease development. The normal intestine is constantly
exposed to luminal microbial and dietary antigens, but mucosal immune responses are normally
tightly regulated. In Crohn disease, the interaction between host immunity and intestinal
microbiota becomes abnormal, leading to persistent inflammation. Dysbiosis, altered microbial
composition, and defective containment of luminal bacteria contribute to chronic mucosal and
transmural injury.

Epithelial barrier dysfunction also contributes. Defective epithelial integrity permits luminal
bacterial products to enter the mucosa and activate dendritic cells, macrophages, and T
lymphocytes. This promotes cytokine-driven inflammation and perpetuates tissue damage.

Environmental factors modify risk and disease activity. Cigarette smoking is a well-established
risk factor for Crohn disease and is associated with more aggressive disease. Dietary factors,
nonsteroidal anti-inflammatory drug exposure, physical stress, emotional stress, and other
environmental influences may contribute to disease reactivation or severity. Oral contraceptive
use has been associated with increased risk in some studies, although it is not a defining
etiologic factor.

The most appropriate etiologic formulation is therefore: genetically susceptible host + altered
intestinal microbiota + epithelial barrier dysfunction + dysregulated mucosal immunity +
environmental modifiers.

Pathogenesis

The central pathogenic event in Crohn disease is dysregulated mucosal immune activation
against intestinal microbial antigens. In genetically susceptible individuals, defects in microbial
sensing, epithelial barrier function, autophagy, and immune regulation impair normal tolerance
to luminal microbiota. Bacterial products cross the epithelial barrier and activate dendritic cells
and macrophages. These cells stimulate T lymphocyte responses and cytokine production.

Crohn disease is classically associated with Th1 and Th17-skewed immune responses. Th1
activation promotes interferon-γ-mediated macrophage activation. Th17 pathways, supported
by IL-23 signaling, recruit neutrophils and amplify tissue inflammation. Tumor necrosis factor
contributes significantly to mucosal injury, granuloma formation, endothelial activation,
leukocyte recruitment, and persistence of inflammation.

The inflammatory process is not limited to the mucosa. It extends through the full thickness of
the bowel wall, producing transmural inflammation. This full-thickness pattern explains the
characteristic complications of Crohn disease: fissures, fistulas, abscesses, perforation,
strictures, and creeping fat.
Repeated injury and repair produce chronic architectural distortion. Crypt injury leads to
cryptitis, crypt abscesses, crypt destruction, and regenerative branching. Chronic inflammation
and fibrosis expand the submucosa and muscularis propria. Over time, fibrostenotic remodeling
produces rigid narrowing of the lumen and stricture formation.

Granuloma formation reflects macrophage-dominant chronic inflammation. The granulomas

are classically noncaseating granulomas and may be present in the mucosa, submucosa,
muscularis propria, serosa, mesenteric lymph nodes, or even extraintestinal sites. Their
presence is one of the strongest histological clues to Crohn disease, but granulomas are not
present in every case.

The major pathological sequence is:

genetic susceptibility and environmental modifiers → abnormal host–microbiota interaction →

epithelial barrier dysfunction → dysregulated Th1/Th17 mucosal immune response →
cytokine-driven chronic inflammation → transmural inflammation → deep fissuring ulcers,
granulomas, fibrosis, strictures, fistulas, and creeping fat.

Macroscopic Findings

Grossly, Crohn disease most commonly involves the terminal ileum, ileocecal valve, cecum,
and colon, but any part of the gastrointestinal tract may be affected. The involvement is
characteristically discontinuous. Multiple sharply demarcated diseased segments are separated
by intervening normal bowel, producing skip lesions.

The earliest gross lesions are aphthous ulcers. These may enlarge, become multiple, and
coalesce into elongated linear or serpentine ulcers oriented along the long axis of the bowel.
Deep ulcers may extend between mucosal folds and form deep fissuring ulcers. These fissures
may penetrate deeply into the bowel wall and become the basis for sinus tracts, perforation,
abscess formation, or fistulas.

The mucosa may show a classic cobblestone appearance. This results from alternating areas
of ulcerated, depressed mucosa and edematous or relatively preserved intervening mucosa. The
mucosal surface becomes irregular, coarsely textured, and nodular.

The bowel wall is typically thickened and firm because of transmural edema, chronic
inflammation, submucosal fibrosis, and hypertrophy of the muscularis propria. In long-standing
disease, the affected bowel may become narrowed and rigid, producing a hose-pipe appearance.
The lumen is often markedly narrowed by strictures.
A characteristic serosal finding is creeping fat, in which mesenteric adipose tissue wraps
around and adheres to the inflamed serosal surface. This feature reflects the transmural nature
of the disease and is particularly helpful in gross pathology.

The gross pathological constellation is skip lesions, aphthous ulcers, serpentine linear ulcers,
deep fissuring ulcers, cobblestone appearance, thickened bowel wall, strictures, narrow
lumen, serosal inflammation, and creeping fat.

Histopathological Findings

Histopathologically, Crohn disease is defined by chronic active inflammation with transmural

distribution and architectural distortion. The most important microscopic pattern is transmural
chronic inflammation with noncaseating granulomas.

Active mucosal disease shows neutrophilic injury of the crypt epithelium. Neutrophils infiltrate
crypt epithelium, producing cryptitis. Collections of neutrophils within crypt lumens form crypt
abscesses. Crypt destruction may accompany active inflammation and ulceration.

Ulceration is common and may show an abrupt transition between ulcerated mucosa and
adjacent preserved mucosa. Deep fissuring ulcers may extend through the mucosa into the
submucosa, muscularis propria, or even toward the serosa. This fissuring pattern is a key
microscopic correlate of fistula and abscess formation.

Chronic mucosal injury produces architectural distortion. Normally straight and parallel crypts
become irregular, branched, shortened, and haphazardly oriented. Repeated cycles of injury and
regeneration produce crypt branching, crypt dropout, mucosal atrophy, and distorted mucosal
architecture.

Metaplastic changes may be present. Pseudopyloric metaplasia may appear as gastric antral-
type glands, especially in chronically injured ileal mucosa. Paneth cell metaplasia may be found
in the left colon, where Paneth cells are normally absent. These changes support chronicity.

The inflammatory infiltrate is composed of lymphocytes, plasma cells, macrophages, and

neutrophils in active areas. Lymphoid aggregates may be prominent, especially in the
submucosa and deeper bowel wall. Submucosal edema and fibrosis are common. In chronic
disease, fibrosis may extend through all layers and disrupt the muscularis propria.

Granulomas are a major diagnostic clue. Crohn disease may show noncaseating granulomas,
often sarcoid-like, composed of epithelioid histiocytes with or without multinucleated giant
cells. Granulomas may be found in any layer of the bowel wall, including mucosa, submucosa,
muscularis propria, and serosa. They may also be found in mesenteric lymph nodes.
Granulomas may occur in areas of active inflammation or in grossly uninvolved regions. Their
presence strongly supports Crohn disease, but their absence does not exclude the diagnosis.

The most characteristic microscopic constellation is transmural inflammation, cryptitis,

crypt abscesses, deep fissuring ulceration, crypt architectural distortion, pseudopyloric
metaplasia, Paneth cell metaplasia in the left colon, lymphoid aggregates, submucosal
fibrosis, muscularis propria hypertrophy, and noncaseating granulomas.

Immunohistochemistry is not the main diagnostic basis for Crohn disease. CD3 may highlight
T lymphocytes, CD20 highlights B-cell aggregates, CD68 highlights macrophages and
granulomas, and special stains may be used to exclude infectious granulomatous diseases when
necessary. Acid-fast bacilli stains and fungal stains are important when tuberculosis, atypical
mycobacterial infection, or fungal disease is in the differential diagnosis.

The concise histopathological formulation is:

Transmural chronic active inflammation with deep fissuring ulcers, crypt architectural
distortion, lymphoid aggregates, fibrosis, and noncaseating granulomas.

Electron Microscopic Findings

No disease-defining ultrastructural alteration has been established for Crohn disease. Reported
ultrastructural changes mainly reflect epithelial injury, altered epithelial barrier integrity,
inflammatory cell infiltration, and nonspecific mucosal damage.

The decisive morphological abnormalities are demonstrated by gross examination and light
microscopy: skip lesions, transmural inflammation, deep fissuring ulcers, cobblestone
mucosa, thickened bowel wall, creeping fat, strictures, crypt architectural distortion, and
noncaseating granulomas.

Differential Diagnosis

The most important differential diagnosis is ulcerative colitis. Ulcerative colitis is limited to the
colon and rectum and shows continuous mucosal disease beginning in the rectum. Inflammation
is generally limited to the mucosa and submucosa. In contrast, Crohn disease may involve any
gastrointestinal segment, shows skip lesions, has transmural inflammation, produces deep
fissuring ulcers, and may show noncaseating granulomas, strictures, fistulas, and creeping
fat.

Intestinal tuberculosis can closely mimic Crohn disease because both may involve the ileocecal
region and both may show granulomatous inflammation. Tuberculosis more often shows
caseating granulomas, confluent granulomas, acid-fast bacilli, and necrotizing lymphadenitis.
Transverse ulcers and prominent necrotic lymph nodes support tuberculosis. Acid-fast staining,
culture, PCR, and clinicopathological correlation are essential when tuberculosis is considered.

Yersinia enterocolitica infection may involve the terminal ileum and mesenteric lymph nodes
and may mimic ileal Crohn disease. It usually produces acute ileitis, mesenteric lymphadenitis,
and sometimes granulomatous inflammation, but lacks the chronic transmural fibrosis, creeping
fat, long-standing architectural distortion, and typical Crohn-type discontinuous fibrostenotic
disease.

Ischemic colitis may show segmental disease and ulceration, but the pathology is ischemic
rather than immune-mediated chronic transmural inflammation. Features supporting ischemia
include withered crypts, hyalinization of lamina propria, hemorrhage, coagulative mucosal
necrosis, and vascular disease. Noncaseating granulomas and chronic transmural Crohn-type
fibrosis are not characteristic.

Diverticular disease-associated colitis may mimic inflammatory bowel disease in the sigmoid
colon. It is usually localized to areas of diverticulosis and lacks classic ileal involvement, skip
lesions outside the diverticular segment, creeping fat, and deep Crohn-type transmural
granulomatous disease.

NSAID enteropathy may produce ulcers, diaphragm-like strictures, and small intestinal injury.
However, it lacks the full Crohn constellation of chronic transmural inflammation, creeping fat,
noncaseating granulomas, and typical discontinuous inflammatory bowel disease distribution.

Behçet disease may produce ileocecal ulcers and may resemble Crohn disease. Behçet ulcers
are often large, deep, punched-out lesions and are associated with systemic vasculitis. Histology
may show vasculitis rather than classic transmural granulomatous Crohn disease.
 Gross / Key
Distinguishing
Disease Distribution Structural Histopathological
Feature
Pattern Finding

Skip lesions,
Transmural chronic
Any GI deep fissuring
active inflammation Discontinuous
segment; most ulcers,
with noncaseating transmural
Crohn commonly cobblestone
granulomas, cryptitis, granulomatous
disease terminal ileum, appearance,
crypt abscesses, inflammatory bowel
ileocecal valve, thickened bowel
architectural disease
cecum, colon wall, strictures,
distortion, fibrosis
creeping fat

Continuous
Colon and mucosal disease, Mucosal and Continuous rectal-
rectum only; broad-based submucosal chronic based colitis without
Ulcerative
continuous from ulcers, active colitis with transmural
colitis
rectum pseudopolyps; no crypt abscesses and granulomatous
proximally creeping fat or architectural distortion disease
typical strictures

Caseating granulomas, Caseation necrosis,

Ulcers, strictures,
Intestinal Often ileocecal confluent granulomas, AFB positivity,
necrotic lymph
tuberculosis region possible acid-fast necrotizing
nodes
bacilli lymphadenitis

Acute infectious
Terminal ileum,
Yersinia Acute ileitis and Acute inflammation, pattern without
mesenteric
ileitis lymphadenitis possible granulomas chronic Crohn-type
lymph nodes
transmural fibrosis

Segmental Withered crypts,

Watershed Ischemic epithelial
Ischemic ulceration, lamina propria
colonic regions; injury rather than
colitis hemorrhage, hyalinization, mucosal
segmental granulomatous
necrosis necrosis
 Gross / Key
Distinguishing
Disease Distribution Structural Histopathological
Feature
Pattern Finding

transmural
inflammation

Diverticular Segment with

Localized colitis
disease- diverticulosis, Chronic active colitis Disease confined to
in diverticular
associated usually sigmoid near diverticula diverticular segment
segment
colitis colon

Drug-associated
ulcers/diaphragm
Ulcers, erosions, Ulceration and disease without
NSAID Small intestine
diaphragm-like nonspecific Crohn-type
enteropathy or colon
strictures inflammation granulomatous
transmural
inflammation

Large deep Ulceration with Systemic vasculitic

Behçet Ileocecal region
punched-out vasculitis in some disease rather than
disease may be involved
ulcers cases primary IBD
ALZHEIMER DISEASE

Alzheimer disease is a progressive neurodegenerative disorder and the most common

pathological substrate of dementia. It is defined by selective neuronal and synaptic loss in
vulnerable cortical and limbic regions, together with extracellular β-amyloid deposition and
intracellular tau accumulation. The disease primarily affects the cerebral cortex, hippocampus,
entorhinal cortex, amygdala, basal forebrain, and other association cortical regions.

The essential pathological identity of Alzheimer disease is the coexistence of extracellular

neuritic plaques composed of aggregated amyloid-β peptide and intraneuronal
neurofibrillary tangles composed of hyperphosphorylated tau. These lesions are associated
with neuronal loss, synaptic loss, reactive astrocytosis, microglial activation, and progressive
cortical atrophy.

The key structural abnormalities include diffuse cortical atrophy, prominent hippocampal
volume loss, widespread extracellular neuritic plaque formation, and intraneuronal
neurofibrillary tangles involving the cerebral cortex and hippocampus. The characteristic
ultrastructural correlate of neurofibrillary tangles is Paired helical filament formation.

Etiology

Alzheimer disease is etiologically heterogeneous. Most cases are sporadic and multifactorial,
whereas a smaller subset is familial and genetically determined. The final common pathway is
abnormal accumulation of amyloid-β and tau proteins in vulnerable brain regions.

The most important risk factor is aging. Sporadic late-onset Alzheimer disease represents the
majority of cases and results from interaction between age-related neuronal vulnerability,
impaired protein clearance, genetic risk factors, neuroinflammation, oxidative injury, synaptic
dysfunction, and cerebrovascular influences.

Genetic factors are important. The strongest genetic risk factor for late-onset Alzheimer disease
is the APOE ε4 allele. APOE ε4 increases the risk and lowers the age of onset by promoting
amyloid-β accumulation, impairing amyloid clearance, and enhancing amyloid-related and tau-
related neuronal injury. APOE ε2 appears relatively protective compared with APOE ε3 and
APOE ε4.

Familial early-onset Alzheimer disease is uncommon but mechanistically important. It is

associated with mutations that increase production of amyloidogenic amyloid-β, especially
Aβ42. The major genes include APP on chromosome 21, PSEN1 encoding presenilin-1, and
PSEN2 encoding presenilin-2. Presenilins are components of the γ-secretase complex, and
pathogenic mutations favor increased production of the longer, aggregation-prone Aβ42
peptide.

Trisomy 21 is strongly associated with Alzheimer-type pathology because the APP gene is
located on chromosome 21. Increased APP gene dosage promotes increased amyloid-β
generation, explaining why Alzheimer-type neuropathological changes develop in individuals
with Down syndrome with advancing age.

Environmental and vascular modifiers may influence disease expression, but Alzheimer disease
is not primarily an infectious, inflammatory, vascular, or toxic disorder. Its central etiologic
framework is age-related and genetically modulated protein misfolding and aggregation,
particularly involving amyloid-β and tau.

Pathogenesis

The pathogenesis of Alzheimer disease centers on abnormal processing and accumulation of

amyloid-β peptide and hyperphosphorylated tau. These two protein abnormalities interact with
synaptic dysfunction, neuronal injury, neuroinflammation, and progressive brain atrophy.

Amyloid-β is derived from amyloid precursor protein, a transmembrane protein. In the

nonamyloidogenic pathway, APP is cleaved by α-secretase and γ-secretase, producing soluble
nonpathogenic fragments. In the amyloidogenic pathway, APP is cleaved by β-secretase and γ-
secretase, producing amyloid-β peptides. Aβ42 is particularly prone to aggregation.

Aβ42 forms soluble oligomers, larger aggregates, and fibrils. Soluble amyloid-β oligomers are
highly injurious because they impair synaptic function, disturb mitochondrial activity, alter
neuronal signaling, and reduce synaptic density. Larger aggregates form extracellular amyloid
plaques. Plaques are morphologic hallmarks, but soluble oligomers are considered especially
important mediators of neuronal dysfunction.

Tau is a microtubule-associated protein normally involved in stabilizing neuronal microtubules.

In Alzheimer disease, tau becomes abnormally hyperphosphorylated. Hyperphosphorylated tau
loses its normal microtubule-stabilizing function and aggregates into insoluble filaments. These
filaments form neurofibrillary tangles within neurons. Loss of tau function disrupts axonal
transport, while tau aggregation contributes to neuronal stress and death.
The principal pathogenic sequence is:

amyloidogenic APP processing → increased Aβ42 generation → Aβ oligomer formation and

plaque deposition → synaptic dysfunction and microglial activation → tau
hyperphosphorylation → neurofibrillary tangle formation → neuronal and synaptic loss →
cortical and hippocampal atrophy.

Neuroinflammation contributes to disease progression. Amyloid deposits activate microglia and

astrocytes. These cells may participate in amyloid clearance, but persistent activation also
releases inflammatory mediators, promotes oxidative injury, alters tau phosphorylation, and
contributes to synaptic loss.

The distribution of pathology is highly characteristic. Alzheimer-type changes are prominent in

the hippocampus, entorhinal cortex, association cortex, amygdala, and basal forebrain. Primary
motor and sensory cortices are relatively spared until late stages. This selective vulnerability
explains the dominant involvement of memory and higher cortical functions.

Macroscopic Findings

Grossly, Alzheimer disease is characterized by brain atrophy, most prominently affecting the
cerebral cortex and hippocampal formation. The brain shows diffuse cortical atrophy, often
most pronounced in the frontal, temporal, and parietal lobes. The gyri become narrowed, and
the sulci become widened because of loss of cortical tissue.

The hippocampus and medial temporal lobe structures show marked volume loss. Prominent
hippocampal volume loss is a major macroscopic correlate of Alzheimer pathology because
the hippocampus and entorhinal cortex are among the earliest and most severely affected
regions.

The loss of brain parenchyma may produce compensatory ventricular enlargement, known as
hydrocephalus ex vacuo. The lateral ventricles may be enlarged because of cortical and
subcortical tissue loss rather than obstructive hydrocephalus.

The macroscopic pattern is therefore diffuse cortical atrophy, widened sulci, narrowed gyri,
ventricular enlargement due to tissue loss, and prominent hippocampal volume loss. These
changes reflect widespread neuronal and synaptic degeneration rather than a mass-forming,
inflammatory, demyelinating, or vascular occlusive process.
Histopathological Findings

Histopathologically, Alzheimer disease is diagnosed by the presence and distribution of neuritic

plaques and neurofibrillary tangles, together with neuronal loss, synaptic loss, reactive
astrocytosis, and microglial activation.

The most important extracellular lesion is the neuritic plaque. Neuritic plaques are focal,
spherical collections of abnormal dystrophic neurites surrounding a central amyloid-β core.
They are often accompanied by reactive astrocytes and activated microglia at the periphery. The
amyloid core may be highlighted by Congo red, thioflavin, silver stains, or
immunohistochemistry for amyloid-β.

A second plaque form is the diffuse plaque. Diffuse plaques are amyloid-β deposits that lack a
prominent surrounding neuritic reaction. They may represent an early stage of plaque
development. They are found in superficial cerebral cortex, basal ganglia, and cerebellar cortex
but are less specific than neuritic plaques.

The most important intracellular lesion is the neurofibrillary tangle. Neurofibrillary tangles
are bundles of abnormal filaments within neuronal cytoplasm. They appear as basophilic
fibrillary structures that displace or encircle the neuronal nucleus. Their major component is
hyperphosphorylated tau. Tangles may persist extracellularly after neuronal death, forming
“ghost tangles.”

The key histopathological constellation is widespread extracellular neuritic plaque

formation, intraneuronal neurofibrillary tangles involving the cerebral cortex and
hippocampus, neuronal loss, synaptic loss, reactive astrocytosis, and microglial proliferation.

The regional distribution is essential. Lesions are prominent in the hippocampus, entorhinal
cortex, amygdala, association neocortex, basal forebrain, and raphe nuclei. The number of
neurofibrillary tangles generally correlates better with severity of dementia than the number of
neuritic plaques.

Cerebral amyloid angiopathy is another important pathological finding. It consists of amyloid-

β deposition within the walls of leptomeningeal and cortical blood vessels. It is common in
Alzheimer disease and may predispose to vascular fragility and lobar hemorrhage.

Special stains and immunohistochemistry support diagnosis and lesion characterization.

Amyloid-β immunohistochemistry highlights plaques and amyloid angiopathy. Phospho-tau
immunohistochemistry highlights neurofibrillary tangles, neuropil threads, and abnormal
neurites. Silver stains may demonstrate plaques and tangles. Congo red may identify amyloid
deposits, especially in vessel walls, and may show apple-green birefringence under polarized
light when amyloid is abundant.

The concise diagnostic histopathological formulation is:

Alzheimer disease is characterized by widespread extracellular neuritic plaques composed

of amyloid-β and intraneuronal neurofibrillary tangles composed of hyperphosphorylated
tau, most prominently involving the cerebral cortex and hippocampus, with neuronal loss,
synaptic loss, reactive astrocytosis, microglial activation, and cerebral amyloid
angiopathy.

Electron Microscopic Findings

The characteristic ultrastructural finding in Alzheimer disease is Paired helical filament

formation. These paired helical filaments are the ultrastructural substrate of neurofibrillary
tangles and are composed principally of hyperphosphorylated tau.

On electron microscopy, neurofibrillary tangles appear as bundles of abnormal paired helical

filaments within neuronal cytoplasm. These filaments reflect abnormal tau aggregation and are
central to Alzheimer-type neurodegeneration. Their presence corresponds to the light
microscopic neurofibrillary tangle.

Amyloid plaques contain extracellular fibrillar amyloid-β aggregates, often associated with
dystrophic neurites, degenerating neuronal processes, reactive astrocytic processes, and
microglial elements. However, for examination and diagnostic teaching purposes, the key
ultrastructural phrase is Paired helical filament formation.

Differential Diagnosis

The most important differential diagnosis is dementia with Lewy bodies. Dementia with Lewy
bodies shows cortical and brainstem Lewy bodies composed of α-synuclein. Histologically,
Lewy bodies are round eosinophilic intracytoplasmic inclusions with a dense core and pale
halo. Immunohistochemistry for α-synuclein highlights Lewy bodies. Alzheimer disease is
distinguished by amyloid-β neuritic plaques and tau-positive neurofibrillary tangles, especially
in the hippocampus and association cortex.

Frontotemporal lobar degeneration is another major differential diagnosis. It produces selective

frontal and temporal lobe degeneration and may be associated with tau, TDP-43, or FUS protein
inclusions. Compared with Alzheimer disease, FTLD tends to show more prominent frontal
and/or temporal lobar atrophy and lacks the typical combination of abundant amyloid-β neuritic
plaques and widespread Alzheimer-type neurofibrillary tangles.

Vascular dementia is caused by cumulative ischemic injury, multiple infarcts, small vessel
disease, lacunar infarcts, or strategic infarcts. Grossly and microscopically, vascular dementia
shows infarcts, arteriosclerosis, arteriolosclerosis, white matter ischemic injury, and gliosis.
Alzheimer disease instead shows a primary neurodegenerative pattern with neuritic plaques,
neurofibrillary tangles, and hippocampal-cortical atrophy.

Prion disease, especially Creutzfeldt-Jakob disease, may produce rapidly progressive dementia.
Histology shows spongiform change, neuronal loss, gliosis, and deposition of abnormal prion
protein. Variant forms may show florid plaques. Immunohistochemistry demonstrates abnormal
prion protein. Alzheimer disease lacks the dominant spongiform encephalopathy pattern and
instead shows amyloid-β plaques and tau tangles.

Hippocampal sclerosis may produce memory-predominant impairment and hippocampal

atrophy, but histology shows neuronal loss and gliosis in the hippocampus, often without the
Alzheimer-type burden of amyloid-β neuritic plaques and tau neurofibrillary tangles.

Parkinson disease with dementia may overlap clinically and pathologically with dementia with
Lewy bodies. Its key pathology is α-synuclein-positive Lewy bodies, especially in substantia
nigra and other brainstem nuclei, with variable cortical involvement. Alzheimer disease is
defined by amyloid-β plaques and tau tangles rather than primary α-synucleinopathy.

Normal pressure hydrocephalus may show ventricular enlargement, but the enlargement is due
to altered cerebrospinal fluid dynamics rather than parenchymal atrophy. Alzheimer disease
may show ventricular enlargement secondary to tissue loss, that is hydrocephalus ex vacuo,
together with cortical and hippocampal atrophy and Alzheimer-type microscopic lesions.
 Main Gross / Key
Distinguishing
Disease Anatomic Structural Histopathological
Feature
Distribution Pattern Finding

Widespread
extracellular
neuritic plaque
Cerebral Diffuse cortical
formation,
cortex, atrophy,
intraneuronal Amyloid-β plaques
hippocampus, prominent
neurofibrillary plus
entorhinal hippocampal
Alzheimer tangles, neuronal hyperphosphorylated
cortex, volume loss,
disease loss, synaptic loss, tau tangles, maximal
amygdala, widened sulci,
reactive in hippocampal-
association narrowed gyri,
astrocytosis, cortical networks
cortex, basal hydrocephalus
microglial
forebrain ex vacuo
activation; EM:
Paired helical
filament formation

Variable cortical α-synucleinopathy

Cortex and atrophy; α-synuclein- with Lewy bodies
Dementia with
brainstem substantia nigra positive Lewy rather than amyloid-
Lewy bodies
nuclei depigmentation bodies β/tau-dominant
may be present pathology

Selective
Tau, TDP-43, or frontotemporal
Frontotemporal Focal frontal
Frontal and FUS inclusions degeneration; lacks
lobar and/or temporal
temporal lobes depending on classic abundant AD-
degeneration lobar atrophy
subtype type plaques and
tangles
 Main Gross / Key
Distinguishing
Disease Anatomic Structural Histopathological
Feature
Distribution Pattern Finding

Multifocal Multiple infarcts,

cortical, lacunes, white Ischemic neuronal
Dementia due to
Vascular subcortical, or matter loss, gliosis,
cumulative vascular
dementia white matter rarefaction, infarcts,
injury
ischemic small vessel arteriolosclerosis
lesions disease

Often no marked Spongiform change,

Cerebral
gross neuronal loss, Rapidly progressive
Creutzfeldt- cortex, basal
abnormality gliosis, abnormal spongiform
Jakob disease ganglia,
early; atrophy in prion protein encephalopathy
cerebellum
advanced disease deposition

Hippocampal
Selective neuronal
Hippocampal Hippocampal neuronal loss without
Hippocampus loss and gliosis in
sclerosis atrophy full Alzheimer
hippocampal sectors
plaque-tangle burden

Substantia
nigra, α-synuclein- Primary
Parkinson
brainstem Substantia nigra positive Lewy synucleinopathy with
disease with
nuclei, depigmentation bodies and Lewy parkinsonian
dementia
limbic/cortical neurites pathology
regions

Ventricular Periventricular Hydrocephalus due to

Ventricular
Normal enlargement changes related to CSF flow/absorption
system and
pressure disproportionate CSF dynamics; no disorder, not
periventricular
hydrocephalus to cortical defining plaque- hydrocephalus ex
white matter
atrophy tangle pathology vacuo
GOODPASTURE SYNDROME

Goodpasture syndrome is an autoimmune pulmonary–renal disease caused by autoantibodies

directed against basement membrane antigens shared by renal glomeruli and pulmonary alveoli.
The disease is classically characterized by anti-glomerular basement membrane antibody-
mediated rapidly progressive glomerulonephritis together with pulmonary hemorrhage.

The central pathological lesion is antibody-mediated injury to basement membranes. In the

kidney, the disease produces necrotizing crescentic glomerulonephritis. In the lung, it produces
necrotizing hemorrhagic interstitial pneumonitis with intraalveolar hemorrhage. The most
important diagnostic immunopathological feature is linear deposition of IgG, often
accompanied by C3, along the glomerular basement membrane. A similar linear
immunoglobulin deposition pattern may be demonstrable along alveolar septal basement
membranes in lung tissue.

Goodpasture syndrome should be distinguished from Goodpasture disease or anti-GBM disease

limited to the kidney. In strict usage, Goodpasture syndrome refers to the combined pulmonary
and renal expression of anti-GBM antibody disease.

Etiology

Goodpasture syndrome is caused by circulating anti-GBM autoantibodies. These antibodies are

directed against epitopes in the noncollagenous domain of the alpha-3 chain of type IV collagen,
a structural component of basement membranes. This antigen is present in glomerular basement
membranes and alveolar basement membranes, explaining the combined renal and pulmonary
injury pattern.

The disease is autoimmune in nature. It is not an immune complex deposition disease in the
classic granular pattern; rather, antibodies bind directly to intrinsic basement membrane
antigens. This direct antibody binding produces a smooth linear immunofluorescence pattern
along basement membranes.

Genetic susceptibility contributes to disease risk. Certain HLA associations, especially HLA-
DR-related susceptibility, have been described in anti-GBM disease. Genetic susceptibility
alone is not sufficient; environmental or inflammatory triggers may expose or modify basement
membrane epitopes and promote autoantibody formation.

Pulmonary injury is often influenced by environmental factors that damage alveolar basement
membranes or increase antigen accessibility. Cigarette smoking, hydrocarbon exposure,
inhalational injury, infection, and other forms of pulmonary inflammation may increase the
likelihood of clinically evident lung hemorrhage in patients with anti-GBM antibodies.

The etiologic framework is therefore: genetically susceptible host, loss of immune tolerance to
type IV collagen basement membrane antigen, circulating anti-GBM autoantibody formation,
and antibody-mediated injury of glomerular and alveolar basement membranes.

Pathogenesis

The pathogenesis of Goodpasture syndrome is a type II hypersensitivity reaction. Circulating

IgG autoantibodies bind directly to type IV collagen epitopes within glomerular and alveolar
basement membranes. This produces complement activation, recruitment of inflammatory
cells, and tissue injury.

In the kidney, antibody binding along the glomerular basement membrane activates
complement and promotes leukocyte-mediated damage. The glomerular capillary wall
undergoes necrotizing injury, with breaks in the glomerular basement membrane. Plasma
proteins, fibrin, macrophages, and inflammatory mediators enter Bowman’s space. This
stimulates proliferation of parietal epithelial cells and recruitment of monocytes, forming
crescents.

Crescents are the defining light microscopic lesion of rapidly progressive glomerulonephritis.
They compress the glomerular tuft and may eventually obliterate Bowman’s space. Cellular
crescents may evolve into fibrocellular and then fibrous crescents, producing progressive
glomerulosclerosis and renal failure.

In the lung, the same anti-basement membrane antibodies bind alveolar basement membranes.
Complement-mediated and inflammatory injury to alveolar walls produces focal alveolar wall
necrosis and intraalveolar hemorrhage. Recurrent hemorrhage leads to accumulation of
hemosiderin-laden macrophages and fibrous thickening of alveolar septa.

The major pathological sequence is:

loss of tolerance to type IV collagen antigen → circulating anti-GBM IgG antibodies → linear
antibody binding along glomerular and alveolar basement membranes → complement
activation and inflammatory injury → necrotizing crescentic glomerulonephritis and pulmonary
hemorrhage.
The essential pathogenic idea is that Goodpasture syndrome is not primarily caused by
deposited circulating immune complexes. It is caused by autoantibodies binding in situ to
basement membrane antigens, generating a linear immunofluorescence pattern.

Macroscopic Findings

Gross findings depend on the relative severity of renal and pulmonary involvement.

In the kidney, rapidly progressive glomerulonephritis may produce enlarged, pale kidneys with
smooth external surfaces. The cut surface may show a pale cortex and congested medulla. These
changes reflect acute severe glomerular injury and renal swelling. In advanced or chronic
disease, renal scarring may develop because crescents undergo organization and glomeruli
become sclerotic.

In the lung, the lungs may be heavy and show red-brown areas of consolidation due to alveolar
hemorrhage. Recurrent hemorrhage may impart a brown discoloration related to hemosiderin
accumulation. Pulmonary involvement is usually diffuse or patchy and reflects hemorrhage into
alveolar spaces rather than a primary mass-forming or suppurative process.

The combined gross picture is therefore pale enlarged kidneys in the setting of crescentic
glomerulonephritis and heavy red-brown lungs with hemorrhagic consolidation in the setting
of diffuse alveolar hemorrhage.

Histopathological Findings

In the kidney, the principal light microscopic lesion is necrotizing crescentic

glomerulonephritis. Glomeruli show extracapillary proliferation within Bowman’s space.
Crescents are formed by proliferation of parietal epithelial cells and influx of monocytes and
macrophages. Fibrin is commonly present in Bowman’s space and supports crescent formation.

The glomerular tuft may show segmental necrosis, rupture or breaks in the glomerular basement
membrane, and inflammatory cell infiltration. As crescents enlarge, they compress the
glomerular tuft and may partially or completely fill Bowman’s space. With time, cellular
crescents may become fibrocellular and then fibrous, leading to irreversible glomerular
scarring.

Tubules may contain red blood cell casts, granular casts, and proteinaceous material. Tubular
epithelial injury may occur secondary to severe glomerular injury. The interstitium may show
edema, inflammation, and eventually fibrosis in chronic disease.
Immunofluorescence is central to diagnosis. Renal biopsy shows a strong, smooth, linear
staining pattern for IgG along the glomerular basement membrane. C3 is often also present in
a linear distribution. This linear pattern is a key feature distinguishing anti-GBM disease from
immune complex-mediated glomerulonephritides, which usually show granular deposition.

In the lung, microscopic examination shows focal necrosis of alveolar walls with intraalveolar
hemorrhage. Alveolar spaces contain red blood cells and hemosiderin-laden macrophages,
especially after repeated hemorrhagic episodes. Alveolar septa may show fibrous thickening,
and type II pneumocyte hyperplasia may be present as a reparative response. Linear
immunoglobulin deposition may be demonstrable along alveolar septal basement membranes.

The concise renal histopathological formulation is:

necrotizing crescentic glomerulonephritis with linear IgG and C3 deposition along the
glomerular basement membrane.

The concise pulmonary histopathological formulation is:

necrotizing hemorrhagic interstitial pneumonitis with intraalveolar hemorrhage, hemosiderin-

laden macrophages, septal injury, and possible linear immunoglobulin deposition along alveolar
septa.

Electron Microscopic Findings

Electron microscopy may show breaks or ruptures in the glomerular basement membrane,
reflecting severe capillary wall injury. Fibrin may be present in Bowman’s space in association
with crescent formation.

A crucial point is that anti-GBM disease does not produce the typical discrete electron-dense
immune complex deposits seen in immune complex glomerulonephritides. The antibody binds
directly and diffusely to intrinsic basement membrane antigen, corresponding to the smooth
linear immunofluorescence pattern. Therefore, the absence of granular electron-dense immune
complex deposits supports anti-GBM disease when correlated with linear IgG staining.

In pulmonary tissue, ultrastructural changes may include alveolar basement membrane injury,
endothelial and epithelial damage, and intraalveolar hemorrhage-related changes. No separate
disease-defining pulmonary ultrastructural structure is required beyond the basement
membrane injury pattern.
Differential Diagnosis

The most important differential diagnosis is ANCA-associated pauci-immune crescentic

glomerulonephritis, especially granulomatosis with polyangiitis and microscopic polyangiitis.
These disorders can produce rapidly progressive glomerulonephritis and pulmonary
hemorrhage, but renal immunofluorescence shows little or no immune deposition. ANCA
serology, necrotizing small-vessel vasculitis, and granulomatous respiratory tract lesions favor
granulomatosis with polyangiitis. Goodpasture syndrome is distinguished by linear IgG
deposition along the glomerular basement membrane.

Immune complex-mediated rapidly progressive glomerulonephritis can also produce crescents.

It may occur in lupus nephritis, postinfectious glomerulonephritis, IgA nephropathy, or
membranoproliferative glomerulonephritis. Immunofluorescence shows granular
immunoglobulin and complement deposition, not smooth linear IgG. Electron microscopy often
shows electron-dense immune complex deposits.

Lupus nephritis may produce crescentic glomerulonephritis and pulmonary involvement.

However, lupus nephritis usually shows immune complex deposition with a granular “full-
house” immunofluorescence pattern involving IgG, IgA, IgM, C3, and C1q. Extraglomerular
immune deposits, wire-loop lesions in diffuse proliferative lupus nephritis, and systemic
autoimmune features support lupus nephritis rather than anti-GBM disease.

IgA nephropathy may rarely present with crescentic lesions. The defining immunofluorescence
pattern is mesangial IgA-dominant deposition. Pulmonary hemorrhage is not a defining feature.
This contrasts with Goodpasture syndrome, which shows linear IgG along glomerular basement
membranes.

Postinfectious glomerulonephritis may produce acute nephritic syndrome and sometimes

crescentic transformation. It shows diffuse endocapillary proliferation, neutrophilic infiltration,
granular IgG and C3 deposition, and subepithelial hump-shaped electron-dense deposits. These
findings separate it from anti-GBM disease.

Idiopathic pulmonary hemosiderosis may produce recurrent pulmonary hemorrhage with

hemosiderin-laden macrophages but lacks anti-GBM-mediated crescentic glomerulonephritis
and linear IgG deposition along glomerular basement membranes. It is mainly a pulmonary
hemorrhage syndrome without the defining renal anti-GBM lesion.
Pulmonary hemorrhage from cardiac disease, coagulopathy, infection, or diffuse alveolar
damage may show intraalveolar hemorrhage and hemosiderin-laden macrophages, but does not
show the combined pattern of anti-GBM crescentic glomerulonephritis and linear basement
membrane immunoglobulin deposition.

Main Gross /
Key Histopathological Distinguishing
Disease Organs Structural
Finding Feature
Involved Pattern

Enlarged pale
Necrotizing crescentic
kidneys in acute
glomerulonephritis; Anti-GBM
severe renal
linear IgG and C3 along antibody disease
Goodpasture Kidney and disease; heavy
GBM; pulmonary with pulmonary–
syndrome lung red-brown lungs
alveolar hemorrhage renal basement
with
with hemosiderin-laden membrane injury
hemorrhagic
macrophages
consolidation

Pulmonary
ANCA- Pauci-immune IF
Kidney, lung, hemorrhage may Necrotizing crescentic
associated pauci- pattern and
systemic occur; renal GN with little or no
immune ANCA
small vessels crescentic immune deposition
crescentic GN association
disease

Necrotizing
Necrotizing
Upper granulomatous Respiratory tract
respiratory
Granulomatosis respiratory inflammation, granulomas and
lesions and renal
with polyangiitis tract, lung, necrotizing vasculitis, PR3-ANCA
small-vessel
kidney pauci-immune crescentic association
disease
GN
 Main Gross /
Key Histopathological Distinguishing
Disease Organs Structural
Finding Feature
Involved Pattern

Variable renal
Kidney; Granular IF and
Immune enlargement;
systemic Crescents with granular electron-dense
complex- sometimes
disease- immune deposits immune complex
mediated RPGN systemic organ
dependent deposits
lesions

Variable renal
Kidney; involvement;
Immune complex GN,
systemic severe cases may Granular full-
Lupus nephritis often full-house IF;
autoimmune show diffuse house IF pattern
possible crescents
disease proliferative
lesions

Diffuse endocapillary
Enlarged
proliferation, Postinfectious
Postinfectious hypercellular
Kidney neutrophils, granular immune complex
GN kidneys in acute
IgG/C3, subepithelial pattern
phase
humps

Usually no
distinctive gross Mesangial proliferation
Mesangial IgA
IgA nephropathy Kidney abnormality with IgA-dominant
deposition
unless chronic mesangial deposits
scarring

Pulmonary
Heavy brown Intraalveolar
Idiopathic hemorrhage
lungs from hemorrhage and
pulmonary Lung without anti-
recurrent hemosiderin-laden
hemosiderosis GBM crescentic
hemorrhage macrophages
GN
BURKITT LYMPHOMA

Burkitt lymphoma is a highly aggressive mature B-cell non-Hodgkin lymphoma derived from
germinal center B cells. It is one of the fastest growing human tumors and is characterized by
deregulated MYC expression, extremely high proliferative activity, and a distinctive diffuse
pattern of intermediate-sized neoplastic lymphoid cells. The tumor occurs in endemic, sporadic,
and immunodeficiency-associated forms. Despite differences in epidemiology and anatomic
distribution among these variants, the core morphology is essentially similar.

The pathological identity of Burkitt lymphoma is a diffuse, monomorphic proliferation of

medium-sized B lymphoid cells with high mitotic activity, abundant apoptosis, and numerous
benign macrophages containing phagocytosed nuclear debris. This creates the characteristic
Starry-sky appearance.

The disease commonly presents as extranodal tumor formation. In sporadic Burkitt lymphoma,
abdominal involvement is frequent, particularly the ileocecal region. Gross disease may form
a large, homogeneous solid mass, and advanced tumor may appear as a soft gray-white tumor
filling the abdominal cavity with extensive mesenteric lymph node involvement.
Biochemically and biologically, the tumor often has a very high proliferative burden; this
corresponds to markedly increased cell turnover and may be associated with markedly
elevated serum LDH, tumor lysis syndrome, and multiorgan complications in advanced
disease.

Etiology

Burkitt lymphoma is etiologically linked to genetic events that activate MYC, most commonly
chromosomal translocations involving the MYC locus on chromosome 8. The classical
translocation is t(8;14), which juxtaposes MYC to the immunoglobulin heavy chain locus on
chromosome 14. Less common variant translocations include t(2;8), involving the
immunoglobulin κ light chain locus, and t(8;22), involving the immunoglobulin λ light chain
locus. All of these rearrangements result in deregulated MYC expression.

Epstein–Barr virus contributes to a subset of cases. EBV is strongly associated with endemic
Burkitt lymphoma and is present in a smaller proportion of sporadic cases. EBV infection
promotes survival and proliferation of B cells, but EBV alone is insufficient to produce Burkitt
lymphoma. The critical transforming event remains MYC activation.
Immunodeficiency is another important etiologic context. Burkitt lymphoma may occur in
association with HIV infection and other states of impaired immune surveillance. In this setting,
reduced control of EBV-infected B cells and impaired immune regulation may contribute to
lymphomagenesis.

The etiologic framework is therefore: germinal center B-cell origin, MYC deregulation through
immunoglobulin locus-associated translocation, variable EBV contribution, and in some cases
immunodeficiency-associated loss of immune surveillance.

Pathogenesis

The central pathogenic event in Burkitt lymphoma is MYC overexpression. MYC is a

transcription factor that promotes cellular growth, ribosome biogenesis, metabolic
reprogramming, cell-cycle progression, and proliferation. When MYC is placed under the
control of immunoglobulin enhancer elements, it becomes constitutively overexpressed in B
cells.

The result is a tumor with exceptionally rapid cell cycling. The proliferative fraction is
characteristically very high, reflected by an approximately 100% Ki-67 proliferation index.
This high proliferative rate is a defining biological feature and helps separate Burkitt lymphoma
from many other mature B-cell lymphomas.

MYC-driven proliferation is accompanied by high rates of apoptosis. Numerous apoptotic

tumor cells are rapidly cleared by macrophages. These macrophages contain ingested nuclear
debris and are scattered among sheets of darkly staining tumor cells, producing the
characteristic microscopic pattern.

The tumor cells retain a germinal center B-cell phenotype. They usually express surface IgM,
pan-B-cell markers, and germinal center markers. Immunohistochemically, the tumor cells are
typically positive for CD20, CD10, and BCL6, and show very high Ki-67 labeling. BCL2 is
usually negative or weak, which helps distinguish classic Burkitt lymphoma from some high-
grade B-cell lymphomas with MYC and BCL2 rearrangements.

The major pathogenic sequence is:

MYC translocation involving immunoglobulin loci → deregulated MYC overexpression →

accelerated cell growth and proliferation → extremely high mitotic activity and apoptosis →
macrophage-mediated clearance of apoptotic debris → starry-sky morphology.
Macroscopic Findings

Gross findings depend on the anatomic site involved. Burkitt lymphoma often forms rapidly
enlarging extranodal masses. In sporadic disease, abdominal involvement is common, and the
bowel, mesentery, retroperitoneum, and ovaries may be involved. The ileocecal region is a
typical site of abdominal disease.

Grossly, the tumor is usually soft, fleshy, and gray-white. It may form a bulky mass that expands
involved tissue and may infiltrate adjacent structures. In advanced abdominal disease, a soft
gray-white tumor filling the abdominal cavity may be accompanied by extensive mesenteric
lymph node involvement.

In lymph nodes, the architecture is effaced by a diffuse lymphoid proliferation. In extranodal

tissue, the tumor forms sheets of malignant lymphoid cells with a soft, fish-flesh appearance
typical of high-grade lymphoid malignancy. Necrosis may be present, especially in large tumors
with very rapid growth.

Bone marrow involvement may produce a leukemic phase. Central nervous system involvement
may also occur, particularly in advanced disease. These findings reflect the high-grade biology
of the tumor rather than a unique gross morphology.

Histopathological Findings

Histopathologically, Burkitt lymphoma is composed of a diffuse, monotonous proliferation of

intermediate-sized lymphoid cells. The cells are relatively uniform and have round to oval
nuclei, finely clumped chromatin, and multiple small nucleoli. The cytoplasm is deeply
basophilic and may contain lipid vacuoles, especially on touch preparations or cytologic smears.

The growth pattern is diffuse rather than follicular. The tumor cells are tightly packed and show
very high mitotic activity. Apoptotic bodies are numerous because of rapid cellular turnover.
Interspersed among the neoplastic cells are numerous benign macrophages that contain
phagocytosed apoptotic nuclear debris.

The most characteristic histopathological finding is Starry-sky appearance. The “sky” is

formed by the dense sheet of darkly staining neoplastic lymphoid cells, while the “stars” are
pale macrophages with abundant cytoplasm containing ingested apoptotic debris. This pattern
reflects the biological combination of explosive proliferation and high apoptosis.
Immunohistochemically, Burkitt lymphoma shows a mature B-cell phenotype with germinal
center differentiation. The neoplastic cells are positive for CD20, CD10, and BCL6. They
typically express surface IgM with light-chain restriction. The proliferation index is
characteristically extremely high, often approaching 100% Ki-67 proliferation index. This
near-total Ki-67 labeling is one of the strongest diagnostic clues.

Molecular and cytogenetic studies demonstrate MYC rearrangement. The most common
abnormality is t(8;14), involving MYC and the immunoglobulin heavy chain locus. Variant
translocations involving immunoglobulin light chain loci may also occur. EBV-encoded RNA
in situ hybridization may be positive, especially in endemic cases and in some
immunodeficiency-associated cases.

The concise histopathological formulation is:

a diffuse monomorphic proliferation of intermediate-sized germinal center B cells with very

high mitotic and apoptotic activity, CD20, CD10, and BCL6 positivity, approximately 100%
Ki-67 proliferation index, MYC rearrangement, and Starry-sky appearance.

Electron Microscopic Findings

No disease-defining ultrastructural alteration has been established for Burkitt lymphoma.

Ultrastructural examination may show lymphoid blasts with prominent nucleoli, cytoplasmic
lipid vacuoles, high apoptotic activity, and macrophages containing phagocytosed nuclear
debris. These findings parallel the light microscopic and cytologic morphology.

The decisive diagnostic features are established by histology, immunophenotyping,

proliferation index, and cytogenetic or molecular demonstration of MYC rearrangement.

Differential Diagnosis

The most important differential diagnosis is diffuse large B-cell lymphoma. Diffuse large B-
cell lymphoma is composed of larger, more pleomorphic neoplastic B cells and usually has a
lower and more variable Ki-67 proliferation index than Burkitt lymphoma. It may express CD20
and sometimes germinal center markers, but it lacks the classic monomorphic intermediate-
sized cytology and typical near-100% proliferation index of Burkitt lymphoma. Some high-
grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements may resemble
Burkitt lymphoma and require molecular classification.
B-lymphoblastic leukemia/lymphoma may enter the differential diagnosis because it can
present with high-grade lymphoid proliferation and extranodal or marrow disease. However,
lymphoblasts express immaturity markers such as TdT, CD34, or CD99 in many cases, whereas
Burkitt lymphoma is a mature B-cell neoplasm expressing surface IgM and germinal center
markers.

Mantle cell lymphoma, blastoid variant, may show aggressive behavior and high mitotic
activity. It is distinguished by cyclin D1 overexpression, SOX11 positivity, CD5 expression,
and t(11;14). Burkitt lymphoma instead shows germinal center phenotype, MYC
rearrangement, and usually lacks cyclin D1 expression.

Follicular lymphoma may express CD10 and BCL6 because it is also of germinal center B-cell
origin. However, follicular lymphoma usually has a nodular or follicular growth pattern, lower
proliferative index, frequent BCL2 expression, and t(14;18). Burkitt lymphoma has diffuse
architecture, MYC rearrangement, near-total Ki-67 staining, and starry-sky morphology.

Classical Hodgkin lymphoma is separated by Reed–Sternberg cells in a mixed inflammatory

background, usually with CD30 and CD15 expression and weak PAX5. Burkitt lymphoma is a
diffuse monomorphic mature B-cell tumor with CD20 expression, germinal center phenotype,
and MYC rearrangement.

Plasma cell myeloma or plasmablastic lymphoma may be considered when there is aggressive
extranodal disease, but these tumors show plasma cell differentiation markers such as CD138,
MUM1, cytoplasmic immunoglobulin, and often lack the typical CD10-positive germinal
center Burkitt phenotype. Plasmablastic lymphoma is frequently EBV-associated and occurs in
immunodeficiency contexts but lacks the classic Burkitt morphology and immunophenotype.

Reactive follicular hyperplasia may show tingible-body macrophages and a starry-sky-like

appearance in germinal centers, but the architecture is preserved, follicles are polarized, mantle
zones are retained, and the process is polyclonal. Burkitt lymphoma effaces tissue architecture
by diffuse monomorphic malignant B-cell proliferation.
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

Diffuse
Extranodal
monomorphic
sites; Large,
intermediate-sized
sporadic form homogeneous
B-cell proliferation Highly
often solid mass; soft
with CD20, CD10, aggressive
abdominal gray-white tumor
BCL6 positivity, germinal center
with ileocecal filling the
Burkitt lymphoma approximately B-cell
region abdominal
100% Ki-67 lymphoma
involvement; cavity; extensive
proliferation index, driven by MYC
lymph nodes mesenteric lymph
MYC translocation
and marrow node involvement
rearrangement, and
may be may be present
Starry-sky
involved
appearance

Larger
pleomorphic
Nodal or
Diffuse large B-cell Bulky nodal or Diffuse sheets of cells; Ki-67
extranodal
lymphoma extranodal mass large atypical B cells variable; lacks
sites
classic Burkitt
monomorphism

Double-hit or
High-grade B-cell High-grade B-cell
triple-hit
lymphoma with morphology with
Nodal or Aggressive mass- genetics rather
MYC and BCL2 rearrangements of
extranodal forming disease than classic
and/or BCL6 MYC plus BCL2
Burkitt
rearrangements and/or BCL6
lymphoma

Bone marrow, Marrow Immature Precursor B-cell

B-lymphoblastic
blood, lymph replacement or lymphoblasts neoplasm rather
leukemia/lymphoma
nodes, mass lesion expressing TdT and than mature
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

extranodal other precursor surface IgM-

tissues markers positive B-cell
lymphoma

Lymph
CD5-positive
nodes, spleen, Diffuse or nodular Blastoid cells with
Blastoid mantle cell cyclin D1-
marrow, lymphoid cyclin D1 and
lymphoma positive t(11;14)
extranodal infiltration SOX11 positivity
lymphoma
sites

Neoplastic follicles
composed of Follicular
Lymph
Nodular centrocytes and pattern and
Follicular lymphoma nodes,
lymphadenopathy centroblasts; t(14;18)/BCL2
marrow
CD10/BCL6/BCL2 overexpression
positivity

CD30/CD15-
positive Reed–
Reed–Sternberg
Lymph Sternberg cells,
Classical Hodgkin Nodal cells in mixed
nodes, not diffuse
lymphoma enlargement inflammatory
mediastinum mature B-cell
background
Burkitt
morphology

Polarized germinal Polyclonal

Preserved nodal
Reactive follicular centers with reactive process
Lymph nodes architecture with
hyperplasia tingible-body with preserved
reactive follicles
macrophages architecture
PAGET DISEASE OF BONE

Paget disease of bone, also known as osteitis deformans, is a chronic disorder of skeletal
remodeling characterized by excessive osteoclastic bone resorption followed by compensatory,
excessive, and structurally disorganized osteoblastic bone formation. The result is enlarged,
deformed, hypervascular, and mechanically weak bone. Although the affected bone may
become thickened and sclerotic, its architecture is abnormal; therefore, the increased bone mass
does not represent normal skeletal strength.

The disease may be monostotic or polyostotic. Commonly affected sites include the pelvis,
spine, skull, femur, tibia, and other bones of the axial skeleton and weight-bearing skeleton.
The disease evolves through three overlapping pathological phases. The initial osteolytic phase
is dominated by excessive osteoclastic resorption. The mixed osteolytic-osteoblastic phase is
characterized by simultaneous bone resorption and exuberant new bone formation. The late
osteosclerotic phase is dominated by thickened, dense, disorganized bone.

The fundamental pathological concept is abnormal high-turnover bone remodeling. Paget

disease is not simply a disease of increased bone formation; it is a disease in which excessive
osteoclast activity initiates uncontrolled remodeling, and the subsequent osteoblast response
produces structurally disorganized lamellar bone. This explains the paradoxical combination of
skeletal enlargement, deformity, increased radiographic density, and susceptibility to fracture.

Etiology

The etiology of Paget disease of bone is not fully established. Current understanding supports
a multifactorial process involving genetic susceptibility, abnormal osteoclast regulation, and
possible environmental modifiers.

Genetic predisposition is important. Familial clustering is well recognized, and mutations in

SQSTM1, the gene encoding sequestosome-1/p62, are identified in a subset of familial and
sporadic cases. Sequestosome-1 participates in signaling pathways that regulate osteoclast
activity, particularly pathways related to NF-κB activation. Mutations may enhance osteoclast
differentiation, survival, and resorptive function.

The RANK–RANKL–OPG axis is central to the biology of osteoclasts and is highly relevant
to the disease. Increased osteoclast activity may result from abnormal signaling that promotes
osteoclast formation or prolongs osteoclast survival. In juvenile Paget-like disorders,
abnormalities involving RANK signaling or osteoprotegerin regulation further support the
concept that disturbed osteoclast control is the initiating skeletal defect.

Environmental factors have also been proposed. Historical observations suggested a possible
relationship with paramyxoviral infection of osteoclast precursors, including measles virus-like
agents. However, this remains controversial, and no single viral agent has been established as
the universal cause. If environmental triggers contribute, they likely act in genetically
susceptible individuals by modifying osteoclast behavior rather than by directly producing a
conventional infectious osteomyelitis.

The most appropriate etiologic formulation is therefore: genetically influenced dysregulation

of osteoclast function, possibly modified by environmental factors, leading to excessive
osteoclastic resorption and secondary disorganized osteoblastic repair.

Pathogenesis

The central pathogenic event in Paget disease is excessive osteoclast-mediated bone resorption.
Osteoclasts in pagetic lesions are increased in number, enlarged, and may contain an unusually
high number of nuclei. These osteoclasts excavate bone rapidly and produce the initial
osteolytic phase of the disease.

The skeleton responds to this excessive resorption by activating osteoblasts. Osteoblasts deposit
new bone at an accelerated rate, but this newly formed bone is laid down in a haphazard and
poorly coordinated fashion. Normal lamellar architecture is disrupted, and bone remodeling
becomes spatially and temporally disorganized.

During the mixed phase, osteoclastic resorption and osteoblastic formation occur
simultaneously. The marrow spaces often become replaced by loose fibrovascular tissue. The
affected bone becomes hypervascular and metabolically active. This increased vascularity helps
explain why extensive polyostotic disease can rarely contribute to high-output cardiac strain.

In the late osteosclerotic phase, osteoblastic activity predominates and the bone becomes
thickened and dense. However, the architecture remains abnormal. Irregular lamellar units are
separated by prominent cement lines, producing the classic mosaic or jigsaw puzzle pattern.
This microscopic pattern reflects repeated cycles of abnormal resorption and formation.

The major pathological sequence is:

excessive osteoclast activation → accelerated bone resorption → compensatory osteoblast
activation → rapid and disorganized new bone formation → mosaic lamellar bone with
prominent cement lines → enlarged, sclerotic, hypervascular, mechanically weak bone.

The essential pathogenic idea is that Paget disease is a high-turnover remodeling disorder in
which the initiating abnormality is osteoclast hyperactivity and the final structural abnormality
is disorganized bone formation.

Macroscopic Findings

Gross findings vary according to the phase of disease and the skeletal site involved. In early
osteolytic lesions, the affected bone may show areas of thinning and resorption. In mixed and
sclerotic stages, the involved bone becomes enlarged, thickened, heavy, and deformed.

Long bones may show bowing deformity, particularly in weight-bearing bones such as the
femur and tibia. The affected segment may be expanded, with cortical thickening and narrowing
of the medullary cavity. Despite the increased thickness, the bone is structurally weak because
its architecture is abnormal.

In the skull, the calvarium may become thickened and enlarged. The diploic space may be
expanded, and the skull may show patchy areas of sclerosis. Radiologically, this may
correspond to the so-called cotton-wool appearance, produced by irregular foci of sclerosis
within affected cranial bones.

In the pelvis and vertebrae, the affected bones may become enlarged, dense, and deformed.
Vertebral involvement may produce bony expansion and sclerosis. Pelvic involvement may be
extensive and may alter joint mechanics, contributing to secondary osteoarthritis.

The bone may be hypervascular, particularly during active phases. Cut surfaces may appear
coarse, thickened, and irregular. In advanced disease, the cortex and cancellous bone lose their
normal structural distinction and show a heavy, sclerotic, disorganized appearance.

The classical gross impression is enlarged, thickened, deformed, hypervascular, sclerotic bone
that is paradoxically fragile and mechanically incompetent.
Histopathological Findings

Histopathological findings depend on the stage of disease.

In the osteolytic phase, the dominant finding is increased osteoclastic bone resorption.
Numerous osteoclasts line trabecular and endosteal bone surfaces. These osteoclasts are often
large and may contain many nuclei. Resorption pits are prominent, and the bone is actively
removed.

In the mixed phase, osteoclastic resorption and osteoblastic bone formation coexist. Osteoblasts
line many bone surfaces and deposit new osteoid. The marrow spaces are frequently replaced
by loose fibrovascular tissue. The bone trabeculae become irregularly shaped, thickened, and
disorganized.

In the osteosclerotic phase, the hallmark is mosaic lamellar bone. This consists of irregularly
oriented lamellar bone units separated by prominent cement lines. These cement lines produce
a jigsaw puzzle-like pattern. The mosaic pattern is the most characteristic microscopic feature
of established Paget disease.

The trabeculae are thick, irregular, and haphazardly arranged. The marrow spaces may be
narrowed and replaced by fibrous tissue. Osteoblastic and osteoclastic activity may persist even
in sclerotic lesions, but the dominant appearance is dense, architecturally abnormal bone.

The osteoclasts may be unusually large and hypernucleated. The osteoblasts are increased
during active repair. The combination of enlarged osteoclasts, active osteoblastic deposition,
fibrovascular marrow replacement, and mosaic lamellar bone reflects the high-turnover nature
of the disease.

The diagnostic histopathological formulation is:

a high-turnover skeletal remodeling disorder characterized by enlarged osteoclasts, increased

osteoclastic resorption, compensatory osteoblastic bone formation, fibrovascular marrow
replacement, and mosaic lamellar bone with prominent cement lines.

Immunohistochemistry is not central to diagnosis. Histochemical or immunohistochemical

markers may demonstrate osteoclasts, osteoblasts, or remodeling activity, but the diagnosis is
primarily based on the characteristic architecture on routine histology, together with radiologic
and biochemical correlation.
Differential Diagnosis

The most important differential diagnosis is osteosclerotic metastatic carcinoma. Metastatic

carcinoma, especially prostate carcinoma, may produce dense sclerotic bone lesions.
Histologically, however, metastatic carcinoma shows infiltrating malignant epithelial cells
within marrow spaces, often with reactive bone formation. Paget disease shows disorganized
remodeling and mosaic lamellar bone without malignant epithelial infiltration.

Osteosarcoma must be considered when pagetic bone develops an aggressive destructive lesion,
rapidly enlarging mass, cortical destruction, or soft tissue extension. Osteosarcoma shows
malignant osteoid produced directly by atypical malignant tumor cells. Paget disease alone
shows abnormal remodeling without malignant cytologic atypia. Secondary osteosarcoma is a
recognized complication of Paget disease, especially in severe long-standing polyostotic
disease.

Fibrous dysplasia may mimic Paget disease because both can produce bone expansion and
deformity. Fibrous dysplasia shows irregular curvilinear trabeculae of woven bone in a bland
fibrous stroma, often described as Chinese-letter trabeculae, usually without prominent
osteoblastic rimming. Paget disease instead shows high-turnover remodeling and mosaic
lamellar bone with prominent cement lines.

Hyperparathyroidism with osteitis fibrosa cystica can produce bone resorption, marrow
fibrosis, and giant cell-rich lesions. It is driven by excess parathyroid hormone and often shows
subperiosteal bone resorption, brown tumors, and biochemical abnormalities of calcium and
phosphate metabolism. Paget disease is a focal or multifocal remodeling disorder, usually with
normal serum calcium and phosphate and elevated alkaline phosphatase in active disease.

Osteomalacia is a disorder of defective mineralization. Histologically, it shows excessive

unmineralized osteoid with widened osteoid seams. Paget disease shows excessive and
disorganized remodeling with mosaic lamellar bone rather than a primary mineralization defect.

Osteopetrosis produces diffusely dense, brittle bones because of defective osteoclast-mediated

bone resorption. In contrast, Paget disease begins with excessive osteoclastic resorption and
progresses to disorganized compensatory bone formation. Osteopetrosis is generally diffuse and
developmental or inherited, whereas Paget disease is usually focal, monostotic or polyostotic,
and acquired later in life.
Chronic osteomyelitis may cause sclerosis, deformity, cortical thickening, and irregular bone
architecture. It is distinguished by chronic inflammatory infiltrates, necrotic bone sequestra,
involucrum formation, sinus tracts, and possible organisms. Paget disease lacks suppurative
infection, sequestrum formation, and pathogen-driven necrotic bone inflammation.

Gross / Key
Main Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

Enlarged osteoclasts,
Enlarged, increased resorption,
Pelvis, spine, thickened, compensatory
High-turnover
skull, femur, deformed, osteoblast activity,
disorganized
Paget disease of bone tibia; hypervascular, fibrovascular
remodeling with
monostotic or sclerotic but marrow, mosaic
mosaic pattern
polyostotic mechanically lamellar bone with
weak bone prominent cement
lines

Axial
skeleton Tumor cell
Sclerotic Malignant epithelial
common; infiltration
Osteosclerotic metastatic cells in marrow with
prostate distinguishes it
metastatic carcinoma deposits, often reactive bone
carcinoma from Paget
multifocal formation
classically disease
osteoblastic

Pagetic bone,
Aggressive Malignant osteoid
often pelvis, Malignant
Osteosarcoma arising destructive mass produced by
femur, cytology and
in Paget disease with possible soft pleomorphic tumor
humerus, tumor osteoid
tissue extension cells
skull
 Gross / Key
Main Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

Ribs,
Chinese-letter
craniofacial Expansile lesion
Irregular woven woven bone
bones, femur, with ground-
Fibrous dysplasia bone trabeculae in without Paget-
tibia; glass radiologic
bland fibrous stroma type mosaic
monostotic or appearance
lamellae
polyostotic

Parathyroid
Osteoclastic hormone-driven
Hyperparathyroidism Generalized Bone resorption,
resorption, marrow bone resorption
/ osteitis fibrosa skeletal cystic lesions,
fibrosis, giant cell with calcium-
cystica involvement brown tumors
lesions phosphate
abnormalities

Excess
Generalized Soft bones, unmineralized Primary
Osteomalacia skeletal pseudofractures, osteoid with mineralization
involvement deformity widened osteoid defect
seams

Failure of
Defective
Diffuse osteoclastic
Diffusely dense, resorption, not
Osteopetrosis skeletal resorption with
brittle bones excessive
involvement retained primary
remodeling
spongiosa

Chronic
Sclerosis, Infectious
inflammation,
Chronic Focal deformity, necrotic bone
necrotic bone,
osteomyelitis infected bone sequestrum, with sequestrum
fibrosis, possible
involucrum formation
organisms
SMALL CELL LUNG CARCINOMA

Small cell lung carcinoma is a highly aggressive malignant epithelial tumor of the lung showing
neuroendocrine differentiation. It belongs to the spectrum of high-grade pulmonary
neuroendocrine carcinomas and is biologically distinct from non-small cell lung carcinomas. It
is characterized by rapid growth, early lymphovascular invasion, early distant metastasis, high
mitotic activity, extensive necrosis, and frequent association with paraneoplastic hormone
production.

The tumor is strongly associated with cigarette smoking and usually arises centrally, near the
hilum or major bronchi. It is composed of small malignant cells with scant cytoplasm,
hyperchromatic nuclei, finely granular chromatin, inconspicuous nucleoli, nuclear molding,
frequent mitoses, and extensive necrosis. The tumor cells express epithelial markers and
neuroendocrine markers, including synaptophysin, chromogranin, and CD56. At the molecular
level, small cell lung carcinoma is strongly associated with inactivation of TP53 and RB tumor
suppressor pathways.

The essential pathological identity of small cell lung carcinoma is therefore a high-grade
neuroendocrine carcinoma of the lung with small hyperchromatic tumor cells, salt-and-pepper
chromatin, nuclear molding, crush artifact, extensive necrosis, very high proliferative activity,
and neuroendocrine differentiation.

Etiology

The most important etiologic factor is cigarette smoking. Small cell lung carcinoma has one of
the strongest associations with tobacco exposure among lung cancers. Tobacco smoke contains
multiple carcinogens, including polycyclic aromatic hydrocarbons, nitrosamines, and other
mutagenic compounds that produce widespread genetic injury in respiratory epithelium.

The carcinogenic effect of smoking is dose-related. The risk increases with duration and
intensity of exposure. Although smoking cessation reduces risk over time, the risk does not
immediately return to baseline because tobacco-related genetic damage may persist in the
bronchial epithelium.

Occupational and environmental carcinogens may contribute to lung cancer risk, including
asbestos, radon, arsenic, nickel, chromium, radiation, air pollution, and industrial exposures.
However, for small cell lung carcinoma, tobacco exposure remains the dominant etiologic
factor.
The cell of origin is thought to be a pulmonary neuroendocrine cell or a progenitor cell capable
of neuroendocrine differentiation within the bronchial epithelium. This explains the
neuroendocrine marker expression and the ability of the tumor to produce peptide hormones.

Unlike squamous cell carcinoma, a well-defined sequence of precursor lesions has not been
clearly established for small cell lung carcinoma. The tumor often appears clinically and
pathologically as an already invasive, high-grade malignancy with early dissemination.

Pathogenesis

Small cell lung carcinoma develops through accumulation of carcinogen-induced genetic

alterations in bronchial epithelial or neuroendocrine-lineage cells. The most characteristic
molecular abnormalities are loss of function of TP53 and RB. These alterations disrupt cell-
cycle control, DNA damage response, apoptosis regulation, and genomic stability.

RB inactivation releases cells from normal G1–S checkpoint control. TP53 inactivation impairs
DNA damage-induced cell-cycle arrest and apoptosis. Together, these alterations permit rapid
accumulation of additional mutations and promote a highly proliferative malignant phenotype.

The tumor also shows neuroendocrine differentiation. Neoplastic cells may produce peptide
hormones or hormone-like substances, explaining the association with paraneoplastic
syndromes. These include ectopic ACTH production causing Cushing syndrome, inappropriate
ADH production causing hyponatremia, and other neuroendocrine-related manifestations.
Neurologic paraneoplastic syndromes may also occur because of immune cross-reactivity
between tumor antigens and neural tissues.

Small cell lung carcinoma has a high growth fraction and rapidly develops necrosis because the
proliferating tumor outgrows its vascular supply. Fragility of tumor cells produces crush artifact
in small biopsies. Nuclear DNA released from crushed tumor cells may deposit on vessel walls
as basophilic material, producing the Azzopardi effect.

The major pathogenic sequence is:

tobacco carcinogen exposure → diffuse genetic injury of bronchial epithelium or

neuroendocrine-lineage progenitor cells → TP53 and RB inactivation → uncontrolled
proliferation and impaired apoptosis → high-grade neuroendocrine carcinoma → early nodal
and distant metastasis.
The essential pathogenic concept is that small cell lung carcinoma is not simply a small-cell
variant of other lung carcinomas. It is a genetically and biologically distinct high-grade
neuroendocrine carcinoma with rapid systemic spread and characteristic molecular alterations.

Macroscopic Findings

Grossly, small cell lung carcinoma usually arises centrally, in relation to major bronchi and hilar
structures. The tumor commonly appears as a pale gray or gray-white mass. It may extend into
adjacent lung parenchyma, infiltrate bronchial walls, and invade hilar and mediastinal lymph
nodes early.

The cut surface is typically soft, friable, and gray-white. Necrosis is common and may be
extensive. Hemorrhage may also be present. Because of central location, the tumor may obstruct
bronchi and produce distal atelectasis, obstructive pneumonitis, bronchiectasis, or secondary
infection.

The tumor may form a bulky hilar mass with mediastinal involvement. Invasion of adjacent
structures may occur, including mediastinum, pleura, pericardium, and large vessels. Lymph
node metastasis is often present at diagnosis, particularly in hilar and mediastinal lymph nodes.

Distant metastases are common and may involve liver, bone marrow, adrenal glands, brain, and
bone. The adrenal glands may be extensively infiltrated by metastatic tumor. Disseminated
disease is frequent even when the primary tumor is not very large.

The classical gross pattern is a centrally located, pale gray, soft, friable, necrotic lung mass with
early hilar and mediastinal lymph node involvement and frequent distant metastasis.

Histopathological Findings

Histopathologically, small cell lung carcinoma is composed of sheets, nests, trabeculae, or

diffuse infiltrates of small malignant cells. The cells are round, oval, or fusiform and have scant
cytoplasm. Because the cytoplasm is minimal, the tumor appears as densely packed blue cells
on routine hematoxylin and eosin staining.

The nuclei are hyperchromatic and contain finely granular chromatin, often described as salt-
and-pepper chromatin. Nucleoli are inconspicuous or absent. Nuclear molding is characteristic,
reflecting close apposition of fragile tumor nuclei against one another. The nuclear-to-
cytoplasmic ratio is very high.
Mitotic figures are numerous. Apoptotic bodies are common. Necrosis is often extensive and
may be geographic. The combination of high mitotic activity, apoptosis, and necrosis reflects
the extremely high-grade biology of the tumor.

Crush artifact is a classic feature in small biopsies. The tumor cells are fragile, and mechanical
distortion during biopsy processing produces smearing, nuclear distortion, and crushed
basophilic material. Nuclear DNA released from necrotic or crushed tumor cells may coat
vascular walls, producing the Azzopardi effect.

Immunohistochemistry is essential in confirming neuroendocrine differentiation and excluding

mimics. The tumor cells usually express cytokeratins, often in a dot-like paranuclear pattern.
Neuroendocrine markers such as synaptophysin, chromogranin, and CD56 are commonly
positive. TTF-1 is frequently positive in pulmonary small cell carcinoma, although it is not
entirely specific. Ki-67 proliferation index is very high, often exceeding 50% and commonly
much higher.

The tumor may produce peptide hormones. Immunohistochemistry may demonstrate hormone
production in selected cases, but routine diagnosis relies on morphology and neuroendocrine
marker expression rather than demonstration of specific hormones.

The concise histopathological formulation is:

a high-grade neuroendocrine carcinoma composed of diffuse sheets of small cells with scant
cytoplasm, hyperchromatic nuclei, finely granular salt-and-pepper chromatin, inconspicuous
nucleoli, nuclear molding, numerous mitoses, apoptosis, extensive necrosis, crush artifact,
cytokeratin expression, neuroendocrine marker positivity, and very high Ki-67 proliferation
index.

Electron Microscopic Findings

Electron microscopy demonstrates membrane-bound dense-core neurosecretory granules

within the cytoplasm of tumor cells. These granules represent neuroendocrine differentiation
and correspond to the immunohistochemical expression of neuroendocrine markers such as
synaptophysin, chromogranin, and CD56.

The ultrastructural finding of dense-core neurosecretory granules is a classic supportive feature

of pulmonary neuroendocrine tumors. In small cell lung carcinoma, this finding reinforces the
interpretation of the tumor as a high-grade neuroendocrine carcinoma, particularly when
correlated with light microscopic features such as scant cytoplasm, nuclear molding, high
mitotic activity, necrosis, and crush artifact.

Differential Diagnosis

The most important differential diagnosis is large cell neuroendocrine carcinoma. Both tumors
are high-grade neuroendocrine carcinomas of the lung and may express synaptophysin,
chromogranin, and CD56. Large cell neuroendocrine carcinoma, however, is composed of
larger cells with more abundant cytoplasm, prominent nucleoli, and neuroendocrine
architectural patterns such as organoid nesting, trabeculae, rosettes, or palisading. Small cell
lung carcinoma has smaller cells, scant cytoplasm, inconspicuous nucleoli, more striking
nuclear molding, and frequent crush artifact.

Typical and atypical carcinoid tumors are lower-grade neuroendocrine tumors. Typical
carcinoid shows organoid nesting, trabeculae, or rosettes, with low mitotic activity and no
necrosis. Atypical carcinoid shows increased mitoses and focal necrosis but remains less
aggressive and less proliferative than small cell lung carcinoma. Ki-67 proliferation index is far
lower in carcinoid tumors than in small cell carcinoma.

Squamous cell carcinoma may be centrally located and strongly associated with smoking, but
it shows squamous differentiation. Keratinization, keratin pearls, and intercellular bridges
support squamous cell carcinoma. It lacks the classic small hyperchromatic neuroendocrine
morphology, nuclear molding, diffuse neuroendocrine marker expression, and dense-core
neurosecretory granules of small cell carcinoma.

Lung adenocarcinoma may express TTF-1 and arise in the lung, but it shows glandular
differentiation, mucin production, acinar, papillary, lepidic, micropapillary, or solid growth
patterns. Neuroendocrine marker expression is not the defining feature. Adenocarcinoma cells
usually have more abundant cytoplasm and more prominent nucleoli than small cell carcinoma.

Metastatic small round blue cell tumors may enter the differential diagnosis, particularly in
small biopsy specimens. Lymphoma is distinguished by leukocyte common antigen expression
and absence of cytokeratin. Ewing sarcoma is usually CD99-positive and associated with
EWSR1 rearrangement. Poorly differentiated metastatic neuroendocrine carcinoma from
another site may closely resemble pulmonary small cell carcinoma and requires
clinicopathologic correlation.
Basaloid squamous cell carcinoma may resemble small cell carcinoma because of small blue
cell morphology. However, basaloid squamous carcinoma shows squamous immunophenotype,
often p40 and p63 positivity, and lacks diffuse neuroendocrine marker expression.

Crushed lymphoid infiltrates may mimic small cell carcinoma in bronchial biopsies.
Immunohistochemistry is decisive: lymphoid lesions express leukocyte markers, whereas small
cell lung carcinoma expresses cytokeratins and neuroendocrine markers.

Gross /
Main Site / Key Histopathological Distinguishing
Disease Structural
Distribution Finding Feature
Pattern

Pale gray, soft, High-grade

Central lung, friable central Small hyperchromatic cells pulmonary
major mass with with scant cytoplasm, salt- neuroendocrine
bronchi, hilar necrosis; hilar and-pepper chromatin, carcinoma with
Small cell lung
region; early and nuclear molding, numerous TP53/RB
carcinoma
nodal and mediastinal mitoses, necrosis, crush inactivation
distant node artifact, neuroendocrine and dense-core
metastasis involvement marker positivity neurosecretory
common granules

Larger cell size

Large cells with
Large and prominent
Large cell Lung, often neuroendocrine architecture,
aggressive nucleoli
neuroendocrine peripheral or prominent nucleoli, high
pulmonary compared with
carcinoma central mitotic rate, necrosis,
mass small cell
neuroendocrine markers
carcinoma

Central Polypoid Organoid nests, trabeculae, Low-grade

Typical
bronchi endobronchial rosettes, low mitotic activity, neuroendocrine
carcinoid tumor
common mass or well- no necrosis tumor
 Gross /
Main Site / Key Histopathological Distinguishing
Disease Structural
Distribution Finding Feature
Pattern

demarcated
lesion

Intermediate-
grade
Well-
neuroendocrine
Bronchial or demarcated Neuroendocrine morphology
Atypical tumor with
peripheral mass, with increased mitoses and
carcinoid tumor lower
lung sometimes focal necrosis
proliferation
infiltrative
than small cell
carcinoma

Squamous
Endobronchial Keratinization, keratin differentiation
Squamous cell Central lung
or hilar mass, pearls, intercellular bridges, rather than
carcinoma common
may cavitate p40/p63 positivity neuroendocrine
phenotype

Peripheral
Gland formation, mucin
gray-white Glandular
production,
Peripheral mass, differentiation
Adenocarcinoma lepidic/acinar/papillary/solid
lung common sometimes and mucin
patterns, TTF-1 often
scar- production
positive
associated

Nodal or Cytokeratin
Mediastinum, Monomorphic lymphoid
extranodal negative,
Lymphoma lung, lymph proliferation expressing
lymphoid leukocyte
nodes leukocyte markers
mass marker positive
 Gross /
Main Site / Key Histopathological Distinguishing
Disease Structural
Distribution Finding Feature
Pattern

p40/p63-
positive
Basaloid Central or Aggressive squamous
Basaloid nests with
squamous cell peripheral mass-forming lineage without
squamous marker expression
carcinoma lung carcinoma diffuse
neuroendocrine
profile
MINIMAL CHANGE DISEASE

Minimal change disease is a primary podocytopathy and one of the prototypical causes of
nephrotic syndrome. It is characterized by severe proteinuria caused by podocyte injury, while
the glomeruli appear essentially normal by routine light microscopy. The name “minimal
change” reflects this discrepancy between marked functional glomerular permeability
abnormality and minimal or absent structural abnormality on standard light microscopic
examination.

The disease is also known as lipoid nephrosis, foot process disease, and nil deposit disease.
“Lipoid nephrosis” refers to lipid accumulation in tubular epithelial cells caused by reabsorption
of filtered lipoproteins. “Foot process disease” refers to the characteristic ultrastructural
alteration of podocytes. “Nil deposit disease” emphasizes the lack of significant immune
deposits by immunofluorescence.

The essential pathological identity of minimal change disease is podocyte injury with selective
disruption of the glomerular filtration barrier. Light microscopy shows essentially normal-
appearing glomeruli on light microscopy without significant hypercellularity, basement
membrane thickening, or crescent formation. Immunofluorescence shows failure to
demonstrate significant immunoglobulin or complement deposition. The defining
ultrastructural lesion is Diffuse effacement of podocyte foot processes.

Etiology

The etiology of minimal change disease is heterogeneous. Most cases are idiopathic, especially
in children. Secondary forms occur in association with immune dysregulation, infections, drugs,
and neoplasms. The unifying concept is injury to podocytes and their slit diaphragm apparatus
rather than immune complex deposition within the glomerulus.

Idiopathic minimal change disease is the most common form. It is thought to arise from
immune-mediated functional alteration of podocytes. The disease often responds to
corticosteroid therapy, supporting an immune-regulated pathogenesis, although a single
causative immune mediator has not been definitively established.

Secondary minimal change disease may occur in association with Hodgkin lymphoma and other
lymphoid neoplasms. This association supports the concept that T-cell or cytokine-related
immune dysregulation can alter podocyte function. Minimal change disease may also be
associated with viral infections, allergic states, and immune activation.
Drug-associated minimal change disease is classically linked to nonsteroidal anti-inflammatory
drugs, and it has also been reported with other medications such as interferon-related therapies,
rifampicin, and immune-modulating agents. NSAID-associated disease may occur with
interstitial nephritis, making renal biopsy interpretation important.

The etiologic framework is therefore: idiopathic or secondary podocyte injury, often immune-
mediated, leading to altered slit diaphragm function and increased glomerular permeability to
albumin.

Pathogenesis

The central pathogenic event is podocyte injury. Podocytes are visceral epithelial cells that
cover the outer aspect of the glomerular capillary wall and form interdigitating foot processes
connected by slit diaphragms. The slit diaphragm is a key component of the glomerular filtration
barrier, together with fenestrated endothelium and the glomerular basement membrane.

In minimal change disease, circulating or locally produced immune mediators are thought to
injure podocytes or alter podocyte cytoskeletal organization. This causes retraction,
simplification, and flattening of podocyte foot processes. The slit diaphragm becomes
functionally disrupted, allowing excessive leakage of albumin across the filtration barrier.

The proteinuria is often selective, especially in children, meaning that albumin is lost
preferentially compared with larger plasma proteins. This selectivity reflects a permeability
abnormality that primarily affects charge and slit diaphragm function rather than producing
severe inflammatory destruction of the capillary wall.

The lack of immune deposits distinguishes minimal change disease from immune complex-
mediated glomerular diseases. There is no dominant glomerular hypercellularity, no crescentic
injury, and no typical immune complex pattern. The glomerular capillary wall is functionally
abnormal because of podocyte injury rather than structurally thickened by deposits.

The major pathological sequence is:

immune-mediated or idiopathic podocyte injury → cytoskeletal reorganization and slit

diaphragm dysfunction → foot process effacement → increased albumin permeability →
nephrotic-range proteinuria → tubular reabsorption of filtered proteins and lipids.
The essential pathogenic idea is that minimal change disease is a podocyte functional-structural
disorder. The severe proteinuria is disproportionate to the almost normal appearance of
glomeruli on routine histology.

Macroscopic Findings

Grossly, the kidneys are usually normal in size and shape. In uncomplicated minimal change
disease, there is no characteristic gross scarring, cortical thinning, granular surface, or
destructive renal lesion.

When proteinuria is severe, the renal cortex may be pale, but this is not specific. The lack of
gross abnormality corresponds to the absence of major light microscopic glomerular structural
damage.

The older term lipoid nephrosis reflects lipid accumulation in renal tubular epithelial cells rather
than a distinctive gross renal abnormality. Tubular lipid accumulation results from reabsorption
of filtered lipoproteins in the setting of heavy proteinuria and hyperlipidemia.

The macroscopic teaching point is that minimal change disease produces severe nephrotic
syndrome with kidneys that are grossly unremarkable or only subtly pale, because the decisive
lesion is ultrastructural podocyte injury rather than a grossly visible destructive glomerular
process.

Histopathological Findings

On light microscopy, the defining feature is the absence of significant glomerular abnormality.
The glomeruli are typically normal in size and cellularity. There is no significant endocapillary
hypercellularity, no mesangial proliferation, no capillary wall thickening, no segmental
sclerosis, and no crescent formation.

The most important light microscopic phrase is essentially normal-appearing glomeruli on

light microscopy without significant hypercellularity, basement membrane thickening, or
crescent formation. This pattern explains the name minimal change disease.

The proximal convoluted tubules may contain protein resorption droplets and lipid vacuoles.
These tubular changes reflect heavy proteinuria and lipiduria. The tubular epithelial cells may
appear swollen and vacuolated. Hyaline droplets may be present in proximal tubular epithelial
cytoplasm because filtered plasma proteins are reabsorbed.
The interstitium is usually unremarkable, though mild edema may be present. Blood vessels
usually show no specific change attributable to minimal change disease. Significant interstitial
fibrosis, tubular atrophy, or vascular scarring should prompt consideration of chronicity or an
alternative/additional renal disease.

Immunofluorescence is characteristically negative or nonspecific. There is failure to

demonstrate significant immunoglobulin or complement deposition. This absence of
immune deposits helps separate minimal change disease from membranous nephropathy, lupus
nephritis, postinfectious glomerulonephritis, IgA nephropathy, and membranoproliferative
glomerulonephritis.

Special stains such as PAS, silver stain, and trichrome generally confirm preservation of
glomerular architecture. They do not show the spike formation of membranous nephropathy,
the tram-track duplication of membranoproliferative patterns, or the segmental sclerosis of focal
segmental glomerulosclerosis.

The concise histopathological formulation is:

minimal or absent glomerular change on light microscopy, tubular protein-lipid resorption

changes, negative or nonspecific immunofluorescence, and ultrastructural podocyte foot
process effacement.

Electron Microscopic Findings

Electron microscopy demonstrates the defining lesion: Diffuse effacement of podocyte foot
processes. The podocyte foot processes are flattened, broadened, and simplified, with loss of
the normal interdigitating architecture. Slit diaphragms are reduced or functionally disrupted.

Additional podocyte changes may include cytoplasmic vacuolization, microvillous

transformation, and occasional focal detachment from the glomerular basement membrane.
These findings reflect podocyte injury and cytoskeletal remodeling.

Importantly, electron microscopy does not show the characteristic immune complex deposits
expected in many other glomerular diseases. There are no subepithelial hump-shaped deposits,
no mesangial immune complex deposits, no organized fibrillar deposits, and no glomerular
basement membrane lamellation typical of hereditary nephritis. The glomerular basement
membrane is usually of normal thickness and contour.
The ultrastructural formulation is:

Diffuse effacement of podocyte foot processes with podocyte simplification and slit
diaphragm disruption, in the setting of absent significant immune deposits.

Differential Diagnosis

The most important differential diagnosis is focal segmental glomerulosclerosis. Both diseases
are podocytopathies and both may show foot process effacement. Focal segmental
glomerulosclerosis, however, shows sclerosis involving segments of some glomeruli on light
microscopy. It may also show hyalinosis, adhesions to Bowman capsule, and more frequent
tubulointerstitial scarring. Minimal change disease shows essentially normal glomeruli on light
microscopy and has negative or nonspecific immunofluorescence.

Membranous nephropathy is a major cause of nephrotic syndrome in adults. It shows diffuse

thickening of glomerular capillary walls on light microscopy, granular IgG and complement
deposition along the glomerular basement membrane on immunofluorescence, and
subepithelial electron-dense deposits on electron microscopy. Spike and dome changes may be
seen on silver stain or EM. These findings distinguish it from minimal change disease.

Postinfectious glomerulonephritis may present with proteinuria but usually has nephritic
features. Light microscopy shows diffuse endocapillary hypercellularity with neutrophils.
Immunofluorescence shows granular IgG and C3 deposition, and electron microscopy shows
subepithelial hump-shaped electron-dense deposits. These features are absent in minimal
change disease.

Membranoproliferative glomerulonephritis shows mesangial and endocapillary proliferation,

thickened capillary walls, and duplication of the glomerular basement membrane, producing a
tram-track appearance. Immunofluorescence and electron microscopy demonstrate immune
complex or complement-related deposits depending on subtype. Minimal change disease lacks
this proliferative and basement membrane duplication pattern.

IgA nephropathy is typically associated with mesangial IgA deposition. Light microscopy may
show mesangial proliferation, and immunofluorescence demonstrates IgA-dominant mesangial
deposits. Electron microscopy shows mesangial electron-dense deposits. Minimal change
disease lacks mesangial immune deposits and significant mesangial proliferation.

Alport syndrome is a hereditary disorder of type IV collagen affecting the glomerular basement
membrane. Electron microscopy shows irregular thickening, thinning, splitting, and lamellation
of the glomerular basement membrane, producing a basket-weave appearance. Minimal change
disease instead shows podocyte foot process effacement with an otherwise preserved
glomerular basement membrane.

Diabetic nephropathy may produce nephrotic-range proteinuria but shows glomerular basement
membrane thickening, mesangial expansion, nodular glomerulosclerosis, arteriolar hyalinosis,
and tubulointerstitial fibrosis. Minimal change disease lacks diabetic nodular lesions and
diabetic microangiopathic changes.

Main Renal
Light Immunofluores Electron Microscopy /
Compartme
Microscopy cence Key Distinction
nt / Target
Disease

Essentially
normal-
appearing
glomeruli on
light microscopy
without Failure to
significant demonstrate
hypercellularity, significant
Minimal change Podocyte / slit Diffuse effacement of
basement immunoglobuli
disease diaphragm podocyte foot processes
membrane n or
thickening, or complement
crescent deposition
formation;
tubular protein-
lipid resorption
changes may be
present
 Main Renal
Light Immunofluores Electron Microscopy /
Compartme
Microscopy cence Key Distinction
nt / Target
Disease

Focal and
Podocyte
segmental Often
Focal segmental with
sclerosis, nonspecific IgM Foot process effacement
glomeruloscleros segmental
hyalinosis, and C3 trapping plus segmental sclerosis
is glomerular
adhesions; some in sclerotic areas
scarring
glomeruli normal

Podocyte /
GBM Granular IgG Subepithelial electron-
Membranous Diffuse capillary
immune and complement dense deposits; spike
nephropathy wall thickening
complex along GBM and dome pattern
disease

Immune
Diffuse
Postinfectious complex- Subepithelial hump-
endocapillary Granular IgG
glomerulonephri mediated shaped electron-dense
hypercellularity and C3
tis glomerulonep deposits
with neutrophils
hritis

Immune
Mesangial/endoca
complex or
pillary Subendothelial/intrame
Mesangium complement-
Membranoprolif proliferation; mbranous deposits or
and capillary dominant
erative pattern GBM duplication; complement-related
wall pattern
tram-track deposits
depending on
appearance
type

IgA-dominant
Mesangial Mesangial electron-
IgA nephropathy Mesangium mesangial
proliferation, dense deposits
deposits
 Main Renal
Light Immunofluores Electron Microscopy /
Compartme
Microscopy cence Key Distinction
nt / Target
Disease

variable
segmental lesions

Type IV Abnormal type

Progressive Irregular GBM
collagen IV collagen
glomerulosclerosi thickening, thinning,
Alport syndrome GBM chain
s in advanced splitting, lamellation;
structural expression in
disease basket-weave pattern
defect some cases

GBM thickening,
Glomerular mesangial Usually
GBM thickening; no
basement expansion, nonspecific
Diabetic isolated diffuse
membrane, nodular linear
nephropathy podocyte foot process
mesangium, glomerulosclerosi IgG/albumin
effacement pattern
arterioles s, arteriolar staining
hyalinosis
HASHIMOTO THYROIDITIS

Hashimoto thyroiditis, also called chronic lymphocytic thyroiditis, autoimmune thyroiditis,

diffuse lymphocytic thyroiditis, or struma lymphomatosa, is a chronic autoimmune
inflammatory disease of the thyroid gland. It is the most common cause of hypothyroidism in
regions where iodine intake is sufficient. The disease is characterized by immune-mediated
destruction of thyroid follicles, dense lymphoplasmacytic infiltration, formation of lymphoid
follicles with germinal centers, Hürthle cell metaplasia of follicular epithelium, and variable
fibrosis.

The pathological identity of Hashimoto thyroiditis is chronic autoimmune injury of thyroid

follicular cells. The gland may initially become diffusely enlarged because of lymphoid
infiltration and epithelial change. As destruction progresses, thyroid follicles are depleted,
colloid becomes reduced, fibrosis increases, and the gland may eventually become atrophic and
functionally insufficient.

Hashimoto thyroiditis is important not only as a cause of hypothyroidism but also as a prototype
of organ-specific autoimmune disease. It demonstrates how cell-mediated immunity,
autoantibodies, and chronic inflammation combine to destroy an endocrine organ. The disease
also creates a background in which primary thyroid lymphoma, especially extranodal marginal
zone lymphoma of mucosa-associated lymphoid tissue type, may rarely develop.

Etiology

The etiology of Hashimoto thyroiditis is autoimmune. The disease results from loss of immune
tolerance to thyroid antigens, followed by chronic immune-mediated destruction of thyroid
follicular epithelium. It is not a primary infectious thyroiditis, and it is not caused by iodine
deficiency. In fact, it is the most common cause of hypothyroidism in iodine-sufficient regions.

Genetic susceptibility is important. Familial clustering is well recognized, and asymptomatic

relatives may have circulating antithyroid antibodies. Susceptibility has been linked to immune-
regulation genes, including CTLA4 and other loci that influence T-cell activation and immune
tolerance. HLA associations, including HLA-DR-related susceptibility, have also been
described.

Autoantibodies are a central diagnostic feature. The most important antibodies are anti-thyroid
peroxidase antibodies and anti-thyroglobulin antibodies. TSH receptor-blocking antibodies
may be present in some patients and may contribute to hypothyroidism by interfering with TSH-
mediated stimulation of thyroid follicular cells. These antibodies are useful diagnostically,
although the degree of antibody elevation does not always precisely correlate with the extent of
thyroid destruction.

Hashimoto thyroiditis is associated with other autoimmune diseases. These include Graves
disease, type 1 diabetes mellitus, autoimmune gastritis with pernicious anemia, systemic lupus
erythematosus, Sjögren syndrome, rheumatoid arthritis, Addison disease, and autoimmune
polyglandular syndromes. This association supports the broader concept of genetically
determined immune dysregulation.

Environmental factors may modify risk. Excess iodine intake has been associated with
increased frequency of autoimmune thyroiditis in susceptible populations. Infections, hormonal
factors, immune activation, and other environmental influences may contribute, but they do not
replace autoimmunity as the primary etiologic mechanism.

The etiologic formulation is therefore: genetically susceptible host, loss of immune tolerance
to thyroid antigens, antithyroid autoantibody formation, T-cell–mediated follicular injury, and
chronic autoimmune destruction of thyroid parenchyma.

Pathogenesis

The central pathogenic mechanism is autoimmune destruction of thyroid follicular epithelial

cells. Several immune pathways contribute to this injury.

CD8-positive cytotoxic T lymphocytes directly injure thyroid follicular epithelial cells. This
cell-mediated cytotoxicity is one of the major mechanisms of follicular destruction. CD4-
positive helper T cells also contribute by producing inflammatory cytokines, including
interferon-gamma, which recruit and activate macrophages and amplify tissue injury.

Antithyroid antibodies are common and diagnostically important. Anti-thyroid peroxidase and
anti-thyroglobulin antibodies reflect the autoimmune response against thyroid antigens. They
may contribute to follicular cell injury through antibody-dependent cellular cytotoxicity or
complement-mediated mechanisms, although they may also represent a consequence of tissue
damage and antigen release.

Repeated immune injury causes progressive destruction of thyroid follicles. As follicles are lost,
colloid decreases and thyroid hormone synthetic capacity declines. Surviving follicular
epithelial cells undergo oncocytic metaplasia, forming Hürthle cells. These cells have abundant
granular eosinophilic cytoplasm due to accumulation of mitochondria and represent a
metaplastic response to chronic injury.

The lymphoid infiltrate becomes organized into lymphoid follicles with germinal centers. This
reflects sustained local immune activation within the thyroid. With chronicity, interstitial
fibrosis increases. In some cases, fibrosis is marked, producing a fibrosing variant of Hashimoto
thyroiditis.

The major pathological sequence is:

loss of immune tolerance to thyroid antigens → T-cell activation and antithyroid antibody
production → cytotoxic T-cell and cytokine-mediated follicular epithelial injury → follicular
destruction and colloid depletion → Hürthle cell metaplasia → lymphoid follicles with germinal
centers → progressive fibrosis and thyroid atrophy.

The essential pathogenic idea is that Hashimoto thyroiditis is not a nonspecific chronic
inflammation of the thyroid. It is a structured autoimmune attack on thyroid follicular cells,
resulting in glandular destruction and hypothyroidism.

Macroscopic Findings

Grossly, the thyroid gland in classic Hashimoto thyroiditis is usually diffusely and
symmetrically enlarged. The gland is firm, rubbery, and may show accentuation of normal
lobulation. The external contour is generally maintained, although the gland may appear
diffusely swollen.

The cut surface is pale, tan, yellow-tan, or flesh-like and may appear finely nodular because of
lymphoid infiltration and altered follicular architecture. The gland is typically firm rather than
soft because of chronic inflammation and fibrosis.

In early disease, diffuse enlargement is common. With progression, the gland may become
smaller as follicular destruction and fibrosis increase. In late atrophic disease, the thyroid may
be reduced in size and fibrotic. The fibrosing variant shows more prominent fibrosis and a firm
enlarged gland, sometimes producing compression of adjacent neck structures.

The gross appearance may mimic multinodular goiter or a thyroid neoplasm if enlargement is
irregular or nodular. However, the classical gross pattern is diffuse, symmetric, firm, rubbery
thyroid enlargement with a pale, lobulated cut surface.
Histopathological Findings

Histopathologically, Hashimoto thyroiditis is characterized by diffuse lymphoplasmacytic

infiltration of thyroid parenchyma, lymphoid follicle formation with germinal centers,
destruction and atrophy of thyroid follicles, Hürthle cell change, and variable fibrosis.

The inflammatory infiltrate is composed mainly of lymphocytes and plasma cells, with variable
macrophages and immunoblasts. The infiltrate permeates the thyroid parenchyma and
separates, surrounds, or replaces thyroid follicles. Lymphoid follicles with well-developed
germinal centers are a characteristic feature and represent organized intrathyroidal immune
activation.

Thyroid follicles are reduced in number and often atrophic. Many follicles contain scant or
absent colloid. Follicular epithelial cells may be flattened in areas of atrophy. In other areas,
follicular epithelial cells undergo Hürthle cell metaplasia. Hürthle cells, also known as
oncocytic or oxyphilic cells, have abundant granular eosinophilic cytoplasm and enlarged
nuclei. Their granular cytoplasm reflects abundant mitochondria.

Fibrosis is variable. In classic Hashimoto thyroiditis, there may be mild to moderate interstitial
fibrosis or fibrous thickening of septa. In the fibrosing variant, fibrosis is more extensive and
may replace large areas of thyroid parenchyma. Unlike Riedel thyroiditis, however, the fibrosis
of Hashimoto thyroiditis generally remains within the thyroid gland and does not typically
extend widely into adjacent soft tissues.

Residual follicles may show epithelial injury, collapse, or regenerative change. Germinal center
formation may be prominent enough to simulate intrathyroidal lymphoid tissue. Plasma cells
may be abundant. The combination of follicular destruction, Hürthle cell change, lymphoid
follicles, and fibrosis is highly characteristic.

Immunohistochemistry is usually not required for diagnosis but may be useful in selected cases
to evaluate lymphoid proliferations or exclude lymphoma. The lymphoid infiltrate in
uncomplicated Hashimoto thyroiditis is polyclonal and composed of mixed B and T
lymphocytes. CD20 highlights B-cell follicles, CD3 highlights T-cell-rich interfollicular areas,
and plasma cell markers demonstrate polytypic plasma cells. Light-chain restriction or an
abnormal monomorphic B-cell population raises concern for lymphoma.
The concise histopathological formulation is:

chronic autoimmune lymphocytic thyroiditis with dense lymphoplasmacytic infiltration,

lymphoid follicles with germinal centers, thyroid follicular atrophy and destruction, Hürthle
cell metaplasia, colloid depletion, and variable fibrosis.

Differential Diagnosis

The most important differential diagnosis is Graves disease. Both diseases are autoimmune
thyroid disorders and may show lymphoid infiltrates. Graves disease, however, is characterized
by diffuse follicular epithelial hyperplasia, tall crowded follicular cells, scalloped colloid, and
increased hormone production driven by TSH receptor-stimulating antibodies. Hashimoto
thyroiditis shows follicular destruction, Hürthle cell metaplasia, lymphoid follicles with
germinal centers, colloid depletion, and eventual hypothyroidism.

Subacute granulomatous thyroiditis, also called de Quervain thyroiditis, is a painful, self-

limited granulomatous thyroiditis often following a viral illness. Histology shows disrupted
follicles with extravasated colloid surrounded by histiocytes and multinucleated giant cells.
This granulomatous, colloid-centered inflammatory pattern differs from the lymphoid follicle-
rich autoimmune destruction and Hürthle cell metaplasia of Hashimoto thyroiditis.

Painless or subacute lymphocytic thyroiditis may resemble Hashimoto thyroiditis because it

also shows lymphocytic inflammation and may occur postpartum. However, it is typically self-
limited and often shows lymphocytic inflammation without the same degree of follicular
destruction, prominent Hürthle cell change, and chronic fibrosis characteristic of established
Hashimoto thyroiditis.

Riedel thyroiditis is a rare fibrosing thyroiditis, often considered part of IgG4-related disease.
It produces a hard, fixed thyroid mass because dense fibrosis extends beyond the thyroid into
adjacent neck structures. Hashimoto thyroiditis may show fibrosis, but it usually remains
intrathyroidal and is accompanied by prominent lymphoid follicles and Hürthle cell change.

Multinodular goiter may produce thyroid enlargement and nodularity, but it shows variably
sized follicles, colloid-rich nodules, hemorrhage, fibrosis, and cystic change. It lacks the dense
lymphoplasmacytic autoimmune infiltrate, germinal centers, and widespread Hürthle cell
metaplasia typical of Hashimoto thyroiditis.

Hürthle cell neoplasm may be considered when oncocytic cells form a dominant nodule.
Hürthle cell adenoma or carcinoma shows a circumscribed or invasive neoplastic proliferation
of oncocytic follicular cells. In contrast, Hashimoto thyroiditis shows diffuse autoimmune
thyroiditis with Hürthle cell metaplasia in a background of lymphoid follicles and follicular
destruction. Capsular or vascular invasion supports carcinoma.

Primary thyroid lymphoma may arise in the background of Hashimoto thyroiditis and must be
considered when there is a rapidly enlarging thyroid mass or a monomorphic lymphoid
infiltrate. Lymphoma shows architectural effacement by a clonal lymphoid proliferation, often
B-cell lineage, and may infiltrate and destroy thyroid follicles. Immunohistochemistry and
clonality studies are important when lymphoma is suspected.

Papillary thyroid carcinoma may coexist with thyroiditis and may be confused with Hürthle
cell-rich or lymphocyte-rich lesions in small samples. Papillary carcinoma is distinguished by
its nuclear features, including optically clear nuclei, nuclear grooves, nuclear overlap,
pseudoinclusions, papillary architecture, and psammoma bodies.

Gross / Key
Distinguishing
Disease Main Pattern Structural Histopathological
Feature
Pattern Finding

Diffuse Dense
symmetric lymphoplasmacytic
Autoimmune
firm rubbery infiltrate, lymphoid
follicular
Chronic thyroid follicles with
Hashimoto destruction with
autoimmune enlargement; germinal centers,
thyroiditis Hürthle cell
thyroiditis late atrophic follicular destruction,
change and
and fibrotic Hürthle cell
germinal centers
gland may metaplasia, variable
occur fibrosis

TSH receptor-
Diffuse follicular
Autoimmune Diffuse soft to stimulating
epithelial
Graves disease hyperfunctioning firm thyroid antibodies with
hyperplasia, tall
thyroid disease enlargement hyperplasia
crowded cells,
rather than
 Gross / Key
Distinguishing
Disease Main Pattern Structural Histopathological
Feature
Pattern Finding

scalloped colloid, destructive

lymphoid infiltrates thyroiditis

Disrupted follicles,
Focal or Colloid-
Subacute extravasated colloid,
Granulomatous asymmetric centered
granulomatous granulomatous
thyroiditis firm thyroid granulomatous
thyroiditis inflammation with
involvement reaction
giant cells

Lymphocytic
Mild diffuse
inflammation, Transient
Painless Self-limited enlargement
sometimes germinal autoimmune
lymphocytic lymphocytic or no marked
centers, less thyroiditis, often
thyroiditis thyroiditis gross
prominent chronic postpartum
abnormality
destruction

Hard fixed Dense fibrosis with

Fibrosing thyroid mass lymphoplasmacytic
Extrathyroidal
Riedel thyroiditis thyroiditis / IgG4- with extension infiltrate; may show
invasive fibrosis
related pattern into adjacent IgG4-positive plasma
soft tissue cells

Multinodular Nodular
enlarged Variably sized hyperplasia
Hyperplastic
thyroid with follicles with colloid without
Multinodular goiter nodular thyroid
colloid, and nodular autoimmune
disease
hemorrhage, architecture follicular
cystic change destruction

Oncocytic Monomorphic Neoplastic

Hürthle cell Solitary
follicular oncocytic follicular oncocytic
adenoma/carcinoma encapsulated
neoplasm cell proliferation; proliferation
 Gross / Key
Distinguishing
Disease Main Pattern Structural Histopathological
Feature
Pattern Finding

or invasive carcinoma shows rather than

nodule capsular/vascular diffuse
invasion autoimmune
metaplasia

Clonal
Lymphoid
lymphoma
neoplasm, often Rapidly Monomorphic clonal
Primary thyroid rather than
arising in enlarging lymphoid infiltrate,
lymphoma polyclonal
Hashimoto thyroid mass often B-cell lineage
autoimmune
background
infiltrate

Infiltrative or
Papillary structures, Diagnostic
Malignant nodular
Papillary thyroid clear nuclei, grooves, papillary
follicular thyroid tumor,
carcinoma pseudoinclusions, carcinoma
epithelial tumor may have
psammoma bodies nuclear features
calcifications
LANGERHANS CELL HISTIOCYTOSIS

Langerhans cell histiocytosis is a clonal proliferative disorder of Langerhans-type dendritic

cells. Langerhans cells are antigen-presenting dendritic cells normally found in the epidermis
and in several other tissues. In this disease, neoplastic or clonal Langerhans-type cells
accumulate in tissues and produce destructive inflammatory lesions, most characteristically in
bone, skin, lymph nodes, lung, liver, spleen, bone marrow, and the hypothalamic-pituitary
region.

The older term histiocytosis X was used when the cellular origin was uncertain. This term has
largely been replaced because the proliferating cells are now known to be Langerhans-type
dendritic cells. The disease includes a spectrum of clinicopathological patterns that were
historically separated as eosinophilic granuloma, Hand-Schüller-Christian disease, and
Letterer-Siwe disease. These are now understood as different manifestations of the same basic
disease process.

The essential pathological identity of Langerhans cell histiocytosis is a proliferation of

Langerhans-type cells with folded or grooved nuclei, accompanied by a mixed inflammatory
infiltrate rich in eosinophils. The lesional cells express CD1a, langerin, S-100 protein, and
MHC class II antigens. Langerin is closely linked to the formation of Birbeck granules, the
characteristic ultrastructural organelles of Langerhans cells.

Etiology

The etiology of Langerhans cell histiocytosis is best understood as clonal neoplastic

proliferation driven by activation of the MAP kinase pathway. The disease was historically
debated as either reactive or neoplastic because lesions contain abundant inflammatory cells
and may sometimes regress. However, clonality and recurrent activating molecular alterations
support its classification as a neoplastic disorder of dendritic cells.

A major etiologic and pathogenetic mechanism is acquired mutation in BRAF, especially BRAF
V600E, which activates the MAP kinase signaling pathway. Other MAP kinase pathway
alterations may also occur, including mutations or rearrangements involving MAP2K1 and
related pathway genes. These abnormalities promote survival, proliferation, and accumulation
of lesional Langerhans-type cells.

The disease is not caused by ordinary infection, and it is not simply a granulomatous
inflammatory reaction. The eosinophil-rich inflammatory background may make the lesion
look inflammatory, but the defining cellular population is clonal Langerhans-type dendritic
cells.

The degree of disease dissemination is related to the stage and distribution of the involved
dendritic precursor cells. Lesions restricted to a single tissue or organ system tend to behave
more indolently, whereas multisystem disease reflects broader distribution of the abnormal
clone and has more aggressive behavior.

The etiologic formulation is therefore: acquired activating mutation in the MAP kinase pathway,
clonal proliferation of Langerhans-type dendritic cells, and tissue-destructive inflammatory
lesions with prominent eosinophils.

Pathogenesis

The central pathogenic event is activation of MAP kinase signaling in Langerhans-type

dendritic cells or their precursors. Constitutive activation of this pathway promotes cell
survival, proliferation, and tissue accumulation. The proliferating cells retain
immunophenotypic and ultrastructural features of Langerhans cells, including expression of
CD1a and langerin.

The lesional cells produce cytokines and chemokines that recruit inflammatory cells,
particularly eosinophils, lymphocytes, plasma cells, neutrophils, and macrophages. This
inflammatory microenvironment contributes to tissue destruction. In bone lesions,
inflammatory mediators and osteoclast-activating signals promote osteolysis, leading to lytic
bone defects.

Bone involvement is common because lesional cells accumulate in medullary cavities and
produce local destruction. Lesions may expand and erode cortex, sometimes extending into soft
tissue. In the skull, ribs, vertebrae, pelvis, and long bones, this produces sharply demarcated
osteolytic lesions.

In multisystem disease, lesional cells infiltrate skin, liver, spleen, lymph nodes, lung, and bone
marrow. Bone marrow involvement may impair hematopoiesis. Liver and spleen involvement
may reflect disseminated disease. Pulmonary involvement can occur as part of multisystem
disease or as isolated pulmonary LCH, particularly in adults with smoking-associated disease.

The major pathogenic sequence is:

MAP kinase pathway activation in Langerhans-type dendritic cells → clonal cellular
proliferation and survival → cytokine-mediated inflammatory recruitment → eosinophil-rich
destructive tissue lesions → osteolysis or organ infiltration depending on site and extent.

The essential concept is that Langerhans cell histiocytosis is both neoplastic and inflammatory:
the lesional Langerhans-type cells are clonal, while the tissue damage is amplified by the
accompanying inflammatory infiltrate.

Macroscopic Findings

Gross findings depend on the involved organ and extent of disease.

In bone, Langerhans cell histiocytosis typically produces lytic lesions. The lesion may appear
as a destructive, sharply demarcated defect within the medullary cavity. The bone may be
eroded, thinned, or expanded. Cortical destruction may occur, and soft tissue extension can be
present in larger lesions. Commonly involved bones include the skull, ribs, femur, vertebrae,
pelvis, and mandible.

The cut surface of a bone lesion may be soft, tan-gray, reddish-brown, or granular. Areas of
hemorrhage or necrosis may be present. The lesion may be friable because of its cellular and
inflammatory composition.

In skin, lesions may appear as papules, plaques, crusted lesions, or seborrheic dermatitis-like
eruptions. In multisystem disease, cutaneous involvement can be widespread.

In lymph nodes, involved nodes may be enlarged and partially or completely effaced by lesional
cell infiltrates. In the lung, nodular lesions, cystic changes, and fibrotic remodeling may be
present, particularly in pulmonary LCH. In the liver and spleen, enlargement may occur in
disseminated disease.

In multisystem disease, multiple organs may be involved simultaneously. The gross

pathological picture may include destructive osteolytic lesions, hepatosplenomegaly,
lymphadenopathy, pulmonary lesions, and marrow infiltration.

Histopathological Findings

Histologically, Langerhans cell histiocytosis is characterized by sheets, clusters, or aggregates

of Langerhans-type cells accompanied by a variable inflammatory infiltrate. The lesional cells
are medium-sized to large cells with abundant pale eosinophilic or slightly vacuolated
cytoplasm. Their nuclei are irregular, folded, indented, or grooved, often described as coffee
bean-like. Nuclear chromatin is usually fine, and nucleoli may be inconspicuous or small.

The inflammatory background is a major feature. Eosinophils are usually prominent, especially
in bone lesions historically called eosinophilic granuloma. Lymphocytes, plasma cells,
macrophages, neutrophils, and multinucleated giant cells may also be present. Areas of
necrosis, hemorrhage, and fibrosis may occur depending on the age and site of the lesion.

In bone lesions, the infiltrate replaces marrow and destroys trabecular bone. Osteolysis results
from both cellular infiltration and osteoclast-mediated bone resorption. Reactive bone
formation may be limited. In older lesions, fibrosis and xanthomatous macrophages may
become more conspicuous.

In lymph nodes, the infiltrate may involve sinuses, paracortex, or diffuse areas. The lesional
cells may be mixed with abundant eosinophils and other inflammatory cells. In skin, the
epidermis and dermis may be involved, and epidermotropism of Langerhans-type cells can
occur.

Immunohistochemistry is central to diagnosis. Lesional cells express CD1a and langerin. S-100
protein is also typically positive, although it is less specific than CD1a and langerin. Langerin
is particularly important because it correlates with Birbeck granule formation. The cells also
express MHC class II antigens. CD68 may be variably positive because of histiocytic/dendritic
differentiation, but CD68 alone is not specific.

Molecular testing may demonstrate activating MAP kinase pathway alterations, especially
BRAF V600E. Demonstration of BRAF mutation supports the clonal neoplastic nature of the
disease and may have therapeutic implications in selected patients.

The concise histopathological formulation is:

a proliferation of CD1a-positive and langerin-positive Langerhans-type dendritic cells with

grooved or folded nuclei and abundant pale cytoplasm, accompanied by an eosinophil-rich
mixed inflammatory infiltrate and, in bone, destructive osteolytic involvement.

Electron Microscopic Findings

Electron microscopy shows Birbeck granules within the cytoplasm of lesional Langerhans cells.
Birbeck granules are pentalaminar rod-shaped or racket-shaped cytoplasmic organelles. They
may show a characteristic dilated terminal end, producing the classic tennis-racket appearance.
These granules are related to langerin, a transmembrane protein involved in Birbeck granule
formation. The ultrastructural identification of Birbeck granules historically played a central
diagnostic role and remains a classic high-yield teaching feature of Langerhans cell
histiocytosis. In contemporary diagnostic practice, langerin immunohistochemistry serves as a
practical correlate of Birbeck granules.

Differential Diagnosis

The most important differential diagnosis is reactive histiocytic proliferation. Reactive

histiocytic lesions may contain macrophages and inflammatory cells, but they lack the
characteristic Langerhans-type cytology, strong CD1a and langerin expression, and Birbeck
granules. Reactive lesions also lack clonal MAP kinase pathway-driven neoplastic proliferation.

Rosai-Dorfman disease can mimic Langerhans cell histiocytosis because both are histiocytic
disorders. Rosai-Dorfman disease shows large S-100-positive histiocytes with emperipolesis,
meaning intact lymphocytes or other inflammatory cells within histiocyte cytoplasm. Rosai-
Dorfman cells are typically CD68-positive and CD163-positive but CD1a-negative and
langerin-negative. This immunophenotype separates it from LCH.

Erdheim-Chester disease is a non-Langerhans cell histiocytosis with foamy histiocytes, fibrosis,

and Touton giant cells. It commonly involves long bones bilaterally and symmetrically,
producing osteosclerotic lesions rather than the typical lytic bone lesions of LCH. Erdheim-
Chester histiocytes are usually CD68-positive and CD163-positive but CD1a-negative and
langerin-negative. MAP kinase mutations may be present, including BRAF V600E, but the
phenotype is distinct from LCH.

Juvenile xanthogranuloma is a benign non-Langerhans histiocytic lesion composed of foamy

histiocytes and Touton giant cells. It is typically CD68-positive and factor XIIIa-positive and
lacks CD1a and langerin expression. The absence of Langerhans cell markers and Birbeck
granules distinguishes it from LCH.

Hodgkin lymphoma may enter the differential diagnosis when lymph nodes contain
inflammatory backgrounds rich in eosinophils. Hodgkin lymphoma is defined by Reed-
Sternberg cells or variants in an appropriate inflammatory background. Reed-Sternberg cells
express CD30 and often CD15, with weak PAX5 in classical Hodgkin lymphoma. LCH instead
shows CD1a-positive and langerin-positive Langerhans-type cells with grooved nuclei.
Ewing sarcoma may mimic LCH in bone because both can produce destructive bone lesions.
Ewing sarcoma is a small round blue cell tumor composed of sheets of uniform primitive cells,
typically CD99-positive, and associated with EWSR1 gene rearrangement. It lacks grooved
Langerhans-type cells, eosinophil-rich inflammatory background, CD1a/langerin expression,
and Birbeck granules.

Osteomyelitis may produce destructive bone lesions with inflammatory infiltrates. Acute
osteomyelitis is neutrophil-rich, whereas chronic osteomyelitis shows chronic inflammation,
fibrosis, necrotic bone, and possible sequestrum formation. It lacks the diagnostic population
of CD1a-positive and langerin-positive Langerhans-type cells.

Metastatic carcinoma or melanoma may enter the differential diagnosis in destructive bone or
nodal lesions. Metastatic carcinoma shows epithelial marker expression such as cytokeratin,
while melanoma may express SOX10, HMB45, and Melan-A. LCH is defined by Langerhans
cell markers and characteristic cytology.
 Gross / Key
Main Site / Distinguishing
Structural Histopathological
Distribution Feature
Pattern Finding
Disease

Lytic bone
CD1a-positive and
lesions; soft
langerin-positive Langerin-
tan-gray
Bone, skin, lymph Langerhans-type cells positive
destructive
nodes, lung, liver, with grooved or Langerhans cell
Langerhans cell tissue lesions;
spleen, marrow, folded nuclei, proliferation
histiocytosis multisystem
hypothalamic- eosinophil-rich with tennis-
organ
pituitary region inflammatory racket Birbeck
infiltration in
infiltrate, and Birbeck granules
disseminated
granules on EM
disease

Mixed macrophage- Lacks

Lymph nodes, Reactive
Reactive rich inflammation CD1a/langerin-
inflammatory enlargement or
histiocytic without clonal positive lesional
sites, tissue injury inflammatory
proliferation Langerhans cell cells and Birbeck
areas tissue mass
proliferation granules

Massive nodal Large histiocytes with Emperipolesis

Rosai-Dorfman Lymph nodes, enlargement or emperipolesis; S-100 and absence of
disease extranodal sites extranodal positive, CD1a langerin/CD1a
mass negative expression

Bilateral
Long bones,
symmetric Foamy histiocytes, Non-Langerhans
retroperitoneum,
Erdheim-Chester osteosclerotic fibrosis, Touton giant histiocytosis
cardiovascular
disease long bone cells; CD68 positive, with
system, CNS,
lesions; fibrotic CD1a negative osteosclerosis
lung
infiltrates
 Gross / Key
Main Site / Distinguishing
Structural Histopathological
Distribution Feature
Pattern Finding
Disease

Foamy histiocytes
Skin, soft tissue; Yellow-brown and Touton giant Benign non-
Juvenile
occasionally papule or cells; factor XIIIa Langerhans
xanthogranuloma
systemic nodule positive, CD1a histiocytic lesion
negative

Reed-Sternberg cells Reed-Sternberg

Classical Lymph nodes, in mixed cell neoplasm
Hodgkin mediastinum, Nodal mass inflammatory rather than
lymphoma spleen background; Langerhans cell
CD30/CD15 positive proliferation

Destructive Sheets of small round

Primitive small
Bone and soft bone mass, blue cells; CD99
Ewing sarcoma round cell
tissue often with soft positive; EWSR1
sarcoma
tissue extension rearranged

Lytic or Infectious
sclerotic Neutrophilic or inflammation
destructive chronic inflammatory without
Osteomyelitis Bone
bone lesion, bone destruction with CD1a/langerin-
possible necrotic bone positive
sequestrum Langerhans cells
EWING SARCOMA

Ewing sarcoma is an aggressive malignant small round cell tumor of bone and soft tissue. It is
classically a tumor of the pediatric and adolescent age group and is one of the major primary
malignant bone tumors. In bone, it usually arises in the medullary cavity and most often
involves the diaphysis or metadiaphysis of long bones, although it can also occur in flat bones
and extraskeletal soft tissues.

The tumor belongs to the Ewing sarcoma family of tumors, unified by recurrent gene fusions
involving EWSR1 and members of the ETS transcription factor family, most commonly FLI1.
The defining biological abnormality is a fusion transcription factor that alters chromatin
binding, transcriptional regulation, cellular differentiation, and proliferation.

Pathologically, Ewing sarcoma is composed of sheets of uniform primitive small round cells
with scant cytoplasm. Because the cytoplasm is rich in glycogen, it may appear clear on routine
sections and may show PAS positivity. The tumor does not produce osteoid, bone, or cartilage.
This point is essential in separating it from small cell osteosarcoma, which may resemble Ewing
sarcoma cytologically but produces malignant osteoid.

Etiology

The etiology of Ewing sarcoma is primarily genetic at the somatic tumor level. The disease is
not caused by chronic inflammation, infection, radiation exposure in ordinary cases, or inherited
skeletal remodeling disease. Most cases arise sporadically through acquisition of a
characteristic chromosomal translocation.

The major genetic event is a balanced chromosomal translocation involving EWSR1 on

chromosome 22. In most cases, EWSR1 fuses with FLI1 on chromosome 11, producing the
t(11;22)(q24;q12) translocation. Less commonly, EWSR1 fuses with other ETS family
transcription factor genes, such as ERG. These fusions generate abnormal transcription factors
that drive the malignant phenotype.

The precise cell of origin is not fully settled. Mesenchymal stem cells and primitive
neuroectodermal cells have been proposed. The tumor’s primitive small round cell morphology
and neural marker expression in some cases historically led to its relationship with primitive
neuroectodermal tumor terminology. Contemporary classification emphasizes the shared
molecular basis within the Ewing sarcoma family.
Unlike osteosarcoma, Ewing sarcoma is not defined by malignant osteoid production. Unlike
chondrosarcoma, it is not a cartilage-forming tumor. Unlike lymphoma, it is not a lymphoid
neoplasm despite its small round blue cell morphology. Its etiologic identity is therefore rooted
in an EWSR1-associated fusion-driven sarcoma.

Pathogenesis

The central pathogenic mechanism is formation of an abnormal chimeric transcription factor,

most commonly EWSR1–FLI1. The EWSR1 portion contributes a strong transcriptional
activation domain, while the FLI1 portion contributes DNA-binding function. The resulting
fusion protein binds chromatin and dysregulates transcriptional programs that control
proliferation, differentiation, survival, and cellular identity.

EWSR1–FLI1 alters the expression of many downstream genes. It promotes proliferation,

inhibits normal differentiation, and establishes an aberrant transcriptional state compatible with
primitive sarcoma growth. The fusion also influences epigenetic regulation, enhancer activity,
and chromatin accessibility.

The tumor grows rapidly in the medullary cavity and extends through cortical bone. As the
tumor expands, it invades the cortex, lifts the periosteum, and extends into adjacent soft tissue.
The periosteal reaction to the advancing tumor produces layered reactive bone, classically
described radiologically as an onion-skin pattern.

The cytoplasmic glycogen accumulation is a useful morphological clue. Tumor cells often show
PAS-positive cytoplasmic glycogen, which may be digested by diastase. This feature supports
Ewing sarcoma in the appropriate histological and immunophenotypic context.

The major pathological sequence is:

EWSR1-associated fusion formation → abnormal fusion transcription factor activity →

dysregulated proliferation and impaired differentiation → primitive small round cell sarcoma
→ medullary bone growth → cortical destruction, periosteal reaction, and soft tissue extension.

The key pathogenic distinction is that Ewing sarcoma is driven by a recurrent fusion
transcription factor, whereas many other bone sarcomas show complex karyotypes or matrix-
producing differentiation.
Macroscopic Findings

Grossly, Ewing sarcoma usually arises in the medullary cavity of bone. It commonly involves
the diaphysis of long tubular bones, including the femur, tibia, fibula, humerus, and pelvic
bones. Flat bones such as pelvis, ribs, scapula, and vertebrae may also be involved.

The tumor expands within the marrow cavity and invades outward through cortical bone.
Cortical destruction is common. Extension beneath and through the periosteum produces a soft
tissue mass. The periosteal reaction may be layered, corresponding to the characteristic onion-
skin appearance on imaging.

The cut surface is typically soft, tan-white, gray-white, or fleshy. Areas of hemorrhage and
necrosis are frequent. The tumor may be friable and may replace the marrow extensively. Soft
tissue extension can be substantial and may appear disproportionate to the degree of initial
cortical destruction.

Because the tumor is highly cellular and poorly differentiated, it may resemble other soft, fleshy,
high-grade malignant tumors grossly. The definitive diagnosis depends on microscopic
morphology, immunohistochemistry, and molecular confirmation of the characteristic fusion.

Histopathological Findings

Histologically, Ewing sarcoma is one of the classic small round blue cell tumors. It is composed
of diffuse sheets, nests, or lobules of uniform primitive small round cells. The cells are usually
slightly larger than lymphocytes and are more cohesive than lymphoid cells.

The nuclei are round to oval with finely dispersed chromatin. Nucleoli are usually
inconspicuous. Cytoplasm is scant, but may appear clear because of abundant glycogen. Cell
borders may be indistinct. Mitotic activity is variable but often brisk. Necrosis is common,
especially in larger tumors.

PAS staining may demonstrate cytoplasmic glycogen. Diastase digestion removes glycogen-
related PAS positivity, supporting the interpretation. However, PAS positivity is supportive
rather than diagnostic because other tumors may also contain glycogen.

Homer-Wright rosettes may be present in some cases. These consist of circular arrangements
of tumor cells around a central fibrillary space. Their presence suggests neural differentiation
but is not required for diagnosis.
The tumor does not produce osteoid, bone, or cartilage. This is a critical histopathological point.
Any convincing malignant osteoid produced directly by tumor cells should prompt
consideration of small cell osteosarcoma rather than Ewing sarcoma.

Immunohistochemistry typically shows strong membranous CD99 expression. However, CD99

is sensitive but not specific, and it must be interpreted with morphology and molecular findings.
NKX2.2 is a useful supportive marker in many cases. FLI1 may be positive but is not fully
specific. Cytokeratin may be focally positive in some cases, which can create diagnostic
difficulty. Leukocyte common antigen is negative, helping exclude lymphoma. Desmin and
myogenin are negative, helping exclude rhabdomyosarcoma.

Molecular confirmation is often decisive. Fluorescence in situ hybridization, RT-PCR, or next-

generation sequencing may demonstrate EWSR1 rearrangement or a specific EWSR1–ETS
fusion. The most common fusion is EWSR1–FLI1.

The concise histopathological formulation is:

a malignant small round blue cell tumor composed of sheets of uniform primitive cells with
scant glycogen-rich cytoplasm, strong membranous CD99 expression, absence of malignant
osteoid or cartilage production, and EWSR1-associated fusion, most commonly EWSR1–FLI1.

Differential Diagnosis

The most important differential diagnosis is small cell osteosarcoma. Small cell osteosarcoma
can closely mimic Ewing sarcoma because it is composed of small round cells and occurs in
bone. The decisive distinction is malignant osteoid production by tumor cells. Ewing sarcoma
does not produce osteoid, bone, or cartilage. Identification of even focal malignant osteoid
supports small cell osteosarcoma.

Lymphoblastic lymphoma may resemble Ewing sarcoma as a small round blue cell tumor.
Lymphoblastic lymphoma expresses leukocyte common antigen and precursor lymphoid
markers such as TdT. Ewing sarcoma lacks a true lymphoid immunophenotype and is instead
characterized by CD99 expression and EWSR1-associated fusion.

Rhabdomyosarcoma may enter the differential diagnosis, particularly in soft tissue or

extraskeletal presentations. Rhabdomyosarcoma shows skeletal muscle differentiation and
expresses myogenic markers such as desmin, myogenin, and MyoD1. Ewing sarcoma lacks
definitive myogenic differentiation.
Neuroblastoma may mimic Ewing sarcoma in children and may form small round blue cell
tumors with rosettes. Neuroblastoma often shows neuropil, ganglion cell differentiation in some
cases, and expression of neuroendocrine markers. It may also be associated with adrenal or
sympathetic chain origin. Ewing sarcoma is defined by EWSR1-associated fusion and usually
strong membranous CD99.

Mesenchymal chondrosarcoma contains small round cell areas that may resemble Ewing
sarcoma. However, it also contains islands of well-differentiated hyaline cartilage. This biphasic
pattern with cartilaginous differentiation separates it from Ewing sarcoma.

Desmoplastic small round cell tumor may express EWSR1 rearrangement but usually involves
EWSR1–WT1 fusion and occurs most often as multiple serosal or intra-abdominal masses. It
shows polyphenotypic immunoreactivity, often including cytokeratin, desmin with perinuclear
dot-like staining, and WT1 nuclear positivity with appropriate antibody clone. Ewing sarcoma
usually has EWSR1–FLI1 or related ETS fusion and lacks the classic desmoplastic small round
cell tumor immunophenotype.

Poorly differentiated synovial sarcoma may mimic Ewing sarcoma. Synovial sarcoma is
associated with SS18–SSX fusion and may express cytokeratin and EMA. It may show a
monophasic spindle cell pattern or poorly differentiated round cell pattern. Molecular testing
distinguishes it from Ewing sarcoma.

Metastatic small cell carcinoma may resemble Ewing sarcoma in small biopsies. Carcinoma
expresses epithelial markers strongly and diffusely and usually lacks EWSR1–ETS fusion. In
bone lesions, metastatic small cell carcinoma should especially be considered in adults.
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

Medullary
tumor with
cortical Sheets of uniform
destruction, primitive small
Diaphysis or periosteal round cells with
metadiaphysis of reaction, scant glycogen-rich EWSR1–FLI1 or
long bones; onion-skin cytoplasm, strong related EWSR1–
Ewing sarcoma pelvis, ribs, pattern, soft CD99 expression, ETS fusion-driven
vertebrae; tissue no osteoid or small round cell
extraskeletal soft extension, cartilage sarcoma
tissue possible tan-white production,
soft mass EWSR1-associated
with fusion
hemorrhage
and necrosis

Small round
Metaphysis of malignant cells
Small cell Destructive Osteoid production
long bones with direct
osteosarcoma bone mass by tumor cells
common malignant osteoid
production

Lymph nodes,
Soft tissue or
mediastinum, Lymphoblasts Precursor
Lymphoblastic marrow
marrow, expressing TdT and lymphoid
lymphoma infiltrative
extranodal tissue lymphoid markers immunophenotype
mass
including bone

Primitive tumor
Soft tissue, head Soft tissue Myogenic
Rhabdomyosarcoma cells with skeletal
and neck, mass differentiation
muscle
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

genitourinary differentiation;
tract, extremities desmin, myogenin,
MyoD1 positive

Neuroendocrine
Adrenal medulla, Adrenal or
Small round blue differentiation and
sympathetic paraspinal
Neuroblastoma cells with neuropil sympathetic
chain; metastasis mass; bone
and rosettes nervous system
to bone possible metastases
origin

Lobulated
mass, Biphasic pattern:
Mesenchymal Bone and soft sometimes small round cells Cartilaginous
chondrosarcoma tissue with plus islands of differentiation
calcified hyaline cartilage
cartilage

Multiple
Small round cells in
Peritoneal/serosal intra- WT1-associated
Desmoplastic small desmoplastic
surfaces, abdominal polyphenotypic
round cell tumor stroma; EWSR1–
abdomen or serosal tumor
WT1 fusion
masses

Deep soft tissue Poorly Synovial sarcoma

Poorly differentiated near joints; may Deep soft differentiated round fusion and
synovial sarcoma involve bone tissue mass or spindle cells; epithelial marker
secondarily SS18–SSX fusion profile

Small
Bone metastasis Destructive Epithelial
Metastatic small cell hyperchromatic
from lung or other metastatic neuroendocrine
carcinoma cells with nuclear
site bone lesion carcinoma rather
molding and
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

neuroendocrine than EWSR1-

marker positivity fusion sarcoma
KARTAGENER SYNDROME

Kartagener syndrome is a congenital disorder within the spectrum of primary ciliary dyskinesia,
a genetically heterogeneous disease caused by defective structure or function of motile cilia.
The syndrome is classically defined by the triad of chronic sinus disease, bronchiectasis, and
situs inversus. The basic pathological abnormality is impaired ciliary motility caused most
commonly by defective dynein arms within the ciliary axoneme.

Motile cilia are essential for mucociliary clearance in the respiratory tract, for normal movement
of mucus and trapped microorganisms, and for normal left-right body axis determination during
embryogenesis. Similar axonemal structures are present in sperm flagella; therefore, the same
structural defect may impair sperm motility.

The central pathological identity of Kartagener syndrome is a congenital defect of ciliary

motility producing impaired mucociliary clearance, recurrent airway infection, chronic
bronchial inflammation, and irreversible bronchiectatic destruction. The characteristic
extracardiopulmonary anatomic association is situs inversus, reflecting defective embryonic
nodal ciliary function.

The key pathology-related features are chronic sinus disease, situs inversus totalis, bilateral
diffuse cylindrical bronchiectasis, markedly impaired sperm motility, markedly dilated
bronchi filled with mucopurulent material, chronic inflammatory changes, and extensive
bronchiectatic destruction. The characteristic ultrastructural lesion is Dynein arm defect.

Etiology

Kartagener syndrome is caused by inherited defects affecting the structure and function of
motile cilia. It is usually inherited as an autosomal recessive disorder. The broader disease
category is primary ciliary dyskinesia, in which many different genes may be affected.

The most frequently implicated genes encode proteins required for dynein arm assembly, ciliary
axonemal stability, or ciliary motility. Important examples include dynein axonemal heavy
chain 5 (DNAH5), dynein axonemal intermediate chain 1 (DNAI1), dynein axonemal heavy
chain 11 (DNAH11), coiled-coil domain containing 39 (CCDC39), coiled-coil domain
containing 40 (CCDC40), and other genes involved in axonemal organization. These genes
encode components or assembly factors of the ciliary motor apparatus.

The dynein arms are adenosine triphosphate-dependent motor protein complexes attached to
peripheral microtubule doublets of motile cilia. They generate the sliding forces that allow cilia
to beat. When dynein arms are absent, shortened, or dysfunctional, ciliary beating becomes
ineffective or immotile.

The syndrome is not caused by secondary inflammatory destruction of cilia alone. Chronic
airway inflammation and infection develop as consequences of the congenital ciliary defect.
This distinction is important because acquired ciliary injury may occur in chronic bronchitis,
smoking-related airway disease, or infection, but Kartagener syndrome is a primary inherited
axonemal disorder.

The etiologic formulation is therefore: autosomal recessive mutation affecting motile ciliary
axonemal proteins or assembly factors → defective dynein arm structure or function →
impaired ciliary motility → abnormal mucociliary clearance, situs inversus, and bronchiectasis.

Pathogenesis

The central pathogenic process is defective motile ciliary beating. Normal motile cilia have a
9+2 axonemal arrangement, consisting of nine peripheral microtubule doublets surrounding two
central microtubules. Inner and outer dynein arms attached to the peripheral doublets generate
force through adenosine triphosphate hydrolysis, allowing coordinated bending and beating of
the cilium.

In Kartagener syndrome, the dynein arm apparatus is structurally absent or functionally

defective. This produces ineffective ciliary movement. In the respiratory tract, impaired
mucociliary clearance prevents normal removal of mucus, bacteria, and inhaled particles.
Retained secretions predispose to recurrent and persistent infection.

Repeated infection and chronic inflammation damage the bronchial wall. Neutrophil-rich
inflammation and bacterial colonization promote release of proteases and oxidants. These
mediators destroy smooth muscle and supporting elastic tissue within bronchial walls. Once the
bronchial wall is structurally weakened, the airway becomes permanently dilated, producing
bronchiectasis.

The ciliary defect also affects paranasal sinus drainage and middle ear clearance. This explains
chronic sinus disease and recurrent otitis media in the broader primary ciliary dyskinesia
phenotype. In the male reproductive tract, defective flagellar motility causes impaired sperm
movement and may produce infertility.

During embryogenesis, motile nodal cilia are required to establish normal left-right asymmetry.
Dysfunction of these cilia randomizes left-right body axis development. Approximately half of
patients with primary ciliary dyskinesia may have situs inversus; when situs inversus occurs
together with chronic sinus disease and bronchiectasis, the clinicopathological syndrome is
called Kartagener syndrome.

The major pathological sequence is:

inherited axonemal dynein arm defect → ineffective ciliary beating → impaired mucociliary
clearance → recurrent infection and mucus retention → chronic bronchial inflammation →
destruction of bronchial smooth muscle and elastic tissue → irreversible bronchiectasis.

The essential pathogenic idea is that bronchiectasis in Kartagener syndrome is secondary to

congenital ciliary immotility. The airway dilation is not the initiating lesion; it is the structural
consequence of chronic infection and inflammatory destruction of the bronchial wall.

Macroscopic Findings

Grossly, the dominant pulmonary lesion is bronchiectasis. The affected lungs may show diffuse
or segmental involvement, often with prominent lower respiratory tract disease. The bronchi
and bronchioles are permanently dilated and may extend abnormally close to the pleural
surface.

The characteristic bronchiectatic airways are markedly dilated bronchi filled with
mucopurulent material. The lumina contain thick mucus, pus, and inflammatory exudate. The
bronchial walls are thickened because of chronic inflammation, fibrosis, and destruction of
normal supporting structures.

In diffuse disease, the cut surface may show multiple dilated airways, sometimes producing a
honeycomb-like appearance. Depending on the pattern of airway dilation, bronchiectasis may
be cylindrical, fusiform, saccular, or varicose. In Kartagener syndrome, bilateral diffuse
cylindrical bronchiectasis is a classic structural pattern.

The surrounding lung parenchyma may show atelectasis, fibrosis, chronic pneumonitis, and
secondary infection-related changes. Pleural fibrosis and adhesions may develop in chronic
severe disease.

Situs inversus totalis is an anatomic laterality abnormality in which thoracic and abdominal
organs are arranged as a mirror image of normal. In Kartagener syndrome, this corresponds to
situs inversus totalis and reflects embryonic nodal ciliary dysfunction rather than acquired
cardiopulmonary disease.
The gross pathological picture is therefore chronic bronchiectatic lung disease with mucus- and
pus-filled dilated bronchi, chronic inflammatory destruction of bronchial walls, and associated
laterality abnormality when situs inversus is present.

Histopathological Findings

The histopathology is dominated by chronic bronchiectatic airway injury. The affected bronchi
show permanent dilation with destruction of smooth muscle and elastic tissue in the bronchial
wall. This structural loss is the basis of irreversible bronchiectasis.

The bronchial epithelium may be ulcerated, denuded, hyperplastic, or show squamous

metaplasia. Chronic irritation and infection promote epithelial remodeling. Goblet cell
hyperplasia and mucous gland enlargement may contribute to excessive mucus production.

The bronchial lumina contain mucopurulent exudate composed of mucus, neutrophils, cellular
debris, bacteria, and desquamated epithelial cells. This corresponds to markedly dilated
bronchi filled with mucopurulent material.

The bronchial wall shows acute and chronic inflammation. Neutrophils are abundant during
active infection and acute exacerbation. Lymphocytes, plasma cells, macrophages, and fibrosis
are prominent in chronic disease. These changes correspond to chronic inflammatory
changes.

As inflammation persists, proteolytic injury destroys bronchial smooth muscle and elastic
fibers. The wall becomes weakened, fibrotic, and permanently dilated. This produces extensive
bronchiectatic destruction. Adjacent lung parenchyma may show chronic inflammation,
organizing pneumonia, atelectatic change, and peribronchial fibrosis.

The sinonasal mucosa shows chronic inflammatory changes related to defective mucociliary
clearance. The same basic defect may affect eustachian tube and middle ear mucociliary
function, predisposing to chronic otitis media.

In reproductive tissue, sperm flagella may appear structurally abnormal or functionally

immotile. The pathology-relevant concept is markedly impaired sperm motility, reflecting
the shared axonemal basis of motile cilia and sperm flagella.

The concise histopathological formulation is:

primary ciliary dyskinesia-associated bronchiectasis with chronically inflamed, permanently

dilated bronchi; mucopurulent luminal exudate; epithelial ulceration or squamous metaplasia;
destruction of bronchial smooth muscle and elastic tissue; peribronchial fibrosis; and secondary
chronic inflammatory lung injury.

Electron Microscopic Findings

Electron microscopy demonstrates the characteristic axonemal abnormality: Dynein arm

defect. The most classic finding is absence, shortening, or structural abnormality of outer
dynein arms, inner dynein arms, or both within the ciliary axoneme.

Normal motile cilia have a 9+2 microtubular arrangement, with nine peripheral microtubule
doublets surrounding a central pair. Dynein arms project from the peripheral doublets and
generate ciliary motion. In Kartagener syndrome, dynein arm abnormalities impair the sliding
movement of microtubule doublets and produce ineffective ciliary beating.

Electron microscopy of bronchial epithelial samples may show loss of outer dynein arms, loss
of inner dynein arms, combined dynein arm loss, abnormal radial spokes, microtubular
disorganization, or central pair abnormalities, depending on the underlying genetic defect. In
classic teaching and in the examined disease pattern, the high-yield ultrastructural phrase is
Dynein arm defect.

The same axonemal abnormality may be present in sperm flagella, explaining impaired motility.
Thus, the EM finding directly links the respiratory, reproductive, and laterality features of the
disease.

Differential Diagnosis

The most important differential diagnosis is cystic fibrosis. Cystic fibrosis also causes chronic
sinopulmonary infection and bronchiectasis, but it results from mutations in the cystic fibrosis
transmembrane conductance regulator gene, which encodes a chloride channel. The primary
abnormality is dehydrated, thick secretions due to abnormal ion transport rather than defective
ciliary dynein arms. Pancreatic exocrine disease, meconium ileus, elevated sweat chloride, and
absence of situs inversus support cystic fibrosis rather than Kartagener syndrome.

Postinfectious bronchiectasis may occur after severe necrotizing pneumonia, tuberculosis,

measles, pertussis, or other destructive infections. In postinfectious bronchiectasis, airway
dilation follows a major inflammatory injury. There is no congenital ciliary motility defect, no
consistent situs inversus, and no sperm flagellar dynein arm abnormality.
Obstructive bronchiectasis may occur distal to airway obstruction by tumor, foreign body,
mucus plug, lymph node compression, or post-inflammatory stenosis. This form is usually
localized to the obstructed segment or lobe. Kartagener syndrome tends to produce diffuse
disease because the underlying abnormality affects motile cilia throughout the respiratory tract.

Immunodeficiency-associated bronchiectasis results from recurrent infections due to impaired

humoral or cellular immunity. Common variable immunodeficiency, immunoglobulin A
deficiency, and other immune defects may cause repeated infections and bronchiectasis. These
disorders do not show the primary axonemal dynein arm defect or situs inversus typical of
Kartagener syndrome.

Allergic bronchopulmonary aspergillosis may cause bronchiectasis, especially central

bronchiectasis, in patients with asthma or cystic fibrosis. It is associated with allergic mucin,
eosinophil-rich inflammation, fungal hyphae, elevated immunoglobulin E, and hypersensitivity
to Aspergillus. The underlying lesion is allergic fungal airway disease rather than congenital
ciliary dyskinesia.

Chronic bronchitis may produce mucus hypersecretion and chronic airway inflammation,
especially in smoking-related disease, but it does not usually produce the congenital triad of
chronic sinus disease, bronchiectasis, and situs inversus. Acquired ciliary dysfunction may
occur in chronic smoking-related injury, but it is not equivalent to inherited primary ciliary
dyskinesia.

Young syndrome may show bronchiectasis and obstructive azoospermia, but ciliary
ultrastructure is typically normal. Infertility is due to obstruction rather than primary sperm
flagellar immotility. This distinguishes it from Kartagener syndrome, where sperm motility is
impaired because of an axonemal defect.
 Gross / Key
Distinguishing
Disease Primary Defect Structural Histopathological
Feature
Pattern Finding

Dynein arm
Bilateral Markedly dilated
defect in ciliary
diffuse bronchi filled with
Inherited axonemes with
cylindrical mucopurulent
primary ciliary impaired
Kartagener bronchiectasis, material, chronic
dyskinesia with mucociliary
syndrome situs inversus inflammatory
Dynein arm clearance and
totalis, chronic changes, extensive
defect markedly
sinonasal bronchiectatic
impaired sperm
disease destruction
motility

Cystic fibrosis
transmembrane Diffuse Thick dehydrated
conductance bronchiectasis, Mucus obstruction, secretions,
regulator gene mucus chronic infection, pancreatic
Cystic fibrosis
mutation causing plugging, bronchiectatic involvement,
abnormal pancreatic destruction elevated sweat
chloride disease chloride
transport

History and
Segmental or
Airway Chronic distribution of
diffuse
Postinfectious destruction after suppurative airway destructive
bronchiectasis
bronchiectasis necrotizing inflammation and infection; no
depending on
infection wall destruction congenital ciliary
infection
defect

Local airway
Localized Chronic
obstruction by Localized disease
Obstructive bronchiectasis inflammation and
tumor, foreign with identifiable
bronchiectasis distal to dilation distal to
body, mucus obstruction
obstruction blocked airway
plug, or stenosis
 Gross / Key
Distinguishing
Disease Primary Defect Structural Histopathological
Feature
Pattern Finding

Impaired Diffuse or Abnormal

Immunodeficiency- immune defense recurrent Chronic airway immunoglobulins
associated causing infection- inflammation and or immune
bronchiectasis recurrent related destruction function; no
infection bronchiectasis dynein arm defect

Asthma/cystic
Central
Allergic Hypersensitivity Allergic mucin, fibrosis
bronchiectasis
bronchopulmonary to Aspergillus in eosinophils, fungal background with
and mucus
aspergillosis airway hyphae allergic fungal
plugging
airway disease

Mucous gland Smoking-related

Thickened enlargement, mucus disease
Chronic irritant-
bronchi with goblet cell without situs
Chronic bronchitis induced mucus
mucus hyperplasia, inversus or
hypersecretion
hypersecretion chronic congenital
inflammation axonemal defect

Infertility due to
Obstructive Airway
Bronchiectasis obstruction;
azoospermia inflammation and
Young syndrome with male ciliary
with bronchiectatic
infertility ultrastructure
bronchiectasis change
usually preserved
AMYOTROPHIC LATERAL SCLEROSIS

Amyotrophic lateral sclerosis is a progressive neurodegenerative motor neuron disease

characterized by degeneration of both upper motor neurons and lower motor neurons. The term
“amyotrophic” refers to muscle wasting caused by denervation, while “lateral sclerosis” refers
to degeneration and gliotic sclerosis of the lateral corticospinal tracts in the spinal cord.

The disease primarily targets motor neurons in the cerebral motor cortex, corticospinal tracts,
brain stem motor nuclei, and anterior horns of the spinal cord. Sensory neurons are relatively
spared. This selective involvement explains why the pathological core of the disease is motor
system degeneration rather than a diffuse encephalopathy, demyelinating disease, primary
myopathy, or peripheral sensory neuropathy.

Pathologically, amyotrophic lateral sclerosis is defined by loss of lower motor neurons in the
anterior horns of the spinal cord and motor cranial nerve nuclei, together with degeneration of
upper motor neurons and descending corticospinal tracts. Loss of anterior horn cells produces
denervation atrophy of skeletal muscle. Degeneration of corticospinal tracts produces lateral
column pallor, myelin loss, axonal loss, and gliosis.

The essential pathological identity is combined upper and lower motor neuron degeneration
with anterior horn cell loss, corticospinal tract degeneration, reactive gliosis, motor root
atrophy, and neurogenic skeletal muscle atrophy.

Etiology

The etiology of amyotrophic lateral sclerosis is heterogeneous. Most cases are sporadic, while
a minority are familial. The disease is not a primary inflammatory, infectious, vascular,
demyelinating, or muscular disorder. It is a neurodegenerative disease centered on selective
vulnerability of motor neurons.

Familial forms are associated with mutations in several genes involved in protein homeostasis,
ribonucleic acid metabolism, cytoskeletal regulation, mitochondrial function, axonal transport,
oxidative stress response, and autophagy. Important genes include superoxide dismutase 1
(SOD1), chromosome 9 open reading frame 72 (C9orf72), TAR DNA-binding protein gene
(TARDBP), fused in sarcoma gene (FUS), optineurin gene (OPTN), valosin-containing protein
gene (VCP), and TANK-binding kinase 1 gene (TBK1).
Superoxide dismutase 1 (SOD1) mutations were among the earliest genetic causes identified.
Mutant superoxide dismutase 1 protein may misfold and acquire toxic properties, causing
oxidative stress, mitochondrial injury, axonal dysfunction, and motor neuron degeneration.

Chromosome 9 open reading frame 72 (C9orf72) repeat expansion is one of the most important
genetic abnormalities associated with familial amyotrophic lateral sclerosis and with
amyotrophic lateral sclerosis-frontotemporal dementia overlap. It produces disease through
toxic ribonucleic acid foci, abnormal dipeptide repeat proteins, and impaired cellular
homeostasis.

TAR DNA-binding protein 43 (TDP-43) pathology is central in most sporadic cases and many
familial cases. TAR DNA-binding protein 43 is a ribonucleic acid-binding protein normally
present in the nucleus. In amyotrophic lateral sclerosis, it may become mislocalized to the
cytoplasm, phosphorylated, ubiquitinated, and aggregated. This produces cytoplasmic
inclusions and loss of normal nuclear function.

Environmental factors have been proposed, including trauma, intense physical exertion, toxins,
smoking, heavy metals, pesticides, and military exposure, but none provides a universal causal
explanation. The disease is best regarded as a convergence of genetic susceptibility, protein
misfolding, impaired ribonucleic acid processing, excitotoxicity, mitochondrial dysfunction,
axonal transport failure, and non-neuronal glial contributions.

Pathogenesis

The pathogenesis of amyotrophic lateral sclerosis involves selective degeneration of motor

neurons through multiple intersecting mechanisms. The final common outcome is progressive
loss of upper and lower motor neurons.

Protein misfolding and aggregation are central mechanisms. In most cases, abnormal
cytoplasmic aggregates containing TAR DNA-binding protein 43 are found in affected neurons
and glial cells. These inclusions are often ubiquitinated, indicating involvement of the ubiquitin-
proteasome system. Abnormal protein aggregation may impair cellular trafficking, ribonucleic
acid processing, stress granule dynamics, and neuronal survival.

Ribonucleic acid metabolism is strongly implicated. TAR DNA-binding protein 43 and fused
in sarcoma protein are ribonucleic acid-binding proteins. Mutations or mislocalization of these
proteins disrupt messenger ribonucleic acid splicing, transport, stabilization, and translation.
Motor neurons are particularly vulnerable because of their long axons, high metabolic demands,
and dependence on precise local protein synthesis.

Excitotoxicity contributes to motor neuron injury. Glutamate is the major excitatory

neurotransmitter in the central nervous system. Excessive glutamatergic stimulation increases
intracellular calcium, activates calcium-dependent enzymes, damages mitochondria, and
promotes neuronal death. Impaired glutamate clearance by astrocytes may amplify this process.

Oxidative stress and mitochondrial dysfunction are also important. Motor neurons have high
energy requirements and long axons, making them vulnerable to mitochondrial failure. Mutant
superoxide dismutase 1 and other abnormalities may increase oxidative injury, impair
respiratory chain function, and promote apoptosis-like or necroptosis-like neuronal death
pathways.

Axonal transport failure contributes to degeneration. Motor neurons depend on long-distance

transport between cell bodies and neuromuscular junctions. Cytoskeletal abnormalities,
neurofilament accumulation, and transport defects impair delivery of essential organelles,
proteins, and trophic signals. Distal axonal degeneration and neuromuscular junction
denervation may precede complete loss of the neuronal cell body.

Glial cells are important modifiers of disease. Astrocytes, microglia, and oligodendrocytes may
contribute to motor neuron injury through impaired glutamate uptake, inflammatory mediator
release, oxidative stress, and defective metabolic support. Although amyotrophic lateral
sclerosis is not primarily an inflammatory disease, glial activation participates in disease
progression.

The major pathological sequence is:

genetic or sporadic molecular injury → abnormal protein homeostasis and ribonucleic acid
processing → mitochondrial dysfunction, excitotoxicity, oxidative stress, and axonal transport
failure → selective motor neuron degeneration → corticospinal tract degeneration and anterior
horn cell loss → denervation atrophy of skeletal muscle.

The essential pathogenic idea is that amyotrophic lateral sclerosis is a selective motor neuron
degeneration in which abnormal protein handling and ribonucleic acid biology converge with
metabolic and axonal vulnerability.

Macroscopic Findings
Gross findings may be subtle, especially early in disease. In advanced disease, the spinal cord
may show atrophy of anterior roots because of loss of lower motor neurons and their axons.
Anterior spinal nerve roots may appear thin compared with posterior sensory roots.

The lateral columns of the spinal cord may show pallor due to degeneration of the corticospinal
tracts. This tract degeneration is the anatomical basis of the term lateral sclerosis. The spinal
cord may show mild atrophy, particularly in regions with prominent motor neuron loss.

The motor cortex may show variable atrophy, especially involving the precentral gyrus in
advanced disease. Brain stem motor nuclei may be affected, particularly in bulbar forms.
Extraocular motor nuclei are relatively spared in most cases.

Skeletal muscles innervated by affected motor neurons become atrophic. Grossly, affected
muscles may appear shrunken, pale, and reduced in bulk. The distribution may be regional and
corresponds to the pattern of denervation.

The classical gross pathological picture is attenuation of anterior motor roots, pallor of lateral
corticospinal tracts, selective motor system involvement, and skeletal muscle wasting due to
denervation.

Histopathological Findings

In the spinal cord, the most important microscopic lesion is loss of anterior horn motor neurons.
The anterior horns show reduced numbers of large motor neurons, accompanied by reactive
gliosis. Remaining neurons may show shrinkage, chromatolysis, or degenerative changes.

The anterior roots show loss of myelinated motor fibers. This corresponds to degeneration of
axons arising from anterior horn cells. Posterior sensory roots are relatively preserved, which
supports the selective motor nature of the disease.

The lateral corticospinal tracts show degeneration with myelin pallor, axonal loss, macrophage-
mediated myelin clearance, and astrocytic gliosis. These changes reflect upper motor neuron
pathway degeneration.

Motor cranial nerve nuclei in the brain stem may be involved, especially nuclei supplying
bulbar musculature. The hypoglossal nucleus may show neuronal loss and gliosis. Extraocular
motor nuclei are relatively spared in most cases, which is a characteristic distributional feature.

Cytoplasmic inclusions may be seen in affected neurons. In many cases, inclusions contain TAR
DNA-binding protein 43. These inclusions may be highlighted by immunohistochemistry for
phosphorylated TAR DNA-binding protein 43 or ubiquitin. Bunina bodies may be present in
some cases; these are small eosinophilic intracytoplasmic inclusions in anterior horn cells and
are regarded as a classic pathological feature of amyotrophic lateral sclerosis.

Skeletal muscle shows neurogenic atrophy. Denervated muscle fibers become small and
angulated. Groups of atrophic fibers may be seen because motor neurons innervate groups of
muscle fibers. Reinnervation by collateral sprouting from surviving motor neurons may
produce fiber type grouping. With progression, denervation atrophy becomes more extensive.

The concise histopathological formulation is:

selective motor neuron degeneration with anterior horn cell loss, anterior root myelinated fiber
loss, corticospinal tract degeneration, reactive gliosis, TAR DNA-binding protein 43-positive
cytoplasmic inclusions in many cases, and neurogenic skeletal muscle atrophy with groups of
small angulated fibers.

Differential Diagnosis

The most important differential diagnosis is spinal muscular atrophy. Spinal muscular atrophy
is a genetic lower motor neuron disease caused by abnormalities in survival motor neuron 1
gene (SMN1). It primarily affects anterior horn cells and produces lower motor neuron
degeneration, but it lacks the combined upper motor neuron degeneration and lateral
corticospinal tract sclerosis characteristic of amyotrophic lateral sclerosis.

Primary lateral sclerosis is a motor neuron disorder dominated by upper motor neuron
degeneration. It shows corticospinal tract involvement without the prominent lower motor
neuron loss and denervation atrophy typical of amyotrophic lateral sclerosis. The distinction is
based on the predominance of corticospinal tract disease and relative absence of anterior horn
cell degeneration.

Progressive muscular atrophy is dominated by lower motor neuron degeneration. It may

resemble amyotrophic lateral sclerosis because of anterior horn cell loss and skeletal muscle
denervation. However, corticospinal tract degeneration and upper motor neuron involvement
are absent or minimal.

Spinal and bulbar muscular atrophy, also known as Kennedy disease, is an X-linked
trinucleotide repeat disorder caused by CAG repeat expansion in the androgen receptor gene. It
produces lower motor neuron degeneration with bulbar and limb involvement, often
accompanied by androgen insensitivity features such as gynecomastia and testicular atrophy. It
lacks the classical upper motor neuron tract degeneration of amyotrophic lateral sclerosis.

Cervical spondylotic myelopathy may mimic amyotrophic lateral sclerosis because it can
produce weakness, spasticity, and lower motor neuron signs at the level of compression.
Pathologically, it is a compressive myelopathy with spinal cord tissue injury, demyelination,
and gliosis at the compressed segment, rather than diffuse motor neuron degeneration with TAR
DNA-binding protein 43 pathology.

Multifocal motor neuropathy may present with progressive motor weakness but is a peripheral
nerve disorder. It is associated with conduction block and may show immune-mediated
demyelination of motor nerves. Sensory nerves are often spared, but the pathological process
is peripheral nerve demyelination rather than degeneration of upper and lower motor neurons.

Myasthenia gravis produces weakness due to autoimmune injury at the neuromuscular junction.
It does not cause anterior horn cell loss, corticospinal tract degeneration, or neurogenic atrophy
as the primary lesion. The key pathology is reduction of acetylcholine receptors and
simplification of postsynaptic folds at the neuromuscular junction.

Inclusion body myositis may cause slowly progressive muscle weakness and atrophy and may
mimic motor neuron disease clinically. However, it is a primary inflammatory-degenerative
myopathy with endomysial inflammation, rimmed vacuoles, myofiber degeneration, and
tubulofilamentous inclusions. Amyotrophic lateral sclerosis is a motor neuron disease with
neurogenic denervation atrophy rather than primary myofiber inflammation.

Gross /
Primary Site of Key Histopathological Distinguishing
Disease Structural
Injury Finding Feature
Pattern

Upper motor Anterior horn cell loss,

Attenuated
neurons, lower anterior root myelinated Combined upper
Amyotrophic anterior motor
motor neurons, fiber loss, corticospinal and lower motor
lateral roots, lateral
corticospinal tract degeneration, neuron
sclerosis corticospinal
tracts, anterior reactive gliosis, TAR degeneration
tract pallor,
horn cells DNA-binding protein
 Gross /
Primary Site of Key Histopathological Distinguishing
Disease Structural
Injury Finding Feature
Pattern

skeletal muscle 43-positive inclusions in

wasting many cases, neurogenic
atrophy

Survival motor
Skeletal muscle neuron 1 gene-
Spinal Lower motor wasting; related lower
Anterior horn cell loss
muscular neurons of anterior horn motor neuron
with neurogenic atrophy
atrophy anterior horn cell disease without
involvement corticospinal tract
sclerosis

Upper motor Corticospinal tract Upper motor

Primary
neurons and Lateral column degeneration with neuron-
lateral
corticospinal degeneration relative sparing of lower predominant
sclerosis
tracts motor neurons disease

Lower motor
neuron-
Muscle wasting
Progressive Lower motor neuron predominant
Lower motor and anterior
muscular loss with denervation disease without
neurons horn cell
atrophy atrophy significant upper
involvement
motor neuron
pathology

X-linked
Spinal and Lower motor Bulbar and limb Lower motor neuron
androgen receptor
bulbar neurons in spinal lower motor degeneration with
CAG repeat
muscular cord and brain neuron androgen receptor-
disease with
atrophy stem involvement related inclusions
androgen
 Gross /
Primary Site of Key Histopathological Distinguishing
Disease Structural
Injury Finding Feature
Pattern

insensitivity
features

Focal cord Segmental cord injury,

Cervical Compressed Structural
compression demyelination, gliosis,
spondylotic cervical spinal compressive
and axonal loss at
myelopathy cord myelopathy
myelomalacia compression site

Peripheral nerve
Peripheral motor
Multifocal involvement Motor nerve
Peripheral motor neuropathy rather
motor without primary demyelination with
nerves than motor neuron
neuropathy spinal cord conduction block
degeneration
degeneration

Junctional
Muscles may Reduced acetylcholine
Myasthenia Neuromuscular transmission
appear grossly receptors and simplified
gravis junction disorder rather
normal until late postsynaptic folds
than neuron loss

Endomysial
inflammation, rimmed Primary
Inclusion Skeletal muscle Muscle atrophy, vacuoles, degenerating inflammatory-
body myositis fibers often selective myofibers, degenerative
tubulofilamentous myopathy
inclusions
WEGENER GRANULOMATOSIS / GRANULOMATOSIS WITH POLYANGIITIS

Wegener granulomatosis, currently termed granulomatosis with polyangiitis, is an

antineutrophil cytoplasmic antibody-associated necrotizing vasculitis characterized by
destructive granulomatous inflammation of the respiratory tract and necrotizing vasculitis of
small- to medium-sized vessels. The disease most characteristically involves the upper
respiratory tract, lower respiratory tract, and kidneys.

The classic pathological triad consists of necrotizing granulomatous inflammation of the upper
and/or lower respiratory tract, necrotizing or granulomatous vasculitis affecting small- to
medium-sized vessels, and focal necrotizing glomerulonephritis, often with crescent formation.
Limited forms may be restricted to the respiratory tract, while systemic forms may involve the
kidneys, skin, eyes, peripheral nerves, heart, joints, and other organs.

The disease is a prototype of antineutrophil cytoplasmic antibody-associated vasculitis. The

most characteristic serologic association is proteinase 3-antineutrophil cytoplasmic antibody,
historically corresponding to cytoplasmic antineutrophil cytoplasmic antibody. The vascular
injury is usually pauci-immune, meaning that immunoglobulin and complement deposition is
minimal or absent in the affected vessels and glomeruli.

The essential pathological identity is necrotizing granulomatous inflammation of the respiratory

tract combined with pauci-immune necrotizing small- to medium-vessel vasculitis and
necrotizing crescentic glomerulonephritis.

Etiology

The precise etiology of granulomatosis with polyangiitis is not fully established. The disease is
best understood as an autoimmune vasculitis in which antineutrophil cytoplasmic antibodies,
especially proteinase 3-antineutrophil cytoplasmic antibody, participate in neutrophil activation
and vascular injury.

Antineutrophil cytoplasmic antibodies are autoantibodies directed against enzymes within

neutrophil cytoplasmic granules and monocyte lysosomes. In granulomatosis with polyangiitis,
the dominant target is proteinase 3, a serine protease found in neutrophil granules. Less
commonly, myeloperoxidase-antineutrophil cytoplasmic antibody may be detected, but
myeloperoxidase association is more typical of microscopic polyangiitis and eosinophilic
granulomatosis with polyangiitis.
Genetic susceptibility contributes to disease risk. Associations with immune-regulatory genes
and genes related to the proteinase 3-antineutrophil cytoplasmic antibody phenotype have been
described. These genetic factors probably influence the tendency to produce pathogenic
antineutrophil cytoplasmic antibodies and to sustain abnormal neutrophil-mediated
inflammation.

Environmental and infectious triggers have been proposed. Inhaled antigens, respiratory
infections, nasal carriage of Staphylococcus aureus, silica exposure, and other mucosal immune
stimuli may contribute to disease initiation or relapse in susceptible individuals. However, no
single infectious agent has been established as the direct cause.

The etiologic framework is therefore: genetically susceptible host, mucosal or environmental

immune trigger, loss of tolerance to neutrophil granule antigens, development of proteinase 3-
antineutrophil cytoplasmic antibody, neutrophil activation, and necrotizing granulomatous
vasculitis.

Pathogenesis

The central pathogenic event is antineutrophil cytoplasmic antibody-mediated activation of

primed neutrophils. Inflammatory cytokines prime neutrophils and cause antigens such as
proteinase 3 and myeloperoxidase to become expressed or more accessible at the neutrophil
surface. Circulating antineutrophil cytoplasmic antibodies bind these antigens and activate
neutrophils.

Activated neutrophils adhere to endothelium and release reactive oxygen species, proteolytic
enzymes, neutrophil extracellular traps, and inflammatory mediators. This causes endothelial
injury, fibrinoid necrosis, and transmural vascular damage. Because the injury is driven
primarily by activated neutrophils rather than by deposition of circulating immune complexes,
the lesions are typically pauci-immune.

Granulomatous inflammation is a defining feature in the respiratory tract. The exact mechanism
of granuloma formation is not completely established, but it likely reflects a cell-mediated
immune response to inhaled or mucosal antigens, persistent neutrophil-rich necrosis,
macrophage activation, and fibroblastic organization. The result is necrotizing granulomatous
inflammation, especially in the upper airways and lungs.

In the kidney, the disease produces pauci-immune necrotizing glomerulonephritis. Capillary

wall necrosis permits fibrin leakage into Bowman space, stimulating parietal epithelial cell
proliferation and macrophage recruitment. This produces crescents. The glomerular
immunofluorescence pattern is typically sparse or negative for immunoglobulins and
complement, distinguishing it from immune complex-mediated glomerulonephritis and anti-
glomerular basement membrane disease.

The major pathological sequence is:

mucosal or environmental immune trigger in susceptible host → proteinase 3-antineutrophil

cytoplasmic antibody formation → neutrophil priming and antibody-mediated neutrophil
activation → endothelial injury and fibrinoid necrosis → pauci-immune necrotizing vasculitis
→ respiratory tract necrotizing granulomatous inflammation and renal necrotizing crescentic
glomerulonephritis.

The essential pathogenic concept is that granulomatosis with polyangiitis combines two
processes: destructive granulomatous inflammation, especially in the respiratory tract, and
antineutrophil cytoplasmic antibody-associated pauci-immune necrotizing vasculitis.

Macroscopic Findings

Gross findings depend on the organ involved.

In the upper respiratory tract, lesions may involve the nasal cavity, paranasal sinuses,
nasopharynx, palate, larynx, or trachea. The mucosa may show ulceration, necrosis, crusting,
and destructive inflammatory lesions. Advanced disease may destroy cartilage and bone,
producing deformity of nasal and midline structures.

In the lung, lesions vary from patchy parenchymal infiltrates to multiple nodular masses.
Pulmonary nodules may be bilateral and may undergo central necrosis and cavitation. The cut
surface of pulmonary nodules may show gray-white necrotic centers surrounded by
hemorrhagic or inflammatory tissue. Cavitating nodules are a characteristic gross and radiologic
expression of necrotizing granulomatous inflammation.

The airways may show ulceration, inflammation, stenosis, or destructive changes. Tracheal or
subglottic stenosis may develop in chronic disease because of scarring.

In the kidney, gross findings may be subtle in early disease. In severe rapidly progressive
glomerulonephritis, kidneys may become enlarged and pale. Petechial cortical hemorrhages
may be present in some cases. Chronic renal involvement may produce scarring and cortical
thinning.
Other organs may show vasculitic lesions, hemorrhage, infarction, ulceration, or nodular
inflammatory lesions depending on the vascular bed involved.

The classical gross pattern is necrotizing destructive lesions of the upper respiratory tract,
cavitating pulmonary nodules, and renal changes of necrotizing crescentic glomerulonephritis.

Histopathological Findings

The histopathological features are best understood by separating respiratory tract lesions,
vascular lesions, and renal lesions.

In the respiratory tract, the characteristic lesion is necrotizing granulomatous inflammation. The
necrosis is often irregular, basophilic, and surrounded by palisading histiocytes, multinucleated
giant cells, lymphocytes, plasma cells, neutrophils, and fibroblastic proliferation. The
granulomas may be poorly formed rather than compact and sarcoid-like. Geographic necrosis
may be present.

The inflammatory background is often mixed. Neutrophils may be abundant and may undergo
leukocytoclasia, producing nuclear dust. Microabscess-like areas may occur within necrotizing
granulomas. Epithelioid histiocytes and multinucleated giant cells support granulomatous
inflammation. Fibroblastic proliferation around necrotic foci is common in organizing lesions.

The vasculitis is necrotizing and may involve capillaries, venules, arterioles, small arteries, and
medium-sized arteries. The vessel wall may show fibrinoid necrosis, transmural inflammation,
endothelial damage, and destruction of the wall. The inflammation may be granulomatous or
nongranulomatous. Segmental or circumferential necrotizing vasculitis may be present.

Pulmonary lesions often show a combination of parenchymal necrotizing granulomatous

inflammation and necrotizing vasculitis. Alveolar hemorrhage may occur when pulmonary
capillaritis is prominent. Organizing pneumonia-like changes may be present adjacent to
necrotizing lesions.

In the kidney, granulomas are usually not the dominant lesion. The characteristic renal lesion is
pauci-immune focal necrotizing glomerulonephritis, often with crescents. Glomeruli show
segmental fibrinoid necrosis, rupture of capillary loops, fibrin in Bowman space, and crescent
formation. Crescents may be cellular, fibrocellular, or fibrous depending on disease duration.

Immunofluorescence in renal biopsies typically shows little or no immunoglobulin or

complement deposition. This pauci-immune pattern is central to classification. Electron
microscopy, when used for renal evaluation, lacks prominent immune complex-type electron-
dense deposits.

Special stains and ancillary studies may be required to exclude infection, especially tuberculosis
and fungal disease, because necrotizing granulomatous inflammation in the respiratory tract has
a broad differential diagnosis. Acid-fast bacilli stains and fungal stains should be considered
when morphology or clinical setting raises concern.

Immunohistochemistry is not usually required for routine diagnosis, but it may help
characterize inflammatory components or exclude malignancy in difficult biopsies. The most
important diagnostic correlation is the combination of necrotizing granulomatous
inflammation, necrotizing vasculitis, pauci-immune glomerulonephritis, and proteinase 3-
antineutrophil cytoplasmic antibody serology.

The concise histopathological formulation is:

necrotizing granulomatous inflammation of the respiratory tract with necrotizing small- to

medium-vessel vasculitis, often accompanied by pauci-immune focal necrotizing crescentic
glomerulonephritis.

Differential Diagnosis

The most important differential diagnosis is microscopic polyangiitis. Both granulomatosis

with polyangiitis and microscopic polyangiitis are antineutrophil cytoplasmic antibody-
associated pauci-immune vasculitides and may cause necrotizing crescentic glomerulonephritis
and pulmonary hemorrhage. Microscopic polyangiitis lacks granulomatous inflammation and
typically shows necrotizing small-vessel vasculitis with myeloperoxidase-antineutrophil
cytoplasmic antibody more often than proteinase 3-antineutrophil cytoplasmic antibody.
Granulomatosis with polyangiitis is distinguished by necrotizing granulomatous inflammation
of the respiratory tract.

Eosinophilic granulomatosis with polyangiitis, formerly Churg-Strauss syndrome, is another

antineutrophil cytoplasmic antibody-associated vasculitis. It is characterized by asthma,
eosinophilia, eosinophil-rich necrotizing granulomatous inflammation, and small- to medium-
vessel vasculitis. Myeloperoxidase-antineutrophil cytoplasmic antibody is more common than
proteinase 3-antineutrophil cytoplasmic antibody. The eosinophil-rich pattern and asthma-
associated pathology distinguish it from granulomatosis with polyangiitis.
Tuberculosis can closely mimic granulomatosis with polyangiitis because both may produce
necrotizing granulomatous inflammation and cavitary pulmonary lesions. Tuberculosis shows
caseating granulomas and may demonstrate acid-fast bacilli. It does not produce the typical
pauci-immune antineutrophil cytoplasmic antibody-associated necrotizing vasculitis and
crescentic glomerulonephritis pattern. Acid-fast staining, culture, and molecular testing are
important when tuberculosis is considered.

Fungal infections such as aspergillosis, mucormycosis, histoplasmosis, and blastomycosis may

produce necrotizing granulomatous inflammation in the lung or upper airway. Fungal organisms
may be demonstrated by Grocott methenamine silver or periodic acid-Schiff stains.
Angioinvasive fungi can produce vascular necrosis, creating a strong mimic. Demonstration of
organisms separates fungal infection from autoimmune vasculitis.

Anti-glomerular basement membrane disease can produce pulmonary hemorrhage and rapidly
progressive glomerulonephritis. It is distinguished by linear immunoglobulin G deposition
along the glomerular basement membrane and antibodies directed against type IV collagen.
Granulomatosis with polyangiitis instead shows pauci-immune glomerulonephritis and
necrotizing granulomatous respiratory tract inflammation.

Polyarteritis nodosa is a necrotizing vasculitis of medium-sized muscular arteries. It typically

spares glomeruli, capillaries, venules, and pulmonary circulation. It does not produce
necrotizing granulomatous inflammation of the upper and lower respiratory tract. Its lesions
involve medium arteries and may show aneurysms and infarcts.

Sarcoidosis may produce noncaseating granulomas in the lung and other organs. The
granulomas are usually well-formed and non-necrotizing, and vasculitis is not the dominant
lesion. Sarcoidosis lacks pauci-immune necrotizing crescentic glomerulonephritis and
proteinase 3-antineutrophil cytoplasmic antibody association.

Cocaine-induced midline destructive lesion may mimic sinonasal granulomatosis with

polyangiitis. It can produce destructive nasal and palatal lesions and may be associated with
antineutrophil cytoplasmic antibody positivity in some patients. The pattern of localized
destructive midline necrosis, toxic injury, and drug exposure history must be distinguished from
systemic granulomatosis with polyangiitis.

Extranodal natural killer/T-cell lymphoma, nasal type, can cause destructive midline lesions of
the nasal cavity and palate. Histology shows angiocentric and angiodestructive atypical
lymphoid infiltrates, necrosis, and Epstein-Barr virus association. Immunophenotyping and
Epstein-Barr virus-encoded ribonucleic acid in situ hybridization distinguish it from
granulomatosis with polyangiitis.

Key
Main Site / Gross / Structural Distinguishing
Disease Histopathological
Distribution Pattern Feature
Finding

Necrotizing
Necrotizing upper
granulomatous
Upper airway lesions, Proteinase 3-
inflammation with
respiratory cavitating antineutrophil
Granulomatosis necrotizing
tract, lungs, pulmonary cytoplasmic
with vasculitis and
kidneys; small- nodules, renal antibody-associated
polyangiitis pauci-immune
to medium- rapidly progressive granulomatous
focal necrotizing
sized vessels glomerulonephritis respiratory vasculitis
crescentic
pattern
glomerulonephritis

No granulomatous
Small vessels; Pulmonary Pauci-immune
inflammation; often
kidney, lung, hemorrhage and necrotizing small-
Microscopic myeloperoxidase-
skin, nerves, renal crescentic vessel vasculitis
polyangiitis antineutrophil
gastrointestinal glomerulonephritis without
cytoplasmic
tract may occur granulomas
antibody-associated

Respiratory Eosinophil-rich
Eosinophilic Pulmonary
tract, small- to necrotizing Asthma-associated
granulomatosis infiltrates and
medium-sized granulomatous eosinophil-rich
with systemic vasculitic
vessels, heart, inflammation and vasculitis
polyangiitis lesions
nerves vasculitis

Lung, lymph Cavitary

Caseating Infectious
Tuberculosis nodes, many pulmonary lesions,
granulomas with granulomatous
organs caseous necrosis
 Key
Main Site / Gross / Structural Distinguishing
Disease Histopathological
Distribution Pattern Feature
Finding

possible acid-fast disease with acid-

bacilli fast organisms

Necrotizing Granulomatous
Lung, sinuses,
Fungal granulomatous or inflammation with Demonstrable fungal
disseminated
infection angioinvasive fungal organisms hyphae or yeasts
sites
lesions on special stains

Crescentic
Anti- glomerulonephritis
Pulmonary Anti-type IV
glomerular with linear
Kidney and hemorrhage and collagen antibody
basement immunoglobulin G
lung rapidly progressive disease with linear
membrane along glomerular
renal disease immunofluorescence
disease basement
membrane

Medium-vessel
Arterial Segmental
Medium-sized disease without
Polyarteritis aneurysms, transmural
muscular glomerulonephritis
nodosa thrombosis, necrotizing
arteries or respiratory
infarcts arteritis
granulomas

Lung, lymph Bilateral hilar Well-formed Non-necrotizing

Sarcoidosis nodes, skin, lymphadenopathy, noncaseating granulomas without
many organs pulmonary nodules granulomas necrotizing vasculitis

Angiocentric
Extranodal Nasal cavity, atypical lymphoid Clonal lymphoma
Destructive
natural killer/T- palate, upper infiltrate with rather than
midline mass or
cell lymphoma, aerodigestive necrosis; Epstein- autoimmune
ulcerative lesion
nasal type tract Barr virus- vasculitis
associated
PROSTATIC ADENOCARCINOMA

Prostatic adenocarcinoma is the most common malignant tumor of the prostate and one of the
most important malignant epithelial tumors in men. It is an invasive gland-forming carcinoma
arising from prostatic secretory epithelium, most often in the peripheral zone of the gland.
Because of this peripheral origin, early tumors may not produce prominent urethral obstruction,
in contrast to benign prostatic hyperplasia, which usually arises in the periurethral transition
zone.

The tumor is typically an acinar adenocarcinoma. It is characterized histologically by small,

crowded, infiltrative glands lined by a single layer of malignant secretory epithelial cells. A key
diagnostic feature is absence of the basal cell layer that is normally present in benign prostatic
glands. The malignant cells often show enlarged nuclei and prominent nucleoli, while cytologic
pleomorphism may be relatively modest compared with other carcinomas.

The pathological identity of prostatic adenocarcinoma is therefore an infiltrative malignant

epithelial tumor of the prostate with abnormal glandular architecture, loss of basal cells, nuclear
enlargement, prominent nucleoli, stromal invasion, frequent perineural invasion, and grading
based on glandular growth pattern.

Etiology

The etiology of prostatic adenocarcinoma is multifactorial. The major contributors include age-
related risk, androgenic stimulation, genetic susceptibility, inherited cancer predisposition,
acquired somatic molecular alterations, racial and geographic influences, and environmental
factors.

Androgens are essential for normal development and maintenance of prostatic epithelium and
also support growth and survival of many prostate cancer cells. The importance of androgen
signaling is supported by the androgen dependence of many prostate cancers and the therapeutic
effect of androgen deprivation in advanced disease. Androgen receptor signaling promotes
survival and proliferation of prostatic epithelial cells, but androgen exposure alone is not
sufficient to explain malignant transformation.

Age is a major risk factor. Prostatic adenocarcinoma increases in frequency with advancing age
and is often multifocal. Latent microscopic carcinoma is common in older men, but only a
subset progresses to clinically significant disease. The distinction between indolent microscopic
carcinoma and biologically aggressive carcinoma is one reason grading and staging are central
in prostate pathology.

Genetic susceptibility is important. Familial clustering is well recognized, and risk is increased
in first-degree relatives. Inherited mutations in DNA repair genes may increase risk and
influence tumor behavior. These include breast cancer susceptibility gene 2 (BRCA2), breast
cancer susceptibility gene 1 (BRCA1), ataxia telangiectasia mutated gene (ATM), checkpoint
kinase 2 gene (CHEK2), and genes involved in mismatch repair such as mutL homolog 1
(MLH1), mutS homolog 2 (MSH2), mutS homolog 6 (MSH6), and postmeiotic segregation
increased 2 gene (PMS2). BRCA2-associated prostate carcinoma is particularly associated with
increased risk and more aggressive disease.

Somatic molecular alterations are common. A frequent event is fusion between transmembrane
protease serine 2 (TMPRSS2), an androgen-regulated gene, and ETS-related gene (ERG), an
ETS-family transcription factor gene. This fusion places ERG under androgen-regulated control
and alters transcriptional programs involved in invasion and tumor progression. Loss of
phosphatase and tensin homolog (PTEN), a tumor suppressor that negatively regulates the
phosphoinositide 3-kinase/AKT pathway, is associated with tumor progression and adverse
behavior.

High-grade prostatic intraepithelial neoplasia is an important precursor lesion. High-grade

prostatic intraepithelial neoplasia consists of architecturally benign ducts and acini lined by
cytologically atypical secretory cells with partial preservation of basal cells. Many molecular
alterations found in invasive carcinoma may also be present in high-grade prostatic
intraepithelial neoplasia, supporting its role as a precursor.

Environmental and lifestyle factors may modify risk. Diet, obesity, chronic inflammation, and
exposure to certain carcinogens have been considered, although their roles are less direct than
androgenic, genetic, and molecular factors. Geographic and racial differences in incidence and
mortality also suggest interactions between genetic background, environment, access to
screening, and health disparities.

Pathogenesis

The pathogenesis of prostatic adenocarcinoma involves stepwise transformation of prostatic

secretory epithelium through precursor lesions and invasive carcinoma. The process is driven
by androgen receptor signaling, accumulated genetic alterations, epigenetic changes, altered
stromal-epithelial interactions, and progressive ability to invade.

High-grade prostatic intraepithelial neoplasia represents a preinvasive stage in many cases. In

this lesion, luminal secretory cells show nuclear enlargement, prominent nucleoli, and cytologic
atypia while remaining confined within preexisting ducts and acini. The basal cell layer is
diminished but not completely absent. Progression to invasive carcinoma requires breach of the
basal cell layer and invasion into prostatic stroma.

Loss of basal cells is a key event in invasive carcinoma. Benign prostatic glands have a basal
cell layer beneath the luminal secretory epithelium. In invasive adenocarcinoma, malignant
glands lack this basal layer. This is diagnostically important and is often assessed by basal cell
immunohistochemical markers when morphology is equivocal.

Androgen receptor signaling promotes growth and survival of many prostate cancer cells. The
transmembrane protease serine 2–ETS-related gene fusion links an androgen-regulated
promoter to an oncogenic transcription factor, thereby integrating androgen signaling with
oncogenic transcriptional reprogramming. Loss of phosphatase and tensin homolog activates
the phosphoinositide 3-kinase/AKT pathway, promoting survival, growth, and progression.

The tumor invades by forming abnormal glands that infiltrate between benign glands and
through fibromuscular stroma. Perineural invasion is frequent and is an important diagnostic
clue. Lymphovascular invasion may occur, particularly in higher-grade or advanced tumors.

The major pathological sequence is:

genetic and hormonal susceptibility → high-grade prostatic intraepithelial neoplasia → loss of

basal cell layer → infiltrative acinar adenocarcinoma → stromal and perineural invasion →
local extension and metastasis.

The essential pathogenic concept is that prostatic adenocarcinoma is a gland-forming

malignancy whose diagnosis depends heavily on architectural infiltration, absence of basal
cells, and glandular growth pattern rather than on extreme cytologic atypia alone.

Macroscopic Findings

Gross findings vary with tumor size, grade, and extent. Many early cancers are small and may
not be grossly visible. When visible, prostatic adenocarcinoma most commonly arises in the
peripheral zone, especially the posterior aspect of the prostate.
Grossly, the tumor may appear as a firm, gritty, gray-white or yellow-white area within the
peripheral prostate. The malignant area is often more solid and fibrotic than the surrounding
benign spongy prostatic tissue. The prostate may be enlarged, normal in size, or occasionally
smaller than normal depending on accompanying benign hyperplasia, fibrosis, or tumor
distribution.

The cut surface may show irregular firm areas. Because many tumors are multifocal and small,
gross examination may underestimate tumor extent. Careful sampling of the peripheral zone
and suspicious firm areas is therefore important in radical prostatectomy specimens.

Local extension may involve the prostatic capsule, periprostatic soft tissue, seminal vesicles,
bladder neck, or periurethral region. Seminal vesicle invasion is an important adverse staging
feature. Tumor may also extend along perineural spaces.

Metastatic spread occurs through lymphatic and hematogenous routes. Regional lymph node
metastases may involve obturator, pelvic, iliac, sacral, and para-aortic nodes. Hematogenous
spread classically involves the axial skeleton, especially pelvis, lumbar spine, and other
vertebral bones. The skeletal metastases are typically osteoblastic, producing bone-forming
lesions rather than purely lytic destruction.

The classical gross pattern is a firm, fibrotic, gray-white to yellow-white tumor in the peripheral
zone of the prostate, with potential extracapsular extension, seminal vesicle invasion, regional
lymph node metastasis, and osteoblastic skeletal metastasis in advanced disease.

Histopathological Findings

Most prostatic adenocarcinomas are acinar adenocarcinomas. The classic microscopic pattern
is an infiltrative proliferation of small malignant glands set within fibromuscular prostatic
stroma. The malignant glands are usually smaller than benign glands and are more crowded.
They may be arranged back-to-back or haphazardly infiltrate between benign glands.

The glands are lined by a single layer of cuboidal to low columnar malignant epithelial cells.
Unlike benign glands, malignant glands lack a basal cell layer. This absence of basal cells is
one of the most important diagnostic features.

The tumor cells often have enlarged nuclei and prominent nucleoli. Cytoplasm may be
amphophilic, basophilic, clear, or eosinophilic. Cytologic atypia may be mild to moderate, and
marked pleomorphism is not required for diagnosis. Mitotic figures are usually uncommon in
lower-grade tumors but may be more frequent in high-grade carcinoma.
Architectural disturbance is essential. Benign glands may show branching, papillary infolding,
corpora amylacea, and a surrounding basal cell layer. Malignant glands are crowded,
infiltrative, and lack the normal lobular organization. They usually lack the papillary infoldings
and basal cell layer typical of benign prostatic glands.

Perineural invasion is a classic and frequent finding. Malignant glands or tumor cells may track
around or along nerves within the prostate. In a small biopsy, perineural invasion is a strong
supportive feature of carcinoma when seen with atypical glands.

Higher-grade tumors show more complex architecture. Gleason pattern 3 consists of individual,
separate, infiltrative glands. Gleason pattern 4 includes fused glands, poorly formed glands,
cribriform glands, or glomeruloid structures. Gleason pattern 5 shows no gland formation and
may consist of solid sheets, cords, single infiltrating cells, or comedonecrosis. The Gleason
grading system is based on architectural pattern rather than nuclear atypia alone.

The Gleason score is obtained by adding the most common architectural pattern and the second
most common pattern. Contemporary reporting also uses Grade Groups, which correlate with
prognosis. Grade Group 1 corresponds to Gleason score 3+3=6; Grade Group 2 to Gleason
score 3+4=7; Grade Group 3 to Gleason score 4+3=7; Grade Group 4 to Gleason score 8; and
Grade Group 5 to Gleason scores 9–10.

High-grade prostatic intraepithelial neoplasia may be present adjacent to invasive carcinoma. It

shows cytologically atypical luminal cells with enlarged nuclei and prominent nucleoli within
preexisting ducts and acini, with at least partial basal cell preservation. It supports a field of
neoplastic transformation but does not by itself represent invasive carcinoma.

Immunohistochemistry is very useful in difficult biopsies. Basal cell markers such as p63, high-
molecular-weight cytokeratin, and cytokeratin 5/6 are absent around invasive malignant glands
but present around benign glands and high-grade prostatic intraepithelial neoplasia. Alpha-
methylacyl-CoA racemase is often overexpressed in prostatic adenocarcinoma and supports
malignancy, although it is not entirely specific. Prostate-specific antigen, prostatic acid
phosphatase, NK3 homeobox 1 (NKX3.1), and prostatic-specific membrane antigen may
support prostatic origin, especially in metastatic carcinoma.
The concise histopathological formulation is:

infiltrative acinar adenocarcinoma composed of small crowded glands lacking basal cells, lined
by malignant secretory cells with enlarged nuclei and prominent nucleoli, often with perineural
invasion, graded by Gleason architectural pattern.

Differential Diagnosis

The most important differential diagnosis is benign prostatic hyperplasia. Benign prostatic
hyperplasia arises primarily in the transition zone and produces nodular glandular and stromal
proliferation. Histologically, benign glands are larger, more variably shaped, often show
papillary infolding, contain basal cells, and are embedded in nodular fibromuscular stroma.
Prostatic adenocarcinoma usually arises in the peripheral zone and shows small infiltrative
glands lacking basal cells.

High-grade prostatic intraepithelial neoplasia is an important precursor and mimic. It shows

cytologically atypical secretory cells with prominent nucleoli within preexisting glands and
ducts. The key distinction is that high-grade prostatic intraepithelial neoplasia retains at least a
discontinuous basal cell layer and lacks stromal invasion. Invasive adenocarcinoma lacks basal
cells and infiltrates stroma.

Atypical small acinar proliferation is a diagnostic category used when small atypical glands are
suspicious but insufficient for definitive carcinoma. It may represent undersampled
adenocarcinoma, tangentially cut benign glands, or mimics. Additional levels and
immunohistochemistry for basal cell markers and alpha-methylacyl-CoA racemase may help.

Adenosis, also called atypical adenomatous hyperplasia, may mimic low-grade

adenocarcinoma because it consists of small crowded glands. It usually occurs in the transition
zone and shows a lobular arrangement. Basal cells are present, although sometimes patchy, and
nucleoli are less prominent. The infiltrative pattern of carcinoma is absent.

Atrophic glands and post-atrophic hyperplasia may mimic carcinoma because small glands may
appear crowded and cytoplasm may be scant. However, these glands usually retain basal cells
and have a benign lobular arrangement. Inflammation may accompany atrophic changes.
Immunohistochemistry may demonstrate basal cell preservation.

Sclerosing adenosis may mimic carcinoma because of crowded small glands in a sclerotic
stroma. It retains basal cells and often has a lobular pattern. Myoepithelial or basal markers help
distinguish it from adenocarcinoma.
Chronic prostatitis can produce glandular distortion, epithelial atypia, and prominent nucleoli.
The presence of inflammation, preservation of basal cells, and lack of infiltrative malignant
architecture favor prostatitis.

Urothelial carcinoma involving the prostate may mimic high-grade prostatic carcinoma.
Urothelial carcinoma may involve prostatic ducts or invade prostatic stroma. It typically
expresses urothelial markers such as GATA binding protein 3 (GATA3), p63, p40, uroplakin,
and high-molecular-weight cytokeratin, while prostatic adenocarcinoma usually expresses
prostate-specific antigen, NK3 homeobox 1, and prostatic-specific membrane antigen.

Colorectal adenocarcinoma invading or metastasizing to the prostate may mimic prostatic

adenocarcinoma. Colorectal carcinoma usually expresses caudal type homeobox 2 (CDX2),
cytokeratin 20, and special AT-rich sequence-binding protein 2 (SATB2), and lacks prostate-
specific antigen and NK3 homeobox 1 expression.

Main Site / Gross /

Key Histopathological Distinguishing
Disease Distributio Structural
Finding Feature
n Pattern

Peripheral Firm gray-

zone, white to
especially yellow-white
Small crowded infiltrative
posterior peripheral Invasive acinar
glands lacking basal cells;
Prostatic prostate; tumor; carcinoma with
enlarged nuclei, prominent
adenocarcinom may extend advanced basal cell loss and
nucleoli, perineural
a to seminal disease may glandular
invasion; Gleason
vesicles, show infiltrative pattern
architectural grading
lymph extracapsular
nodes, axial extension and
skeleton osteoblastic
 Main Site / Gross /
Key Histopathological Distinguishing
Disease Distributio Structural
Finding Feature
n Pattern

bone
metastases

Nodular
Transition Large variable glands with
enlargement Nodular benign
Benign prostatic zone / papillary infolding, basal
with glandular process with basal
hyperplasia periurethral cells, and fibromuscular
and stromal cell preservation
prostate nodules
hyperplasia

Preexisting
High-grade Cytologically atypical
ducts and Preinvasive lesion
prostatic Usually not luminal cells with
acini, often without stromal
intraepithelial grossly visible prominent nucleoli but
peripheral invasion
neoplasia retained basal cells
zone

Diagnostic
Atypical small Suspicious small atypical
Small biopsy Not a gross uncertainty
acinar glands insufficient for
finding lesion category requiring
proliferation definite carcinoma
further evaluation

Adenosis / Small nodular

Small crowded glands in Benign lobular
atypical Transition lesion or
lobular arrangement with small-gland
adenomatous zone microscopic
basal cells proliferation
hyperplasia finding

Basal cell
Post-atrophic Peripheral or Crowded atrophic glands
Usually preservation and
hyperplasia / transition with basal cells, often with
microscopic benign lobular
atrophy zone inflammation
architecture
 Main Site / Gross /
Key Histopathological Distinguishing
Disease Distributio Structural
Finding Feature
n Pattern

Firm
Usually Crowded glands in Basal cell-positive
Sclerosing microscopic or
transition sclerotic stroma with benign glandular
adenosis small nodular
zone basal/myoepithelial cells proliferation
lesion

Prostate, May be grossly Inflammatory infiltrates Inflammation and

Chronic
variable unremarkable with reactive epithelial basal cell
prostatitis
zones or firm atypia preservation

Infiltrative
Urothelial Prostatic Urothelial carcinoma Urothelial
tumor
carcinoma urethra, morphology; immunophenotype
involving
involving ducts, or GATA3/p63/p40/uroplaki rather than prostate
prostatic
prostate stroma n positivity lineage
urethral region

Colorectal Glandular carcinoma with Intestinal

Direct Infiltrative
adenocarcinom colorectal morphology; immunophenotype
invasion or pelvic/prostati
a involving CDX2/cytokeratin , prostate markers
metastasis c lesion
prostate 20/SATB2 positivity negative
MEMBRANOUS NEPHROPATHY

Membranous nephropathy is a glomerular disease characterized by diffuse thickening of the

glomerular capillary wall caused by subepithelial immune deposits along the glomerular
basement membrane. It is one of the major causes of nephrotic syndrome in adults. The disease
primarily injures podocytes and the outer aspect of the glomerular capillary wall, producing
heavy proteinuria with relatively little cellular proliferation or inflammatory infiltration on light
microscopy.

The lesion is called “membranous” because the glomerular capillary walls appear diffusely
thickened, giving the impression of a thickened filtration membrane. The essential pathological
abnormality is not true primary thickening of the native basement membrane at the beginning,
but deposition of immune complexes between podocytes and the glomerular basement
membrane, followed by reactive basement membrane material formation around these deposits.

Primary membranous nephropathy is usually an autoimmune podocyte disease. Secondary

membranous nephropathy may occur in association with autoimmune disease, infections,
malignancy, drugs, or toxic exposures. Regardless of cause, the defining pattern is diffuse
subepithelial immune complex deposition with granular immunoglobulin and complement
staining along the glomerular basement membrane.

Etiology

Membranous nephropathy may be primary or secondary.

Primary membranous nephropathy is an autoimmune disease in which antibodies react with

podocyte antigens and form immune complexes in situ along the subepithelial aspect of the
glomerular basement membrane. The most important target antigen is phospholipase A2
receptor (PLA2R), a podocyte antigen. Circulating anti-phospholipase A2 receptor antibodies
are present in a large proportion of patients with primary membranous nephropathy and are
useful in diagnosis and disease monitoring.

Other podocyte antigens have also been identified in subsets of primary membranous
nephropathy. These include thrombospondin type 1 domain-containing 7A (THSD7A), neural
epidermal growth factor-like 1 protein (NELL1), exostosin 1/exostosin 2 (EXT1/EXT2),
semaphorin 3B (SEMA3B), and other antigens recognized in more recently defined
clinicopathological subsets. These antigen associations indicate that membranous nephropathy
is a pattern of glomerular injury that can be produced by different autoimmune antigen-antibody
systems.

Secondary membranous nephropathy occurs in association with systemic lupus erythematosus,

chronic hepatitis B infection, chronic hepatitis C infection, syphilis, malaria, schistosomiasis,
solid tumors, B-cell lymphoid neoplasms, and drugs. Important drug associations include
penicillamine, gold salts, captopril, and nonsteroidal anti-inflammatory drugs. Inorganic salts
such as gold and mercury have also been implicated.

In lupus-associated membranous nephropathy, immune complexes may contain nuclear

antigens or other lupus-related antigens rather than a primary podocyte antigen alone. In
infection-associated disease, microbial antigens or infection-driven immune complexes may
participate. In malignancy-associated disease, tumor antigens or malignancy-related immune
dysregulation may contribute.

The etiologic formulation is therefore: primary autoimmune podocyte antigen disease in most
idiopathic cases, or secondary immune complex-mediated subepithelial glomerular injury
associated with autoimmune disease, infection, malignancy, or drugs.

Pathogenesis

The central pathogenic process is in situ immune complex formation along the subepithelial
side of the glomerular basement membrane. In primary membranous nephropathy, circulating
antibodies bind podocyte antigens expressed on the podocyte surface or in the subepithelial
region. This produces immune deposits between podocytes and the glomerular basement
membrane.

These immune deposits activate complement and injure podocytes. Although the dominant
autoantibody in phospholipase A2 receptor-associated primary disease is often immunoglobulin
G4, which is not a strong classical complement activator, complement activation still occurs
through nonclassical pathways. Complement-mediated injury includes formation of membrane
attack complex (MAC), which damages podocytes without necessarily producing a prominent
influx of inflammatory cells.

Podocyte injury disrupts the slit diaphragm and filtration barrier. Protein leakage develops
because podocytes are unable to maintain normal size and charge selectivity of the filtration
barrier. Podocyte foot processes undergo effacement, and persistent injury may lead to podocyte
detachment, segmental sclerosis, and progressive chronic kidney disease.
As immune deposits accumulate, new basement membrane-like material is laid down between
and around the deposits. On silver stains, this produces small projections of basement
membrane material between deposits. These projections are called spikes. With time, basement
membrane material may surround and incorporate the deposits, causing progressive capillary
wall thickening.

The major pathological sequence is:

autoantibody binding to podocyte antigen or subepithelial antigen → in situ immune complex

formation → complement activation and membrane attack complex-mediated podocyte injury
→ proteinuria and podocyte foot process effacement → basement membrane reaction around
deposits → spike-and-dome pattern → progressive capillary wall thickening and possible
glomerulosclerosis.

The essential pathogenic idea is that membranous nephropathy is a podocyte-facing immune

deposit disease. The immune deposits are subepithelial, the immunofluorescence pattern is
granular, and the dominant clinical expression is nephrotic syndrome rather than a proliferative
nephritic pattern.

Macroscopic Findings

Gross renal changes are not specific. In active nephrotic disease, the kidneys may be normal in
size or mildly enlarged, pale, and smooth. The pale appearance reflects edema, lipid
accumulation, and altered renal cortical appearance associated with nephrotic syndrome rather
than a unique gross lesion.

In early membranous nephropathy, there is no distinctive gross abnormality that establishes the
diagnosis. The decisive abnormalities are microscopic, immunopathological, and
ultrastructural.

In long-standing disease, progressive glomerulosclerosis, tubular atrophy, interstitial fibrosis,

and vascular sclerosis may produce small, granular, chronically scarred kidneys. These late
changes reflect chronic kidney disease and are not specific to membranous nephropathy.

The gross pathological teaching point is that membranous nephropathy is primarily a

glomerular capillary wall disease whose diagnostic features are demonstrated by renal biopsy,
immunofluorescence, and electron microscopy rather than by gross examination.
Histopathological Findings

Light microscopy shows diffuse thickening of glomerular capillary walls. The glomeruli are
usually not hypercellular. Mesangial and endocapillary proliferation are absent or minimal in
primary membranous nephropathy. This absence of significant cellular proliferation helps
separate membranous nephropathy from membranoproliferative glomerulonephritis, lupus
proliferative nephritis, and postinfectious glomerulonephritis.

In early disease, capillary wall thickening may be subtle on hematoxylin and eosin sections.
Periodic acid-Schiff stain and silver stains better demonstrate basement membrane alterations.
Silver stain may reveal spikes of basement membrane material projecting between immune
deposits. This spike formation becomes more conspicuous as the disease progresses.

With progression, immune deposits become surrounded and incorporated by basement

membrane-like material. The capillary walls become more thickened and rigid. Late disease
may show segmental or global glomerulosclerosis, tubular atrophy, interstitial fibrosis, and
chronic vascular changes.

Immunofluorescence microscopy shows granular deposits of immunoglobulin and complement

along the glomerular capillary walls. The typical pattern is granular immunoglobulin G and
complement component 3 along the glomerular basement membrane. This granular capillary
loop pattern reflects immune complex deposition and contrasts with the smooth linear
immunoglobulin G pattern of anti-glomerular basement membrane disease.

In primary phospholipase A2 receptor-associated membranous nephropathy, immunostaining

for phospholipase A2 receptor may be positive in glomerular immune deposits, and serum anti-
phospholipase A2 receptor antibody may support diagnosis and disease monitoring.
Immunoglobulin G subclass staining may show immunoglobulin G4 predominance in many
primary cases. Secondary forms may show different immunoglobulin G subclass patterns and
additional deposits, depending on the underlying disease.

In lupus-associated membranous nephropathy, immunofluorescence may show a “full-house”

pattern with immunoglobulin G, immunoglobulin A, immunoglobulin M, complement
component 3, and complement component 1q. Mesangial and subendothelial deposits may also
be present, supporting lupus nephritis rather than primary membranous nephropathy.

The concise histopathological formulation is:

diffuse glomerular capillary wall thickening without significant hypercellularity, granular
immunoglobulin G and complement component 3 along the glomerular basement membrane,
and basement membrane spike formation around subepithelial deposits.

Electron Microscopic Findings

Electron microscopy demonstrates subepithelial electron-dense deposits between the

glomerular basement membrane and podocytes. These deposits are distributed along the outer
aspect of glomerular capillary loops and correspond to the granular capillary loop staining
pattern seen by immunofluorescence.

As the disease evolves, basement membrane-like material forms between adjacent subepithelial
deposits. This creates the classic spike-and-dome pattern: the “domes” correspond to immune
deposits, and the “spikes” correspond to intervening projections of glomerular basement
membrane material. With progression, the deposits become increasingly incorporated into the
thickened glomerular basement membrane.

Podocyte foot process effacement is also present because podocyte injury is central to
nephrotic-range proteinuria. In advanced disease, podocyte detachment, glomerular basement
membrane remodeling, and segmental sclerosis may be seen.

The key ultrastructural formulation is:

subepithelial electron-dense immune deposits along the glomerular basement membrane with
intervening basement membrane spikes, producing a spike-and-dome pattern, accompanied by
podocyte foot process effacement.

Differential Diagnosis

The most important differential diagnosis is minimal change disease. Minimal change disease
also produces nephrotic syndrome and podocyte foot process effacement. However, light
microscopy in minimal change disease shows essentially normal glomeruli,
immunofluorescence is negative or nonspecific, and electron microscopy lacks immune
complex deposits. Membranous nephropathy shows diffuse capillary wall thickening, granular
immunoglobulin G and complement component 3 along the glomerular basement membrane,
and subepithelial deposits.

Focal segmental glomerulosclerosis may present with nephrotic syndrome and podocyte injury.
It is distinguished by focal and segmental sclerosis involving some glomeruli and portions of
affected glomeruli. Immunofluorescence may show nonspecific immunoglobulin M and
complement component 3 trapping in sclerotic areas. Electron microscopy shows foot process
effacement but not the diffuse subepithelial immune deposits and spike-and-dome pattern of
membranous nephropathy.

Membranoproliferative glomerulonephritis shows glomerular basement membrane thickening

but also has mesangial and endocapillary hypercellularity. Silver stains often show double-
contour or tram-track splitting of the glomerular basement membrane. Electron microscopy
commonly reveals subendothelial deposits in immune complex-mediated
membranoproliferative glomerulonephritis. This differs from the subepithelial deposits of
membranous nephropathy.

Postinfectious glomerulonephritis may show subepithelial deposits, but these are typically large
hump-shaped deposits and are associated with diffuse endocapillary proliferation and
neutrophilic infiltration. Immunofluorescence shows granular immunoglobulin G and
complement component 3 in a coarse pattern. Membranous nephropathy shows more uniform
subepithelial deposits with capillary wall thickening and little cellular proliferation.

Lupus nephritis, class V, is a membranous pattern associated with systemic lupus

erythematosus. It may closely mimic primary membranous nephropathy. Features supporting
lupus include full-house immunofluorescence, tubuloreticular inclusions in endothelial cells,
mesangial deposits, subendothelial deposits, extraglomerular immune deposits, and clinical-
serologic evidence of systemic lupus erythematosus.

Diabetic nephropathy may produce diffuse glomerular basement membrane thickening and
nephrotic-range proteinuria. However, diabetic nephropathy shows mesangial expansion,
nodular glomerulosclerosis, arteriolar hyalinosis, and diffuse diabetic microangiopathic
changes. It lacks granular subepithelial immune deposits and spike-and-dome formation.

Amyloidosis may produce nephrotic syndrome and capillary wall or mesangial deposits. Congo
red stain demonstrates amyloid with apple-green birefringence under polarized light. Electron
microscopy shows randomly arranged nonbranching fibrils rather than subepithelial immune
complex deposits.

Anti-glomerular basement membrane disease may show capillary wall injury and rapidly
progressive glomerulonephritis, but immunofluorescence shows smooth linear
immunoglobulin G along the glomerular basement membrane. Membranous nephropathy
shows granular immunoglobulin G and complement component 3 along the glomerular
basement membrane.

Main Renal Electron

Immunofluoresc
Disease Compartm Light Microscopy Microscopy / Key
ence
ent / Target Distinction

Granular
immunoglobulin
Podocyte- G and Subepithelial
facing Diffuse capillary complement electron-dense
glomerular wall thickening component 3 deposits with
capillary without significant along the intervening
Membranous
wall / cellular glomerular glomerular
nephropathy
subepithelia proliferation; spike basement basement membrane
l immune formation on silver membrane; spikes; spike-and-
deposit stain phospholipase A2 dome pattern; foot
disease receptor positivity process effacement
in many primary
cases

Essentially normal
Diffuse podocyte
Podocyte / glomeruli; tubular
Minimal change Negative or foot process
slit protein-lipid
disease nonspecific effacement without
diaphragm resorption changes
immune deposits
may be present

Often nonspecific
Podocyte Focal and segmental Foot process
immunoglobulin
Focal segmental with sclerosis, effacement plus
M and
glomerulosclerosis segmental hyalinosis, segmental sclerosis;
complement
scarring adhesions no diffuse
component 3
 Main Renal Electron
Immunofluoresc
Disease Compartm Light Microscopy Microscopy / Key
ence
ent / Target Distinction

trapping in subepithelial
sclerosis deposits

Mesangial/endocapi
llary
Subendothelial or
hypercellularity, Granular immune
Mesangium intramembranous
Membranoprolifer lobular deposits or
and deposits rather than
ative accentuation, complement-
capillary uniform
glomerulonephritis double-contour or dominant pattern
wall subepithelial
tram-track depending on type
deposits
basement
membrane splitting

Immune Granular
Diffuse
complex- immunoglobulin Large subepithelial
Postinfectious endocapillary
mediated G and hump-shaped
glomerulonephritis proliferation with
nephritic complement deposits
neutrophils
lesion component 3

Full-house pattern
Immune with
complex immunoglobulin Subepithelial
disease Capillary wall G, deposits plus
Lupus associated thickening; may immunoglobulin possible
membranous with have mesangial or A, mesangial/subendot
nephritis systemic proliferative immunoglobulin helial deposits and
lupus changes M, complement tubuloreticular
erythematos component 3, and inclusions
us complement
component 1q
 Main Renal Electron
Immunofluoresc
Disease Compartm Light Microscopy Microscopy / Key
ence
ent / Target Distinction

Diffuse and nodular

Glomerular
mesangial
Glomerular Usually basement membrane
expansion,
basement nonspecific linear thickening without
Diabetic glomerular
membrane, immunoglobulin subepithelial
nephropathy basement
mesangium, G or albumin immune complex
membrane
arterioles staining spike-and-dome
thickening,
pattern
arteriolar hyalinosis

Mesangium Amorphous Random

Variable
and extracellular nonbranching fibrils
Amyloidosis depending on
capillary deposits; Congo red rather than immune
amyloid type
walls positive complex deposits

Smooth linear
Glomerular Basement
immunoglobulin
Anti-glomerular basement Necrotizing membrane
G along
basement membrane crescentic rupture/fibrin; no
glomerular
membrane disease intrinsic glomerulonephritis granular immune
basement
antigen deposits
membrane
INVASIVE DUCTAL CARCINOMA

Invasive ductal carcinoma of the breast, more precisely termed invasive breast carcinoma of no
special type, is the most common form of invasive breast carcinoma. It is a malignant epithelial
tumor arising from the terminal duct-lobular unit and showing invasion beyond the basement
membrane into breast stroma. The older term “ductal” does not necessarily mean that the tumor
arises from large ducts; rather, it distinguishes this common invasive carcinoma from special
histological types such as invasive lobular carcinoma, tubular carcinoma, mucinous carcinoma,
medullary-pattern carcinoma, and others.

The essential pathological identity of invasive ductal carcinoma is an infiltrative malignant

epithelial proliferation forming variable tubules, nests, cords, trabeculae, sheets, or solid
aggregates within desmoplastic breast stroma. Unlike carcinoma in situ, invasive carcinoma
breaches the myoepithelial cell layer and basement membrane and infiltrates surrounding
fibrous stroma and adipose tissue. This invasive growth permits lymphovascular spread and
distant metastasis.

Invasive ductal carcinoma is a heterogeneous group. Tumors are graded by tubule formation,
nuclear pleomorphism, and mitotic activity. They are also classified biologically by expression
of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2.
These biomarkers are essential because they define major therapeutic and prognostic categories.

Etiology

The etiology of invasive ductal carcinoma is multifactorial. It reflects interaction between

hormonal influences, genetic susceptibility, acquired somatic mutations, precursor lesions,
reproductive factors, environmental exposures, and age-related accumulation of genomic
injury.

Hormonal exposure is important. Prolonged estrogenic stimulation increases risk by promoting

proliferation of breast epithelial cells. Early menarche, late menopause, nulliparity, delayed first
full-term pregnancy, and some forms of postmenopausal hormone therapy increase lifetime
estrogen exposure and thereby increase risk. Pregnancy and breastfeeding tend to reduce risk,
partly by decreasing cumulative hormonal cycling and promoting terminal differentiation of
breast epithelium.

Genetic susceptibility is a major etiologic category. Germline mutations in breast cancer

susceptibility gene 1 and breast cancer susceptibility gene 2 significantly increase risk. Breast
cancer susceptibility gene 1-associated tumors are often high-grade and may show a basal-like
or triple-negative phenotype. Breast cancer susceptibility gene 2-associated tumors more often
resemble sporadic hormone receptor-positive breast carcinoma. Other hereditary risk genes
include partner and localizer of breast cancer susceptibility gene 2 (PALB2), tumor protein p53
gene in Li-Fraumeni syndrome, phosphatase and tensin homolog gene (PTEN) in Cowden
syndrome, cadherin 1 gene (CDH1) especially in hereditary diffuse gastric cancer and lobular
breast carcinoma risk, checkpoint kinase 2 gene (CHEK2), and ataxia telangiectasia mutated
gene (ATM).

Acquired somatic genetic alterations vary by tumor subtype. Luminal estrogen receptor-
positive carcinomas often show alterations in phosphatidylinositol-4,5-bisphosphate 3-kinase
catalytic subunit alpha gene, GATA binding protein 3 gene (GATA3), mitogen-activated protein
kinase pathways, and chromatin regulatory genes. Human epidermal growth factor receptor 2-
positive tumors show amplification of the ERBB2 gene encoding HER2. Basal-like or triple-
negative tumors often show tumor protein p53 gene mutation and genomic instability.

Precursor lesions are important. Ductal carcinoma in situ is a noninvasive malignant epithelial
proliferation confined by the basement membrane and myoepithelial layer. It is a direct
precursor for many invasive ductal carcinomas. Atypical ductal hyperplasia and flat epithelial
atypia are earlier proliferative lesions associated with increased risk. Lobular carcinoma in situ
is primarily a risk marker and nonobligate precursor, particularly for invasive lobular carcinoma
but also for some invasive carcinomas.

Environmental and lifestyle influences include obesity, alcohol intake, physical inactivity, and
prior therapeutic radiation exposure to the chest. Obesity is particularly relevant after
menopause because adipose tissue becomes an important source of estrogen through aromatase
activity.

The etiologic formulation is therefore: hormonal stimulation, inherited or acquired genomic

instability, precursor epithelial neoplasia, and progressive acquisition of invasive capacity
within the terminal duct-lobular unit.

Pathogenesis

The pathogenesis of invasive ductal carcinoma involves stepwise transformation of breast

epithelial cells, progression through precursor lesions, and acquisition of stromal invasion.
The normal breast terminal duct-lobular unit is composed of luminal epithelial cells and an
outer myoepithelial cell layer supported by a basement membrane. In noninvasive carcinoma,
malignant epithelial cells proliferate within ducts or lobules but remain confined by the
basement membrane and myoepithelial layer. In invasive carcinoma, tumor cells breach this
boundary and enter the surrounding stroma.

Ductal carcinoma in situ is the most important recognized precursor for many invasive ductal
carcinomas. It consists of malignant epithelial cells filling ducts and lobules while
myoepithelial cells and basement membrane remain intact. Progression to invasive carcinoma
requires loss or disruption of myoepithelial containment, degradation of basement membrane,
stromal invasion, and activation of tumor-stroma interactions.

Tumor cells invade through secretion of proteases, altered adhesion molecules, epithelial-
mesenchymal transition-like changes, and interaction with carcinoma-associated fibroblasts,
inflammatory cells, endothelial cells, and extracellular matrix. Stromal fibroblasts respond by
producing dense collagenous desmoplasia. This desmoplastic response is responsible for the
firm, hard consistency and retraction often seen grossly.

Molecular pathways differ by intrinsic subtype. Luminal carcinomas are driven by estrogen
receptor signaling and often retain gland-forming differentiation. Human epidermal growth
factor receptor 2-positive carcinomas are driven by ERBB2 amplification and HER2 signaling,
producing increased proliferation and survival. Triple-negative carcinomas lack estrogen
receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression and
often show basal-like molecular features, high grade, tumor protein p53 gene mutation, and
aggressive behavior.

Lymphovascular invasion permits regional lymph node metastasis, especially to axillary lymph
nodes. Hematogenous dissemination may involve bone, lung, liver, brain, and other organs. The
pattern of metastatic spread is influenced by tumor subtype, grade, lymphovascular invasion,
and host-tumor interactions.

The major pathological sequence is:

genetic and hormonal risk factors → epithelial atypia and proliferative precursor lesions →
ductal carcinoma in situ in many cases → basement membrane and myoepithelial layer breach
→ invasive carcinoma within desmoplastic stroma → lymphovascular invasion and metastasis.
The essential pathogenic concept is that invasive ductal carcinoma is defined not merely by
cytologic malignancy, but by stromal invasion beyond the duct-lobular basement membrane
and loss of myoepithelial containment.

Macroscopic Findings

Grossly, invasive ductal carcinoma most often forms an irregular, firm, poorly circumscribed
mass. The tumor is classically hard because of abundant desmoplastic stroma; this produces the
traditional term scirrhous carcinoma. The cut surface is typically gray-white to yellow-white,
gritty, and fibrous. It may cut with resistance or a grating sensation because of dense
collagenous stroma.

The margins are often stellate or infiltrative rather than smooth and circumscribed. The tumor
extends irregularly into surrounding breast parenchyma and adipose tissue. Retraction of
adjacent tissue may occur because desmoplastic fibrosis contracts. This may produce skin
dimpling, nipple retraction, or architectural distortion in gross specimens and imaging.

Tumor size varies widely. Some tumors are small and detected by screening, whereas others are
large, fixed, or associated with ulceration. Necrosis and hemorrhage may be present, especially
in high-grade tumors. Calcifications may occur, particularly when associated ductal carcinoma
in situ is present.

The most common location is the upper outer quadrant of the breast, followed by the central
region. Tumors may be multifocal or multicentric, especially when associated with extensive in
situ disease.

In advanced cases, the tumor may infiltrate the skin, nipple, chest wall, or pectoral fascia.
Lymphatic invasion of dermal lymphatics may produce inflammatory carcinoma as a clinical-
pathological pattern. Regional lymph nodes, particularly axillary nodes, may be enlarged by
metastatic carcinoma or by reactive changes.

The classical gross pathological impression is an irregular, stony-hard, gray-white infiltrative

mass with desmoplastic retraction and extension into surrounding breast stroma and fat.

Histopathological Findings

Histologically, invasive ductal carcinoma of no special type shows infiltrating malignant

epithelial cells arranged in variable patterns. The tumor may form tubules, nests, cords,
trabeculae, solid sheets, or poorly formed glandular structures. The degree of tubule formation
is a major component of histological grading.

The malignant glands and nests infiltrate fibrous stroma and adipose tissue in an irregular
haphazard pattern. The invasive glands lack a myoepithelial cell layer and are not confined by
an intact basement membrane. Loss of myoepithelial cells is a key distinction from ductal
carcinoma in situ and benign glandular lesions.

Tumor cells show variable cytologic atypia. Low-grade tumors form more tubules and have
relatively uniform nuclei. High-grade tumors show poor tubule formation, marked nuclear
pleomorphism, prominent nucleoli, high mitotic activity, necrosis, and sometimes syncytial or
solid growth. Apoptosis and comedo-type necrosis may be present, particularly in high-grade
tumors associated with high-grade ductal carcinoma in situ.

The stroma is often desmoplastic. Dense collagenous stromal response surrounds and separates
invasive tumor nests. This stromal reaction contributes to the firm gross character of the lesion.
Tumor-associated lymphocytic infiltrates may be variable and are often more prominent in
some high-grade and triple-negative tumors.

Perineural invasion may occur but is not as central diagnostically as in some other carcinomas.
Lymphovascular invasion is important because it supports metastatic potential and correlates
with nodal involvement and adverse prognosis. Tumor emboli may be present within lymphatic
or vascular spaces.

Associated ductal carcinoma in situ is common. It may show solid, cribriform, papillary,
micropapillary, or comedo patterns. The grade and biomarker profile of associated ductal
carcinoma in situ often resemble the invasive component.

Histologic grading is performed using the Nottingham system, which evaluates tubule
formation, nuclear pleomorphism, and mitotic count. The sum of these components assigns
grade 1, grade 2, or grade 3. Grade is an important prognostic factor and is integrated with
tumor size, lymph node status, hormone receptor status, human epidermal growth factor
receptor 2 status, and proliferation.

Immunohistochemistry is essential in contemporary breast pathology. Estrogen receptor and

progesterone receptor expression identify hormone-responsive tumors. Human epidermal
growth factor receptor 2 immunohistochemistry and, when equivocal, in situ hybridization for
ERBB2 amplification identify tumors eligible for HER2-directed therapy. Ki-67 may be used
as a proliferation marker in some settings, although interpretation thresholds vary.

Myoepithelial markers help distinguish invasive carcinoma from in situ carcinoma or benign
mimics. p63, smooth muscle myosin heavy chain, calponin, smooth muscle actin, and
cytokeratin 5/6 may highlight myoepithelial cells around benign glands and in situ carcinoma.
In invasive carcinoma, a continuous myoepithelial layer is absent around tumor nests and
glands.

Additional markers may help classify difficult tumors. GATA binding protein 3 (GATA3),
mammaglobin, and gross cystic disease fluid protein 15 support breast origin, especially in
metastases. E-cadherin is usually retained in invasive ductal carcinoma and lost in classic
invasive lobular carcinoma, although interpretation must be integrated with morphology.

The concise histopathological formulation is:

an invasive malignant epithelial tumor composed of irregular glands, nests, cords, and solid
aggregates infiltrating desmoplastic breast stroma and adipose tissue, lacking a myoepithelial
layer, showing variable nuclear atypia and mitotic activity, often associated with ductal
carcinoma in situ, and classified by grade and receptor profile.

Differential Diagnosis

The most important differential diagnosis is invasive lobular carcinoma. Invasive lobular
carcinoma is composed of discohesive tumor cells infiltrating in single-file linear cords and
targetoid patterns around ducts. It often shows loss of E-cadherin expression due to cadherin 1
gene alterations. Invasive ductal carcinoma more often forms cohesive nests, cords, tubules,
and solid structures and typically retains E-cadherin expression.

Ductal carcinoma in situ is distinguished by confinement of malignant epithelial cells within

ducts and lobules with preservation of the myoepithelial cell layer and basement membrane.
Invasive ductal carcinoma lacks a surrounding myoepithelial layer and infiltrates stroma and
fat. Myoepithelial markers are useful in separating these entities.

Sclerosing adenosis may mimic invasive carcinoma because it produces distorted small glands
in dense stroma. However, sclerosing adenosis retains lobulocentric architecture and
myoepithelial cells around glands. The epithelial cells lack the cytologic and architectural
malignancy of invasive carcinoma. Myoepithelial immunostains support benignity.
Radial scar or complex sclerosing lesion may simulate carcinoma grossly and radiologically
because it produces stellate fibrosis and architectural distortion. Histologically, it has a central
fibroelastotic core with entrapped benign glands radiating outward. Myoepithelial cells are
preserved around benign glands, unlike invasive carcinoma.

Tubular carcinoma is a special type of invasive breast carcinoma composed of well-formed

angulated tubules infiltrating desmoplastic stroma. It is usually low grade and has a favorable
prognosis. It differs from invasive ductal carcinoma of no special type by its highly uniform
tubular architecture and excellent differentiation.

Mucinous carcinoma is a special type of invasive breast carcinoma characterized by clusters of

tumor cells floating in abundant extracellular mucin. It is usually well circumscribed and has a
better prognosis than invasive carcinoma of no special type when pure. Invasive ductal
carcinoma of no special type lacks predominant extracellular mucin lakes.

Medullary-pattern carcinoma is a high-grade carcinoma with syncytial growth, pushing

borders, and prominent lymphoplasmacytic infiltrate. It may be associated with breast cancer
susceptibility gene 1-related tumors and triple-negative phenotype. It differs from ordinary
invasive ductal carcinoma by its circumscribed pushing margin and syncytial architecture.

Metaplastic carcinoma may contain squamous, spindle cell, chondroid, osseous, or sarcomatoid
differentiation. It is distinguished by overt metaplastic elements and often triple-negative
phenotype. Invasive ductal carcinoma of no special type lacks dominant metaplastic
differentiation.

Metastatic carcinoma to the breast may mimic primary invasive breast carcinoma. Clinical
context, morphology, absence of in situ carcinoma, and immunophenotype help distinguish it.
Markers such as GATA binding protein 3, mammaglobin, gross cystic disease fluid protein 15,
estrogen receptor, and site-specific markers for suspected primaries may be useful.
 Gross /
Main Site / Key Histopathological Distinguishing
Disease Structural
Distribution Finding Feature
Pattern

Irregular, firm, Infiltrating malignant

Breast, most
gray-white to glands, nests, cords, and Most common
often upper
yellow-white, solid aggregates in invasive breast
Invasive outer quadrant;
infiltrative desmoplastic stroma carcinoma; cohesive
ductal may spread to
scirrhous mass and fat; absent infiltrative
carcinoma axillary nodes
with myoepithelial layer; carcinoma of no
and distant
desmoplastic variable grade and special type
organs
retraction receptor profile

Poorly defined Discohesive cells in

Invasive Breast, often Single-file
thickening or single-file and targetoid
lobular multifocal or infiltrative pattern
mass; may be patterns; E-cadherin
carcinoma bilateral and loss of cohesion
subtle grossly loss

Malignant epithelial Noninvasive lesion

Ductal Calcifications or
Duct-lobular cells confined within with intact
carcinoma ductal lesion; no
system ducts with preserved myoepithelial
in situ stromal invasion
myoepithelial layer boundary

Distorted benign glands Benign lobulocentric

Lobulocentric Firm area or
Sclerosing in sclerotic stroma with process with
benign breast imaging
adenosis preserved myoepithelial
lesion abnormality
myoepithelial cells preservation

Radial scar /
Stellate lesion Central fibroelastotic Benign glands with
complex Breast
mimicking scar with entrapped myoepithelial cells
sclerosing parenchyma
carcinoma benign glands radiating from scar
lesion

Special type with

Tubular Small firm Well-formed angulated
Breast excellent tubular
carcinoma stellate lesion tubules in desmoplastic
differentiation
 Gross /
Main Site / Key Histopathological Distinguishing
Disease Structural
Distribution Finding Feature
Pattern

stroma, low-grade
nuclei

Soft, gelatinous,
Tumor cell clusters
Mucinous often Abundant
Breast floating in extracellular
carcinoma circumscribed extracellular mucin
mucin lakes
mass

Syncytial high-grade
Medullary- Soft, fleshy, tumor sheets with Syncytial growth
pattern Breast circumscribed lymphoplasmacytic with prominent
carcinoma mass infiltrate and pushing immune infiltrate
border

Carcinoma with
Firm or fleshy squamous, spindle,
Metaplastic Overt metaplastic
Breast mass, often high chondroid, osseous, or
carcinoma differentiation
grade sarcomatoid
differentiation

Circumscribed or
Absence of in situ
Metastatic Breast infiltrative
Morphology depends carcinoma and non-
carcinoma secondary lesion, usually
on primary tumor breast
to breast involvement without in situ
immunophenotype
component
OLIGODENDROGLIOMA

Oligodendroglioma is an infiltrating diffuse glioma composed of neoplastic cells resembling

oligodendrocytes. In contemporary classification, the diagnosis requires both characteristic
morphology and a defining molecular profile: mutation in isocitrate dehydrogenase 1 (IDH1)
or isocitrate dehydrogenase 2 (IDH2), together with whole-arm codeletion of chromosomes 1p
and 19q. Thus, the full modern diagnostic entity is oligodendroglioma, IDH-mutant and 1p/19q-
codeleted.

The tumor arises within the central nervous system and is most often located in the cerebral
hemispheres, especially the frontal and temporal lobes. It is an infiltrating glioma and therefore
extends through brain parenchyma rather than forming a truly encapsulated neoplasm. Despite
its infiltrative nature, oligodendroglioma often has a more favorable prognosis than other adult-
type diffuse gliomas when grade is taken into account.

The pathological identity of oligodendroglioma rests on a combination of infiltrative growth,

oligodendroglial cytology, delicate branching vasculature, frequent calcification, and the
molecular signature of IDH mutation with 1p/19q codeletion. In pathology teaching, the classic
microscopic pattern is a proliferation of uniform round tumor cells with prominent
perinuclear halos (“fried-egg appearance”) and a delicate branching capillary network
(“chicken-wire” vascular pattern). The corresponding diagnostic entity is
Oligodendroglioma.

Etiology

The etiology of oligodendroglioma is primarily molecular and genetic at the somatic tumor
level. The disease is not caused by infection, trauma, vascular injury, inflammation, or
demyelination. Its defining cause is acquisition of genetic alterations that transform glial-
lineage precursor cells into an infiltrating glioma.

The essential molecular alterations are mutation in isocitrate dehydrogenase 1 or isocitrate

dehydrogenase 2 and combined whole-arm loss of chromosomes 1p and 19q. IDH1 and IDH2
encode metabolic enzymes that normally participate in cellular metabolism. Mutant IDH
enzymes produce the oncometabolite D-2-hydroxyglutarate, which alters DNA methylation,
histone methylation, cellular differentiation, and gene expression. This creates an epigenetically
altered state that supports glioma formation.
The 1p/19q codeletion is required for the diagnosis of oligodendroglioma in current
classification. It usually results from an unbalanced translocation followed by loss of derivative
chromosomal material, producing combined deletion of chromosome arms 1p and 19q. This
molecular alteration is associated with oligodendroglial morphology, better response to therapy,
and more favorable prognosis compared with many other diffuse gliomas.

Mutations in the promoter of telomerase reverse transcriptase (TERT) are also common. These
mutations increase telomerase activity, helping tumor cells maintain telomere length and sustain
replicative capacity.

Additional genetic alterations may involve genes located on the deleted chromosome arms,
including homolog of Drosophila capicua transcriptional repressor (CIC) on chromosome 19q
and far upstream element binding protein 1 (FUBP1) on chromosome 1p. These alterations
contribute to tumor biology and support the molecular identity of oligodendroglioma.

The etiologic formulation is therefore: glial precursor cell transformation driven by IDH
mutation, 1p/19q codeletion, telomerase reverse transcriptase promoter mutation, and
additional cooperating genetic changes.

Pathogenesis

The central pathogenic process begins with IDH mutation. Mutant isocitrate dehydrogenase
produces D-2-hydroxyglutarate, which inhibits enzymes involved in DNA and histone
demethylation. This produces widespread epigenetic dysregulation and impairs normal glial
differentiation. The resulting cell population becomes permissive for additional genetic events.

Whole-arm codeletion of chromosomes 1p and 19q then defines the oligodendroglial lineage
of the diffuse glioma. Loss of tumor suppressor genes and altered transcriptional regulation
contribute to tumor growth. Telomerase reverse transcriptase promoter mutation supports
cellular immortality by maintaining telomeres.

The tumor infiltrates cerebral white and gray matter. Oligodendroglioma cells spread through
the parenchyma and may accumulate around neurons, a pattern known as satellitosis. The tumor
also has a characteristic vascular architecture: thin, branching, anastomosing capillaries create
the classic chicken-wire pattern.

Calcification is very common and may range from microscopic deposits to extensive calcified
foci. Calcification is so frequent that it is a major radiologic and gross clue. It reflects chronic
tumor growth, altered microenvironment, and dystrophic mineralization within the neoplastic
tissue.

The major pathological sequence is:

IDH1 or IDH2 mutation → D-2-hydroxyglutarate accumulation → epigenetic dysregulation

and impaired differentiation → 1p/19q codeletion and cooperating tumor suppressor losses →
telomerase reverse transcriptase promoter mutation and replicative maintenance → infiltrating
oligodendroglial tumor with calcification and chicken-wire vasculature.

The essential pathogenic concept is that oligodendroglioma is not diagnosed by morphology

alone. The “fried-egg” and “chicken-wire” pattern is strongly suggestive, but the current
integrated diagnosis requires IDH mutation and 1p/19q codeletion.

Macroscopic Findings

Grossly, oligodendroglioma usually forms an infiltrative mass in the cerebral hemispheres,

especially the frontal or temporal lobes. The tumor may extend through cortical and subcortical
regions, producing an infiltrative cortical-subcortical lesion. In the examined disease pattern,
imaging may demonstrate an infiltrative frontal lobe mass extending into the cortical-
subcortical region, with T2 hyperintensity and focal calcification.

The cut surface is often gray, gelatinous, and soft. Cystic change may be present. Foci of
hemorrhage can occur, particularly in higher-grade tumors. Calcifications are common and may
be gritty on sectioning. The tumor may appear relatively well demarcated grossly compared
with some astrocytic diffuse gliomas, but histologically it is infiltrative.

In lower-grade oligodendroglioma, the lesion may be slow-growing and relatively

circumscribed on imaging or gross inspection. However, it remains a diffuse infiltrating glioma.
In higher-grade tumors, the mass may show increased cellularity, necrosis, hemorrhage, and
microvascular proliferation.

The gross pathological constellation is a gelatinous gray infiltrating hemispheric mass,

commonly frontal or temporal, often with cystic change, hemorrhage, and calcification. The
most characteristic macroscopic-radiologic clue is calcification within a cortical-subcortical
frontal or temporal lobe tumor.

Histopathological Findings
Histologically, oligodendroglioma is composed of sheets of relatively uniform round cells. The
nuclei are round to oval and contain finely granular chromatin. The cytoplasm often appears
clear around the nucleus, producing a perinuclear halo. This creates the classic uniform round
tumor cells with prominent perinuclear halos (“fried-egg appearance”).

The “fried-egg” appearance is partly accentuated by fixation artifact, but it remains a classic
diagnostic teaching feature. The tumor cells have relatively sharp cell borders and a
monotonous oligodendroglial appearance. Nuclear atypia is generally mild in grade 2 tumors,
while grade 3 tumors show increased cellularity, nuclear anaplasia, mitotic activity, and may
show microvascular proliferation or necrosis.

The tumor typically contains a delicate branching capillary network (“chicken-wire”

vascular pattern). These thin anastomosing capillaries surround and separate tumor cells in a
fine reticular pattern. This vascular architecture is one of the strongest light microscopic clues
to oligodendroglioma.

Calcification is very common. It may appear as microscopic mineral deposits scattered within
tumor tissue or as larger calcified foci. Calcification may be extensive and is an important
feature in both histology and imaging.

Tumor cells may cluster around preexisting neurons, producing perineuronal satellitosis. They
may also infiltrate cortex, white matter, and leptomeninges. Cortical involvement helps explain
why seizures are common in the disease, although detailed clinical framing is not necessary for
pathology diagnosis.

Anaplastic oligodendroglioma, central nervous system World Health Organization grade 3,

shows higher cellularity, increased mitotic activity, nuclear anaplasia, and often microvascular
proliferation and/or necrosis. These features indicate more aggressive biological behavior. Even
in grade 3 tumors, the integrated molecular identity remains IDH-mutant and 1p/19q-codeleted.

Immunohistochemistry and molecular testing are central to contemporary diagnosis. IDH1

R132H mutant protein immunohistochemistry may identify the common IDH1 mutation.
ATRX chromatin remodeler (ATRX) expression is usually retained in oligodendroglioma,
helping distinguish it from many IDH-mutant astrocytomas, which often show ATRX loss.
Tumor protein p53 (p53) accumulation is usually not strong and diffuse in oligodendroglioma,
whereas it is more often prominent in IDH-mutant astrocytoma. Molecular testing confirms
1p/19q codeletion. Telomerase reverse transcriptase promoter mutation is common and
supports the molecular profile.

The concise histopathological formulation is:

an infiltrating IDH-mutant and 1p/19q-codeleted glioma composed of uniform round tumor

cells with prominent perinuclear halos (“fried-egg appearance”), accompanied by a
delicate branching capillary network (“chicken-wire” vascular pattern), frequent
calcification, and variable anaplastic features depending on grade.

Differential Diagnosis

The most important differential diagnosis is IDH-mutant astrocytoma. Both are adult-type
diffuse gliomas and may arise in cerebral hemispheres. IDH-mutant astrocytoma lacks 1p/19q
codeletion, often shows ATRX loss and p53 overexpression, and has astrocytic cytology with
fibrillary background rather than classic oligodendroglial perinuclear halos and chicken-wire
vasculature. Molecular testing is decisive.

Glioblastoma, IDH-wild-type, may enter the differential diagnosis when a high-grade

infiltrating glioma shows necrosis and microvascular proliferation. Glioblastoma usually lacks
IDH mutation and 1p/19q codeletion and often shows molecular features such as telomerase
reverse transcriptase promoter mutation, epidermal growth factor receptor gene amplification,
or chromosome 7 gain/chromosome 10 loss pattern. The presence of IDH mutation plus 1p/19q
codeletion supports oligodendroglioma rather than glioblastoma.

Central neurocytoma may mimic oligodendroglioma because it can show uniform round cells
and delicate vasculature. However, central neurocytoma typically arises within the ventricular
system, especially near the foramen of Monro, and expresses neuronal markers such as
synaptophysin. Oligodendroglioma is an infiltrating hemispheric glioma with IDH mutation
and 1p/19q codeletion.

Clear cell ependymoma can resemble oligodendroglioma because of clear cytoplasm and
perinuclear halos. Ependymoma may show perivascular pseudorosettes, ependymal rosettes,
epithelial membrane antigen dot-like or ring-like staining, and a location near ventricular
surfaces or spinal cord. It lacks the defining IDH mutation and 1p/19q codeletion of
oligodendroglioma.

Dysembryoplastic neuroepithelial tumor may mimic oligodendroglioma in cortical lesions with

seizures. It is a low-grade glioneuronal tumor with a multinodular architecture, specific
glioneuronal element, floating neurons in mucin-rich matrix, and cortical location. It does not
show the molecular profile of oligodendroglioma.

Metastatic clear cell carcinoma, especially renal cell carcinoma, may mimic clear cell glial
tumors in small biopsies. Metastatic carcinoma expresses epithelial markers such as
cytokeratins and site-specific markers such as paired box gene 8 (PAX8) in renal cell carcinoma.
Oligodendroglioma expresses glial markers and has the IDH-mutant, 1p/19q-codeleted
molecular profile.

Lymphoma may mimic a hypercellular infiltrative brain tumor but is composed of atypical
lymphoid cells expressing leukocyte markers. Primary central nervous system lymphoma
usually shows angiocentric growth and expresses B-cell markers such as CD20.
Oligodendroglioma lacks lymphoid immunophenotype and shows oligodendroglial cytology
with glial molecular alterations.

Gross / Key
Main Site / Distinguishing
Disease Structural Histopathologica
Distribution Feature
Pattern l Finding

Infiltrative
Uniform round
frontal lobe
tumor cells with
Cerebral mass
prominent
hemispheres, extending into
perinuclear
especially the cortical- IDH-mutant and
halos (“fried-egg
frontal and subcortical 1p/19q-codeleted
Oligodendrogliom appearance”)
temporal region, T2 diffuse glioma;
a and delicate
lobes; hyperintensity diagnosis:
branching
cortical- , focal Oligodendroglioma
capillary
subcortical calcification;
network
involvement gelatinous gray
(“chicken-wire”
mass with
vascular
possible cysts,
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathologica
Distribution Feature
Pattern l Finding

hemorrhage, pattern); frequent

calcification calcification

Astrocytic IDH-mutant but

Infiltrative cytology, 1p/19q non-codeleted;
IDH-mutant Cerebral
gray-white fibrillary ATRX loss and p53
astrocytoma hemispheres
glioma background, overexpression
variable atypia common

Necrotic,
High cellularity, IDH-wild-type high-
Cerebral hemorrhagic,
nuclear atypia, grade diffuse glioma
Glioblastoma, IDH- hemispheres, infiltrative
mitoses, necrosis, with
wild-type often older mass; ring-
microvascular necrosis/microvascula
adults enhancing
proliferation r proliferation
lesion

Ventricular
Uniform round
system,
cells with Ventricular neuronal
especially
Central Intraventricular neuronal tumor rather than
lateral
neurocytoma mass differentiation; IDH-mutant 1p/19q-
ventricle near
synaptophysin codeleted glioma
foramen of
positive
Monro

Ventricular Clear cells with

surfaces, Well- perivascular
Ependymal
spinal cord, or demarcated pseudorosettes;
Clear cell differentiation rather
cerebral mass near epithelial
ependymoma than oligodendroglial
parenchyma ependymal membrane
molecular profile
depending on surfaces antigen dot-like
subtype staining
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathologica
Distribution Feature
Pattern l Finding

Specific Low-grade
Dysembryoplastic Cerebral Cortical glioneuronal glioneuronal tumor
neuroepithelial cortex, often multinodular element, floating with cortical
tumor temporal lobe lesion neurons in multinodular
mucinous matrix architecture

Clear cell
Well-
Brain carcinoma with
demarcated Epithelial metastatic
Metastatic clear cell metastasis, vascular network;
metastatic tumor rather than glial
renal cell carcinoma often gray- cytokeratin and
mass, often tumor
white junction paired box gene 8
hemorrhagic
positive

Deep brain,
Angiocentric
Primary central periventricula Infiltrative or
atypical lymphoid Lymphoid
nervous system r regions, mass-forming
infiltrate, usually immunophenotype
lymphoma corpus lesion
CD20 positive
callosum
PAGET DISEASE OF BREAST

Paget disease of breast, also called Paget disease of the nipple, is an intraepidermal
manifestation of an underlying breast carcinoma, most often ductal carcinoma in situ or invasive
ductal carcinoma. It is characterized by malignant glandular epithelial cells, called Paget cells,
spreading into the epidermis of the nipple and areola. The disease produces an eczematoid,
crusted, fissured, or ulcerated lesion of the nipple-areola complex.

The essential pathological identity of Paget disease of breast is epidermotropic spread of

malignant ductal carcinoma cells from the underlying lactiferous ducts into the nipple
epidermis. The intraepidermal malignant cells have adenocarcinoma-type morphology and
usually share immunophenotypic features with the underlying ductal carcinoma.

Paget disease of breast is important because the visible nipple lesion may be the first
manifestation of an underlying ductal carcinoma. The associated carcinoma may be ductal
carcinoma in situ, invasive ductal carcinoma, or both. When a palpable subareolar or breast
mass is present, invasive carcinoma is more likely; when no mass is present, ductal carcinoma
in situ is often found in the underlying ducts.

Etiology

The etiology of Paget disease of breast is tied to the biology of underlying ductal carcinoma. In
most cases, Paget disease represents extension of malignant ductal epithelial cells from ductal
carcinoma in situ or invasive ductal carcinoma along the lactiferous ducts into the epidermis of
the nipple.

The dominant pathogenetic hypothesis is the epidermotropic migration theory. According to

this model, malignant cells from an underlying ductal carcinoma migrate through the ductal
system and reach the nipple epidermis. These cells then proliferate within the epidermis and
produce the characteristic eczematoid nipple lesion.

A second, less accepted hypothesis proposes that Paget disease may arise as an in situ malignant
transformation of epidermal cells of the nipple itself. This model may explain rare cases without
demonstrable underlying carcinoma, but most cases are best explained by migration from
underlying ductal carcinoma.

The molecular etiology reflects the associated breast carcinoma. Many cases of mammary Paget
disease are associated with human epidermal growth factor receptor 2 overexpression or
amplification. Estrogen receptor and progesterone receptor expression may be variable,
depending on the underlying carcinoma. HER2-positive ductal carcinoma in situ is particularly
associated with Paget disease of the nipple.

The etiologic formulation is therefore: underlying ductal carcinoma, especially ductal

carcinoma in situ or invasive ductal carcinoma, with epidermotropic extension of malignant
glandular cells into the nipple epidermis.

Pathogenesis

The central pathogenic process is intraepidermal spread of malignant ductal epithelial cells.
Tumor cells arise in an underlying ductal carcinoma and migrate through the lactiferous ducts
toward the nipple surface. After reaching the nipple epidermis, they infiltrate the epidermal
layers as single cells or small clusters.

Paget cells disturb normal epidermal architecture. They separate keratinocytes, occupy lower
and upper epidermal layers, and may extend into adnexal structures. Their presence produces
epidermal hyperplasia, spongiosis, crusting, erosion, ulceration, and inflammatory changes.
This explains why the lesion may resemble eczema or dermatitis grossly.

The malignant cells are glandular in type. They often contain abundant pale or amphophilic
cytoplasm, sometimes with mucin. Their large size and cytoplasmic clearing make them stand
out from surrounding keratinocytes. They usually express epithelial and glandular markers and
often express HER2.

The underlying ductal carcinoma may remain in situ or may be invasive. If the underlying lesion
is ductal carcinoma in situ, the malignant process is confined within ducts and epidermis,
without stromal invasion. If invasive ductal carcinoma is present, tumor cells have breached the
basement membrane and invaded breast stroma, increasing the risk of lymph node metastasis
and systemic spread.

The major pathological sequence is:

ductal carcinoma in situ or invasive ductal carcinoma → spread of malignant ductal cells along
lactiferous ducts → intraepidermal colonization of nipple epidermis → Paget cell formation →
eczematoid, crusted, fissured, or ulcerated nipple-areola lesion.

The essential pathogenic concept is that Paget disease of breast is usually not an isolated
epidermal carcinoma; it is an epidermal manifestation of underlying breast ductal carcinoma.

Macroscopic Findings
Grossly, Paget disease of breast involves the nipple and areola. The skin of the nipple-areola
complex is typically erythematous, crusted, scaly, fissured, eroded, or ulcerated. Serous or
serosanguineous oozing may be present from erosions.

The lesion may be sharply or poorly demarcated and may mimic chronic eczema. Thick crusts
may cover the nipple surface. In long-standing cases, nipple retraction, flattening, or destruction
may occur. The areola may show extension of the erythematous or scaly lesion.

A palpable subareolar mass may be present in some cases. When present, it usually corresponds
to underlying invasive ductal carcinoma or extensive ductal carcinoma in situ. In other cases,
there may be no grossly visible breast mass, and the associated carcinoma may be detected only
by histological examination or imaging.

On sectioning the underlying breast tissue, ductal carcinoma in situ may appear as ducts
expanded by tumor, sometimes with necrotic material or calcifications. Invasive ductal
carcinoma, when present, may appear as a firm gray-white infiltrative mass.

The classical gross pathological picture is a crusted, fissured, ulcerated eczematoid lesion of
the nipple and areola, with or without an underlying ductal carcinoma mass.

Histopathological Findings

Histologically, Paget disease of breast is characterized by Paget cells within the epidermis of
the nipple and areola. Paget cells are large malignant epithelial cells with abundant pale, clear,
or amphophilic cytoplasm and enlarged atypical nuclei. The nuclei may be hyperchromatic and
may contain prominent nucleoli. The cytoplasm may show a halo-like clearing.

Paget cells are present singly or in small clusters within the epidermis. They may be located in
the basal, suprabasal, or full thickness of the epidermis. They often spread between
keratinocytes in a pagetoid pattern. The epidermis may show acanthosis, spongiosis,
parakeratosis, crusting, erosion, or ulceration.

The cells are adenocarcinoma-type cells. Cytoplasmic mucin may be demonstrable with mucin
stains such as mucicarmine or periodic acid-Schiff with diastase resistance, depending on the
case. This supports glandular differentiation.

The underlying breast tissue should be carefully examined for ductal carcinoma in situ and
invasive ductal carcinoma. Ductal carcinoma in situ may show solid, comedo, cribriform,
papillary, or micropapillary patterns. Invasive ductal carcinoma, if present, shows malignant
glands, nests, cords, or solid aggregates infiltrating breast stroma and lacking a myoepithelial
layer.

Immunohistochemistry is highly useful. Paget cells usually express cytokeratin 7, epithelial

membrane antigen, carcinoembryonic antigen, and other glandular epithelial markers. HER2 is
frequently overexpressed. Estrogen receptor and progesterone receptor expression are variable
and often depend on the associated carcinoma. GATA binding protein 3 is commonly positive
and supports breast epithelial origin. Gross cystic disease fluid protein 15 and mammaglobin
may be positive in some cases.

Myoepithelial markers are useful in evaluating the underlying carcinoma. p63, smooth muscle
myosin heavy chain, calponin, and cytokeratin 5/6 highlight myoepithelial cells around benign
ducts and ductal carcinoma in situ but are absent around invasive carcinoma.

The concise histopathological formulation is:

intraepidermal Paget cells, present singly or in clusters within nipple epidermis, composed of
large malignant glandular epithelial cells with pale cytoplasm, hyperchromatic nuclei,
cytoplasmic halo, glandular marker expression, frequent HER2 positivity, and association with
underlying ductal carcinoma in situ or invasive ductal carcinoma.

Differential Diagnosis

The most important differential diagnosis is eczema or chronic dermatitis of the nipple. Eczema
shows spongiosis, parakeratosis, inflammatory infiltrates, and epidermal hyperplasia but lacks
malignant intraepidermal Paget cells. Paget disease contains large atypical glandular cells
expressing cytokeratin 7, epithelial membrane antigen, carcinoembryonic antigen, and often
HER2.

Melanoma in situ may mimic Paget disease because both can show pagetoid spread of atypical
cells within the epidermis. Melanoma cells express melanocytic markers such as SRY-box
transcription factor 10, S100 protein, human melanoma black 45, and Melan-A. Paget cells
express epithelial and glandular markers such as cytokeratin 7 and epithelial membrane antigen.

Squamous cell carcinoma in situ of the nipple may show full-thickness epidermal atypia,
dyskeratosis, and atypical keratinocytes. It expresses squamous markers such as p40, p63, and
high-molecular-weight cytokeratin. Paget disease shows glandular epithelial differentiation and
is usually cytokeratin 7 positive.
Pagetoid spread of urothelial carcinoma or other metastatic carcinoma to the nipple skin is rare
but may mimic Paget disease. Clinical context and immunohistochemistry help distinguish the
origin. Urothelial carcinoma may express GATA binding protein 3, p63, p40, uroplakin, and
cytokeratin 20, while mammary Paget disease is typically cytokeratin 7 positive and often
HER2 positive, with associated underlying breast carcinoma.

Toker cell hyperplasia may mimic Paget disease because Toker cells are clear cells found in
nipple epidermis and may express cytokeratin 7. However, Toker cells are bland, small, non-
neoplastic epithelial cells without significant cytologic atypia, mitotic activity, or association
with underlying ductal carcinoma. HER2 overexpression and marked atypia favor Paget
disease.

Extramammary Paget disease may involve vulvar, perianal, scrotal, or other apocrine-rich skin
and may show similar intraepidermal Paget cells. The anatomic site and association with
underlying adnexal or visceral carcinoma determine classification. Mammary Paget disease is
centered on the nipple-areola complex and is strongly associated with ductal carcinoma of the
breast.

Bowen disease, another term for squamous cell carcinoma in situ, may involve the nipple and
produce a scaly plaque. It is distinguished by squamous cytology, keratinocytic atypia, and
squamous immunophenotype rather than glandular Paget cells.
 Gross /
Main Site / Key Histopathological Distinguishing
Disease Structural
Distribution Finding Feature
Pattern

Large malignant Paget

cells singly or in
Crusted, scaly, clusters within
Nipple-areola
fissured, epidermis; pale Epidermal
epidermis with
ulcerated cytoplasm, manifestation of
underlying
Paget disease of eczematoid hyperchromatic nuclei, underlying ductal
lactiferous
breast lesion of nipple cytoplasmic halo; carcinoma in situ
ducts and
and areola; cytokeratin 7, epithelial or invasive ductal
breast
possible membrane antigen, carcinoma
carcinoma
subareolar mass carcinoembryonic
antigen, often HER2
positive

Spongiosis,
Eczema / Erythematous, Benign
Nipple parakeratosis,
chronic scaly, itchy inflammatory
epidermis inflammation, no
dermatitis lesion dermatosis
malignant Paget cells

Pagetoid atypical
melanocytes; SRY-box Melanocytic rather
Epidermis of Pigmented or
Melanoma in transcription factor 10, than glandular
nipple or amelanotic
situ S100, human melanoma epithelial
adjacent skin plaque
black 45, Melan-A differentiation
positive

Squamous
Squamous cell Full-thickness atypical
differentiation
carcinoma in Nipple Scaly plaque or keratinocytes,
rather than
situ / Bowen epidermis erosive lesion dyskeratosis, p40/p63
adenocarcinoma-
disease positivity
type Paget cells
 Gross /
Main Site / Key Histopathological Distinguishing
Disease Structural
Distribution Finding Feature
Pattern

Benign clear cell

Usually Bland clear cytokeratin
Toker cell Nipple population without
microscopic or 7-positive cells without
hyperplasia epidermis underlying
subtle lesion significant atypia
carcinoma pattern

Vulvar, Non-mammary
perianal, Eczematoid anatomic site and
Intraepidermal Paget
Extramammary scrotal, plaque outside different
cells with glandular
Paget disease axillary, or nipple-areola associated
differentiation
apocrine-rich complex carcinoma
skin spectrum

Pagetoid Secondary
Variable lesion Pagetoid carcinoma Urothelial marker
urothelial epidermal or
depending on cells with urothelial profile and clinical
carcinoma mucosal
site immunophenotype context
involvement involvement
INCLUSION BODY MYOSITIS

Inclusion body myositis is a chronic inflammatory-degenerative myopathy characterized by

endomysial inflammation, myofiber degeneration, rimmed vacuoles, and abnormal intracellular
protein aggregates. It is traditionally grouped among inflammatory myopathies, together with
polymyositis and dermatomyositis, but its pathology shows a distinctive combination of
immune-mediated myofiber injury and degenerative protein-aggregation pathology.

The disease primarily affects skeletal muscle and produces slowly progressive myopathic
injury. It has a characteristic predilection for specific muscle groups, especially quadriceps and
finger flexors, but the defining features for pathology are seen in muscle biopsy rather than in
clinical distribution. The biopsy shows endomysial inflammatory infiltrates, necrotic and
regenerating myofibers, and rimmed vacuoles. Electron microscopy demonstrates
cytoplasmic tubulofilamentous inclusions. The diagnostic disease entity is Inclusion body
myositis.

The essential pathological identity of inclusion body myositis is a chronic myopathy in which
inflammatory injury coexists with abnormal accumulation of proteins also implicated in
neurodegenerative disease. Rimmed vacuoles contain aggregates of hyperphosphorylated tau,
amyloid derived from beta-amyloid precursor protein, and TAR DNA-binding protein 43. This
overlap with neurodegenerative protein pathology is one reason inclusion body myositis is often
regarded as both inflammatory and degenerative.

Etiology

The exact etiology of inclusion body myositis is not fully established. The disease is best
understood as a multifactorial disorder involving age-associated muscle vulnerability, abnormal
protein homeostasis, autophagic dysfunction, mitochondrial abnormalities, and immune-
mediated myofiber injury.

Unlike some hereditary myopathies, sporadic inclusion body myositis is not usually caused by
a single inherited mutation. It is mainly an acquired disease. However, genetic background may
influence susceptibility, particularly through immune-regulatory pathways. Certain human
leukocyte antigen associations have been described, supporting an immune contribution.

An autoimmune component is suggested by endomysial inflammatory infiltrates and cytotoxic

T lymphocyte-mediated attack on non-necrotic myofibers. Muscle fibers may express major
histocompatibility complex class I antigens, making them potential targets of cytotoxic immune
recognition. However, the limited response to immunosuppressive therapy suggests that
inflammation is not the sole driver and may be partly secondary to degenerative myofiber injury.

Degenerative protein accumulation is central. Abnormal aggregates include

hyperphosphorylated tau, amyloid-related material derived from beta-amyloid precursor
protein, and TAR DNA-binding protein 43. These proteins are also associated with
neurodegenerative disorders, supporting the concept that defective proteostasis and impaired
autophagic-lysosomal clearance are important in inclusion body myositis.

Environmental triggers are not clearly established. The most coherent etiologic formulation is
therefore an acquired age-associated myopathy in which disordered protein handling and
autophagy interact with chronic immune-mediated myofiber injury.

Pathogenesis

The pathogenesis of inclusion body myositis involves two overlapping processes: inflammatory
myofiber injury and degenerative intracellular protein accumulation.

The inflammatory component is centered in the endomysium. Cytotoxic T lymphocytes and

macrophages surround and invade individual muscle fibers. Some non-necrotic myofibers are
invaded by T cells, supporting a direct immune attack. Upregulation of major histocompatibility
complex class I on muscle fibers contributes to antigen presentation and immune recognition.

The degenerative component is characterized by impaired protein degradation and

accumulation of abnormal proteins within myofibers. Autophagic vacuoles develop, and these
vacuoles become rimmed by basophilic granular material on light microscopy. The abnormal
protein aggregates include hyperphosphorylated tau, amyloid-related proteins derived from
beta-amyloid precursor protein, and TAR DNA-binding protein 43.

Mitochondrial dysfunction may also contribute. Some biopsies show cytochrome c oxidase-
negative fibers, ragged-red-like changes, or mitochondrial DNA abnormalities. These findings
suggest that mitochondrial injury and impaired energy metabolism may amplify myofiber
degeneration.

Muscle fiber degeneration leads to necrosis and regeneration. Regenerating fibers may be
basophilic and express developmental myosin markers. Chronic injury produces endomysial
fibrosis, fatty replacement, and progressive loss of functional muscle fibers.

The major pathological sequence is:

age-associated susceptibility and impaired proteostasis → abnormal autophagic and protein
aggregate accumulation → rimmed vacuole formation → endomysial cytotoxic inflammatory
response → myofiber necrosis and regeneration → chronic fibrosis and fatty replacement →
progressive myopathic damage.

The essential pathogenic idea is that inclusion body myositis is not simply polymyositis with
vacuoles. It is a distinct myopathy with a characteristic combination of endomysial
inflammation, rimmed vacuoles, cytoplasmic tubulofilamentous inclusions, and protein
aggregates associated with degenerative pathways.

Macroscopic Findings

Gross examination of skeletal muscle in inclusion body myositis is generally nonspecific but
reflects chronic myopathic atrophy. Affected muscles may appear reduced in bulk and pale
because of fiber loss, fatty replacement, and fibrosis. In long-standing disease, involved muscles
may show marked atrophy.

The distribution of muscle involvement may be asymmetric or selective. The quadriceps and
finger flexor compartments are often prominently affected. However, in a pathology-focused
specimen evaluation, gross findings alone are not sufficient for diagnosis.

On cut section, chronically affected muscle may appear pale tan, soft, and fatty. Fibrotic tissue
may increase firmness in advanced lesions. These macroscopic changes indicate chronic muscle
loss but do not distinguish inclusion body myositis from other chronic myopathies.

The diagnostic value lies in muscle biopsy. Routine gross pathology mainly supports chronic
skeletal muscle atrophy and fatty-fibrotic replacement, while microscopic examination
identifies the defining pattern.

Histopathological Findings

Histopathologically, inclusion body myositis shows a mixed inflammatory and degenerative

myopathy. The key biopsy findings are endomysial inflammatory infiltrates, necrotic and
regenerating myofibers, and rimmed vacuoles.

The inflammatory infiltrate is predominantly endomysial. It consists mainly of T lymphocytes

and macrophages. Cytotoxic T cells may surround and invade non-necrotic myofibers. This
pattern resembles polymyositis in some areas but is distinguished by the presence of rimmed
vacuoles and degenerative protein aggregates.
Myofiber necrosis and regeneration are present. Necrotic fibers are pale, fragmented, and
infiltrated by macrophages. Regenerating fibers are often basophilic, smaller, and may have
prominent nuclei. Fiber size variation is common, reflecting cycles of injury and repair.

The hallmark lesion is the rimmed vacuole. Rimmed vacuoles are clear intracytoplasmic spaces
bordered by basophilic granular material on hematoxylin and eosin or modified Gomori
trichrome staining. They represent autophagic vacuoles associated with abnormal protein
accumulation. The vacuoles may be multiple and irregular and may occur in non-necrotic or
degenerating fibers.

Additional degenerative findings include eosinophilic cytoplasmic inclusions, congophilic

amyloid deposits in some cases, and abnormal protein aggregates demonstrable by special
stains or immunohistochemistry. Hyperphosphorylated tau, beta-amyloid precursor protein-
derived amyloid, and TAR DNA-binding protein 43 may be detected in affected fibers.

Endomysial fibrosis and fatty replacement are common in chronic disease. These chronic
changes reflect irreversible muscle fiber loss. The degree of fibrosis and fatty replacement may
vary depending on disease duration and biopsy site.

Immunohistochemistry may show major histocompatibility complex class I upregulation on

muscle fibers, CD8-positive cytotoxic T lymphocytes within endomysial infiltrates, and
macrophages highlighted by CD68. Stains for p62/sequestosome 1, TAR DNA-binding protein
43, beta-amyloid, and phosphorylated tau may highlight abnormal protein aggregates. These
markers support the degenerative inclusion-body component of the disease.

The concise histopathological formulation is:

chronic inflammatory-degenerative myopathy with endomysial inflammatory infiltrates,

cytotoxic T cell-associated myofiber injury, necrotic and regenerating myofibers, rimmed
vacuoles, abnormal protein aggregates, endomysial fibrosis, and fatty replacement.

Electron Microscopic Findings

Electron microscopy demonstrates cytoplasmic tubulofilamentous inclusions within affected

myofibers. These inclusions are composed of abnormal filamentous aggregates and correspond
to the degenerative inclusion-body component of the disease.

The tubulofilamentous inclusions may be found in the cytoplasm and sometimes near or within
nuclei. They are associated with autophagic vacuoles and abnormal protein accumulation. This
ultrastructural finding supports the diagnosis when correlated with light microscopic rimmed
vacuoles and endomysial inflammation.

Electron microscopy may also show autophagic vacuoles, myofibrillar disorganization,

mitochondrial abnormalities, and degenerative changes in affected fibers. The key high-yield
ultrastructural phrase is cytoplasmic tubulofilamentous inclusions.

Differential Diagnosis

The most important differential diagnosis is polymyositis. Polymyositis also shows endomysial
inflammatory infiltrates and myofiber necrosis. However, polymyositis lacks the characteristic
rimmed vacuoles and tubulofilamentous inclusions of inclusion body myositis. Many cases
historically diagnosed as polymyositis are now reclassified as inclusion body myositis,
immune-mediated necrotizing myopathy, or antisynthetase syndrome after careful
clinicopathologic evaluation.

Dermatomyositis is distinguished by perifascicular atrophy and a microangiopathic pattern of

injury. In dermatomyositis, inflammation is often perivascular and perimysial, and
complement-mediated capillary injury is important. Inclusion body myositis instead shows
endomysial inflammation, rimmed vacuoles, and degenerative inclusions.

Immune-mediated necrotizing myopathy may show prominent myofiber necrosis and

regeneration, often with sparse inflammation. It may be associated with signal recognition
particle antibodies or 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies. The
absence of rimmed vacuoles and tubulofilamentous inclusions helps separate it from inclusion
body myositis.

Duchenne muscular dystrophy may show necrosis, regeneration, fiber size variation,
endomysial fibrosis, and fatty replacement. However, it is a dystrophinopathy caused by
mutation in the dystrophin gene and shows absence or severe reduction of dystrophin on
immunohistochemistry. It lacks the characteristic endomysial inflammatory-degenerative
pattern with rimmed vacuoles and tubulofilamentous inclusions.

Myofibrillar myopathies may show protein aggregates and rimmed vacuoles in some cases.
They are distinguished by myofibrillar disorganization, desmin-positive aggregates, and genetic
abnormalities affecting myofibrillar structural proteins. Clinical and molecular correlation is
often necessary.
Oculopharyngeal muscular dystrophy can show rimmed vacuoles and nuclear filamentous
inclusions. It is caused by expansions in the polyadenylate-binding protein nuclear 1 gene. The
distribution and molecular abnormality separate it from sporadic inclusion body myositis.

Distal myopathies with rimmed vacuoles may resemble inclusion body myositis. These
hereditary disorders are often caused by mutations affecting proteins involved in autophagy,
membrane repair, or muscle structural maintenance. They generally lack the typical endomysial
inflammatory infiltrate and cytotoxic T-cell invasion seen in inclusion body myositis.

Myasthenia gravis is a neuromuscular junction disorder rather than a primary myopathy. Muscle
biopsy is usually not characterized by rimmed vacuoles, endomysial inflammation, or necrotic-
regenerating myofiber cycles. It is distinguished by autoimmune impairment of neuromuscular
transmission, most often involving acetylcholine receptor antibodies or muscle-specific kinase
antibodies.

Main Gross /
Key Histopathological Distinguishing
Disease Pathological Structural
Finding Feature
Target Pattern

Combined
Endomysial inflammatory-
Chronic inflammatory degenerative
Skeletal muscle muscle infiltrates, necrotic myopathy with
fibers with atrophy, fatty and regenerating rimmed vacuoles
Inclusion body
inflammatory replacement, myofibers, rimmed and
myositis
and degenerative fibrosis in vacuoles; EM: tubulofilamentous
injury advanced cytoplasmic inclusions;
disease tubulofilamentous diagnosis:
inclusions Inclusion body
myositis

Endomysial CD8-
Usually no Lacks rimmed
positive T-cell
Skeletal muscle distinctive vacuoles and
Polymyositis inflammation with
fibers gross lesion; tubulofilamentous
myofiber necrosis and
chronic inclusions
regeneration
 Main Gross /
Key Histopathological Distinguishing
Disease Pathological Structural
Finding Feature
Target Pattern

atrophy may
occur

Muscle Muscle Perifascicular atrophy,

microvasculature atrophy; skin perivascular/perimysial Perifascicular
Dermatomyositis and lesions in inflammation, microangiopathic
perifascicular clinical complement-mediated pattern
fibers context capillary injury

Immune- Muscle Prominent myofiber

Necrotizing
mediated Skeletal muscle atrophy in necrosis and
pattern without
necrotizing fibers severe regeneration with sparse
rimmed vacuoles
myopathy disease inflammation

Progressive
Fiber size variation,
Duchenne Dystrophin- fatty
necrosis, regeneration, X-linked
muscular glycoprotein replacement
fibrosis; absent dystrophinopathy
dystrophy complex and fibrosis
dystrophin
of muscle

Myofibrillar Variable Myofibrillar Desmin-related or

Myofibrillar
structural muscle disorganization and other structural
myopathy
proteins atrophy protein aggregates protein aggregates

Polyadenylate-
Oculopharyngeal Skeletal muscle Selective Rimmed vacuoles and
binding protein
muscular nuclei / protein muscle intranuclear
nuclear 1 gene
dystrophy aggregation involvement filamentous inclusions
expansion

Distal myopathy Distal Rimmed vacuoles with Genetic distal

Distal skeletal
with rimmed muscle hereditary myopathic myopathy without
muscles
vacuoles atrophy pattern typical
 Main Gross /
Key Histopathological Distinguishing
Disease Pathological Structural
Finding Feature
Target Pattern

inflammatory
invasion

Autoimmune
transmission
Postsynaptic
No primary disorder rather
Myasthenia Neuromuscular neuromuscular junction
destructive than
gravis junction simplification; no
muscle mass inflammatory-
rimmed vacuoles
degenerative
myopathy
MALIGNANT MESOTHELIOMA

Malignant mesothelioma is an aggressive malignant tumor derived from mesothelial cells lining
serosal cavities, most commonly the pleura. It may also arise in the peritoneum, pericardium,
and tunica vaginalis, but pleural disease is the classic form in general pathology. The tumor
grows diffusely along serosal surfaces rather than forming an ordinary intraparenchymal lung
carcinoma. In the pleura, it characteristically spreads over both visceral and parietal pleural
surfaces and can encase the lung as a thick tumor rind.

The disease is strongly associated with long-term occupational asbestos exposure.

Amphibole asbestos fibers, especially crocidolite, are particularly implicated. The latency
period is often long, and tumor development reflects chronic fiber-related mesothelial injury,
persistent inflammation, oxidative DNA damage, and accumulation of tumor suppressor gene
alterations. Unlike asbestos-associated lung carcinoma, cigarette smoking does not show the
same synergistic effect for mesothelioma risk.

Etiology

The dominant etiologic factor is asbestos exposure. Inhaled asbestos fibers reach distal
airspaces and pleural surfaces through lymphatic or direct translocation pathways. Fibers may
persist for years because they are poorly cleared. Their persistence leads to chronic mesothelial
injury, macrophage activation, release of reactive oxygen species, and fibrogenic as well as
carcinogenic signaling.

Genetic and molecular alterations are central to tumor development. Commonly affected
pathways include tumor suppressor genes such as BRCA1 associated protein 1 (BAP1), cyclin-
dependent kinase inhibitor 2A (CDKN2A), and neurofibromin 2 (NF2). BAP1 loss is
particularly important in many mesotheliomas and may be detectable by
immunohistochemistry. These alterations impair DNA repair, cell-cycle regulation, and growth
control.

Other proposed cofactors include prior radiation exposure and rare genetic predisposition.
Simian virus 40 has historically been discussed, but it is not accepted as a routine diagnostic
etiologic factor in standard pathology.

Pathogenesis

The pathogenesis begins with asbestos fiber deposition and chronic pleural mesothelial injury.
Fibers induce repeated cycles of cell injury and regeneration. Activated macrophages and
mesothelial cells release inflammatory cytokines, growth factors, and reactive oxygen species.
These mediators promote mesothelial proliferation, DNA damage, and survival of genetically
altered cells.

Mesothelial transformation is facilitated by loss of tumor suppressor pathways. BAP1 loss

impairs chromatin regulation and DNA damage response. CDKN2A loss disrupts cell-cycle
checkpoint control. NF2 alteration affects cytoskeletal and Hippo pathway-related growth
regulation. The result is uncontrolled mesothelial proliferation with invasive capacity.

The tumor spreads along serosal surfaces and invades underlying lung, chest wall, diaphragm,
and mediastinal structures. Pleural effusion is common because tumor disrupts pleural fluid
balance and lymphatic drainage.

Macroscopic Findings

Grossly, pleural malignant mesothelioma typically produces diffuse nodular pleural

thickening and an infiltrative pleural mass encasing the lung circumferentially. At autopsy
or resection, the tumor may form diffuse gray-white pleural tumor thickening encasing the
lung in a rind-like fashion.

The pleural surfaces are thickened, firm, and gray-white. The tumor often obliterates the pleural
cavity and restricts lung expansion. It may invade fissures, diaphragm, chest wall, pericardium,
and mediastinum. The lung parenchyma may be compressed and trapped by the tumor rind.

The cut surface is firm, fibrous, and white to tan. In more cellular regions, it may be fleshy.
Hemorrhagic pleural fluid may be present. The diffuse pleural distribution helps distinguish
malignant mesothelioma from most primary lung carcinomas, which usually arise as
parenchymal masses and secondarily involve the pleura.

Histopathological Findings

Malignant mesothelioma has three major histological patterns: epithelioid, sarcomatoid, and
biphasic. Epithelioid mesothelioma is the most common pattern and may form tubules, papillae,
trabeculae, nests, or solid sheets. Sarcomatoid mesothelioma is composed of malignant spindle
cells and may resemble fibrosarcoma or sarcomatoid carcinoma. Biphasic mesothelioma
contains both epithelioid and sarcomatoid components.

The characteristic histopathological pattern in the examined disease setting is Atypical

mesothelial cell proliferation forming a tubulopapillary pattern. In epithelioid
mesothelioma, tumor cells may be cuboidal, polygonal, or flattened, with eosinophilic
cytoplasm, atypical nuclei, and invasive growth into underlying fibrous tissue or lung.

Immunohistochemistry is essential because epithelioid mesothelioma often resembles

metastatic adenocarcinoma. Mesothelial markers include calretinin, CK5/6, and WT-1.
Additional mesothelial markers include D2-40/podoplanin and mesothelin. Carcinoma markers
such as Ber-EP4, MOC31, claudin-4, thyroid transcription factor-1, and carcinoembryonic
antigen help exclude metastatic adenocarcinoma depending on the differential diagnosis.

Loss of BAP1 nuclear staining supports malignant mesothelioma over reactive mesothelial
proliferation in appropriate contexts. Homozygous deletion of CDKN2A by fluorescence in situ
hybridization may also support malignancy.

Electron Microscopic Findings

Electron microscopy may show long, slender, nonbranching microvilli on the surface of
malignant mesothelial cells. These microvilli are typically more numerous and longer than
those of adenocarcinoma cells. This ultrastructural feature supports mesothelial differentiation
and is a classic high-yield distinction from pulmonary adenocarcinoma, which more often has
shorter, stubby microvilli and glandular secretory features.

Differential Diagnosis

The most important differential diagnosis is metastatic pulmonary adenocarcinoma involving

pleura. Adenocarcinoma typically forms mucin-producing glands and expresses epithelial
carcinoma markers such as claudin-4, Ber-EP4, MOC31, and often thyroid transcription factor-
1 or napsin A if pulmonary in origin. Mesothelioma expresses mesothelial markers and may
show long slender microvilli.

Reactive mesothelial hyperplasia can mimic epithelioid mesothelioma, especially in inflamed

pleura. Invasion into pleural fat or lung, marked cytologic atypia, BAP1 loss, and CDKN2A
deletion favor malignant mesothelioma.

Sarcomatoid carcinoma may mimic sarcomatoid mesothelioma. Diffuse keratin expression may
occur in both, so correlation with pleural distribution, mesothelial markers, carcinoma markers,
and clinical-radiologic findings is required.

Metastatic serous carcinoma may involve pleura or peritoneum and can show papillary
architecture. Paired box gene 8 (PAX8), estrogen receptor, and Wilms tumor 1 (WT-1)
expression patterns must be interpreted carefully because WT-1 may be positive in both serous
carcinoma and mesothelioma.

Key
Distinguishing
Disease Main Site Gross Pattern Histopathological
Feature
Finding

Diffuse
nodular
pleural
thickening,
infiltrative Atypical
pleural mass mesothelial cell
Pleura, less encasing the proliferation Mesothelial tumor
Malignant commonly lung forming a with long, slender,
mesothelioma peritoneum/pericard circumferentia tubulopapillary nonbranching
ium lly, diffuse pattern; calretinin, microvilli
gray-white CK5/6, WT-1
pleural tumor positivity
thickening
encasing the
lung in a rind-
like fashion

Malignant gland Carcinoma

Pulmonary Parenchymal
formation, mucin markers, thyroid
adenocarcino Lung parenchyma lung mass with
production, transcription factor-
ma involving with pleural spread pleural
lepidic/acinar/papil 1/napsin A, short
pleura involvement
lary patterns microvilli

Pleural Reactive Preserved BAP1,

Reactive thickening or mesothelial no CDKN2A
mesothelial Pleura effusion- proliferation homozygous
hyperplasia associated without destructive deletion, no true
reactive change invasion invasion
 Key
Distinguishing
Disease Main Site Gross Pattern Histopathological
Feature
Finding

Carcinoma marker
Malignant spindle
Sarcomatoid Invasive spindle profile and primary
Lung/pleura cells with epithelial
carcinoma cell carcinoma lung carcinoma
differentiation
context

PAX8 and
Metastatic Serosal Papillary serous gynecologic/perito
serous Pleura/peritoneum implants or carcinoma neal serous
carcinoma effusion morphology carcinoma
phenotype
PEMPHIGUS VULGARIS

Pemphigus vulgaris is an autoimmune intraepidermal blistering disease caused by loss of

keratinocyte-to-keratinocyte adhesion. The central lesion is acantholysis within the lower
epidermis and squamous mucosa. The disease is mediated by immunoglobulin G (IgG)
autoantibodies directed against desmosomal cadherins, especially desmoglein 3 and often
desmoglein 1.

The pathological identity of pemphigus vulgaris is a suprabasal acantholytic blister with

retained basal keratinocytes attached to the basement membrane. This produces the classic row-
of-tombstones appearance.

Etiology

Pemphigus vulgaris is an autoimmune disease. The major autoantigens are desmoglein 3 and
desmoglein 1, transmembrane cadherins within desmosomes. Desmosomes are essential for
adhesion between keratinocytes. Autoantibody binding disrupts desmosomal adhesion and
promotes intraepidermal separation.

Genetic susceptibility is related to certain human leukocyte antigen alleles that favor
autoantibody generation. The disease may also be associated with other autoimmune
conditions. Drugs and environmental triggers have been proposed in some cases, but
autoantibody-mediated desmosomal dysfunction is the defining etiologic mechanism.

Pathogenesis

IgG autoantibodies bind desmoglein proteins on keratinocyte surfaces. This directly impairs
desmosomal adhesion and may activate intracellular signaling pathways and proteases that
further weaken intercellular junctions. Keratinocytes detach from one another, producing
acantholysis.

Because basal keratinocytes remain attached to the basement membrane through

hemidesmosomes, the split forms just above the basal layer. The blister is therefore suprabasal
and intraepidermal. Detached acantholytic keratinocytes may float within the blister cavity.

Macroscopic Findings

Grossly, pemphigus vulgaris produces flaccid, fragile vesicles and bullae that rupture easily.
The ruptured bullae leave erosions and crusted denuded surfaces. Mucosal surfaces are often
affected, and oral erosions may be prominent. In pathology-oriented description, the key point
is that the blisters are superficial and fragile because the split is intraepidermal.

Histopathological Findings

Microscopically, pemphigus vulgaris shows suprabasal acantholysis, intraepidermal blister

formation, and a “row of tombstones” appearance caused by basal keratinocytes
remaining attached to the basement membrane. The basal layer remains anchored to the
dermoepidermal junction, while suprabasal keratinocytes lose cohesion and separate.

Acantholytic keratinocytes may be present within the blister cavity. The dermis may show mild
superficial perivascular inflammation with eosinophils or lymphocytes. Secondary erosion and
inflammation may be present in ruptured lesions.

Direct immunofluorescence demonstrates intercellular IgG deposition along the surfaces of

epidermal keratinocytes. This produces a net-like or fishnet pattern throughout the epidermis.
Complement component 3 may also be present. The correct diagnostic entity is Pemphigus
vulgaris.

Differential Diagnosis

Bullous pemphigoid is a subepidermal autoimmune blistering disease caused by antibodies

against hemidesmosomal proteins. It shows tense bullae, subepidermal blistering, eosinophil-
rich inflammation, and linear IgG/complement component 3 deposition along the basement
membrane zone.

Pemphigus foliaceus shows superficial subcorneal acantholysis due to antibodies against

desmoglein 1. Mucosal involvement is minimal or absent because desmoglein 3 preserves
deeper mucosal adhesion.

Dermatitis herpetiformis shows subepidermal vesicles with neutrophilic microabscesses at

dermal papillae and granular immunoglobulin A deposition in dermal papillae. It is linked to
gluten-sensitive enteropathy.

Linear immunoglobulin A bullous dermatosis shows linear immunoglobulin A deposition along

the basement membrane zone and subepidermal blistering.

Epidermolysis bullosa encompasses inherited disorders of structural proteins of the epidermis,

basement membrane zone, or dermis. The level of split depends on the mutated protein and is
not caused by intercellular desmoglein autoantibodies.
 Key
Level of Distinguishing
Disease Immunopathology Histopathological
Blister Feature
Finding

Intercellular IgG Suprabasal

Pemphigus
deposition along acantholysis,
Pemphigus Suprabasal vulgaris; anti-
the surfaces of intraepidermal
vulgaris intraepidermal desmoglein 3 ±
epidermal blister formation,
anti-desmoglein 1
keratinocytes row of tombstones

Linear IgG and

complement Subepidermal
Bullous Hemidesmosomal
Subepidermal component 3 along blister with
pemphigoid antibody disease
basement membrane eosinophils
zone

Anti-desmoglein
Intercellular IgG,
Pemphigus Subcorneal Subcorneal 1; superficial skin-
superficial
foliaceus intraepidermal acantholysis predominant
epidermis
disease

Gluten-sensitive
Granular Neutrophilic
Dermatitis immunoglobulin
Subepidermal immunoglobulin A papillary
herpetiformis A-mediated
in dermal papillae microabscesses
disease

Linear Linear
Linear
immunoglobulin immunoglobulin A Subepidermal
Subepidermal immunoglobulin A
A bullous along basement blister
pattern
dermatosis membrane zone

Variable Usually genetic Split at level Inherited

Epidermolysis
inherited split structural protein determined by mechanical
bullosa
level defect mutated protein fragility disorder

ALPHA-1 ANTITRYPSIN DEFICIENCY

Alpha-1 antitrypsin deficiency is an inherited disorder caused by reduced circulating activity of
alpha-1 antitrypsin, a protease inhibitor primarily synthesized in the liver. The disease produces
two major pathological consequences: lung disease due to unopposed neutrophil elastase
activity and liver disease due to intracellular accumulation of misfolded alpha-1 antitrypsin
within hepatocytes.

Alpha-1 antitrypsin is encoded by serpin family A member 1 (SERPINA1). The most important
severe deficiency allele is the Z allele. The Z variant misfolds, polymerizes, and accumulates
within the endoplasmic reticulum of hepatocytes. As a result, less functional protein is secreted
into the blood, producing systemic deficiency.

Etiology

The disease is genetic and inherited in an autosomal codominant pattern. The most severe
common genotype is PiZZ, where “Pi” refers to protease inhibitor phenotype. The Z mutation
causes abnormal folding of the alpha-1 antitrypsin protein, retention in the endoplasmic
reticulum, and reduced secretion into plasma.

Lung injury results from loss of antiprotease protection. Alpha-1 antitrypsin normally inhibits
neutrophil elastase. When levels are low, elastase damages alveolar walls, especially in the
lower lobes, producing emphysema. Smoking markedly accelerates lung damage because it
increases neutrophil recruitment and oxidatively inactivates residual alpha-1 antitrypsin.

Liver injury results from toxic gain-of-function accumulation of misfolded protein within
hepatocytes. The retained protein causes endoplasmic reticulum stress, hepatocellular injury,
fibrosis, cirrhosis, and increased risk of hepatocellular carcinoma.

Pathogenesis

The pathogenesis has two complementary components.

In the lung, deficiency of circulating alpha-1 antitrypsin allows neutrophil elastase to destroy
elastin and other extracellular matrix components in alveolar septa. Progressive septal
destruction enlarges airspaces and reduces the alveolar surface area available for gas exchange.
The characteristic pattern is panacinar emphysema, usually more severe in lower lobes.

In the liver, mutant alpha-1 antitrypsin accumulates in the rough endoplasmic reticulum of
hepatocytes. This accumulation is especially prominent in periportal hepatocytes. The retained
protein forms globular inclusions that are periodic acid-Schiff positive and diastase resistant.
Chronic hepatocellular stress promotes inflammation, fibrosis, and cirrhosis.

The major pathological sequence is:

SERPINA1 mutation → misfolded alpha-1 antitrypsin retention in hepatocyte endoplasmic

reticulum → reduced circulating antiprotease activity → lung elastase injury and panacinar
emphysema + hepatocyte inclusion accumulation, fibrosis, and cirrhosis.

Macroscopic Findings

In the lung, the characteristic gross lesion is panacinar emphysema. The lower lobes are often
disproportionately involved. The lungs may be overinflated with enlarged airspaces and loss of
normal elastic recoil. Unlike centriacinar emphysema, which is strongly associated with
smoking and upper-lobe predominance, alpha-1 antitrypsin deficiency produces diffuse acinar
destruction.

In the liver, chronic disease may produce nodular cirrhotic transformation. The liver may
become firm and nodular, with fibrous septa dividing regenerative nodules. In advanced
disease, cirrhosis may be accompanied by portal hypertension and risk of hepatocellular
carcinoma.

Histopathological Findings

The lung shows panacinar emphysema, with uniform enlargement of airspaces from respiratory
bronchiole to alveoli within the acinus. Alveolar septa are thinned and destroyed. There is loss
of elastic tissue and capillary bed reduction. Inflammation may be mild unless infection or
smoking-related injury is superimposed.

The liver shows hepatocellular accumulation of abnormal alpha-1 antitrypsin globules. These
inclusions are classically PAS-D–positive cytoplasmic globules, particularly within
periportal hepatocytes. “PAS-D” means periodic acid-Schiff stain after diastase digestion; the
globules remain positive after diastase because they are glycoprotein-rich rather than glycogen.

The globules are round, eosinophilic cytoplasmic inclusions on routine sections and are most
prominent in periportal hepatocytes. Chronic injury may produce portal inflammation, bridging
fibrosis, and cirrhosis. In established cirrhosis, regenerative nodules are surrounded by fibrous
septa.
Immunohistochemistry for alpha-1 antitrypsin can highlight the hepatocellular inclusions. The
pathological combination of liver inclusions and emphysema supports the systemic nature of
the disease.

Electron Microscopic Findings

Electron microscopy demonstrates accumulation of electron-dense protein material within

dilated endoplasmic reticulum cisternae. This finding directly reflects retention of misfolded
alpha-1 antitrypsin within hepatocyte rough endoplasmic reticulum.

This ultrastructural feature is an excellent teaching detail because it connects the genetic
protein-folding defect with the light microscopic PAS-D-positive globules and the clinical-
pathological liver disease.

Differential Diagnosis

Wilson disease can produce liver disease and cirrhosis, but it is caused by ATPase copper
transporting beta (ATP7B) mutation with copper accumulation. Copper-associated protein
deposition, copper stains, and hepatic copper quantification distinguish it from alpha-1
antitrypsin deficiency.

Hemochromatosis causes iron overload with hepatocellular iron deposition, fibrosis, cirrhosis,
and systemic iron-related injury. Prussian blue stain highlights iron, not PAS-D-positive protein
globules.

Alcohol-related liver disease may cause steatosis, steatohepatitis, Mallory-Denk bodies,

pericellular fibrosis, and cirrhosis. It lacks periportal PAS-D-positive alpha-1 antitrypsin
globules and does not primarily produce genetic antiprotease deficiency.

Autoimmune hepatitis shows interface hepatitis with plasma cell-rich inflammation, hepatocyte
rosettes, and autoantibody associations. It is not defined by hepatocellular retention of alpha-1
antitrypsin protein.

Chronic viral hepatitis may progress to cirrhosis but shows viral hepatitis patterns with portal
inflammation, interface activity, and viral serologic markers rather than PAS-D-positive
periportal globules.
 Key
Main Distinguishing
Disease Gross Pattern Histopathological
Organs Feature
Finding

Alpha-1 antitrypsin
PAS-D–positive
deficiency with
Panacinar cytoplasmic
Alpha-1 electron-dense
Lung and emphysema; globules,
antitrypsin protein material
liver nodular cirrhotic particularly within
deficiency within dilated
transformation periportal
endoplasmic
hepatocytes
reticulum cisternae

Liver,
Cirrhosis or acute Copper-associated ATP7B mutation and
Wilson disease brain,
liver injury hepatocellular injury copper accumulation
cornea

Liver,
Micronodular Iron deposition in
pancreas, Prussian blue-positive
Hemochromatosis cirrhosis in hepatocytes and
heart, iron overload
advanced disease other tissues
joints

Steatosis,
Alcohol-related Fatty enlarged ballooning, Mallory- Alcohol-associated
Liver
liver disease liver or cirrhosis Denk bodies, steatohepatitis pattern
pericellular fibrosis

Chronic Autoimmune serology

Autoimmune Interface hepatitis
Liver hepatitis/cirrhosis and plasma cell-rich
hepatitis with plasma cells
pattern hepatitis

Portal inflammation, Viral

Chronic viral Chronic hepatitis
Liver interface activity, serologic/molecular
hepatitis and cirrhosis
lobular hepatitis evidence
IDIOPATHIC PULMONARY FIBROSIS

Idiopathic pulmonary fibrosis is a chronic progressive fibrosing interstitial pneumonia of

unknown cause. Its histopathological and radiological correlate is usual interstitial pneumonia.
The disease is defined by patchy, progressive, irreversible interstitial fibrosis that preferentially
involves subpleural and basal lung regions.

The pathological identity of idiopathic pulmonary fibrosis is spatially and temporally

heterogeneous fibrosis. This means that areas of relatively normal lung, early fibroblastic
proliferation, dense established fibrosis, and honeycomb remodeling coexist within the same
lung. The most characteristic histological lesion is Fibroblastic foci with temporal
heterogeneity.

“Idiopathic” indicates that known causes of usual interstitial pneumonia-like fibrosis, such as
asbestosis, connective tissue disease, chronic hypersensitivity pneumonitis, drug injury, and
radiation injury, must be excluded before assigning this diagnosis.

Etiology

The exact cause is unknown. Current understanding emphasizes repeated alveolar epithelial
injury in a genetically susceptible host, followed by abnormal repair and excessive fibrosis. The
disease is not primarily a neutrophilic pneumonia, granulomatous infection, or immune
complex alveolitis.

Genetic risk factors include mutations affecting telomere maintenance and surfactant biology.
Telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC) mutations
are associated with familial pulmonary fibrosis and support the role of cellular senescence.
Variants in mucin 5B (MUC5B) are strongly associated with idiopathic pulmonary fibrosis risk.
Surfactant protein gene mutations may also contribute in selected families.

Environmental and epithelial stressors may include smoking, microaspiration from

gastroesophageal reflux, viral injury, metal or wood dust exposure, and other irritants. These
factors are not sufficient alone in most individuals; they act on susceptible alveolar epithelium.

Pathogenesis

The central pathogenic event is repeated injury and defective repair of alveolar epithelial cells,
especially type II pneumocytes. Injured epithelium releases profibrotic mediators that stimulate
fibroblast and myofibroblast proliferation. Transforming growth factor-beta is particularly
important in promoting extracellular matrix deposition.

Fibroblastic foci represent zones of active fibroblast and myofibroblast proliferation within a
myxoid matrix. These foci are the leading edge of ongoing fibrosis. Older areas become
collagen-rich and hypocellular. The coexistence of young fibroblastic foci and old dense
fibrosis creates temporal heterogeneity.

Progressive fibrosis destroys alveolar walls and remodels distal airspaces into cystic
honeycomb spaces lined by bronchiolar epithelium or hyperplastic type II pneumocytes.
Pulmonary arteries may develop secondary hypertensive changes due to chronic hypoxic
vasoconstriction and vascular remodeling.

The major pathological sequence is:

repeated alveolar epithelial injury → abnormal epithelial repair → profibrotic mediator release
→ fibroblast and myofibroblast proliferation → collagen deposition → usual interstitial
pneumonia pattern → honeycomb lung and respiratory failure.

Macroscopic Findings

Grossly, the pleural surfaces may appear cobblestoned because of retraction of fibrous scars
along interlobular septa. The lungs show lower lobe and subpleural predominance. The cut
surface contains firm, rubbery, white fibrotic areas.

In advanced disease, the lungs demonstrate marked lower lobe volume loss, firm fibrotic
areas, and subpleural honeycomb change. Honeycomb change consists of cystic, thick-
walled airspaces caused by end-stage fibrotic remodeling. The distribution is typically basal
and subpleural.

High-resolution computed tomography correlates with the gross pattern and may show
bilateral subpleural and basal-predominant reticular opacities, traction bronchiectasis,
and honeycomb change.

Histopathological Findings

The histological pattern is usual interstitial pneumonia. The hallmark is patchy interstitial
fibrosis with temporal heterogeneity. Fibrosis is most prominent in subpleural regions and along
interlobular septa. Areas of normal or near-normal lung alternate with dense scarred lung.
The most characteristic histopathological finding is Fibroblastic foci with temporal
heterogeneity. Fibroblastic foci are small aggregates of fibroblasts and myofibroblasts
embedded in pale myxoid extracellular matrix, usually located at the interface between normal
lung and established fibrosis.

Older lesions show dense collagenous fibrosis and architectural distortion. Alveolar walls
collapse and are replaced by fibrous scar. Cystic honeycomb spaces develop and are lined by
bronchiolar epithelium or hyperplastic type II pneumocytes. Mild chronic interstitial
inflammation may be present but is usually not the dominant feature.

The essential microscopic constellation is usual interstitial pneumonia with patchy subpleural
fibrosis, fibroblastic foci, temporal heterogeneity, honeycomb remodeling, and relatively sparse
inflammation.

Differential Diagnosis

Nonspecific interstitial pneumonia shows more uniform interstitial inflammation and/or fibrosis
without the marked temporal heterogeneity and fibroblastic foci typical of usual interstitial
pneumonia. It is often associated with connective tissue disease and has a better prognosis.

Hypersensitivity pneumonitis may show bronchiolocentric chronic inflammation, poorly

formed granulomas, giant cells, and airway-centered fibrosis. Exposure history and
granulomatous airway-centered pattern distinguish it from idiopathic pulmonary fibrosis.

Asbestosis can closely mimic usual interstitial pneumonia but is linked to asbestos exposure
and asbestos bodies. It often begins in lower lobes and subpleural regions and may coexist with
pleural plaques.

Sarcoidosis shows well-formed noncaseating granulomas with lymphatic distribution. Fibrosis

may occur in advanced disease, but granulomas and upper lobe-predominant lymphatic pattern
distinguish it.

Diffuse alveolar damage shows hyaline membranes in the acute phase and organizing interstitial
fibrosis later. It is temporally more acute and lacks the classic patchy usual interstitial
pneumonia pattern with established honeycomb fibrosis.

Cryptogenic organizing pneumonia is characterized by intraalveolar plugs of organizing

fibroblastic tissue, called Masson bodies, within alveolar ducts and alveoli. The underlying
architecture is usually preserved, unlike the destructive fibrosis of usual interstitial pneumonia.
 Key
Gross / Imaging Distinguishing
Disease Main Pattern Histopathologica
Pattern Feature
l Finding

Bilateral
subpleural and
basal-
predominant
reticular
opacities,
Idiopathic usual
traction
interstitial
Idiopathic bronchiectasis, Fibroblastic foci
Usual interstitial pneumonia
pulmonary honeycomb with temporal
pneumonia pattern after
fibrosis change; marked heterogeneity
excluding known
lower lobe
causes
volume loss,
firm fibrotic
areas,
subpleural
honeycomb
change

Nonspecific Uniform interstitial Diffuse bilateral Temporally Lacks marked

interstitial inflammation/fibrosi interstitial uniform fibrosis temporal
pneumonia s disease or inflammation heterogeneity

Mosaic Poorly formed Exposure-related

Hypersensitivit Airway-centered attenuation, granulomas and granulomatous
y pneumonitis immune lung disease bronchiolocentri bronchiolocentric bronchiolocentri
c changes inflammation c pattern

Lower
Interstitial fibrosis Asbestos bodies
Pneumoconiosis- lobe/subpleural
Asbestosis with asbestos and pleural
related fibrosis fibrosis, pleural
bodies plaques
plaques
 Key
Gross / Imaging Distinguishing
Disease Main Pattern Histopathologica
Pattern Feature
l Finding

Nodules along Well-formed Granulomatous

Granulomatous
Sarcoidosis lymphatics, hilar noncaseating lymphatic
interstitial disease
nodes granulomas distribution

Heavy Hyaline
Diffuse alveolar Acute temporal
Acute lung injury edematous lungs membranes and
damage pattern
in acute stage later organization

Cryptogenic Preserved
Intraalveolar Patchy Intraalveolar
organizing architecture with
organization consolidation fibroblastic plugs
pneumonia Masson bodies

MEDULLOBLASTOMA

Medulloblastoma is a highly malignant embryonal tumor of the central nervous system with
neuronal differentiation. It arises in the cerebellum and is one of the classic pediatric malignant
brain tumors. It is classified among embryonal tumors and is characterized by densely cellular
primitive tumor cells, high proliferative activity, and a tendency to spread through cerebrospinal
fluid pathways.

Pathologically, medulloblastoma is a small blue cell tumor of the cerebellum. It frequently

arises in the midline cerebellar vermis and may extend into or compress the fourth ventricle.
The tumor is highly cellular and may show neuronal differentiation. In the examined disease
pattern, the key histopathological structure is Homer-Wright rosettes.

Etiology

Medulloblastoma is driven by genetic and developmental pathway alterations affecting

cerebellar precursor cells. It is not caused by infection or ordinary inflammatory injury. Current
classification recognizes molecular groups including wingless/integrated (WNT)-activated,
sonic hedgehog (SHH)-activated, group 3, and group 4 medulloblastomas.

Wingless/integrated pathway tumors often involve mutations in catenin beta 1 (CTNNB1),

producing nuclear beta-catenin accumulation. Sonic hedgehog pathway tumors involve
abnormalities in genes such as patched 1 (PTCH1), smoothened (SMO), suppressor of fused
homolog (SUFU), or GLI family transcription factors. Group 3 tumors may show MYC
amplification and are often aggressive. Group 4 tumors are common and molecularly distinct,
although their biology is heterogeneous.

Inherited cancer predisposition syndromes may increase risk. These include Gorlin syndrome
involving sonic hedgehog pathway genes, Turcot syndrome, Li-Fraumeni syndrome involving
tumor protein p53 (TP53), and other rare predisposition syndromes.

Pathogenesis

The tumor arises from primitive neuroectodermal or cerebellar precursor cells. Depending on
molecular group, the initiating cell population and pathway activation differ. In sonic hedgehog-
activated tumors, granule neuron precursors are important. In wingless/integrated-activated
tumors, cells near the dorsal brainstem and lower rhombic lip lineage are implicated.

Abnormal developmental signaling prevents normal differentiation and promotes proliferation.

Tumor cells remain primitive, densely packed, and highly mitotically active. High Ki-67
labeling reflects the strong proliferative biology of the tumor.

The tumor grows within the cerebellum and may obstruct the fourth ventricle. It can spread
through cerebrospinal fluid, producing leptomeningeal dissemination along the neuraxis. This
mode of spread is a major pathological and clinical feature of medulloblastoma.

Macroscopic Findings

Grossly, medulloblastoma is usually a soft, friable, gray or pink-gray tumor centered in the
cerebellum. It often arises in the vermis and protrudes into or compresses the fourth ventricle.
In the final disease pattern, imaging and autopsy emphasize a hypercellular midline posterior
fossa mass compressing the fourth ventricle and a soft gray tumor involving the cerebellar
vermis.

The tumor may be well demarcated grossly but is biologically malignant. Hemorrhage and
necrosis may occur. Invasion into adjacent cerebellar tissue and dissemination through
cerebrospinal fluid pathways may be present.

Histopathological Findings

Classic medulloblastoma is composed of densely packed primitive small round blue cells. The
cells have hyperchromatic nuclei, scant cytoplasm, high nuclear-to-cytoplasmic ratio, and
frequent mitotic figures. Apoptosis is common. Necrosis may be present in high-grade or
rapidly growing tumors.

The most characteristic histopathological finding in the examined disease setting is Homer-
Wright rosettes. These consist of tumor cells arranged around a central fibrillary neuropil-like
core. They indicate neuronal differentiation and help support the diagnosis among embryonal
tumors.

Immunohistochemistry may demonstrate synaptophysin positivity, supporting neuronal

differentiation. The tumor often shows a markedly elevated Ki-67 proliferation index,
reflecting its embryonal high-grade biology. Additional markers and molecular tests are used to
assign molecular subgroup.

Histological variants include classic medulloblastoma, desmoplastic/nodular medulloblastoma,

medulloblastoma with extensive nodularity, large cell/anaplastic medulloblastoma, and others
depending on classification system. Large cell/anaplastic morphology is associated with
aggressive behavior, particularly in certain molecular contexts.

The concise histopathological formulation is:

a highly cellular embryonal cerebellar tumor composed of primitive small blue cells with high
mitotic activity, neuronal differentiation, synaptophysin expression, high Ki-67 proliferation
index, and Homer-Wright rosettes.

Differential Diagnosis

Ependymoma may arise near the fourth ventricle and may mimic posterior fossa
medulloblastoma. It shows perivascular pseudorosettes, ependymal rosettes, and epithelial
membrane antigen dot-like staining. Medulloblastoma shows embryonal small blue cell
morphology and Homer-Wright rosettes.

Pilocytic astrocytoma is a common pediatric cerebellar tumor but is low grade. It often forms a
cyst with mural nodule and shows bipolar piloid astrocytes, Rosenthal fibers, and eosinophilic
granular bodies. It lacks the primitive hypercellular embryonal morphology and high Ki-67
index of medulloblastoma.

Atypical teratoid/rhabdoid tumor is a highly malignant embryonal tumor, often in very young
children. It shows rhabdoid cells and loss of integrase interactor 1 (INI1/SMARCB1)
expression. This immunophenotypic loss is decisive.
Central nervous system lymphoma may show dense blue cell infiltrates but is composed of
malignant lymphoid cells, usually CD20-positive B cells, with angiocentric growth. It lacks
neuronal rosettes and synaptophysin-positive embryonal neuronal differentiation.

Metastatic small cell carcinoma may enter the differential in adults. It expresses epithelial
markers and neuroendocrine markers and has systemic tumor context. Medulloblastoma is a
primary cerebellar embryonal tumor.

Hemangioblastoma is a cerebellar tumor in adults and may be associated with von Hippel-
Lindau disease. It shows numerous thin-walled vessels and lipid-rich stromal cells, not
primitive small blue cells with rosettes.

Key
Distinguishing
Disease Main Site Gross Pattern Histopathological
Feature
Finding

Hypercellular
Primitive small
midline
blue cells with
posterior fossa
synaptophysin Embryonal
mass
positivity, cerebellar
Cerebellum, often compressing
markedly tumor with
Medulloblastoma vermis/posterior the fourth
elevated Ki-67 CSF
fossa ventricle; soft
proliferation dissemination
gray tumor
index, and tendency
involving the
Homer-Wright
cerebellar
rosettes
vermis

Intraventricular
Ventricular system, Perivascular
or Ependymal
Ependymoma fourth ventricle, pseudorosettes and
periventricular differentiation
spinal canal ependymal rosettes
mass

Low-grade
Pilocytic Cerebellum, optic Cyst with mural Piloid astrocytes,
astrocytic
astrocytoma pathway, brainstem nodule Rosenthal fibers,
tumor
 Key
Distinguishing
Disease Main Site Gross Pattern Histopathological
Feature
Finding

eosinophilic
granular bodies

Rhabdoid cells
Atypical Posterior fossa or Aggressive SMARCB1-
with
teratoid/rhabdoid cerebral embryonal deficient
INI1/SMARCB1
tumor hemispheres mass rhabdoid tumor
loss

Angiocentric
Primary central Deep malignant
Infiltrative Lymphoid
nervous system brain/periventricular lymphoid cells,
mass tumor
lymphoma regions often CD20
positive

Small cell Metastatic

Metastatic small carcinoma epithelial
Brain metastasis Metastatic mass
cell carcinoma morphology with neuroendocrine
epithelial markers carcinoma

Vascular
Cystic mass Thin-walled stromal tumor,
Cerebellum, spinal
Hemangioblastoma with mural vessels and lipid- often von
cord, retina
nodule rich stromal cells Hippel-Lindau-
associated
BUERGER DISEASE / THROMBOANGIITIS OBLITERANS

Buerger disease, also called thromboangiitis obliterans, is a segmental, thrombosing,

inflammatory disease of small- and medium-sized arteries and veins, primarily affecting the
extremities. The disease most characteristically involves the tibial, radial, ulnar, and other distal
limb vessels. It is strongly associated with tobacco exposure and is distinguished from
atherosclerosis by its inflammatory thrombosing nature, segmental distribution, involvement of
adjacent veins and nerves, and relative preservation of the internal elastic lamina.

The pathological identity of Buerger disease is acute and chronic occlusive inflammation of
vessels, with luminal thrombosis and extension of inflammation into surrounding neurovascular
structures. It is not primarily a lipid-driven intimal plaque disease. Instead, it is a tobacco-
associated inflammatory thrombotic vasculopathy in which small- and medium-sized arteries
become occluded by inflammatory thrombi.

The disease is classically centered on the distal extremities. Visceral vessels are rarely involved.
The key structural lesion is a sharply segmental vasculitis with luminal thrombosis. Early
lesions show mixed inflammatory infiltrates and thrombi containing microabscesses. Later
lesions show organization and recanalization of thrombi, with fibrosis encasing the artery,
adjacent vein, and nearby nerve.

Etiology

The most important etiologic association is tobacco exposure. Buerger disease occurs almost
exclusively in heavy tobacco users. The relationship with tobacco is so strong that continued
exposure is closely linked to disease persistence and progression.

Several mechanisms have been proposed to explain the tobacco association. Tobacco
components may directly injure endothelial cells, causing endothelial dysfunction, reduced
endothelium-dependent vasodilation, release of prothrombotic mediators, and increased
tendency to thrombosis. Alternatively, tobacco-derived reactive compounds may modify vessel
wall components and create neoantigens, inducing an immune reaction against vascular
structures.

Hypersensitivity to tobacco extracts has been described in many patients, supporting an

immune-mediated component. Anti-endothelial cell antibodies (AECAs) have also been
reported, suggesting that endothelial injury may be partly autoimmune or immune-mediated.
Genetic susceptibility may influence disease development. Associations with human leukocyte
antigen (HLA) haplotypes have been reported, including HLA-A9 and HLA-B5 in some
populations. These associations do not independently define the disease but support the concept
that tobacco exposure acts in a genetically predisposed host.

The disease is not caused by ordinary atherosclerotic risk factors alone. Diabetes mellitus,
hyperlipidemia, and hypertension may cause peripheral arterial disease, but they do not
reproduce the characteristic inflammatory thrombotic lesion of Buerger disease.

The etiologic formulation is therefore: tobacco exposure in a genetically susceptible host,

endothelial injury or immune hypersensitivity to tobacco-modified vascular antigens,
prothrombotic endothelial dysfunction, and segmental inflammatory thrombosis of distal
extremity vessels.

Pathogenesis

The central pathogenic process is tobacco-associated inflammatory endothelial injury followed

by thrombosis. Endothelial cell (EC) dysfunction reduces vasodilatory capacity and promotes
a prothrombotic luminal surface. Injured endothelium favors platelet adhesion, coagulation
activation, and luminal thrombus formation.

The inflammatory reaction involves both the vessel wall and the thrombus. In early lesions,
acute and chronic inflammatory cells infiltrate the vessel wall and the thrombus. Neutrophils
may form small microabscesses within the thrombus. These microabscesses may be surrounded
by granulomatous inflammation, producing a distinctive pattern among vasculitides.

Inflammation may extend outward from the artery into adjacent veins and nerves. This triad of
artery, vein, and nerve involvement is highly characteristic because most other vasculitides do
not typically encase all three structures together in an inflammatory-fibrotic process. Neural
involvement helps explain the prominent pain associated with the disease.

The internal elastic lamina is usually relatively preserved, especially compared with destructive
necrotizing arteritides and atherosclerosis. The absence of lipid-rich atheromatous plaque and
the presence of inflammatory thrombus help separate Buerger disease from atherosclerotic
peripheral arterial disease.

With progression, the thrombus organizes. Capillaries and fibroblasts grow into the thrombus,
producing organization and recanalization. In chronic disease, the involved artery, adjacent
vein, and nerve may become encased in dense fibrous tissue. This produces permanent luminal
narrowing or occlusion and chronic ischemic injury of the distal extremity.

The major pathological sequence is:

tobacco-associated endothelial injury or hypersensitivity → endothelial dysfunction and

prothrombotic state → segmental inflammatory thrombosis of small- and medium-sized
extremity vessels → thrombus microabscesses and acute-chronic vasculitis → extension to
adjacent veins and nerves → thrombus organization, recanalization, and fibrosis → chronic
ischemic tissue injury.

The essential pathogenic concept is that Buerger disease is a thromboinflammatory disease of

distal extremity vessels, not a primary atherosclerotic occlusive disease.

Macroscopic Findings

Grossly, Buerger disease affects small- and medium-sized vessels of the extremities in a
segmental pattern. The tibial and radial arteries are classic sites, but other distal limb arteries
may also be involved. Lower extremity vessels are commonly affected.

The involved arterial segments may be firm, narrowed, and occluded by thrombi. The lesions
are discontinuous, with affected segments separated by relatively uninvolved vessel. The lumen
may be partly or completely occluded by thrombus.

Adjacent veins and nerves may be involved. Grossly, the artery, accompanying vein, and nearby
nerve may be bound together by fibrous tissue, forming a fibrotic neurovascular bundle. This
encasement of artery, vein, and nerve is an important structural feature.

Mural thrombi are frequently present. In chronic lesions, organized thrombi may show
recanalization, producing small new vascular channels within the old thrombus. The
surrounding vessel and perivascular tissue become fibrotic.

Ischemic changes in distal tissues may include ulceration, necrosis, or gangrene. Digits may
show dry gangrene in advanced disease. These gross tissue changes are secondary to vascular
occlusion and chronic ischemia.

The gross pathological constellation is segmental occlusion of distal extremity arteries by

thrombi, involvement of accompanying veins and nerves, fibrotic encasement of neurovascular
structures, and ischemic ulceration or gangrene in severe disease.
Histopathological Findings

Histopathological findings vary by disease stage.

In early active lesions, there is acute and chronic inflammation involving small- and medium-
sized arteries. The lumen contains an occlusive or mural thrombus. The thrombus is
inflammatory and may contain neutrophils, lymphocytes, macrophages, and cellular debris.
Small microabscesses within the thrombus are a classic feature.

The microabscesses may be surrounded by granulomatous inflammation, including epithelioid

histiocytes and occasional giant cells. This produces a distinctive inflammatory thrombus
pattern. The vessel wall shows acute and chronic inflammation, but the internal elastic lamina
is often relatively intact.

This preservation of the internal elastic lamina is diagnostically important. In atherosclerosis,

the intima is expanded by lipid-rich plaque, foam cells, cholesterol clefts, necrotic core,
calcification, and fibrous cap formation. In Buerger disease, lipid aggregates are absent, and the
defining process is inflammatory thrombosis rather than atheroma.

In intermediate lesions, the inflammatory infiltrate becomes more mononuclear. Lymphocytes

and macrophages predominate. Epithelioid cell granulomas and Langhans-type giant cells may
be seen in some lesions. Thrombi begin to organize, and endothelial-lined recanalization
channels may develop.

In chronic lesions, inflammation may be less conspicuous. Organized and recanalized thrombi
persist within the lumen. Fibrosis involves the media, adventitia, and surrounding tissue. The
artery, adjacent vein, and nearby nerve may be encased together in dense fibrous tissue. This
chronic fibrotic cuff is a characteristic late feature.

Veins may show thrombophlebitis-like changes. Nerves may be surrounded by inflammatory

and fibrotic tissue, but the primary lesion remains vascular thrombosis and vasculitis.

The concise histopathological formulation is:

segmental acute and chronic thrombosing vasculitis of small- and medium-sized extremity
arteries, with inflammatory luminal thrombi, thrombus microabscesses, occasional
granulomatous inflammation, relative preservation of the internal elastic lamina, extension to
adjacent veins and nerves, and late organization, recanalization, and fibrosis.

Differential Diagnosis
The most important differential diagnosis is atherosclerotic peripheral arterial disease.
Atherosclerosis primarily affects large and medium-sized arteries and is characterized by
intimal fibrofatty plaques with lipid cores, cholesterol clefts, foam cells, calcification, and
fibrous caps. Buerger disease affects distal small- and medium-sized extremity vessels, shows
segmental inflammatory thrombosis, microabscesses in thrombi, and relative preservation of
the internal elastic lamina.

Polyarteritis nodosa may involve medium-sized arteries and produce segmental necrotizing
inflammation. However, polyarteritis nodosa typically involves visceral vessels, especially
renal, gastrointestinal, hepatic, and peripheral nerve vessels. It shows fibrinoid necrosis of the
vessel wall and does not characteristically involve adjacent veins and nerves together in a
fibrotic cuff.

Microscopic polyangiitis affects small vessels and may cause necrotizing vasculitis with
glomerulonephritis and pulmonary capillaritis. It is usually associated with myeloperoxidase-
antineutrophil cytoplasmic antibody and lacks the tobacco-associated distal extremity
thromboinflammatory pattern with thrombus microabscesses and vein-nerve extension.

Antiphospholipid syndrome may produce arterial and venous thromboses, pregnancy

morbidity, and livedoid vascular changes. The lesions are primarily thrombotic rather than
inflammatory, and microabscess-containing inflammatory thrombi are not characteristic.
Laboratory evidence of antiphospholipid antibodies supports that diagnosis.

Thromboembolic occlusion may produce acute limb ischemia, but emboli typically lodge at
arterial bifurcations and are not associated with segmental inflammatory vasculitis, thrombus
microabscesses, or chronic fibrotic encasement of adjacent veins and nerves.

Diabetic peripheral arterial disease and diabetic microangiopathy may produce distal ischemia
and gangrene. The pathology is atherosclerosis of larger arteries, arteriolosclerosis, basement
membrane thickening, and neuropathy-related ulceration. It lacks the segmental inflammatory
thrombotic vasculitis of Buerger disease.

Raynaud disease and Raynaud phenomenon may produce episodic digital ischemia. Primary
Raynaud disease is a functional vasospastic disorder without structural vasculitis. Secondary
Raynaud phenomenon may occur in connective tissue disease, atherosclerosis, or Buerger
disease itself. Persistent inflammatory thrombosis and vascular occlusion favor Buerger
disease.
Systemic sclerosis-associated vasculopathy may produce digital ischemia and ulcers. It is
characterized by intimal proliferation, luminal narrowing, and vascular fibrosis in small arteries
and arterioles, usually in the context of systemic sclerosis. It lacks inflammatory thrombi with
microabscesses and the typical tobacco-associated distal vessel pattern.

Infectious arteritis can cause vessel wall inflammation, thrombosis, and aneurysm formation. It
is distinguished by organisms, suppurative inflammation, adjacent infection, or septic embolic
source. Buerger disease is sterile thromboinflammatory vasculitis linked to tobacco exposure.

Gross / Key
Main Distinguishing
Disease Structural Histopathological
Vessel / Site Feature
Pattern Finding

Acute and chronic

thrombosing
Segmental distal
Small- and vasculitis with
vascular
medium- inflammatory
occlusion, mural
sized thrombi, thrombus Tobacco-associated
or occlusive
arteries and microabscesses, thromboinflammatory
Buerger disease / thrombi, fibrotic
veins of occasional distal extremity
thromboangiitis encasement of
extremities, granulomatous vasculopathy with
obliterans artery-vein-nerve
especially inflammation, adjacent vein and
bundles, distal
tibial and relatively intact nerve involvement
ischemic
radial internal elastic
ulceration or
arteries lamina,
gangrene
organization and
recanalization

Large and
Fibrofatty intimal
medium Plaque-related Lipid-rich
plaque with lipid
Atherosclerotic arteries, stenosis or atheromatous plaque
core, foam cells,
peripheral especially occlusion; rather than
cholesterol clefts,
arterial disease lower calcified arterial inflammatory
fibrous cap,
extremity walls thrombus
calcification
arteries
 Gross / Key
Main Distinguishing
Disease Structural Histopathological
Vessel / Site Feature
Pattern Finding

Medium- Segmental
sized nodular arterial Transmural
Visceral medium-
Polyarteritis muscular lesions, necrotizing arteritis
vessel necrotizing
nodosa arteries, thrombosis, with fibrinoid
vasculitis
often aneurysms, necrosis
visceral infarcts

Capillaries, Myeloperoxidase-
venules, Pulmonary-renal Pauci-immune antineutrophil
Microscopic
arterioles, or systemic small- necrotizing small- cytoplasmic antibody
polyangiitis
small vessel disease vessel vasculitis association and
arteries glomerulonephritis

Arteries and
Recurrent Thrombosis with Autoantibody-
Antiphospholipid veins,
thrombosis and minimal vessel wall mediated
syndrome multiple
ischemic lesions inflammation hypercoagulable state
organs

Arterial
Embolic source and
bifurcations Embolic thrombus
Thromboembolic Acute arterial absence of segmental
or embolic without primary
occlusion occlusion inflammatory vascular
target vasculitis
disease
vessels

Large,
Atherosclerosis,
medium, Atherosclerotic
Diabetic arteriolosclerosis, Diabetes-associated
and small stenosis,
peripheral basement vascular disease and
vessels of microangiopathy,
arterial disease membrane neuropathic ulcers
lower ulcers, gangrene
thickening
extremities
 Gross / Key
Main Distinguishing
Disease Structural Histopathological
Vessel / Site Feature
Pattern Finding

Small
Intimal Scleroderma-pattern
Systemic arteries and
Digital ischemia proliferation, vasculopathy without
sclerosis arterioles,
and ulcers luminal narrowing, thrombus
vasculopathy especially
vascular fibrosis microabscesses
digits

Focal
Thrombosis,
vessels Suppurative
vessel
Infectious adjacent to inflammation with Infection-driven
destruction,
arteritis infection or organisms or septic arteritis
possible mycotic
septic source
aneurysm
emboli
ALPORT SYNDROME

Alport syndrome is a hereditary nephritis caused by structural defects in type IV collagen, the
major collagenous component of the glomerular basement membrane. The disease primarily
affects the kidney, but type IV collagen is also important in the cochlea and ocular structures;
therefore, renal disease may be associated with sensorineural hearing abnormalities and ocular
lesions. In pathology, the central lesion is a genetically determined abnormality of the
glomerular basement membrane that causes progressive glomerular injury, hematuria,
proteinuria, chronic renal damage, and ultimately end-stage kidney disease in severe forms.

The disease belongs to the group of hereditary glomerular basement membrane disorders. It
differs from immune complex glomerulonephritides because the primary abnormality is not
immune deposition, complement activation, or inflammatory glomerular hypercellularity.
Instead, the fundamental defect is abnormal assembly and maintenance of the type IV collagen
network of the glomerular basement membrane.

The pathology-relevant deep features include abnormal expression of type IV collagen alpha
chains within the glomerular basement membrane, bilaterally shrunken kidneys with
cortical thinning, bilateral cortical atrophy and finely granular external surfaces,
glomerulosclerosis, interstitial fibrosis, tubular atrophy, and the characteristic
ultrastructural finding Irregular thickening and lamellation of the glomerular basement
membrane.

Etiology

Alport syndrome is caused by mutations in genes encoding alpha chains of type IV collagen.
Type IV collagen is composed of several alpha chains that form specialized networks in
basement membranes. The mature glomerular basement membrane normally contains a
collagen network rich in alpha-3, alpha-4, and alpha-5 chains of type IV collagen.

The most common form is X-linked Alport syndrome, caused by mutations in collagen type IV
alpha 5 chain gene (COL4A5) on the X chromosome. COL4A5 encodes the alpha-5 chain of
type IV collagen. Because of X-linked inheritance, affected males usually have more severe
disease, whereas heterozygous females may show variable severity due to X-chromosome
inactivation.

Autosomal recessive and autosomal dominant forms also occur. These are caused by mutations
in collagen type IV alpha 3 chain gene (COL4A3) or collagen type IV alpha 4 chain gene
(COL4A4), which encode the alpha-3 and alpha-4 chains of type IV collagen. Autosomal
recessive disease may be severe, whereas autosomal dominant disease may be milder and may
overlap clinically with thin basement membrane nephropathy.

The etiologic basis is therefore a structural collagen defect, not an acquired inflammatory or
immune complex disease. Abnormal type IV collagen chain synthesis, assembly, or distribution
weakens the glomerular basement membrane and makes it vulnerable to progressive
mechanical and filtration-related injury.

Pathogenesis

The central pathogenic event is defective type IV collagen network formation in the glomerular
basement membrane. During renal development, the glomerular basement membrane
undergoes a normal collagen network transition. In Alport syndrome, the mature alpha-3/alpha-
4/alpha-5 type IV collagen network is absent, abnormal, or unstable. This leaves the basement
membrane structurally fragile and functionally abnormal.

The abnormal glomerular basement membrane initially may be thin and attenuated. With
ongoing filtration stress, the basement membrane develops irregular remodeling, splitting,
thickening, thinning, and lamellation. The lamina densa becomes multilayered and fragmented,
producing the characteristic basket-weave ultrastructural pattern.

Podocytes respond to basement membrane abnormality with stress, altered adhesion, and
secondary injury. Persistent glomerular capillary wall instability causes hematuria and later
proteinuria. Progressive glomerular scarring follows. As glomerulosclerosis increases,
tubulointerstitial injury develops, including tubular atrophy and interstitial fibrosis. The kidney
ultimately progresses toward chronic kidney disease and end-stage renal failure in severe forms.

The same type IV collagen chains are important in basement membranes of the inner ear and
ocular structures. Abnormal collagen networks in these sites explain the association with
sensorineural hearing abnormalities and ocular lesions. This systemic basement membrane
involvement is an important conceptual feature of the disease.

The major pathological sequence is:

COL4A5, COL4A3, or COL4A4 mutation → defective alpha-chain composition of type IV

collagen → abnormal glomerular basement membrane network → progressive glomerular
basement membrane thinning, thickening, splitting, and lamellation → hematuria and
proteinuria → glomerulosclerosis → tubular atrophy, interstitial fibrosis, and chronic kidney
disease.

The essential pathogenic idea is that Alport syndrome is a hereditary structural disease of
basement membranes, with the kidney lesion centered on abnormal type IV collagen
architecture within the glomerular basement membrane.

Macroscopic Findings

Gross findings depend on disease stage. Early in the disease, the kidneys may be grossly
unremarkable because the primary abnormality is ultrastructural. As chronic glomerular injury
progresses, the kidneys develop features of chronic renal scarring.

In advanced disease, the kidneys may become bilaterally shrunken kidneys with cortical
thinning. The external surfaces may be finely granular because of chronic nephron loss,
glomerulosclerosis, and interstitial fibrosis. At autopsy or advanced pathological examination,
the kidneys may show bilateral cortical atrophy and finely granular external surfaces.

The cut surface may show cortical thinning, corticomedullary accentuation loss, and increased
firmness. These are nonspecific gross manifestations of chronic kidney disease. They indicate
advanced scarring rather than a unique gross pattern specific only to Alport syndrome.

The gross pathological teaching point is that Alport syndrome is diagnosed by glomerular
basement membrane pathology and type IV collagen abnormalities, while the gross kidney
appearance in late disease reflects chronic renal failure and scarring.

Histopathological Findings

Light microscopic findings vary by stage and may be nonspecific. Early in the disease,
glomeruli may appear normal or show only mild mesangial expansion. Because the defining
abnormality is in basement membrane ultrastructure, routine light microscopy may
underestimate early disease.

With progression, glomeruli develop segmental sclerosis and later global sclerosis. The deep
pathology-relevant chronic renal lesions include glomerulosclerosis, interstitial fibrosis, and
tubular atrophy. These findings reflect progressive nephron loss and chronic kidney damage.

The interstitium may contain lipid-laden foam cells, a helpful but not specific feature described
in hereditary nephritis. Tubules may show atrophy, thyroidization-like changes in chronic
scarring, and proteinaceous casts. The interstitium becomes fibrotic, and chronic inflammatory
cells may be present as part of chronic renal injury.

Immunofluorescence for immunoglobulins and complement is typically negative or nonspecific

because Alport syndrome is not an immune complex glomerulonephritis. There is no
characteristic granular immune complex deposition and no linear anti-glomerular basement
membrane antibody pattern.

Immunohistochemistry or immunofluorescence for type IV collagen alpha chains may

demonstrate abnormal expression of type IV collagen alpha chains within the glomerular
basement membrane. Depending on the genetic defect, staining for alpha-3, alpha-4, and
alpha-5 chains may be absent or altered in the glomerular basement membrane, distal tubular
basement membranes, or epidermal basement membrane. This is diagnostically useful because
it links the biopsy pattern directly to defective collagen composition.

The concise histopathological formulation is:

hereditary nephritis with progressive glomerulosclerosis, tubular atrophy, interstitial fibrosis,

absent or abnormal type IV collagen alpha-chain expression in basement membranes, negative
or nonspecific immune deposits, and characteristic ultrastructural glomerular basement
membrane lamellation.

Electron Microscopic Findings

Electron microscopy provides the most characteristic morphological evidence. The defining
ultrastructural abnormality is Irregular thickening and lamellation of the glomerular
basement membrane.

The glomerular basement membrane shows alternating areas of thinning and thickening. The
lamina densa is split, laminated, and irregularly layered. This creates the classic basket-weave
appearance. Foci of rarefaction may be present within the abnormal basement membrane. These
changes may be segmental early and become more widespread with disease progression.

In early disease, diffuse or segmental thinning of the glomerular basement membrane may
predominate. Later, the combination of thickening, thinning, splitting, and lamellation becomes
more diagnostic. Podocyte foot process effacement may occur secondarily in areas of
proteinuria, but it is not the defining abnormality.

The high-yield ultrastructural formulation is:

Irregular thickening and lamellation of the glomerular basement membrane, with splitting
of the lamina densa and basket-weave remodeling of the glomerular capillary wall.

Differential Diagnosis

The most important differential diagnosis is thin basement membrane nephropathy. Thin
basement membrane nephropathy causes persistent hematuria and shows uniform thinning of
the glomerular basement membrane on electron microscopy. It lacks the widespread progressive
basket-weave lamellation, marked irregular thickening, and severe progressive renal failure
pattern typical of Alport syndrome. It is often caused by heterozygous COL4A3 or COL4A4
variants.

IgA nephropathy may present with hematuria and sometimes progressive renal disease. It is
distinguished by mesangial immunoglobulin A deposition on immunofluorescence and
mesangial electron-dense deposits on electron microscopy. Alport syndrome lacks dominant
mesangial immunoglobulin A deposits and instead shows a structural collagen defect of the
glomerular basement membrane.

Postinfectious glomerulonephritis may show hematuria and proteinuria but has diffuse
endocapillary hypercellularity, neutrophilic infiltrates, granular immunoglobulin and
complement staining, and subepithelial hump-shaped electron-dense deposits. These immune
complex features are not seen in Alport syndrome.

Membranous nephropathy shows nephrotic syndrome, diffuse capillary wall thickening,

granular immunoglobulin G and complement component 3 along the glomerular basement
membrane, and subepithelial electron-dense deposits with spike-and-dome remodeling. Alport
syndrome is a collagen structural disease with glomerular basement membrane lamellation, not
subepithelial immune complex deposition.

Anti-glomerular basement membrane disease shows linear immunoglobulin G deposition along

the glomerular basement membrane and often necrotizing crescentic glomerulonephritis. Alport
syndrome lacks linear anti-glomerular basement membrane antibody deposition and has
inherited type IV collagen chain abnormality.

Diabetic nephropathy may show glomerular basement membrane thickening and proteinuria,
but it is associated with mesangial expansion, nodular glomerulosclerosis, arteriolar hyalinosis,
and diabetic microangiopathy. It does not show the characteristic hereditary glomerular
basement membrane splitting and lamellation pattern of Alport syndrome.
 Electron
Immunofluorescence /
Microscopy
Disease Primary Defect Light Microscopy Immunohistochemistr
/ Key
y
Distinction

Irregular
thickening
Abnormal expression
Type IV and
of type IV collagen
collagen alpha- Glomerulosclerosi lamellation
alpha chains within
chain defect, s, interstitial of the
the glomerular
Alport syndrome most often fibrosis, tubular glomerular
basement membrane;
COL4A5; also atrophy in basement
immune deposits
COL4A3 or progressive disease membrane
usually absent or
COL4A4 with basket-
nonspecific
weave
remodeling

Uniform
glomerular
Usually
Usually minimal or basement
Thin basement heterozygous
no light membrane
membrane COL4A3 or Usually nonspecific
microscopic thinning
nephropathy COL4A4
abnormality without
abnormality
widespread
lamellation

Mesangial Mesangial
Mesangial Mesangial
proliferation and electron-
IgA nephropathy immune immunoglobulin A-
matrix expansion dense
complex disease dominant deposition
may be present deposits

Infection- Diffuse Granular Subepithelia

Postinfectious
associated endocapillary immunoglobulin G and l hump-
glomerulonephriti
immune hypercellularity complement shaped
s
complex disease with neutrophils component 3 electron-
 Electron
Immunofluorescence /
Microscopy
Disease Primary Defect Light Microscopy Immunohistochemistr
/ Key
y
Distinction

dense
deposits

Granular
Subepithelia
immunoglobulin G and
Subepithelial l deposits
Membranous Diffuse capillary complement
immune with spike-
nephropathy wall thickening component 3 along
complex disease and-dome
glomerular basement
pattern
membrane

Autoantibodies Basement
Anti-glomerular against intrinsic membrane
Necrotizing Linear immunoglobulin
basement glomerular rupture and
crescentic G along glomerular
membrane basement fibrin; not
glomerulonephritis basement membrane
disease membrane hereditary
antigen lamellation

Diffuse
basement
Mesangial membrane
Diabetic Often nonspecific
Diabetic expansion, nodular thickening
microangiopathi linear staining for
nephropathy glomerulosclerosis, without
c injury plasma proteins
arteriolar hyalinosis basket-
weave
lamellation
YOLK SAC TUMOR

Yolk sac tumor is a malignant germ cell tumor that recapitulates extraembryonic yolk sac
differentiation. It is also called endodermal sinus tumor. In the testis, it is the most common
malignant germ cell tumor of young children, but it may also occur as a component of mixed
germ cell tumors in adolescents and adults. In the ovary, yolk sac tumor is an important
malignant germ cell tumor of children and young women.

The tumor is characterized by multiple architectural patterns, but the most classic and
diagnostically iconic structure is the Schiller-Duval body. The tumor commonly produces
alpha-fetoprotein and may show glypican-3 expression. These markers support yolk sac
differentiation.

The pathology-relevant deep features include heterogeneous solid intratesticular mass, soft
yellow-white tumor with prominent hemorrhagic areas, alpha-fetoprotein positivity,
glypican-3 positivity, and Schiller-Duval body formation.

Etiology

Yolk sac tumor is a malignant germ cell tumor arising from primitive germ cells capable of
extraembryonic endodermal differentiation. Its etiology differs by age group and anatomic
setting.

In prepubertal testicular yolk sac tumor, the disease often occurs as a pure tumor and has
biological differences from adult postpubertal germ cell tumors. It is generally not associated
with germ cell neoplasia in situ in the same way as many adult testicular germ cell tumors.

In postpubertal testicular tumors, yolk sac tumor frequently occurs as part of a mixed germ cell
tumor. In this setting, it is usually related to germ cell neoplasia in situ and shares the genetic
background of adult-type testicular germ cell tumors, including abnormalities such as
isochromosome 12p or 12p amplification.

Ovarian yolk sac tumor arises from malignant germ cells showing yolk sac differentiation. It is
not driven by ordinary epithelial ovarian carcinoma pathways and should be distinguished from
surface epithelial tumors of the ovary.

The defining etiologic concept is germ cell malignant transformation with differentiation
toward yolk sac and extraembryonic endodermal structures. Its production of alpha-fetoprotein
reflects this differentiation.
Pathogenesis

The pathogenesis centers on malignant germ cell differentiation toward yolk sac lineage. Tumor
cells activate transcriptional programs resembling primitive endoderm and extraembryonic yolk
sac structures. This explains production of alpha-fetoprotein and formation of characteristic
architectural patterns, including reticular, microcystic, papillary, solid, glandular, hepatoid,
polyvesicular vitelline, and endodermal sinus-like patterns.

The Schiller-Duval body is the classic morphologic expression of endodermal sinus

differentiation. It consists of a central blood vessel surrounded by tumor cells within a space
that is also lined by tumor cells, creating a glomeruloid structure. This structure is highly
characteristic when present.

Tumor cells may secrete basement membrane-like material and plasma protein-like material,
producing intra- and extracellular hyaline globules. These globules may be periodic acid-Schiff
positive and diastase resistant. Alpha-fetoprotein may be present within tumor cells and hyaline
globules.

Glypican-3 is commonly expressed in yolk sac tumor. Glypican-3 is a heparan sulfate

proteoglycan expressed in fetal tissues and several tumors with oncofetal differentiation. Its
expression supports yolk sac tumor when interpreted with morphology and alpha-fetoprotein.

The major pathological sequence is:

malignant germ cell transformation → yolk sac / endodermal sinus differentiation → alpha-
fetoprotein production → microcystic-reticular and other growth patterns → Schiller-Duval
body formation and hyaline globule production → aggressive malignant germ cell tumor
behavior.

The essential pathogenic concept is that yolk sac tumor is not a carcinoma, sex cord-stromal
tumor, or lymphoma; it is a malignant germ cell tumor showing extraembryonic endodermal
differentiation.

Macroscopic Findings

Grossly, yolk sac tumor is usually a solid, soft, fleshy mass. In the testis, it forms an
intratesticular tumor that may replace much of the testicular parenchyma. The deep pathology-
relevant gross pattern includes heterogeneous solid intratesticular mass and soft yellow-
white tumor with prominent hemorrhagic areas.
The cut surface is often gray-white to yellow-white, soft, and friable. Hemorrhage and necrosis
may be prominent. Cystic or mucoid areas may be present depending on the architectural
pattern. The tumor may bulge from the cut surface because of its soft cellular composition.

In ovarian yolk sac tumor, the mass is often large, unilateral, solid, and partly cystic, with
hemorrhage and necrosis. The surface may be smooth or disrupted depending on tumor size and
spread.

In mixed germ cell tumors, yolk sac tumor may appear as one component within a variegated
testicular mass containing other elements such as embryonal carcinoma, teratoma, seminoma,
or choriocarcinoma. Careful sampling is important because yolk sac tumor components may be
focal but clinically significant due to alpha-fetoprotein production.

The classical gross pathological impression is a soft, yellow-white, hemorrhagic malignant

germ cell tumor with solid and sometimes cystic areas.

Histopathological Findings

Yolk sac tumor shows diverse architectural patterns. The most common pattern is microcystic
or reticular, in which tumor cells form a loose network of anastomosing spaces and channels.
The spaces may contain eosinophilic fluid. Tumor cells may be cuboidal, flattened, or columnar,
with variable cytologic atypia.

The most characteristic histopathological finding is Schiller-Duval body formation. A

Schiller-Duval body consists of a central blood vessel surrounded by tumor cells, with the entire
structure projecting into a cystic or sinus-like space lined by tumor cells. It resembles a
primitive glomerulus and is highly characteristic of yolk sac tumor when identified.

Other patterns may include solid sheets, papillary structures, glandular or endodermal sinus-
like formations, myxomatous areas, hepatoid differentiation, and polyvesicular vitelline pattern.
Because of this morphological diversity, immunohistochemistry and serum markers are often
very useful.

Hyaline globules are common. These may be intracellular or extracellular and are often
eosinophilic. They may stain with periodic acid-Schiff and resist diastase digestion. They can
contain alpha-fetoprotein and other serum proteins.

Immunohistochemically, tumor cells often show alpha-fetoprotein positivity and glypican-3

positivity. Sal-like protein 4 (SALL4) is also commonly positive and supports germ cell origin,
although it is not specific for yolk sac differentiation. Cytokeratins may be positive. Alpha-
fetoprotein staining may be patchy; therefore, glypican-3 and SALL4 can be helpful in
combination with morphology.

The concise histopathological formulation is:

malignant germ cell tumor with yolk sac differentiation, microcystic-reticular and other
architectural patterns, intra- and extracellular hyaline globules, alpha-fetoprotein positivity,
glypican-3 positivity, and diagnostic Schiller-Duval body formation.

Differential Diagnosis

Embryonal carcinoma is an important differential diagnosis. It may occur in the testis and ovary
and may be part of mixed germ cell tumors. Embryonal carcinoma is composed of primitive
epithelial-like cells growing in solid, glandular, or papillary patterns. It is typically positive for
cluster of differentiation 30 (CD30) and octamer-binding transcription factor 3/4 (OCT3/4),
whereas yolk sac tumor is typically alpha-fetoprotein and glypican-3 positive and lacks strong
diffuse CD30 and OCT3/4 expression.

Seminoma may enter the differential in testicular tumors. Seminoma shows sheets of uniform
cells with clear glycogen-rich cytoplasm, distinct cell borders, central nuclei, and lymphocytic
septa. It is usually positive for OCT3/4 and KIT proto-oncogene receptor tyrosine kinase
(CD117), but not alpha-fetoprotein. Yolk sac tumor shows reticular or endodermal sinus
patterns, hyaline globules, and alpha-fetoprotein production.

Choriocarcinoma is another malignant germ cell tumor. It shows intimately admixed

cytotrophoblast and syncytiotrophoblast without chorionic villi and produces human chorionic
gonadotropin. Yolk sac tumor produces alpha-fetoprotein and forms Schiller-Duval bodies
rather than trophoblastic biphasic proliferation.

Teratoma contains tissues derived from more than one germ cell layer, such as cartilage,
squamous epithelium, respiratory epithelium, intestinal epithelium, neural tissue, muscle, or
bone. Yolk sac tumor shows primitive endodermal/yolk sac differentiation rather than mature
or immature somatic tissues.

Juvenile granulosa cell tumor can enter the differential diagnosis in ovarian tumors and may
show Call-Exner-like spaces. It is a sex cord-stromal tumor and expresses sex cord markers
such as inhibin and calretinin. It lacks alpha-fetoprotein-producing yolk sac differentiation and
Schiller-Duval bodies.
Metastatic adenocarcinoma may mimic yolk sac tumor because of glandular patterns. However,
metastatic carcinoma usually lacks germ cell markers such as SALL4 and does not show the
characteristic combination of alpha-fetoprotein, glypican-3, hyaline globules, and Schiller-
Duval bodies.

Hepatocellular carcinoma-like hepatoid yolk sac tumor may mimic hepatocellular carcinoma.
In a gonadal tumor, germ cell markers and associated germ cell tumor components support yolk
sac tumor. Hepatocellular carcinoma markers and clinical-liver correlation help resolve
metastatic or primary hepatic origin.

Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

Heterogeneous
Microcystic-reticular
solid
pattern, hyaline
intratesticular
globules, alpha- Malignant germ
Testis, ovary, mass; soft
fetoprotein cell tumor with
Yolk sac tumor extragonadal yellow-white
positivity, glypican- yolk sac
germ cell sites tumor with
3 positivity, and differentiation
prominent
Schiller-Duval body
hemorrhagic
formation
areas

Primitive epithelial- CD30 and OCT3/4

Testis, ovary, Soft
Embryonal like cells in solid, positivity; lacks
mixed germ hemorrhagic
carcinoma glandular, or Schiller-Duval
cell tumors necrotic mass
papillary patterns bodies

Testis; OCT3/4 and

Homogeneous Sheets of clear cells
dysgerminoma CD117 positivity;
Seminoma gray-white with lymphocytic
counterpart in alpha-fetoprotein
lobulated mass septa
ovary negative
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

Human chorionic
Testis, ovary,
Cytotrophoblast and gonadotropin-
gestational or Hemorrhagic
Choriocarcinoma syncytiotrophoblast producing
nongestational necrotic tumor
without villi trophoblastic
sites
tumor

Variegated solid-
cystic mass with
Somatic tissue
Testis, ovary, cartilage, bone, Mature or immature
differentiation
Teratoma extragonadal hair, or other tissues from multiple
rather than yolk sac
sites tissues germ layers
pattern
depending on
type

Juvenile Follicle-like spaces Inhibin/calretinin-

Solid-cystic
granulosa cell Ovary and sex cord-stromal positive sex cord-
ovarian mass
tumor morphology stromal tumor

Site-specific
Gonad or other carcinoma
Metastatic Infiltrative Gland-forming
site depending phenotype; lacks
adenocarcinoma metastatic mass carcinoma
on spread germ cell marker
profile

Liver origin or
hepatoid
Hepatocellular Green-yellow or
carcinoma
carcinoma / Liver or hemorrhagic Hepatoid trabecular
phenotype;
hepatoid metastatic sites mass depending tumor cells
correlation with
carcinoma on site
germ cell markers
required
DIABETIC NEPHROPATHY

Diabetic nephropathy is a chronic renal complication of diabetes mellitus and one of the most
important causes of chronic kidney disease and end-stage renal disease worldwide. It represents
the renal expression of diabetic microangiopathy and metabolic injury. The disease affects
multiple renal compartments, including glomeruli, arterioles, tubules, and interstitium, but the
dominant and most characteristic lesions are glomerular basement membrane thickening,
diffuse mesangial sclerosis, nodular glomerulosclerosis, and hyaline arteriolosclerosis.

The pathological identity of diabetic nephropathy is a chronic glomerular and vascular disease
caused by persistent hyperglycemia and its metabolic consequences. It is not an immune
complex glomerulonephritis, not a primary podocytopathy, and not a hereditary basement
membrane disorder. The defining structural abnormalities are thickening of capillary basement
membranes, expansion of mesangial matrix, nodular glomerulosclerosis, and arteriolar
hyalinosis involving both afferent and efferent arterioles.

The classic nodular lesion is called the Kimmelstiel-Wilson nodule. It consists of rounded,
laminated, mesangial matrix nodules within the glomerulus. Although highly characteristic of
diabetic nephropathy, nodular glomerulosclerosis is not always present in early disease; diffuse
mesangial sclerosis and glomerular basement membrane thickening often precede it.

Etiology

The etiologic basis of diabetic nephropathy is long-standing diabetes mellitus. Both type 1
diabetes mellitus and type 2 diabetes mellitus can produce the same renal pathological lesions.
Disease severity is influenced by duration of diabetes, degree of glycemic control, hypertension,
genetic susceptibility, obesity, dyslipidemia, and coexisting vascular disease.

Chronic hyperglycemia is the central etiologic driver. Persistent elevation of glucose promotes
nonenzymatic glycation of proteins in basement membranes, extracellular matrix, plasma
proteins, and vascular walls. These glycated proteins undergo further chemical modification to
form advanced glycation end products. Advanced glycation end products alter matrix structure,
trap plasma proteins, stimulate inflammatory and fibrogenic signaling, and contribute to
vascular and glomerular injury.

Hemodynamic stress is also important. Hyperglycemia produces glomerular hyperfiltration,

especially in early diabetic nephropathy. Increased intraglomerular pressure stresses glomerular
capillary walls and mesangium. Systemic hypertension further worsens this injury by increasing
glomerular capillary pressure and accelerating sclerosis.

Metabolic pathways activated by hyperglycemia also contribute. These include increased

polyol pathway activity, oxidative stress, protein kinase C activation, increased transforming
growth factor-beta signaling, and increased production of extracellular matrix by mesangial
cells. These processes promote thickening of basement membranes and mesangial matrix
accumulation.

The etiologic formulation is therefore: chronic hyperglycemia, advanced glycation end product
formation, glomerular hemodynamic stress, oxidative and cytokine-mediated injury, and
progressive extracellular matrix deposition in glomerular and vascular compartments.

Pathogenesis

The pathogenesis of diabetic nephropathy begins with diabetic microangiopathy. One of the
most consistent morphological features of diabetes is diffuse thickening of basement
membranes in small vessels and capillaries. In the kidney, this affects glomerular capillary
basement membranes, renal tubules, Bowman capsule, and renal microvasculature.

Glomerular basement membrane thickening is one of the earliest structural lesions. It may be
detectable by electron microscopy before major changes are visible by light microscopy.
Despite thickening, the basement membrane becomes abnormally permeable. Loss or alteration
of negatively charged matrix components, together with podocyte stress and endothelial
dysfunction, promotes albumin leakage.

Mesangial expansion develops as mesangial cells produce increased extracellular matrix. This
produces diffuse mesangial sclerosis. As matrix accumulation progresses, rounded nodules of
mesangial matrix form within glomeruli, producing nodular glomerulosclerosis. These nodules
compress capillary loops and reduce filtration surface area.

Arteriolar hyalinosis is a major vascular lesion. In diabetes, hyaline arteriolosclerosis affects

both afferent and efferent arterioles. Efferent arteriolar hyalinosis is especially characteristic
because hypertension alone more classically affects afferent arterioles. Arteriolar narrowing
causes downstream ischemic injury, contributing to tubulointerstitial fibrosis.

Podocyte injury contributes to proteinuria and progression. Podocyte loss or dysfunction

impairs the glomerular filtration barrier. Persistent protein leakage injures tubules and activates
interstitial inflammation and fibrosis. As glomeruli scar, nephron loss produces compensatory
hyperfiltration in remaining nephrons, further accelerating injury.

The major pathological sequence is:

long-standing hyperglycemia → nonenzymatic glycation and advanced glycation end product

formation → glomerular basement membrane thickening and mesangial matrix expansion →
diffuse mesangial sclerosis → nodular glomerulosclerosis → arteriolar hyalinosis and ischemic
tubulointerstitial injury → progressive proteinuria, glomerulosclerosis, and chronic kidney
disease.

The essential pathogenic concept is that diabetic nephropathy is a metabolic and microvascular
renal disease in which hyperglycemia drives matrix accumulation, capillary wall thickening,
arteriolar hyalinosis, and chronic scarring.

Macroscopic Findings

Gross renal findings depend on disease stage. In early diabetic nephropathy, the kidneys may
be enlarged because of glomerular hypertrophy, hyperfiltration, and increased renal blood flow.
The external surface may be smooth, and gross abnormalities may be minimal.

With progressive disease, the kidneys become firm and granular. The cortex may become
thinned because of nephron loss, glomerulosclerosis, tubular atrophy, and interstitial fibrosis.
Chronic ischemic changes from vascular disease contribute to cortical scarring.

In advanced diabetic nephropathy, kidneys may be reduced in size, finely granular, and scarred.
The cut surface may show cortical thinning and loss of corticomedullary distinction. These
changes reflect chronic kidney disease and are not unique to diabetes, but they occur in the
setting of characteristic glomerular and vascular lesions.

Renal papillary necrosis may occur as a complication, particularly in diabetics with infection
or ischemia. Grossly, necrotic papillae may appear pale, yellow-white, friable, or sloughed into
the collecting system. Diabetic pyelonephritis may produce suppurative inflammation,
abscesses, and scarring.

The gross pathological picture is therefore variable: enlarged kidneys in early disease, granular
scarred kidneys in advanced disease, and possible papillary necrosis or pyelonephritis as
superimposed diabetic complications.

Histopathological Findings
The histopathology of diabetic nephropathy includes glomerular lesions, vascular lesions,
tubular lesions, and interstitial lesions.

The earliest glomerular lesion is diffuse thickening of the glomerular capillary basement
membrane. This may be difficult to appreciate on routine light microscopy in early disease and
is best demonstrated by electron microscopy. With progression, the glomerular capillary walls
appear thickened on light microscopy.

Diffuse mesangial sclerosis consists of widespread mesangial matrix expansion. The

mesangium becomes increased and may encroach on capillary lumina. Mesangial cells may be
mildly increased, but matrix accumulation is the dominant feature.

Nodular glomerulosclerosis is the classic lesion. The Kimmelstiel-Wilson nodules are rounded,
laminated, periodic acid-Schiff-positive mesangial matrix nodules. They are usually located in
the peripheral glomerular lobules and compress adjacent capillary loops. Nodular lesions are
highly characteristic of diabetic nephropathy, especially when accompanied by arteriolar
hyalinosis.

Exudative lesions may be present. Fibrin caps consist of plasma protein deposits along the inner
aspect of glomerular capillary loops. Capsular drops are proteinaceous deposits along Bowman
capsule. These lesions reflect increased vascular permeability and plasma protein leakage.

Vascular lesions are prominent. Hyaline arteriolosclerosis affects afferent and efferent
arterioles. The arteriolar walls become thickened by pink hyaline material, and the lumina
narrow. Larger renal arteries may show accelerated atherosclerosis.

Tubulointerstitial lesions develop as disease progresses. Tubular atrophy, interstitial fibrosis,

chronic inflammation, and loss of peritubular capillaries occur. Proteinuria itself contributes to
tubular injury. Armanni-Ebstein lesions may be seen in severe hyperglycemia; these are
glycogen-rich vacuolar changes in tubular epithelium.

Diabetic pyelonephritis may be acute or chronic. Necrotizing papillitis is a severe complication

in which renal papillae undergo ischemic and infectious necrosis. This complication is
associated with diabetes, urinary tract infection, and impaired host defense.

Immunofluorescence may show nonspecific linear staining for immunoglobulin G or albumin

along glomerular and tubular basement membranes due to plasma protein leakage and
glycation-related trapping. This should not be mistaken for anti-glomerular basement
membrane disease, which shows pathogenic linear immunoglobulin G in a different clinical and
histologic context.

The concise histopathological formulation is:

diabetic renal disease characterized by glomerular basement membrane thickening, diffuse

mesangial sclerosis, nodular Kimmelstiel-Wilson glomerulosclerosis, afferent and efferent
hyaline arteriolosclerosis, exudative lesions, tubular atrophy, interstitial fibrosis, and possible
pyelonephritis or necrotizing papillitis.

Electron Microscopic Findings

Electron microscopy demonstrates diffuse thickening of the glomerular basement membrane,

often before overt light microscopic changes are apparent. The thickening is usually uniform
and involves glomerular capillary loops extensively.

Mesangial matrix expansion is also evident ultrastructurally. Podocyte foot process effacement
may be present in areas of heavy proteinuria, but this is secondary and not the primary defining
lesion. There are no diagnostic immune complex-type electron-dense deposits as the principal
lesion.

The key ultrastructural teaching point is diffuse glomerular basement membrane thickening
with mesangial matrix expansion, reflecting diabetic microangiopathy and extracellular matrix
accumulation.

Differential Diagnosis

Hypertensive nephrosclerosis may produce arteriolosclerosis, ischemic glomerular collapse,

tubular atrophy, and interstitial fibrosis. However, diabetic nephropathy shows more prominent
glomerular basement membrane thickening, mesangial expansion, nodular glomerulosclerosis,
and efferent as well as afferent arteriolar hyalinosis. Hypertensive nephrosclerosis lacks classic
Kimmelstiel-Wilson nodules.

Amyloidosis can produce nodular glomerular lesions and nephrotic syndrome. Congo red stain
demonstrates amyloid deposits with apple-green birefringence under polarized light. Electron
microscopy shows randomly arranged nonbranching fibrils. Diabetic nodules are periodic acid-
Schiff-positive mesangial matrix nodules but are Congo red negative and lack amyloid fibrils.

Light chain deposition disease may mimic diabetic nodular glomerulosclerosis. It shows
nodular glomerulosclerosis and monoclonal light chain deposition along basement membranes.
Immunofluorescence demonstrates monoclonal kappa or lambda light chain restriction, and
electron microscopy shows granular powdery electron-dense deposits along basement
membranes.

Membranoproliferative glomerulonephritis may show lobular glomeruli and mesangial

expansion, but it is typically proliferative with double-contour basement membrane changes,
immune complex or complement deposition, and subendothelial or intramembranous deposits.
Diabetic nephropathy is not primarily an immune complex proliferative glomerulonephritis.

Membranous nephropathy may cause nephrotic syndrome but shows diffuse capillary wall
thickening, granular immunoglobulin G and complement staining, and subepithelial immune
deposits with spike-and-dome pattern. Diabetic nephropathy shows mesangial nodules,
arteriolar hyalinosis, and glomerular basement membrane thickening without primary
subepithelial immune deposits.

Focal segmental glomerulosclerosis may develop secondarily in diabetes due to hyperfiltration

injury. Primary focal segmental glomerulosclerosis lacks the full diabetic pattern of nodular
mesangial sclerosis, diffuse diabetic microangiopathy, and afferent-efferent arteriolar
hyalinosis.

Main Renal
Light Immunofluores Electron Microscopy /
Disease Compartme
Microscopy cence Key Distinction
nt / Target

Diffuse mesangial
sclerosis, Often
Glomerular
Kimmelstiel- nonspecific
basement Diffuse glomerular
Wilson nodules, linear
membrane, basement membrane
Diabetic arteriolar immunoglobulin
mesangium, thickening and
nephropathy hyalinosis of G or albumin
arterioles, mesangial matrix
afferent and staining along
tubulointersti expansion
efferent arterioles, basement
tium
tubular atrophy, membranes
interstitial fibrosis
 Main Renal
Light Immunofluores Electron Microscopy /
Disease Compartme
Microscopy cence Key Distinction
nt / Target

Hyaline
arteriolosclerosis,
Vascular ischemic
Small ischemic
Hypertensive scarring without diabetic
arteries and glomerular Nonspecific
nephrosclerosis nodular
arterioles collapse, tubular
glomerulosclerosis
atrophy,
interstitial fibrosis

Amorphous
Mesangium extracellular Random nonbranching
Variable by
Amyloidosis and capillary deposits; nodular fibrils; Congo red
amyloid type
walls expansion positive
possible

Glomerular Nodular Monoclonal Powdery granular

Light chain
and tubular glomerulosclerosi kappa or lambda electron-dense deposits
deposition
basement s may mimic light chain along basement
disease
membranes diabetic nodules deposition membranes

Mesangial/endoca
Immune
Membranoprolif pillary
Mesangium complex or Subendothelial/intrame
erative proliferation,
and capillary complement- mbranous deposits and
glomerulonephrit lobular
wall dominant tram-track change
is accentuation,
pattern
double contours

Granular
Subepithelial immunoglobulin Subepithelial deposits
Membranous Diffuse capillary
capillary G and with spike-and-dome
nephropathy wall thickening
wall complement pattern
component 3
 Main Renal
Light Immunofluores Electron Microscopy /
Disease Compartme
Microscopy cence Key Distinction
nt / Target

Focal and Nonspecific

Podocyte and
Focal segmental segmental immunoglobulin Foot process effacement
segmental
glomeruloscleros sclerosis, M/complement with segmental sclerosis
glomerular
is hyalinosis, trapping in but no diabetic nodules
scarring
adhesions sclerosis
GRAVES DISEASE

Graves disease is an autoimmune thyroid disease and the most common cause of endogenous
hyperthyroidism. It is characterized by diffuse thyroid hyperplasia caused by stimulatory
autoantibodies directed against the thyroid-stimulating hormone receptor. The disease produces
diffuse toxic goiter and may be associated with ophthalmopathy and dermopathy.

The pathological identity of Graves disease is diffuse hypertrophy and hyperplasia of thyroid
follicular epithelium driven by thyroid-stimulating immunoglobulins. The gland is diffusely
enlarged and hypervascular. Microscopically, follicles are lined by tall crowded epithelial cells
with papillary infoldings, and colloid is pale and scalloped because it is actively resorbed during
hormone synthesis and release.

Graves disease is not a nodular hyperplasia and not a destructive thyroiditis. In Hashimoto
thyroiditis, the dominant lesion is autoimmune follicular destruction with Hürthle cell change
and hypothyroidism. In Graves disease, the dominant lesion is antibody-mediated stimulation
of follicular cells, producing diffuse epithelial hyperplasia and hyperthyroidism.

Etiology

The etiology of Graves disease is autoimmune. The central autoantigen is the thyroid-
stimulating hormone receptor on the thyroid follicular epithelial cell membrane. Autoantibodies
of the immunoglobulin G class bind this receptor and mimic thyroid-stimulating hormone,
causing persistent stimulation of thyroid hormone synthesis and follicular epithelial
proliferation.

The major autoantibody is thyroid-stimulating immunoglobulin. Thyroid-stimulating

immunoglobulin binds the thyroid-stimulating hormone receptor and activates it, producing
increased synthesis and release of thyroxine and triiodothyronine. Thyroid growth-stimulating
immunoglobulins may contribute to follicular epithelial proliferation and diffuse thyroid
enlargement. Thyroid-stimulating hormone-binding inhibitor immunoglobulins may block or
stimulate receptor activity depending on their functional properties, explaining occasional
fluctuations in thyroid function.

Genetic susceptibility is important. Graves disease clusters in families and is associated with
immune-regulatory genetic factors, including certain human leukocyte antigen alleles,
cytotoxic T-lymphocyte associated protein 4 gene (CTLA4), and protein tyrosine phosphatase
non-receptor type 22 gene (PTPN22). These associations support the role of defective immune
tolerance and abnormal T-cell regulation.

Graves disease may coexist with or occur in families with other autoimmune diseases, including
Hashimoto thyroiditis, type 1 diabetes mellitus, autoimmune adrenalitis, pernicious anemia,
systemic lupus erythematosus, and other organ-specific autoimmune disorders.

Environmental factors may modify risk. Smoking is particularly important because it increases
the risk and severity of Graves ophthalmopathy. Stress, infections, iodine exposure, and
postpartum immune changes may contribute to disease onset or relapse in susceptible
individuals.

The etiologic formulation is therefore: genetically susceptible host, loss of immune tolerance
to thyroid-stimulating hormone receptor, production of stimulatory immunoglobulin G
autoantibodies, diffuse thyroid follicular stimulation, and extrathyroidal fibroblast activation in
orbit and skin.

Pathogenesis

The central pathogenic event is stimulation of the thyroid-stimulating hormone receptor by

autoantibodies. Thyroid-stimulating immunoglobulin binds to the receptor on thyroid follicular
cells and activates cyclic adenosine monophosphate-mediated signaling, similar to thyroid-
stimulating hormone. This drives thyroid hormone synthesis, thyroglobulin proteolysis, iodine
uptake, and follicular epithelial growth.

Persistent receptor activation causes diffuse follicular epithelial hypertrophy and hyperplasia.
The follicles become small and crowded. The lining epithelium becomes tall and columnar.
Because thyroglobulin is rapidly endocytosed and processed, colloid becomes pale and
scalloped at the edges.

The interstitium may contain lymphoid infiltrates. Lymphoid follicles with germinal centers
may be present. These infiltrates reflect the autoimmune basis of the disease, although the
dominant thyroid lesion is stimulatory hyperplasia rather than destructive lymphocytic
thyroiditis.

Ophthalmopathy results from autoimmune activation of orbital fibroblasts and adipocytes. The
thyroid-stimulating hormone receptor is expressed on orbital fibroblasts and fat cells. Activated
T cells and autoantibodies stimulate fibroblasts to produce glycosaminoglycans, especially
hydrophilic mucopolysaccharides. These substances accumulate in retroorbital tissues,
attracting water, increasing tissue volume, and producing edema. Fibroblast activation and
adipogenesis further expand orbital contents.

Dermopathy, particularly pretibial myxedema, results from similar fibroblast activation and
glycosaminoglycan deposition in the dermis. The dermis becomes expanded by mucinous
material, and the overlying skin may become thickened.

The major pathological sequence is:

loss of tolerance to thyroid-stimulating hormone receptor → production of stimulatory

immunoglobulin G autoantibodies → persistent receptor activation on follicular cells → diffuse
follicular epithelial hypertrophy and hyperplasia → increased hormone synthesis and colloid
resorption → diffuse toxic goiter; plus orbital and dermal fibroblast activation →
glycosaminoglycan deposition, edema, ophthalmopathy, and dermopathy.

The essential pathogenic concept is that Graves disease is a receptor-stimulating autoimmune

disease, not an antibody-mediated destructive thyroiditis.

Macroscopic Findings

Grossly, the thyroid gland is diffusely and symmetrically enlarged. The enlargement is usually
smooth rather than nodular. The gland may be soft to firm and is often markedly hypervascular.

The cut surface is typically red-brown, meaty, and homogeneous. Increased vascularity may
produce a congested appearance. The gland does not usually show the coarse nodularity of
multinodular goiter or the dense destructive lymphoid-fibrotic appearance of Hashimoto
thyroiditis.

In long-standing or treated disease, the gross appearance may be modified by therapy.

Antithyroid treatment can increase colloid and reduce epithelial activity. Radioiodine or surgery
can produce scarring or involutional changes. Untreated active Graves disease shows diffuse
hyperplastic and hypervascular enlargement.

Extrathyroidal gross changes may include expansion of orbital soft tissue due to edema,
glycosaminoglycan deposition, fibroblast proliferation, and adipose tissue expansion. Pretibial
dermopathy may show thickened skin.

The classical gross pathological impression is diffuse, symmetric, hypervascular thyroid

enlargement with a homogeneous red-brown cut surface.
Histopathological Findings

Microscopically, the thyroid shows diffuse follicular epithelial hypertrophy and hyperplasia.
Follicles are lined by tall columnar epithelial cells. The epithelial cells are crowded and may
project into follicular lumina as papillary infoldings. These papillary structures lack
fibrovascular cores, which helps distinguish them from true papillary neoplasia.

The follicles are often small and closely packed. Colloid is reduced, pale, and scalloped along
the edges. Scalloping reflects active endocytosis and proteolysis of thyroglobulin during
increased thyroid hormone synthesis.

The follicular epithelial cells have increased height and abundant cytoplasm. Nuclear crowding
may be present, but diagnostic nuclear features of papillary thyroid carcinoma are absent. The
architecture is diffuse rather than nodular.

The interstitium contains variable lymphocytic infiltrates. Lymphoid follicles with germinal
centers may be seen. Plasma cells may be present but are not usually the dominant feature. The
infiltrate supports autoimmune thyroid disease but does not cause the follicular destruction
characteristic of Hashimoto thyroiditis.

Vascularity is increased. The stroma may contain numerous congested capillaries, supporting
the hypervascular gross appearance. Fibrosis is not a major feature in untreated typical Graves
disease.

In ophthalmopathy, orbital tissues show edema, accumulation of glycosaminoglycans,

lymphocytic infiltration, increased adipose tissue, and fibrosis in chronic cases. Extraocular
muscles may be enlarged by edema and glycosaminoglycan-rich connective tissue expansion.

In dermopathy, the dermis shows mucin deposition, especially glycosaminoglycans, separation

of collagen bundles, and variable lymphocytic inflammation. This produces nonpitting
thickening of the pretibial skin.

The concise histopathological formulation is:

diffuse thyroid follicular epithelial hypertrophy and hyperplasia with tall crowded cells,
papillary infoldings lacking fibrovascular cores, small crowded follicles, pale scalloped colloid,
increased vascularity, and variable lymphoid infiltrates with germinal centers.

Differential Diagnosis
Hashimoto thyroiditis is the most important autoimmune differential diagnosis. Hashimoto
thyroiditis shows lymphoplasmacytic infiltration, lymphoid follicles with germinal centers,
Hürthle cell metaplasia, follicular destruction, colloid depletion, and variable fibrosis. Graves
disease instead shows diffuse follicular epithelial hyperplasia, scalloped colloid, increased
vascularity, and a stimulatory autoantibody mechanism.

Toxic multinodular goiter produces hyperthyroidism but shows nodular enlargement with
variably sized follicles, areas of hyperplasia, colloid-rich nodules, hemorrhage, fibrosis, and
calcification. Graves disease is diffuse and symmetric rather than multinodular.

Toxic follicular adenoma is a solitary hyperfunctioning nodule. Histologically, it is a

circumscribed follicular neoplasm or hyperplastic nodule with autonomous hormone
production. The surrounding thyroid is often suppressed. Graves disease involves the entire
gland diffusely.

Subacute granulomatous thyroiditis may cause transient thyrotoxicosis due to release of

preformed hormone from damaged follicles. Histology shows disrupted follicles, extravasated
colloid, histiocytes, and multinucleated giant cells. Graves disease shows hyperfunctioning
follicular hyperplasia rather than destructive granulomatous inflammation.

Painless lymphocytic thyroiditis may produce transient thyrotoxicosis and lymphocytic

infiltration. It lacks the diffuse tall-cell follicular hyperplasia and prominent scalloped colloid
of active Graves disease. It is a destructive thyroiditis, not a receptor-stimulating disease.

Papillary thyroid carcinoma may be considered because Graves disease can show papillary
epithelial infoldings. However, Graves-related papillae lack fibrovascular cores and do not
show the diagnostic nuclear features of papillary thyroid carcinoma, such as optically clear
nuclei, grooves, pseudoinclusions, nuclear overlap, and psammoma bodies.

Diffuse goiter due to iodine deficiency shows diffuse or nodular follicular hyperplasia
depending on stage. It is driven by thyroid-stimulating hormone elevation due to impaired
hormone synthesis, whereas Graves disease is driven by thyroid-stimulating hormone receptor-
stimulating autoantibodies and usually has suppressed endogenous thyroid-stimulating
hormone.
 Gross / Key
Disease Main Pattern Structural Histopathological Distinguishing Feature
Pattern Finding

Diffuse follicular
epithelial
Diffuse
hypertrophy and
symmetric Thyroid-stimulating
Autoimmune hyperplasia, tall
hypervascula hormone receptor-
receptor- crowded cells,
Graves r thyroid stimulating autoantibodies
stimulating papillary
disease enlargement, with
hyperthyroidis infoldings without
homogeneou ophthalmopathy/dermopat
m fibrovascular
s red-brown hy risk
cores, scalloped
cut surface
colloid, lymphoid
infiltrates

Lymphoplasmacyti
Diffuse firm
c infiltrate,
rubbery
Autoimmune germinal centers,
Hashimoto enlargement Destructive autoimmune
destructive Hürthle cell
thyroiditis or late hypothyroid pattern
thyroiditis change, follicular
atrophic
destruction,
gland
fibrosis

Variably sized
Nodular follicles, colloid
Toxic Multinodular
hyperfunctionin nodules, Multinodular rather than
multinodular enlarged
g thyroid hyperplastic foci, diffuse pattern
goiter thyroid
disease hemorrhage,
fibrosis

Solitary Single Follicular adenoma

Toxic
autonomous circumscribe or hyperplastic Localized autonomous
follicular
hyperfunctionin d nodule with nodule nodule
adenoma
g nodule suppressed morphology
 Gross / Key
Disease Main Pattern Structural Histopathological Distinguishing Feature
Pattern Finding

surrounding
thyroid

Disrupted follicles,
Focal or
Subacute Destructive colloid
asymmetric Granulomatous destructive
granulomatou granulomatous granulomas,
firm thyroid thyroiditis
s thyroiditis thyroiditis multinucleated
involvement
giant cells

Self-limited Mild Lymphocytic

Painless
autoimmune enlargement infiltration without Transient destructive
lymphocytic
lymphocytic or grossly classic Graves thyrotoxicosis
thyroiditis
thyroiditis subtle gland hyperplasia

Papillae with
Papillary Malignant Infiltrative or
fibrovascular cores Papillary carcinoma nuclei
thyroid follicular nodular
and diagnostic and invasive tumor
carcinoma epithelial tumor carcinoma
nuclear features

Impaired
hormone
Follicular
Iodine synthesis with Diffuse or Low iodine-driven thyroid-
hyperplasia and
deficiency thyroid- multinodular stimulating hormone
colloid changes
goiter stimulating goiter elevation
depending on stage
hormone
stimulation
PAPILLARY THYROID CARCINOMA

Papillary thyroid carcinoma is the most common malignant tumor of the thyroid gland and the
most frequent thyroid carcinoma derived from follicular epithelial cells. It is a well-
differentiated thyroid carcinoma defined primarily by its characteristic nuclear features, even
when fully developed papillary architecture is absent. The tumor often spreads through
lymphatics and commonly metastasizes to cervical lymph nodes.

The essential pathological identity of papillary thyroid carcinoma is a follicular cell-derived

malignant epithelial tumor with papillary or follicular architecture and distinctive nuclear
morphology. The diagnostic nuclear features include optically clear nuclei, nuclear grooves,
nuclear overlap, and intranuclear pseudoinclusions. Psammoma bodies are common and are
especially associated with papillary structures.

The pathology-relevant deep features include hypoechoic solid thyroid nodule containing
microcalcifications, central cervical lymphadenopathy, infiltrative tumor mass
compressing the surrounding soft tissues, metastatic involvement of the cervical lymph
nodes, complex papillary structures with fibrovascular cores, optically clear “Orphan
Annie eye” nuclei, nuclear overlap, nuclear grooves, psammoma body formation, and the
diagnostic entity Papillary thyroid carcinoma.

Etiology

The most important environmental risk factor for papillary thyroid carcinoma is ionizing
radiation, especially exposure during childhood or adolescence. Radiation-associated tumors
often show rearrangements involving genes that activate mitogen-activated protein kinase
signaling.

At the molecular level, papillary thyroid carcinoma is driven mainly by constitutive activation
of the mitogen-activated protein kinase pathway. This pathway promotes follicular epithelial
cell proliferation, survival, and altered differentiation.

Important molecular alterations include B-Raf proto-oncogene serine/threonine kinase gene

mutation, most commonly BRAF V600E; rearrangements involving rearranged during
transfection proto-oncogene (RET) producing RET/PTC fusions; neurotrophic receptor
tyrosine kinase gene fusions; and RAS gene mutations. These alterations tend to be mutually
exclusive because each activates overlapping growth-signaling pathways.
BRAF V600E mutation is common in classic papillary thyroid carcinoma and is associated with
activation of downstream mitogen-activated protein kinase kinase and extracellular signal-
regulated kinase signaling. RET/PTC rearrangements are more common in radiation-associated
tumors and in some younger patients. RAS mutations are more often encountered in follicular-
patterned variants.

The etiologic formulation is therefore: follicular epithelial cell transformation driven by

mitogen-activated protein kinase pathway activation, often through BRAF mutation, RET/PTC
rearrangement, neurotrophic receptor tyrosine kinase fusion, or RAS mutation, with ionizing
radiation as an important environmental risk factor.

Pathogenesis

The central pathogenic event is constitutive activation of signaling pathways that normally
regulate thyroid follicular epithelial growth and differentiation. In papillary thyroid carcinoma,
abnormal activation of the mitogen-activated protein kinase pathway promotes sustained
proliferation and survival of follicular epithelial cells.

BRAF mutation produces ligand-independent signaling through the mitogen-activated protein

kinase pathway. RET/PTC and neurotrophic receptor tyrosine kinase fusions create
constitutively active tyrosine kinase fusion proteins. RAS mutations activate downstream
signaling pathways involved in proliferation and differentiation.

These molecular alterations produce a malignant follicular epithelial clone with characteristic
nuclear clearing and architectural abnormalities. The tumor may grow as papillae with
fibrovascular cores, follicles, solid nests, or mixed patterns. Lymphatic invasion is common,
explaining the frequent involvement of cervical lymph nodes. Hematogenous spread is less
common than in follicular thyroid carcinoma.

Psammoma bodies develop from calcification within papillary cores, often related to necrotic
or degenerating papillary tips. Their presence supports papillary carcinoma, especially when
associated with the characteristic nuclear morphology.

The major pathological sequence is:

mitogen-activated protein kinase pathway activation → follicular epithelial malignant

transformation → papillary and/or follicular tumor architecture → diagnostic nuclear changes
→ lymphatic invasion → cervical lymph node metastasis.
The essential pathogenic concept is that papillary thyroid carcinoma is defined more by its
nuclear morphology and molecular pathway activation than by papillary architecture alone.

Macroscopic Findings

Grossly, papillary thyroid carcinoma may be solitary or multifocal. Tumors may be well
circumscribed, partially encapsulated, or infiltrative. The cut surface is often firm, gray-white,
granular, or scar-like. Small tumors may be difficult to identify grossly, whereas larger tumors
may distort the thyroid lobe.

The tumor may contain calcifications, corresponding to microcalcifications radiologically and

psammoma bodies microscopically. Cystic change may occur, especially in some papillary
tumors.

In advanced local disease, the tumor may form an infiltrative tumor mass compressing the
surrounding soft tissues. Extrathyroidal extension may involve perithyroidal soft tissue,
skeletal muscle, trachea, or other neck structures. Lymph node metastases may be present,
corresponding to metastatic involvement of the cervical lymph nodes.

Gross cervical lymph node involvement may appear as enlarged, firm, gray-white nodal
deposits. Some metastatic foci may be cystic, especially in papillary thyroid carcinoma.

The classical gross pathological impression is a firm, gray-white, often infiltrative or multifocal
thyroid tumor with possible calcification and frequent cervical lymph node metastasis.

Histopathological Findings

Histologically, papillary thyroid carcinoma shows malignant follicular epithelial cells arranged
in papillary, follicular, solid, or mixed patterns. The most characteristic architectural pattern
consists of complex papillary structures with fibrovascular cores. These papillae are lined
by one or more layers of neoplastic follicular epithelial cells.

The most important diagnostic features are nuclear. Tumor cell nuclei show optically clear
“Orphan Annie eye” nuclei caused by finely dispersed chromatin. The nuclei also show
nuclear overlap and nuclear grooves. Intranuclear cytoplasmic pseudoinclusions may also be
present and are highly supportive.

Psammoma bodies are concentrically laminated calcified structures. The deep pathology-
relevant histopathological feature is psammoma body formation. Psammoma bodies are
usually located within papillary cores or adjacent stroma and are uncommon in follicular and
medullary thyroid carcinomas.

The tumor may invade lymphatics. Lymphatic invasion explains the frequency of cervical
lymph node metastasis. Blood vessel invasion is less characteristic than in follicular carcinoma.

Immunohistochemistry may support thyroid follicular origin. Tumor cells commonly express
thyroglobulin, thyroid transcription factor-1, and paired box gene 8. BRAF V600E
immunohistochemistry may be positive in tumors harboring the mutation. However, the central
diagnostic basis remains the characteristic nuclear morphology.

The concise histopathological formulation is:

follicular epithelial carcinoma with complex papillary structures with fibrovascular cores,
optically clear “Orphan Annie eye” nuclei, nuclear overlap, nuclear grooves, and
psammoma body formation, with frequent lymphatic spread to cervical lymph nodes;
diagnostic entity: Papillary thyroid carcinoma.

Differential Diagnosis

Follicular adenoma is a benign encapsulated follicular neoplasm. It is composed of well-

differentiated follicles and lacks capsular invasion, vascular invasion, and the nuclear features
of papillary thyroid carcinoma. The absence of papillary carcinoma-type nuclei is crucial.

Follicular carcinoma is a malignant follicular epithelial tumor defined by capsular and/or

vascular invasion. It usually spreads hematogenously and lacks the classic papillary nuclear
features and psammoma bodies. Papillary carcinoma more commonly spreads through
lymphatics.

Medullary thyroid carcinoma arises from parafollicular C cells rather than follicular cells. It
expresses calcitonin and may show amyloid stroma derived from altered calcitonin molecules.
Papillary thyroid carcinoma expresses follicular markers such as thyroglobulin and shows
papillary-type nuclear features.

Anaplastic thyroid carcinoma is an undifferentiated highly aggressive carcinoma composed of

pleomorphic giant cells, spindle cells, or squamoid cells. It lacks the differentiated nuclear and
architectural pattern of papillary thyroid carcinoma.

Hashimoto thyroiditis may produce firm thyroid enlargement and lymphoid infiltrates, and it
may coexist with papillary thyroid carcinoma. Hashimoto thyroiditis shows lymphoplasmacytic
inflammation, Hürthle cell metaplasia, follicular destruction, and germinal centers, not
malignant papillary structures with diagnostic nuclei.

Key
Main Site / Gross / Structural Distinguishing
Disease Histopathological
Distribution Pattern Feature
Finding

Hypoechoic solid
thyroid nodule Complex papillary
containing structures with
microcalcifications, fibrovascular cores, Follicular cell-
Thyroid
central cervical optically clear derived
Papillary follicular
lymphadenopathy, “Orphan Annie carcinoma with
thyroid epithelium;
infiltrative tumor eye” nuclei, nuclear diagnostic
carcinoma cervical lymph
mass compressing the overlap, nuclear papillary-type
nodes common
surrounding soft grooves, nuclear features
tissues, metastatic psammoma body
involvement of the formation
cervical lymph nodes

Microfollicular or Encapsulation
Thyroid
Follicular Solitary encapsulated normofollicular without capsular
follicular
adenoma nodule benign neoplasm or vascular
epithelium
without invasion invasion

Hematogenous
Thyroid Encapsulated or spread and
Follicular Capsular and/or
follicular infiltrative follicular absence of
carcinoma vascular invasion
epithelium tumor classic papillary
nuclei

Medullary Nests/trabeculae of Calcitonin-

Parafollicular C Solitary or multifocal
thyroid neuroendocrine cells positive C-cell
cells thyroid mass
carcinoma with amyloid stroma tumor
 Key
Main Site / Gross / Structural Distinguishing
Disease Histopathological
Distribution Pattern Feature
Finding

Anaplastic Dedifferentiated Pleomorphic giant, Undifferentiated

Large invasive
thyroid thyroid spindle, or squamoid highly aggressive
destructive neck mass
carcinoma carcinoma malignant cells carcinoma

Lymphoid follicles, Autoimmune

Hashimoto Thyroid Diffuse firm thyroid
Hürthle cell change, thyroiditis rather
thyroiditis parenchyma enlargement or atrophy
follicular destruction than carcinoma
RESTRICTIVE CARDIOMYOPATHY / CARDIAC AMYLOIDOSIS

Restrictive cardiomyopathy is a myocardial disease characterized by impaired ventricular

filling due to reduced ventricular compliance. In restrictive physiology, systolic function may
be relatively preserved early, but diastolic filling is severely restricted because the ventricular
myocardium is stiff. Cardiac amyloidosis is one of the most important infiltrative causes of
restrictive cardiomyopathy.

Cardiac amyloidosis results from extracellular deposition of amyloid proteins within the
myocardium, endocardium, valves, intramural vessels, and conduction system. Amyloid
proteins share a common beta-pleated sheet configuration, producing characteristic staining and
ultrastructural properties. In the heart, amyloid deposition causes myocardial stiffness,
conduction abnormalities, arrhythmias, and progressive heart failure.

The pathology-relevant deep features include marked diastolic dysfunction, ventricular wall
thickening, diffuse infiltrative myocardial involvement, marked firmness and a waxy
appearance of the myocardium, Congo red staining reveals apple-green birefringence
under polarized light within extracellular deposits, and the characteristic ultrastructural
finding Nonbranching fibrillar protein deposits.

Etiology

Cardiac amyloidosis may occur as part of systemic amyloidosis or as a predominantly cardiac

amyloid disease. The two major categories are immunoglobulin light chain amyloidosis and
transthyretin amyloidosis.

Immunoglobulin light chain amyloidosis is caused by a clonal plasma cell disorder that
produces misfolded immunoglobulin light chains. These light chains circulate, misfold,
aggregate, and deposit as amyloid fibrils. In the heart, light chain amyloid can produce severe
restrictive cardiomyopathy and may also be directly cardiotoxic.

Transthyretin amyloidosis results from deposition of transthyretin, a transport protein

synthesized mainly by the liver. It may be hereditary, caused by mutant transthyretin, or age-
related, caused by deposition of wild-type transthyretin. Transthyretin amyloidosis often has
prominent cardiac involvement.

Other amyloid types can involve the heart less commonly, depending on systemic disease
context. The unifying etiologic principle is protein misfolding with formation of insoluble
extracellular amyloid fibrils.
Pathogenesis

The central pathogenic event is extracellular amyloid deposition in cardiac tissue. Misfolded
precursor proteins adopt a beta-pleated sheet-rich conformation and aggregate into fibrils.
These fibrils accumulate between cardiac myocytes, within the interstitium, around vessels, and
sometimes in valves and endocardium.

Amyloid expands the interstitium and separates cardiac myocytes. This reduces myocardial
compliance and produces restrictive ventricular filling. The ventricles become stiff and
noncompliant, resulting in elevated filling pressures and atrial dilation. The ventricular cavities
are usually not markedly dilated.

Amyloid infiltration of intramural coronary vessels may cause microvascular ischemia.

Involvement of the conduction system may cause arrhythmias or conduction block. Progressive
myocyte atrophy and interstitial expansion contribute to heart failure.

The major pathological sequence is:

misfolded amyloidogenic precursor protein → beta-pleated sheet fibril formation →

extracellular myocardial deposition → interstitial expansion and myocardial stiffening →
impaired diastolic filling → restrictive cardiomyopathy and heart failure.

The essential pathogenic concept is that cardiac amyloidosis produces restrictive

cardiomyopathy by extracellular infiltration, not by primary myocyte hypertrophy, myocyte
disarray, or ventricular chamber dilation.

Macroscopic Findings

Grossly, the heart may be enlarged or of near-normal size, depending on the extent of amyloid
deposition. The ventricular walls often appear thickened, but the thickening reflects infiltrative
amyloid expansion rather than true hypertrophic cardiomyopathy. The ventricular cavities are
usually normal or small rather than dilated.

The myocardium may show marked firmness and a waxy appearance. The cut surface can
be pale, tan, rubbery, or waxy. The atria are often dilated because restricted ventricular filling
increases atrial pressure.

Valves may be thickened by amyloid deposition. The endocardium may appear thickened in
some cases. Small intramyocardial vessels may also be involved.
The classical gross pathological impression is a stiff, waxy, firm heart with thickened
ventricular walls and nondilated cavities, often with atrial dilation.

Histopathological Findings

Histologically, cardiac amyloidosis shows extracellular deposits of amorphous, pale

eosinophilic material in the myocardial interstitium. Deposits surround and separate cardiac
myocytes. With increasing deposition, myocytes become compressed and atrophic.

Amyloid may also deposit in the walls of intramural vessels, causing luminal narrowing and
vascular fragility. Valvular and endocardial deposits may be present. The conduction system
may be affected, although it is not always sampled histologically.

Routine hematoxylin and eosin staining shows amorphous extracellular material, but special
staining is essential. Congo red staining reveals apple-green birefringence under polarized
light within extracellular deposits. This is the defining histochemical feature of amyloid.

Typing of amyloid is important. Immunohistochemistry, immunofluorescence, mass

spectrometry-based proteomic analysis, or other specialized methods may identify
immunoglobulin light chain amyloid, transthyretin amyloid, or other amyloid proteins.

The concise histopathological formulation is:

extracellular myocardial amyloid deposition separating and compressing cardiac myocytes,

with Congo red positivity and apple-green birefringence under polarized light, producing
restrictive cardiomyopathy.

Electron Microscopic Findings

Electron microscopy demonstrates Nonbranching fibrillar protein deposits. Amyloid fibrils

are extracellular, randomly arranged, nonbranching fibrils, classically approximately 7–10 nm
in diameter.

This ultrastructural feature directly corresponds to the Congo red-positive extracellular deposits
seen by light microscopy. The combination of Congo red apple-green birefringence and
extracellular nonbranching fibrils is the classic morphologic confirmation of amyloid.

Differential Diagnosis

Hypertrophic cardiomyopathy may show ventricular wall thickening and diastolic dysfunction,
but the histological hallmark is myocyte hypertrophy with myofiber disarray and interstitial
fibrosis. Cardiac amyloidosis shows extracellular amyloid deposits rather than primary myocyte
disarray.

Hypertensive heart disease produces concentric left ventricular hypertrophy due to pressure
overload. Myocytes are hypertrophic, and interstitial fibrosis may be present. The myocardium
does not show Congo red-positive amyloid deposits.

Endomyocardial fibrosis causes restrictive physiology due to dense endocardial and

subendocardial fibrosis, often involving ventricular apices and atrioventricular valves. It lacks
systemic amyloid-type deposits and Congo red birefringence.

Loeffler endomyocarditis produces endocardial damage, mural thrombosis, and fibrosis

associated with eosinophilic infiltration and eosinophil-mediated toxicity. It differs from
amyloidosis by its eosinophil-rich inflammatory and thrombotic pattern.

Sarcoidosis can produce restrictive or arrhythmogenic cardiac disease, but histology shows
noncaseating granulomas and fibrosis, not amyloid fibril deposition.

Hemochromatosis may cause restrictive or dilated cardiomyopathy due to iron deposition.

Prussian blue stain demonstrates iron within myocytes. Congo red-positive amyloid is absent.

Gross / Key
Main Pathological Distinguishing
Disease Structural Histopathologic
Process Feature
Pattern al Finding

Ventricular
wall
Congo red
thickening,
staining reveals
Cardiac diffuse
apple-green EM:
amyloidosis / infiltrative
Extracellular amyloid birefringence Nonbranching
restrictive myocardial
deposition in myocardium under polarized fibrillar protein
cardiomyopath involvemen
light within deposits
y t, marked
extracellular
firmness
deposits
and a waxy
appearance
 Gross / Key
Main Pathological Distinguishing
Disease Structural Histopathologic
Process Feature
Pattern al Finding

Asymmetric Myocyte
septal hypertrophy, Myocyte
Hypertrophic Sarcomeric hypertrophic hypertrophy myofiber disarray rather
cardiomyopathy disease or disarray, than amyloid
concentric interstitial deposition
hypertrophy fibrosis

Hypertension-
Concentric Myocyte
associated
Hypertensive Pressure overload left hypertrophy and
hypertrophy
heart disease hypertrophy ventricular interstitial
without Congo
hypertrophy fibrosis
red deposits

Apical
ventricular Dense Fibrotic
Endomyocardial Endocardial/subendocardi fibrosis, endocardial and endocardial
fibrosis al fibrosis reduced subendocardial disease rather
chamber fibrosis than amyloid
compliance

Eosinophilic
Endocardial
inflammation, Hypereosinophil
Loeffler Eosinophil-mediated fibrosis and
necrosis, ic endocardial
endomyocarditis endocardial injury mural
thrombosis, disease
thrombi
fibrosis

Patchy
Noncaseating Granulomas
Cardiac Granulomatous myocardial
granulomas with rather than
sarcoidosis myocardial disease scars or
fibrosis amyloid fibrils
nodules
 Gross / Key
Main Pathological Distinguishing
Disease Structural Histopathologic
Process Feature
Pattern al Finding

Brown firm
myocardium
Hemochromatos Iron deposition in Iron deposition in Prussian blue-
, possible
is myocardium myocytes positive iron
cardiomegal
y
OSTEOSARCOMA

Osteosarcoma is a malignant bone-forming tumor in which malignant mesenchymal tumor cells

produce osteoid or immature bone. Excluding hematopoietic malignancies, it is the most
common primary malignant tumor of bone. The defining diagnostic feature is not merely a bone
mass or sarcomatous cytology, but direct production of malignant osteoid by tumor cells.

The tumor most commonly arises in the metaphysis of long bones, especially around the knee
region, including the distal femur and proximal tibia. It is an aggressive tumor that destroys
cortex, invades surrounding soft tissue, and frequently metastasizes hematogenously to the
lungs.

The pathology-relevant deep features include distal femoral metaphysis, aggressive

destructive bone lesion with periosteal elevation and Codman triangle formation, gray-
white tumor arising from the distal femoral metaphysis, cortical destruction and invasion
into adjacent soft tissues, bilateral pulmonary metastases, SATB2 positivity, and the
diagnostic histopathological feature Malignant osteoid production between pleomorphic
tumor cells.

Etiology

Most osteosarcomas are primary and arise without a recognized preexisting bone disease. Their
development is linked to genetic instability and disruption of tumor suppressor pathways
regulating osteoblast-lineage cells.

Retinoblastoma protein pathway disruption is important. Germline mutation of the

retinoblastoma 1 gene greatly increases osteosarcoma risk, and somatic retinoblastoma pathway
abnormalities are common in sporadic tumors. Tumor protein p53 pathway abnormalities are
also frequent. Germline TP53 mutation in Li-Fraumeni syndrome predisposes strongly to
osteosarcoma.

Other molecular changes include amplification or overexpression of mouse double minute 2

homolog (MDM2) and cyclin-dependent kinase 4 (CDK4) in some low-grade osteosarcomas,
inactivation of cyclin-dependent kinase inhibitor 2A (CDKN2A), and MYC amplification in a
subset of aggressive tumors.

Secondary osteosarcoma may arise in preexisting bone disease or damaged bone. Predisposing
settings include Paget disease of bone, prior radiation exposure, bone infarcts, chronic
osteomyelitis, and certain skeletal dysplasias. Secondary osteosarcomas often occur in older
individuals and may behave aggressively.

The etiologic formulation is therefore: malignant transformation of osteoblast-lineage

mesenchymal cells through genomic instability and tumor suppressor pathway disruption, with
secondary cases arising in abnormal or previously damaged bone.

Pathogenesis

The central pathogenic event is malignant transformation of osteoblast-forming mesenchymal

cells. These cells acquire genetic alterations that permit uncontrolled proliferation, invasion,
and production of osteoid matrix.

Retinoblastoma protein loss disrupts cell-cycle control at the G1-S checkpoint. TP53
dysfunction impairs DNA damage response and apoptosis. Together, these changes permit
accumulation of chromosomal abnormalities and highly anaplastic sarcomatous growth.

The malignant cells retain the ability to produce osteoid, but the osteoid is abnormal, irregular,
and deposited directly by tumor cells. This is the core diagnostic feature. The tumor may also
produce cartilage or fibrous matrix in some variants, but malignant osteoid production is
required for diagnosis.

As the tumor expands in the medullary cavity, it infiltrates and replaces marrow. It destroys
cortical bone and elevates the periosteum. Reactive subperiosteal bone formation at the edge of
periosteal elevation produces the Codman triangle. The tumor extends into adjacent soft tissue
and metastasizes hematogenously, especially to lungs.

The major pathological sequence is:

genetic instability in osteoblast-lineage mesenchymal cells → malignant sarcomatous

proliferation → direct malignant osteoid production → medullary expansion and cortical
destruction → periosteal elevation and soft tissue invasion → hematogenous pulmonary
metastasis.

The essential pathogenic concept is that osteosarcoma is a matrix-defining sarcoma: malignant

osteoid produced directly by atypical tumor cells establishes the diagnosis.

Macroscopic Findings
Grossly, conventional osteosarcoma is a bulky destructive bone tumor. It often arises in the
metaphysis of long bones. The deep pathology-relevant location is distal femoral metaphysis.

The tumor is typically gray-white, tan-white, gritty, and firm because of osteoid and bone
production, but it may also contain soft fleshy areas. Hemorrhage and necrosis are common.
The final gross pattern includes gray-white tumor arising from the distal femoral
metaphysis.

The tumor expands through the medullary cavity and destroys surrounding cortex. The deep
pathology-relevant invasive gross features are cortical destruction and invasion into
adjacent soft tissues. Periosteal elevation produces the radiologic-gross correlate Codman
triangle formation.

The tumor may extend along the medullary canal and into soft tissue. It can occasionally cross
the growth plate, but classic metaphyseal location is typical. Hematogenous spread to the lung
is common, corresponding to bilateral pulmonary metastases in advanced disease.

The classical gross pathological picture is a destructive, gritty, gray-white metaphyseal bone
tumor with cortical destruction, periosteal elevation, soft tissue invasion, hemorrhage, necrosis,
and pulmonary metastases.

Histopathological Findings

Histologically, osteosarcoma is composed of malignant mesenchymal cells producing osteoid.

Tumor cells are pleomorphic, hyperchromatic, and mitotically active. Bizarre tumor giant cells
and atypical mitoses may be present.

The essential histopathological feature is Malignant osteoid production between

pleomorphic tumor cells. The osteoid appears as irregular eosinophilic lace-like or trabecular
matrix deposited directly by malignant tumor cells. This matrix may become mineralized and
form malignant woven bone.

Tumor architecture varies. Osteoblastic osteosarcoma shows abundant osteoid and bone.
Chondroblastic osteosarcoma contains malignant cartilage in addition to osteoid. Fibroblastic
osteosarcoma contains spindle cell sarcoma-like areas but still produces malignant osteoid.
Telangiectatic osteosarcoma contains blood-filled spaces and may resemble aneurysmal bone
cyst, but its septa contain malignant cells and osteoid.
Immunohistochemistry may support osteoblastic differentiation. The deep pathology-relevant
marker is SATB2 positivity. Special AT-rich sequence-binding protein 2 is a nuclear
transcription factor associated with osteoblastic differentiation and is useful as supportive
evidence in osteogenic tumors. It is not a substitute for identifying malignant osteoid, but it
supports osteoblastic lineage.

The concise histopathological formulation is:

high-grade malignant mesenchymal tumor composed of pleomorphic cells with atypical

mitoses and Malignant osteoid production between pleomorphic tumor cells, often with
SATB2 positivity, cortical destruction, soft tissue invasion, and hematogenous pulmonary
metastasis.

Differential Diagnosis

Ewing sarcoma is a malignant small round cell tumor usually involving the diaphysis of long
bones. It is composed of uniform primitive small round cells and is driven by EWSR1-
associated fusion, most commonly EWSR1-FLI1. It does not produce malignant osteoid.
Homer-Wright rosettes may occur in some cases.

Fibrous dysplasia shows irregular woven bone trabeculae within bland fibrous stroma. The
trabeculae are benign and are not produced by pleomorphic malignant tumor cells. Fibrous
dysplasia lacks destructive sarcomatous growth and malignant osteoid.

Giant cell tumor of bone usually arises in the epiphysis of long bones and is composed of
mononuclear stromal cells admixed with numerous osteoclast-like giant cells. It does not show
malignant osteoid production by pleomorphic sarcoma cells.

Chondrosarcoma is a malignant cartilage-producing tumor. It shows atypical chondrocytes

within cartilaginous matrix. The defining matrix is cartilage rather than osteoid. In
chondroblastic osteosarcoma, malignant osteoid must still be present.

Aneurysmal bone cyst is a benign expansile lesion containing blood-filled spaces separated by
fibrous septa with giant cells. Telangiectatic osteosarcoma may mimic it grossly and
radiologically, but telangiectatic osteosarcoma contains malignant cells and malignant osteoid
in the septa.
Osteomyelitis may produce bone destruction, periosteal reaction, and reactive bone formation,
but it shows acute or chronic inflammation, necrotic bone, sequestrum, involucrum, and
organisms in some cases. It lacks malignant pleomorphic osteoid-producing tumor cells.

Key
Main Site / Gross / Structural Distinguishing
Disease Histopathological
Distribution Pattern Feature
Finding

Aggressive
destructive bone
lesion with
periosteal
elevation and
Codman triangle
Malignant osteoid
formation; gray-
Distal femoral production between
white tumor
metaphysis pleomorphic tumor Malignant
arising from the
Osteosarcoma and other long cells; SATB2 bone-forming
distal femoral
bone positivity supports sarcoma
metaphysis;
metaphyses osteoblastic
cortical
differentiation
destruction and
invasion into
adjacent soft
tissues; bilateral
pulmonary
metastases

Diaphysis of Medullary EWSR1 fusion

Sheets of uniform
long bones, destructive tumor tumor without
Ewing sarcoma primitive small round
pelvis, soft with onion-skin malignant
cells
tissue periosteal reaction osteoid

Irregular woven bone

Fibrous Rib, Expansile ground- Benign fibro-
trabeculae in bland
dysplasia craniofacial glass bone lesion osseous lesion
fibrous stroma
 Key
Main Site / Gross / Structural Distinguishing
Disease Histopathological
Distribution Pattern Feature
Finding

bones, femur,
tibia

Mononuclear stromal Giant cell-rich

Epiphysis of Lytic expansile
Giant cell tumor cells with osteoclast- epiphyseal
long bones epiphyseal lesion
like giant cells tumor

Pelvis, ribs, Malignant cartilage Cartilage-

Lobulated
Chondrosarcoma shoulder, long production by producing
cartilaginous mass
bones atypical chondrocytes sarcoma

Benign cystic
Blood-filled spaces
Aneurysmal Long bones, Expansile blood- lesion lacking
with fibrous septa and
bone cyst vertebrae filled cystic lesion malignant
giant cells
osteoid

Any bone,
Infectious
often Bone destruction, Suppurative or
inflammation
Osteomyelitis metaphysis in sequestrum, chronic inflammatory
rather than
hematogenous involucrum bone destruction
sarcoma
infection
KAWASAKI DISEASE

Kawasaki disease is an acute, self-limited, medium-vessel vasculitis with a strong predilection

for coronary arteries. It is also called mucocutaneous lymph node syndrome because of its
characteristic mucocutaneous inflammation and lymph node involvement. In pathology, its
greatest importance is coronary arteritis with risk of aneurysm formation, thrombosis,
myocardial ischemia, myocardial infarction, and sudden death.

The disease affects medium-sized muscular arteries, especially coronary arteries, but other
arteries may also be involved. The dominant lesion is a necrotizing arteritis that damages the
vascular wall. Healing may produce intimal thickening, stenosis, or aneurysmal remodeling.

The pathology-relevant deep features include coronary artery dilatation with saccular
aneurysmal enlargement, coronary artery thrombosis and acute myocardial ischemia,
marked structural disruption of the vessel wall, fragmentation of the internal elastic
lamina on elastic tissue stains, dense CD68-positive inflammatory cell infiltration within
the vascular wall, and the characteristic lesion Transmural necrotizing arteritis involving
the coronary arteries.

Etiology

The precise etiology of Kawasaki disease is unknown. The leading concept is that an abnormal
immune response is triggered by an infectious or environmental stimulus in genetically
susceptible individuals. No single pathogen has been established as the universal cause.

Genetic susceptibility is supported by familial clustering and increased incidence in some

populations. Genes involved in immune regulation, inflammatory signaling, and vascular
response may influence disease risk and severity.

The triggering stimulus is thought to activate innate and adaptive immune pathways. The
resulting immune response targets medium-sized arteries, with special predilection for coronary
arteries. The disease is not a lipid-driven atherosclerotic disease, not an immune complex
vasculitis in the classic sense, and not a granulomatous arteritis.

The etiologic formulation is therefore: genetically susceptible host, probable infectious or

environmental trigger, dysregulated immune activation, and acute necrotizing inflammation of
medium-sized arteries, especially coronary arteries.

Pathogenesis
The central pathogenic process is immune-mediated injury of medium-sized arterial walls. In
the early phase, endothelial activation and inflammatory cell recruitment occur. Monocytes,
macrophages, neutrophils, lymphocytes, and other immune cells infiltrate the vessel wall.

Macrophage-rich inflammation contributes to destruction of the media and elastic lamina. The
deep pathology-relevant immunophenotypic clue is dense CD68-positive inflammatory cell
infiltration within the vascular wall, reflecting abundant macrophages and histiocytes. Elastic
tissue injury produces fragmentation of the internal elastic lamina on elastic tissue stains.

As the inflammatory injury becomes transmural, the full thickness of the artery wall is damaged.
The deep pathology-relevant core lesion is Transmural necrotizing arteritis involving the
coronary arteries. Destruction of the media weakens the vessel wall and predisposes to
aneurysm formation. Endothelial injury and turbulent flow in aneurysmal segments promote
thrombosis.

Coronary thrombosis can occlude the lumen and produce myocardial ischemia or infarction.
Healing may lead to intimal proliferation, fibrosis, stenosis, calcification, or persistent
aneurysmal dilation.

The major pathological sequence is:

immune-mediated medium-vessel arteritis → transmural inflammatory wall injury → elastic

lamina fragmentation and medial destruction → coronary aneurysm formation → thrombosis
or stenosis → myocardial ischemia or infarction.

The essential pathogenic concept is that Kawasaki disease is a coronary-predominant

necrotizing medium-vessel vasculitis whose major morbidity results from arterial wall
destruction and aneurysmal-thrombotic complications.

Macroscopic Findings

Grossly, the most important lesions involve coronary arteries. The coronary arteries may show
dilation, aneurysm formation, thrombosis, or stenosis. The deep pathology-relevant gross
vascular lesion is coronary artery dilatation with saccular aneurysmal enlargement.

Aneurysms may be single or multiple and can involve proximal coronary segments. The vessel
wall may appear thickened, inflamed, or weakened. In fatal cases, thrombi may be present
within aneurysmal segments, corresponding to coronary artery thrombosis and acute
myocardial ischemia.
The myocardium may show ischemic injury or infarction depending on the degree and duration
of coronary obstruction. Acute infarcts may be pale or hemorrhagic depending on timing and
reperfusion. Chronic cases may show fibrous myocardial scars.

Other medium-sized arteries can be involved, but gross pathology outside the cardiovascular
system is usually less significant than the coronary lesions. Healing may produce obstructive
intimal thickening and vascular remodeling.

The classical gross pathological picture is coronary arteritis with aneurysmal dilation, luminal
thrombosis, and myocardial ischemic injury.

Histopathological Findings

Histologically, Kawasaki disease shows necrotizing arteritis of medium-sized arteries,

especially coronary arteries. The deep pathology-relevant diagnostic lesion is Transmural
necrotizing arteritis involving the coronary arteries.

The arterial wall shows inflammatory infiltration involving intima, media, and adventitia. Early
lesions may contain neutrophils, monocytes, macrophages, and lymphocytes. The inflammation
damages smooth muscle cells and elastic tissue. Necrosis of the media weakens the wall.

Elastic stains demonstrate fragmentation of the internal elastic lamina on elastic tissue
stains. The internal elastic lamina may be disrupted, fragmented, or lost in involved segments.
This structural disruption is central to aneurysm formation.

The vessel wall may show marked structural disruption of the vessel wall due to necrosis,
inflammation, and elastic tissue damage. Macrophage-rich inflammation may be highlighted
by CD68, corresponding to dense CD68-positive inflammatory cell infiltration within the
vascular wall.

Thrombosis may develop within aneurysmal or damaged coronary segments. Organization of

thrombi and healing of arteritis may lead to intimal thickening and luminal stenosis. Chronic
lesions may show fibrosis, calcification, and remodeling of the arterial wall.

The concise histopathological formulation is:

acute to subacute Transmural necrotizing arteritis involving the coronary arteries, with
inflammatory destruction of the media, fragmentation of the internal elastic lamina on
elastic tissue stains, macrophage-rich CD68-positive inflammatory cell infiltration,
aneurysmal wall weakening, thrombosis, and healing by intimal thickening and fibrosis.
Differential Diagnosis

Polyarteritis nodosa is a necrotizing vasculitis of medium-sized muscular arteries and may

involve coronary arteries. However, it more often affects renal, gastrointestinal, hepatic, and
peripheral nerve arteries, and lesions are segmental and of different ages. Kawasaki disease is
coronary-predominant and has a mucocutaneous lymph node syndrome context.

Takayasu arteritis is a granulomatous large-vessel vasculitis affecting the aorta and major
branches. It shows granulomatous inflammation with giant cells and chronic wall thickening.
Kawasaki disease affects medium-sized arteries, especially coronary arteries, and shows
necrotizing arteritis rather than granulomatous aortitis.

Microscopic polyangiitis affects capillaries, venules, arterioles, and small arteries. It produces
pauci-immune necrotizing small-vessel vasculitis, glomerulonephritis, and pulmonary
capillaritis. Kawasaki disease is a medium-vessel coronary arteritis.

Leukocytoclastic vasculitis affects small dermal vessels, especially postcapillary venules. It

shows neutrophilic debris and fibrinoid necrosis in small vessels. It does not produce coronary
aneurysms as the defining lesion.

Atherosclerotic coronary artery disease produces intimal fibrofatty plaques, plaque rupture,
thrombosis, and myocardial infarction. It lacks the acute transmural necrotizing arteritis and
elastic lamina destruction typical of Kawasaki disease.

Infectious coronary arteritis or mycotic aneurysm may cause vascular destruction and
thrombosis but is associated with organisms, suppurative inflammation, septic emboli, or
adjacent infection. Kawasaki disease is immune-mediated and sterile in standard pathology
interpretation.
 Gross /
Main Vessel / Key Histopathological Distinguishing
Disease Structural
Site Finding Feature
Pattern

Transmural necrotizing
Coronary
arteritis involving the
artery
coronary arteries,
dilatation with
marked structural Coronary-
Coronary saccular
disruption of the vessel predominant
arteries and aneurysmal
Kawasaki wall, fragmentation of medium-vessel
other enlargement,
disease the internal elastic vasculitis with
medium- coronary artery
lamina on elastic tissue aneurysm and
sized arteries thrombosis and
stains, dense CD68- thrombosis risk
acute
positive inflammatory
myocardial
cell infiltration within
ischemia
the vascular wall

Medium- Systemic
Segmental
sized Transmural necrotizing medium-vessel
Polyarteritis aneurysms,
muscular arteritis with fibrinoid vasculitis with
nodosa thrombosis,
arteries, often necrosis lesions of
infarcts
visceral different ages

Aorta and Large-vessel Granulomatous Large-vessel

Takayasu
major stenosis and wall transmural arteritis with granulomatous
arteritis
branches thickening giant cells arteritis

Small-vessel
antineutrophil
Pulmonary-renal Pauci-immune
Microscopic cytoplasmic
Small vessels small-vessel necrotizing small-vessel
polyangiitis antibody-
disease vasculitis
associated
vasculitis
 Gross /
Main Vessel / Key Histopathological Distinguishing
Disease Structural
Site Finding Feature
Pattern

Neutrophilic small-
Leukocytoclastic Postcapillary Purpuric skin Dermal small-
vessel vasculitis with
vasculitis venules lesions vessel disease
nuclear dust

Degenerative
Fibrofatty
Coronary Atheromatous plaque intimal plaque
Atherosclerotic plaques, plaque
arteries, with lipid core and rather than
coronary disease rupture,
intima fibrous cap necrotizing
thrombosis
arteritis

Destructive Infection-
Suppurative
Infectious Focal vessel arteritis or associated
inflammation with
arteritis involvement mycotic vascular
organisms
aneurysm destruction
ADDISON DISEASE

Addison disease is chronic primary adrenocortical insufficiency caused by destruction or severe

dysfunction of the adrenal cortex. The term “primary” indicates that the adrenal gland itself is
diseased, in contrast to secondary adrenal insufficiency, which results from deficient pituitary
adrenocorticotropic hormone stimulation, or tertiary adrenal insufficiency, which results from
deficient hypothalamic corticotropin-releasing hormone stimulation.

The pathological identity of Addison disease is loss of functional adrenal cortical tissue, leading
to deficiency of glucocorticoids, mineralocorticoids, and adrenal androgens. Because the
adrenal medulla is embryologically and functionally distinct from the cortex, it is usually
preserved in autoimmune Addison disease. The main structural lesion depends on the cause:
autoimmune adrenalitis produces cortical atrophy with lymphocytic inflammation, whereas
infections, hemorrhage, infarction, or metastatic tumors may destroy the gland by different
morphological mechanisms.

In endocrine pathology, Addison disease is important because relatively extensive destruction

of both adrenal cortices is required before clinically significant primary adrenal insufficiency
develops. The gland has substantial functional reserve, so symptoms appear only after most
cortical tissue is lost or nonfunctional.

Etiology

The most common cause of Addison disease in iodine-sufficient and medically developed
regions is autoimmune adrenalitis. Autoimmune adrenalitis is caused by immune-mediated
destruction of adrenal cortical cells. It may occur as an isolated autoimmune disease or as part
of autoimmune polyendocrine syndromes.

Autoimmune adrenalitis is associated with circulating adrenal autoantibodies. Important

antibodies include adrenal cortex antibodies and antibodies directed against steroid 21-
hydroxylase. Steroid 21-hydroxylase is a cytochrome P450 enzyme required for cortisol and
aldosterone biosynthesis. Antibodies against this enzyme are highly specific for autoimmune
Addison disease and may appear before overt adrenal failure.

Autoimmune polyendocrine syndrome type 1 is caused by mutations in the autoimmune

regulator gene. It classically includes chronic mucocutaneous candidiasis, hypoparathyroidism,
and autoimmune adrenal insufficiency. Autoimmune polyendocrine syndrome type 2 more
commonly includes autoimmune adrenal insufficiency, autoimmune thyroid disease, and type
1 diabetes mellitus. These syndromes show that Addison disease often reflects broader failure
of immune tolerance.

Tuberculosis was historically the most common cause of Addison disease and remains
important in some regions. Tuberculous adrenalitis causes granulomatous destruction of both
adrenal glands. Caseating granulomas, fibrosis, and calcification may be present. In advanced
disease, the adrenal cortex may be almost completely destroyed.

Other infections may cause adrenal insufficiency, especially in immunocompromised patients.

These include fungal infections such as histoplasmosis and opportunistic infections associated
with human immunodeficiency virus disease, including cytomegalovirus adrenalitis. These
infections can destroy adrenal tissue directly.

Bilateral adrenal hemorrhage or infarction may produce acute adrenal insufficiency rather than
chronic Addison disease, but organizing bilateral hemorrhagic destruction can leave chronic
adrenal failure. Waterhouse-Friderichsen syndrome is acute adrenal hemorrhage classically
associated with severe sepsis and disseminated intravascular coagulation.

Metastatic carcinoma can cause primary adrenal insufficiency when both glands are extensively
replaced. The adrenal glands are common sites for metastases, especially from lung, breast,
gastrointestinal tract, kidney, and melanoma, but adrenal insufficiency develops only when
bilateral cortical destruction is extensive.

Drug-related adrenal insufficiency may occur through impaired steroid synthesis or adrenal
cortical injury. Long-term exogenous glucocorticoid therapy usually causes secondary adrenal
insufficiency through suppression of adrenocorticotropic hormone, rather than primary Addison
disease. However, drugs that inhibit steroidogenesis may contribute to primary functional
adrenal failure.

The etiologic formulation is therefore: autoimmune adrenal cortical destruction in most

contemporary cases, with infections, metastatic tumors, hemorrhage, infarction, infiltrative
disease, and steroidogenesis-inhibiting drugs as additional causes.

Pathogenesis

The central pathogenic mechanism in Addison disease is loss of adrenal cortical hormone
production. In primary disease, the adrenal cortex cannot produce adequate cortisol,
aldosterone, and adrenal androgens despite increased pituitary adrenocorticotropic hormone
stimulation.
In autoimmune adrenalitis, loss of immune tolerance leads to T lymphocyte-mediated and
antibody-associated destruction of cortical cells. Cytotoxic T cells and macrophage-rich
inflammatory infiltrates damage the cortex. Autoantibodies against steroidogenic enzymes,
especially steroid 21-hydroxylase, serve as important markers of the autoimmune process and
may contribute to immune targeting.

As cortical cells are lost, cortisol production falls. Cortisol normally exerts negative feedback
on the hypothalamus and pituitary. Reduced cortisol removes this feedback, leading to increased
corticotropin-releasing hormone and markedly increased adrenocorticotropic hormone
secretion. Adrenocorticotropic hormone is produced from the precursor proopiomelanocortin,
which also gives rise to melanocyte-stimulating hormone-related peptides. This explains the
hyperpigmentation characteristic of primary adrenal insufficiency.

Loss of aldosterone causes renal sodium wasting, reduced intravascular volume, hyperkalemia,
and metabolic acidosis. This mineralocorticoid deficiency distinguishes primary adrenal
insufficiency from most secondary adrenal insufficiency, in which aldosterone secretion is
relatively preserved because it is mainly regulated by the renin-angiotensin system.

Loss of adrenal androgens may contribute to reduced axillary and pubic hair and reduced
androgenic effects, especially in women. In men, testicular androgen production usually masks
much of this component.

The major pathological sequence is:

autoimmune, infectious, metastatic, hemorrhagic, or infiltrative adrenal cortical injury →

progressive loss of zona glomerulosa, zona fasciculata, and zona reticularis function → reduced
aldosterone, cortisol, and adrenal androgen production → increased adrenocorticotropic
hormone release → systemic manifestations of primary adrenal insufficiency.

The essential pathogenic idea is that Addison disease is a failure of adrenal cortical hormone
synthesis caused by destruction or severe dysfunction of the adrenal cortex, not a primary
pituitary disease.

Macroscopic Findings

Gross findings vary according to the cause.

In autoimmune Addison disease, the adrenal glands are usually small and atrophic. The cortex
is thinned, and the capsule may be thickened. The normal yellow cortical tissue is markedly
reduced. The medulla is relatively preserved because the autoimmune destruction primarily
targets cortical steroidogenic cells.

The cut surface may show a narrow residual cortex surrounding a relatively preserved medulla.
In advanced autoimmune disease, the gland may be difficult to identify because of severe
cortical atrophy and fibrosis.

In tuberculous Addison disease, the adrenal glands may initially be enlarged by granulomatous
inflammation. With chronicity, they become fibrotic and may calcify. The cut surface may show
caseous necrosis, yellow-white granulomatous tissue, fibrosis, and calcified foci.

In metastatic disease, the adrenal glands may be enlarged, nodular, and replaced by tumor.
Bilateral involvement is required for adrenal insufficiency. The cut surface reflects the
metastatic tumor type and may show necrosis, hemorrhage, or infiltrative replacement.

In bilateral adrenal hemorrhage, the glands are enlarged and hemorrhagic. Acute hemorrhage
may largely obliterate the normal cortical-medullary architecture. In healing lesions, fibrosis
and hemosiderin may be present.

The gross pathological teaching point is that autoimmune Addison disease produces small
atrophic adrenal glands with cortical loss, whereas infectious or metastatic causes may produce
enlarged or mass-like adrenal destruction before chronic scarring develops.

Histopathological Findings

In autoimmune adrenalitis, the adrenal cortex shows lymphocytic inflammation, cortical cell
degeneration, and progressive cortical atrophy. The inflammatory infiltrate is mainly
lymphocytes, often with plasma cells and macrophages. The cortex may be extensively replaced
by fibrous tissue and chronic inflammatory cells.

Residual cortical cells may be sparse or absent. The medulla is usually preserved. This
preservation of adrenal medulla is an important morphological clue in autoimmune adrenalitis
because the immune process predominantly targets cortical steroidogenic cells.

The capsule may be thickened. Fibrous stromal replacement becomes more prominent in
chronic lesions. In late disease, the cortex may be reduced to a thin rim or almost completely
absent, while the medulla remains recognizable.

In tuberculous adrenalitis, histology shows granulomatous inflammation, often with caseous

necrosis. Epithelioid histiocytes, Langhans-type giant cells, lymphocytes, fibrosis, and
calcification may be present. Acid-fast bacilli may be demonstrable in some cases with special
stains or molecular methods.

In fungal adrenalitis, granulomatous or necrotizing inflammation may be present depending on

the organism and host immune status. Fungal stains such as Grocott methenamine silver and
periodic acid-Schiff may demonstrate organisms.

In metastatic carcinoma, histology shows replacement of adrenal cortex by malignant epithelial,

melanocytic, or other tumor cells. Residual adrenal tissue may be compressed or infiltrated.
Immunohistochemistry may identify the primary tumor lineage.

In hemorrhagic or infarctive adrenal destruction, histology shows hemorrhage, necrosis,

vascular thrombosis, fibrin, and later organization with hemosiderin-laden macrophages and
fibrosis.

Immunohistochemistry is not essential for ordinary autoimmune Addison disease but may be
used to characterize lymphoid infiltrates or identify metastatic tumor. Steroidogenic factor 1
can highlight adrenal cortical cells when residual cortex must be assessed, while chromogranin
and synaptophysin highlight adrenal medulla. In autoimmune adrenalitis, the practical
diagnostic pattern is cortical atrophy with lymphocytic inflammation and medullary
preservation.

The concise histopathological formulation is:

autoimmune adrenalitis with small atrophic adrenal glands, lymphocytic destruction of the
adrenal cortex, loss of cortical steroidogenic cells, fibrous replacement, and preservation of the
adrenal medulla; alternative causes show granulomatous infection, metastatic replacement,
hemorrhage, or infarction depending on etiology.

Differential Diagnosis

Secondary adrenal insufficiency is caused by decreased adrenocorticotropic hormone secretion

from the pituitary. The adrenal cortex is atrophic because of lack of trophic stimulation,
especially zona fasciculata and zona reticularis. The zona glomerulosa is relatively preserved
because it is regulated mainly by the renin-angiotensin system. Hyperpigmentation is absent
because adrenocorticotropic hormone is low rather than high.

Tertiary adrenal insufficiency is caused by decreased hypothalamic corticotropin-releasing

hormone, often after chronic exogenous glucocorticoid therapy. It resembles secondary adrenal
insufficiency pathologically and hormonally, with low adrenocorticotropic hormone drive and
adrenal cortical atrophy.

Congenital adrenal hyperplasia may produce adrenal insufficiency in some enzyme defects, but
the adrenal cortex is usually hyperplastic because of chronic adrenocorticotropic hormone
stimulation. This contrasts with autoimmune Addison disease, in which the cortex is destroyed
and atrophic.

Bilateral adrenal metastases may cause primary adrenal insufficiency when extensive. The
glands are enlarged or replaced by malignant tumor rather than small and autoimmune-atrophic.
Histology and immunohistochemistry identify metastatic tumor.

Adrenal tuberculosis can cause chronic adrenal insufficiency but shows granulomatous
destruction, caseous necrosis, fibrosis, and possible calcification rather than lymphocytic
autoimmune cortical atrophy alone.

Waterhouse-Friderichsen syndrome is acute adrenal insufficiency due to massive bilateral

adrenal hemorrhage, usually in severe sepsis. The adrenal glands are enlarged and hemorrhagic,
unlike chronic autoimmune Addison disease.

Adrenoleukodystrophy may cause adrenal cortical dysfunction, especially in boys, and is

associated with accumulation of very-long-chain fatty acids due to peroxisomal beta-oxidation
defects. It is distinguished by neurological white matter disease and biochemical-genetic
findings.
 Main Gross / Key
Distinguishing
Disease Pathological Structural Histopathological
Feature
Target Pattern Finding

Small atrophic
adrenal glands Lymphocytic
in autoimmune adrenal cortical
Primary adrenal
disease; destruction with
cortical failure
Adrenal enlarged cortical atrophy
Addison disease with elevated
cortex granulomatous, and medullary
adrenocorticotropi
hemorrhagic, or preservation in
c hormone
tumor-replaced autoimmune
glands in other adrenalitis
causes

Bilateral Low
Cortical atrophy
adrenal cortical adrenocorticotropi
due to low
Secondary adrenal Pituitary- atrophy, c hormone,
adrenocorticotropi
insufficiency adrenal axis especially zona relatively
c hormone
fasciculata and preserved
stimulation
zona reticularis aldosterone

Atrophy from
Adrenal cortical reduced
Hypothalamic atrophy after corticotropin- Often related to
Tertiary adrenal
-pituitary- chronic releasing hormone chronic exogenous
insufficiency
adrenal axis glucocorticoid and glucocorticoids
suppression adrenocorticotropi
c hormone drive

Hyperplastic Enzyme defect

Steroidogenic Bilateral
Congenital adrenal adrenal cortex due with cortical
enzyme adrenal cortical
hyperplasia to chronic hyperplasia rather
pathway hyperplasia
adrenocorticotropi than destruction
 Main Gross / Key
Distinguishing
Disease Pathological Structural Histopathological
Feature
Target Pattern Finding

c hormone
stimulation

Enlarged or Caseating Infectious

Bilateral
Adrenal tuberculosis fibrotic/calcifie granulomatous granulomatous
adrenal glands
d adrenal glands adrenalitis destruction

Metastatic Tumor infiltration

Nodular
Bilateral adrenal Adrenal malignant tumor rather than
enlarged tumor-
metastases glands replacing adrenal autoimmune
replaced glands
cortex adrenalitis

Waterhouse- Adrenal Massive Hemorrhagic Acute septic

Friderichsen vasculature bilateral adrenal necrosis of adrenal hemorrhagic
syndrome and cortex hemorrhage glands adrenal failure

Adrenal
cortex and Adrenal cortical Cortical
Peroxisomal very-
Adrenoleukodystroph central atrophy with dysfunction with
long-chain fatty
y nervous neurologic demyelinating
acid disorder
system white disease disease context
matter
CHURG-STRAUSS SYNDROME / EOSINOPHILIC GRANULOMATOSIS WITH
POLYANGIITIS

Churg-Strauss syndrome, currently termed eosinophilic granulomatosis with polyangiitis, is an

antineutrophil cytoplasmic antibody-associated vasculitis characterized by eosinophil-rich
inflammation, necrotizing granulomas, and necrotizing vasculitis affecting small- to medium-
sized vessels. The disease is strongly associated with asthma, allergic rhinosinusitis, and
peripheral or tissue eosinophilia, but the pathology-focused identity is eosinophil-rich
granulomatous vasculitis.

The disease occupies a distinct position among antineutrophil cytoplasmic antibody-associated

vasculitides. Granulomatosis with polyangiitis is classically proteinase 3-antineutrophil
cytoplasmic antibody-associated and shows necrotizing granulomatous inflammation of the
respiratory tract. Microscopic polyangiitis is usually a non-granulomatous pauci-immune
necrotizing small-vessel vasculitis. Eosinophilic granulomatosis with polyangiitis is
distinguished by asthma-associated eosinophilic tissue inflammation and extravascular
granulomas.

The essential pathological identity is eosinophil-rich necrotizing granulomatous inflammation

together with necrotizing vasculitis of small- and medium-sized vessels.

Etiology

The exact etiology is unknown. The disease is best regarded as an immune-mediated disorder
in which allergic inflammation, eosinophil activation, and antineutrophil cytoplasmic antibody-
associated vascular injury interact.

A major immunological background is type 2 helper T-cell-driven eosinophilic inflammation.

Interleukin-4, interleukin-5, and interleukin-13 promote immunoglobulin E production,
eosinophil maturation, eosinophil survival, and eosinophil recruitment into tissues. Interleukin-
5 is especially important because it drives eosinophil differentiation and survival.

Antineutrophil cytoplasmic antibodies are present in a subset of patients. When present, the
dominant specificity is usually myeloperoxidase-antineutrophil cytoplasmic antibody.
Myeloperoxidase is an enzyme located in neutrophil granules and monocyte lysosomes.
Myeloperoxidase-antineutrophil cytoplasmic antibody is also associated with microscopic
polyangiitis, but the eosinophil-rich granulomatous pattern distinguishes eosinophilic
granulomatosis with polyangiitis.
Genetic susceptibility likely contributes. Immune-regulatory genetic backgrounds may
influence the tendency toward eosinophilic inflammation, autoantibody generation, and
vascular injury. However, no single genetic alteration defines the disease.

Environmental and allergic triggers have been proposed, including inhaled antigens, respiratory
infections, drugs, and immune-modifying exposures. These may precipitate disease expression
in susceptible individuals, but the disease is not a direct infectious vasculitis.

The etiologic formulation is therefore: immune dysregulation with allergic type 2 inflammation,
eosinophil expansion and activation, variable myeloperoxidase-antineutrophil cytoplasmic
antibody formation, and necrotizing eosinophil-rich vasculitis.

Pathogenesis

The pathogenesis has two overlapping components: eosinophil-mediated tissue injury and
antineutrophil cytoplasmic antibody-associated vasculitic injury.

Eosinophils are central effector cells. They release major basic protein, eosinophil cationic
protein, eosinophil peroxidase, leukotrienes, cytokines, and reactive oxygen species. These
mediators injure epithelium, endothelium, nerves, myocardium, and other tissues. Eosinophil-
rich inflammation may occur in lung, sinonasal tissue, skin, peripheral nerves, gastrointestinal
tract, and heart.

Granulomatous inflammation occurs around necrotic eosinophil-rich material and damaged

tissues. Extravascular granulomas may contain eosinophils, macrophages, epithelioid
histiocytes, giant cells, lymphocytes, and necrotic debris. These granulomas are often less
compact than sarcoid granulomas and are associated with necrosis and eosinophils.

In antineutrophil cytoplasmic antibody-positive disease, primed neutrophils express

myeloperoxidase or other antigens at the cell surface. Myeloperoxidase-antineutrophil
cytoplasmic antibodies bind and activate neutrophils. Activated neutrophils adhere to
endothelium and release reactive oxygen species and proteolytic enzymes, producing
endothelial injury, fibrinoid necrosis, and small-vessel vasculitis.

The vasculitis may affect arterioles, venules, capillaries, and small to medium arteries. It may
produce thrombosis, hemorrhage, ischemia, and tissue necrosis. Pauci-immune necrotizing
glomerulonephritis may occur in some cases, but renal involvement is generally less dominant
than in microscopic polyangiitis.
Cardiac involvement is especially important in eosinophilic granulomatosis with polyangiitis
because eosinophil-mediated myocardial injury can produce myocarditis, endocardial injury,
mural thrombosis, and fibrosis. This eosinophilic cardiac injury may be a major cause of
morbidity.

The major pathological sequence is:

immune dysregulation with type 2 helper T-cell polarization → eosinophil expansion and tissue
recruitment → eosinophil-mediated tissue injury and necrosis → extravascular eosinophil-rich
granuloma formation → variable myeloperoxidase-antineutrophil cytoplasmic antibody-
associated neutrophil activation → necrotizing small- and medium-vessel vasculitis.

The essential pathogenic concept is that eosinophilic granulomatosis with polyangiitis

combines allergic eosinophilic inflammation with necrotizing vasculitis; eosinophils are not
incidental but central to tissue injury.

Macroscopic Findings

Gross findings depend on the organs involved.

In the lung, lesions may appear as patchy areas of consolidation, hemorrhage, or nodular
inflammatory foci. Pulmonary infiltrates may be migratory radiologically, but in pathology
specimens they correspond to eosinophil-rich inflammatory infiltrates, granulomatous
inflammation, and vasculitic injury. The airways may show mucus plugging and chronic
inflammatory remodeling in the setting of asthma.

In the upper respiratory tract and paranasal sinuses, mucosa may be edematous, inflamed,
polypoid, or thickened. Nasal polyps may occur. The mucosa may show eosinophil-rich
inflammation.

In the skin, vasculitic lesions may produce purpura, nodules, ulcers, or livedoid changes. Gross
skin lesions correspond to small-vessel vasculitis and extravascular granulomatous
inflammation.

In peripheral nerves, vasculitis of the vasa nervorum may produce ischemic nerve injury. Gross
nerve changes are often subtle, but biopsy may show vasculitic inflammation and axonal
degeneration.
In the heart, eosinophilic myocarditis may produce pale or mottled myocardium, mural thrombi,
endocardial thickening, or later fibrotic scarring. Severe involvement may cause
cardiomyopathy-like changes.

The gross pathological picture is therefore multisystem and variable, with airway-centered
eosinophilic disease, pulmonary infiltrates or hemorrhagic lesions, skin vasculitic lesions, nerve
ischemic injury, and possible eosinophilic myocardial damage.

Histopathological Findings

The characteristic histopathological triad consists of eosinophil-rich inflammation, necrotizing

granulomatous inflammation, and necrotizing vasculitis.

In the lung, there may be dense eosinophilic infiltrates within interstitium, alveolar spaces,
bronchioles, and perivascular regions. Eosinophils may be accompanied by lymphocytes,
plasma cells, macrophages, and neutrophils. Areas of eosinophilic pneumonia-like injury may
be present.

Extravascular granulomas are a key feature. These granulomas are often centered around
necrotic eosinophil-rich material. They contain epithelioid histiocytes, multinucleated giant
cells, lymphocytes, and abundant eosinophils. Necrosis is common and may contain eosinophil
granule debris.

The vasculitis is necrotizing and may involve small and medium-sized vessels. The vessel wall
may show fibrinoid necrosis, transmural inflammatory infiltration, endothelial damage, and
luminal thrombosis. Eosinophils are often prominent within and around affected vessels.
Leukocytoclasia may be present when neutrophils are abundant.

In skin biopsies, small-vessel leukocytoclastic vasculitis with eosinophils may be seen.

Extravascular granulomas may be present in deeper dermis or subcutaneous tissue.

In nerve biopsies, vasculitis of epineurial vessels may be seen, with fibrinoid necrosis,
inflammatory infiltrates, and secondary ischemic axonal injury. Muscle biopsy may show
vasculitis in small arteries and arterioles.

In kidney biopsies, when renal involvement occurs, the lesion is typically pauci-immune focal
necrotizing crescentic glomerulonephritis. Immunofluorescence shows little or no immune
complex deposition. This pattern overlaps with other antineutrophil cytoplasmic antibody-
associated vasculitides.
Immunohistochemistry is not usually required to establish the diagnosis but may help
characterize inflammatory cells. CD68 highlights macrophages and histiocytes in granulomas.
Eosinophil-rich inflammation is recognized morphologically. Antineutrophil cytoplasmic
antibody testing, especially myeloperoxidase-antineutrophil cytoplasmic antibody, supports the
diagnosis in a subset.

The concise histopathological formulation is:

eosinophil-rich necrotizing granulomatous inflammation with necrotizing small- to medium-

vessel vasculitis, often accompanied by tissue eosinophilic infiltrates and, in some cases, pauci-
immune necrotizing crescentic glomerulonephritis.

Differential Diagnosis

Granulomatosis with polyangiitis is the most important antineutrophil cytoplasmic antibody-

associated differential diagnosis. It shows necrotizing granulomatous inflammation of the
respiratory tract and necrotizing vasculitis, often with proteinase 3-antineutrophil cytoplasmic
antibody. However, prominent asthma-associated eosinophilic inflammation and eosinophil-
rich extravascular granulomas favor eosinophilic granulomatosis with polyangiitis.

Microscopic polyangiitis is a pauci-immune necrotizing small-vessel vasculitis, often

associated with myeloperoxidase-antineutrophil cytoplasmic antibody. It lacks granulomatous
inflammation and does not show the dominant eosinophil-rich allergic tissue pattern of
eosinophilic granulomatosis with polyangiitis.

Polyarteritis nodosa is a necrotizing vasculitis of medium-sized muscular arteries. It does not

primarily involve capillaries, venules, or glomeruli and is not characteristically associated with
asthma or eosinophil-rich granulomatous inflammation. It may show fibrinoid necrosis but
lacks the eosinophilic granulomatous component.

Hypereosinophilic syndrome can cause tissue eosinophilic injury, myocarditis, endocardial

fibrosis, and thrombotic complications. However, it lacks the defining necrotizing
granulomatous vasculitis pattern. Persistent unexplained eosinophilia with organ damage but
without vasculitis supports hypereosinophilic syndrome.

Chronic eosinophilic pneumonia may show pulmonary eosinophil-rich infiltrates, but it lacks
systemic necrotizing vasculitis and extravascular granulomas. The disease is mainly an
eosinophilic lung disorder rather than a multisystem vasculitis.
Allergic bronchopulmonary aspergillosis produces asthma-associated eosinophilic airway
disease, mucus plugging, fungal hyphae in allergic mucin, and central bronchiectasis. It is a
hypersensitivity reaction to Aspergillus rather than necrotizing vasculitis. Demonstration of
fungal elements and allergic mucin supports this diagnosis.

Parasitic infection can produce marked eosinophilia and tissue eosinophilic inflammation.
Identification of parasites, ova, larvae, or relevant serology and exposure history distinguishes
infection from eosinophilic granulomatosis with polyangiitis.

Drug hypersensitivity vasculitis may show eosinophils in vessel walls and skin lesions. It is
usually temporally related to drug exposure and often limited to small vessels, especially in the
skin. It lacks the full asthma-associated eosinophilic granulomatous systemic vasculitis pattern.

Sarcoidosis shows well-formed noncaseating granulomas without prominent eosinophil-rich

necrotizing vasculitis. It may involve lung and lymph nodes but lacks necrotizing eosinophilic
granulomas and antineutrophil cytoplasmic antibody-associated small-vessel injury.
 Main Gross / Key
Distinguishing
Disease Pathological Structural Histopathological
Feature
Target Pattern Finding

Asthma-associated
Pulmonary
eosinophilic
Small- to infiltrates, Eosinophil-rich
Churg-Strauss granulomatous
medium-sized sinonasal necrotizing
syndrome / vasculitis, often
vessels, lung, inflammatory granulomatous
eosinophilic myeloperoxidase-
upper airway, disease, skin inflammation with
granulomatosis antineutrophil
skin, nerves, vasculitic lesions, necrotizing
with polyangiitis cytoplasmic
heart possible cardiac vasculitis
antibody-
involvement
associated

Proteinase 3-
Necrotizing antineutrophil
Upper airway, Necrotizing upper
granulomatous cytoplasmic
lung, kidney, airway lesions
Granulomatosis inflammation and antibody-
small- to and cavitating
with polyangiitis pauci-immune associated
medium-sized pulmonary
necrotizing respiratory
vessels nodules
vasculitis granulomatous
vasculitis

Nongranulomatous
Pauci-immune vasculitis, often
Small vessels, Pulmonary-renal necrotizing small- myeloperoxidase-
Microscopic
kidney, lung, small-vessel vessel vasculitis antineutrophil
polyangiitis
skin, nerves disease without cytoplasmic
granulomas antibody-
associated

Transmural
Medium-sized Segmental arterial Medium-vessel
Polyarteritis necrotizing
muscular lesions, vasculitis without
nodosa arteritis with
arteries aneurysms, glomerulonephritis
fibrinoid necrosis
 Main Gross / Key
Distinguishing
Disease Pathological Structural Histopathological
Feature
Target Pattern Finding

thrombosis, or eosinophilic
infarcts granulomas

Persistent
Heart, skin, Tissue
Variable eosinophilia with
lung, nervous eosinophilic
Hypereosinophilic eosinophil- organ damage but
system, infiltration and
syndrome mediated organ no necrotizing
gastrointestinal fibrosis without
damage granulomatous
tract defining vasculitis
vasculitis

Eosinophil-rich Lung-limited
Chronic Pulmonary
alveolar and eosinophilic
eosinophilic Lung consolidation or
interstitial pneumonia without
pneumonia infiltrates
infiltrates systemic vasculitis

Allergic Mucus plugging Allergic mucin Aspergillus

Bronchi and
bronchopulmonary and central with eosinophils hypersensitivity
central airways
aspergillosis bronchiectasis and fungal hyphae airway disease

Demonstrable
Tissue-specific Variable Parasites or ova
infectious
Parasitic infection depending on inflammatory with eosinophil-
organism or
parasite lesions rich inflammation
serologic evidence

Non-necrotizing
Nodular
Lung, lymph Well-formed granulomas
granulomatous
Sarcoidosis nodes, many noncaseating without
disease,
organs granulomas eosinophilic
lymphadenopathy
vasculitis
LUPUS NEPHRITIS

Lupus nephritis is the renal manifestation of systemic lupus erythematosus, an autoimmune

disease characterized by loss of tolerance to nuclear antigens and formation of pathogenic
autoantibodies. In the kidney, the central lesion is immune complex-mediated glomerular injury.
The disease may involve glomeruli, tubules, interstitium, and vessels, but the glomerular
patterns are the most important for diagnosis, classification, prognosis, and treatment.

The pathological identity of lupus nephritis is deposition of immune complexes containing

nuclear antigens and autoantibodies, followed by complement activation, leukocyte
recruitment, endothelial and mesangial injury, and variable glomerular proliferation, necrosis,
crescent formation, or membranous capillary wall thickening. The morphology varies from
minimal mesangial immune deposition to severe diffuse proliferative glomerulonephritis and
membranous lupus nephritis.

Lupus nephritis is classified into six major patterns. Class I is minimal mesangial lupus
nephritis. Class II is mesangial proliferative lupus nephritis. Class III is focal lupus nephritis,
involving fewer than 50% of glomeruli. Class IV is diffuse lupus nephritis, involving 50% or
more of glomeruli and representing the most severe and common proliferative form. Class V is
membranous lupus nephritis. Class VI is advanced sclerosing lupus nephritis.

Etiology

The etiology of lupus nephritis is autoimmune and reflects the systemic immune dysregulation
of systemic lupus erythematosus. The disease results from failure of immune tolerance to
nuclear antigens, especially double-stranded deoxyribonucleic acid, nucleosomes, histones,
ribonucleoproteins, and other nuclear or cytoplasmic components.

Genetic susceptibility is important. Multiple immune-regulatory genes contribute to systemic

lupus erythematosus risk, including genes involved in complement clearance, apoptotic debris
removal, B-cell activation, T-cell regulation, and interferon signaling. Deficiencies of early
complement components, particularly complement component 1q, complement component 2,
and complement component 4, strongly predispose to lupus because they impair clearance of
apoptotic nuclear material.

Environmental triggers may contribute by increasing nuclear antigen exposure or immune

activation. Ultraviolet radiation, infections, drugs, hormones, and other immune-stimulating
factors can promote autoantibody formation or disease flares in susceptible individuals.
Autoantibodies are central. Anti-double-stranded deoxyribonucleic acid antibodies are strongly
associated with lupus nephritis. Anti-Smith antibodies are specific for systemic lupus
erythematosus but are less directly correlated with renal activity. Antiphospholipid antibodies
may produce vascular thrombotic lesions that can coexist with immune complex nephritis.

The etiologic formulation is therefore: genetically susceptible host, defective clearance of

apoptotic nuclear material, loss of B-cell and T-cell tolerance, production of antinuclear
autoantibodies, immune complex formation, complement activation, and inflammatory renal
injury.

Pathogenesis

The central pathogenic mechanism is immune complex deposition and in situ immune complex
formation within glomeruli. Nuclear antigens and antinuclear antibodies form immune
complexes in the circulation or within renal tissue. These complexes deposit in mesangial,
subendothelial, and subepithelial locations depending on disease class.

Mesangial deposits stimulate mesangial cell proliferation and matrix expansion. This is the
dominant process in class II disease. Subendothelial deposits are especially pathogenic because
they are in direct contact with circulating inflammatory cells and complement. They produce
endocapillary proliferation, leukocyte influx, endothelial swelling, capillary wall injury,
necrosis, and sometimes crescents. This is characteristic of proliferative class III and class IV
lupus nephritis.

Subepithelial deposits produce a membranous pattern similar to membranous nephropathy. In

class V lupus nephritis, capillary walls become thickened by subepithelial immune deposits and
reactive basement membrane material. This produces a nephrotic pattern.

Complement activation is central. Classical pathway activation consumes complement and

generates inflammatory mediators. Complement fragments recruit leukocytes, increase
vascular permeability, and amplify tissue injury. Glomerular capillary wall damage may permit
fibrin leakage into Bowman space, promoting crescent formation.

The major pathological sequence is:

loss of tolerance to nuclear antigens → antinuclear autoantibody formation → immune complex

deposition in glomeruli → complement activation → mesangial, endothelial, and epithelial
injury → proliferative, membranous, necrotizing, or sclerosing patterns of lupus nephritis.
The essential pathogenic concept is that lupus nephritis is a pattern-diverse immune complex
glomerulonephritis. The location of immune deposits largely determines the morphology:
mesangial deposits produce mesangial disease, subendothelial deposits produce proliferative
nephritis, and subepithelial deposits produce membranous nephritis.

Macroscopic Findings

Gross renal findings vary with severity and chronicity. Early lupus nephritis may produce no
distinctive gross abnormality. In active severe nephritis, the kidneys may be enlarged and pale,
reflecting acute inflammatory glomerular injury and edema.

In advanced chronic disease, kidneys may become small, firm, and granular because of
glomerulosclerosis, tubular atrophy, interstitial fibrosis, and vascular scarring. Cortical thinning
may be present. These gross changes reflect chronic kidney disease and are not specific to lupus.

In patients with antiphospholipid antibody-associated vascular disease, renal infarcts, cortical

scars, or thrombotic microangiopathic changes may be present. These vascular lesions may
coexist with lupus nephritis and should be recognized separately.

The gross pathological teaching point is that lupus nephritis is diagnosed by renal biopsy
morphology, immunofluorescence, and electron microscopy rather than by a specific gross
renal appearance.

Histopathological Findings

Class I minimal mesangial lupus nephritis shows immune deposits in the mesangium by
immunofluorescence and electron microscopy, but no significant structural abnormality by light
microscopy.

Class II mesangial proliferative lupus nephritis shows mesangial hypercellularity and mesangial
matrix expansion. Immunofluorescence demonstrates mesangial immune deposits. Glomerular
capillary loops are not significantly involved.

Class III focal lupus nephritis involves fewer than 50% of glomeruli. Lesions may be segmental
or global. Affected glomeruli show endocapillary proliferation, mesangial proliferation,
leukocyte accumulation, capillary necrosis, hyaline thrombi, and sometimes crescents.
Unaffected glomeruli may appear normal or show mesangial disease.

Class IV diffuse lupus nephritis involves 50% or more of glomeruli and is the most severe
proliferative form. Glomeruli show diffuse endocapillary and mesangial proliferation,
endothelial swelling, leukocyte infiltration, necrosis, karyorrhexis, hyaline thrombi, and
crescents. Large subendothelial immune deposits may produce circumferential capillary wall
thickening known as wire-loop lesions. Chronic lesions may show segmental or global
glomerulosclerosis.

Class V membranous lupus nephritis shows diffuse thickening of glomerular capillary walls
caused by subepithelial immune deposits and basement membrane-like material formation. It
resembles primary membranous nephropathy but often has mesangial deposits and a full-house
immunofluorescence pattern. It may coexist with proliferative class III or class IV lesions.

Class VI advanced sclerosing lupus nephritis shows global sclerosis of most glomeruli, with
marked tubular atrophy and interstitial fibrosis. Active inflammation may be minimal, and the
biopsy indicates advanced irreversible chronic damage.

Immunofluorescence is central. Lupus nephritis often shows a full-house pattern, meaning

granular staining for immunoglobulin G, immunoglobulin A, immunoglobulin M, complement
component 3, and complement component 1q. Deposits may be mesangial, capillary wall, or
both, depending on class.

The concise histopathological formulation is:

immune complex-mediated glomerulonephritis with class-dependent mesangial, endocapillary,

necrotizing, crescentic, or membranous patterns, often showing full-house granular
immunofluorescence and immune deposits in mesangial, subendothelial, or subepithelial
locations.

Electron Microscopic Findings

Electron microscopy is highly informative in lupus nephritis because it demonstrates the

location and extent of immune complex deposits. Mesangial deposits are seen in class I and
class II disease. Subendothelial electron-dense deposits are prominent in proliferative class III
and class IV disease and correspond to wire-loop lesions on light microscopy. Subepithelial
deposits dominate in class V membranous lupus nephritis.

Tubuloreticular inclusions may be seen within endothelial cells. These structures are associated
with interferon activity and are supportive of systemic lupus erythematosus in the appropriate
setting, although they are not entirely specific.
Electron microscopy also helps assess podocyte injury, basement membrane remodeling, and
chronic scarring. In membranous lupus nephritis, subepithelial deposits may be accompanied
by spike formation and podocyte foot process effacement.

The high-yield ultrastructural formulation is:

electron-dense immune complex deposits in mesangial, subendothelial, and/or subepithelial

locations according to lupus nephritis class, with subendothelial deposits producing wire-loop
lesions and possible endothelial tubuloreticular inclusions.

Differential Diagnosis

Primary membranous nephropathy may mimic class V lupus nephritis. Primary membranous
nephropathy usually shows subepithelial deposits, granular immunoglobulin G and
complement component 3, and often phospholipase A2 receptor positivity. Lupus membranous
nephritis more often shows full-house immunofluorescence, mesangial deposits, complement
component 1q, extraglomerular deposits, and systemic lupus context.

Postinfectious glomerulonephritis may show diffuse endocapillary proliferation, neutrophils,

granular immune deposits, and subepithelial hump-shaped deposits. Lupus nephritis is
distinguished by full-house staining, antinuclear autoimmunity, and class-dependent
mesangial/subendothelial/subepithelial deposits.

IgA nephropathy shows immunoglobulin A-dominant mesangial deposits and mesangial

proliferation. Lupus nephritis usually shows full-house staining rather than isolated
immunoglobulin A dominance.

Membranoproliferative glomerulonephritis may show endocapillary proliferation, mesangial

expansion, and double-contour capillary walls. It lacks the systemic lupus full-house pattern in
typical cases and has different complement or immune complex etiologies.

Anti-glomerular basement membrane disease shows necrotizing crescentic glomerulonephritis

with smooth linear immunoglobulin G staining along the glomerular basement membrane.
Lupus nephritis shows granular immune complex deposition.

Antineutrophil cytoplasmic antibody-associated pauci-immune glomerulonephritis shows

necrotizing crescentic lesions with little or no immune deposition by immunofluorescence.
Lupus nephritis shows immune complex deposits and usually full-house staining.
 Electron
Main Renal
Light Immunofluorescen Microscopy /
Disease Compartment
Microscopy ce Key
/ Target
Distinction

Class-dependent
Mesangial,
mesangial Granular full-house
Glomerular subendothelial,
proliferation, pattern with
mesangium and/or
endocapillary immunoglobulin G,
and capillary subepithelial
proliferation, immunoglobulin A,
walls; electron-dense
Lupus nephritis necrosis, immunoglobulin M,
tubulointerstiti immune
crescents, wire- complement
al and vascular deposits;
loop lesions, component 3, and
lesions may tubuloreticular
membranous complement
coexist inclusions may
thickening, or component 1q
be present
sclerosis

Granular
immunoglobulin G Subepithelial
and complement deposits
Primary membranous Subepithelial Diffuse capillary
component 3; without lupus
nephropathy capillary wall wall thickening
phospholipase A2 full-house
receptor often pattern
positive

Immune
Diffuse Granular
complex- Large
Postinfectious endocapillary immunoglobulin G
mediated subepithelial
glomerulonephritis hypercellularity and complement
glomerular humps
with neutrophils component 3
injury

Mesangial Immunoglobulin A- Mesangial

IgA nephropathy Mesangium proliferation and dominant mesangial electron-dense
matrix expansion deposits deposits
 Electron
Main Renal
Light Immunofluorescen Microscopy /
Disease Compartment
Microscopy ce Key
/ Target
Distinction

Subendothelial
Lobular
or
Membranoproliferati Mesangium glomeruli, Immune complex or
intramembrano
ve and capillary endocapillary complement-
us deposits
glomerulonephritis wall proliferation, dominant pattern
depending on
double contours
subtype

Basement
Glomerular membrane
Necrotizing Smooth linear
Anti-glomerular basement rupture/fibrin
crescentic immunoglobulin G
basement membrane membrane rather than
glomerulonephrit along glomerular
disease intrinsic immune
is basement membrane
antigen complex
deposits

Small-vessel Necrotizing Absence of

Pauci-immune
vasculitic crescentic Little or no immune significant
crescentic
glomerular glomerulonephrit deposition immune
glomerulonephritis
injury is deposits
MULTIPLE MYELOMA

Multiple myeloma is a malignant neoplasm of terminally differentiated B cells, characterized

by clonal proliferation of plasma cells within bone marrow and production of a monoclonal
immunoglobulin or immunoglobulin light chain. The tumor primarily involves the bone marrow
and produces skeletal destruction, marrow failure, immunodeficiency, renal disease, and
amyloid deposition in some cases.

The pathological identity of multiple myeloma is a clonal plasma cell neoplasm associated with
monoclonal protein production and osteolytic bone disease. The malignant plasma cells produce
a monoclonal immunoglobulin, most often immunoglobulin G or immunoglobulin A, or only
kappa or lambda light chains. The monoclonal protein may be detectable in serum or urine. Free
light chains in urine are traditionally called Bence Jones proteins.

The disease causes morbidity through several linked mechanisms: bone destruction,
hypercalcemia, renal injury, suppression of normal humoral immunity, anemia due to marrow
replacement, and tissue deposition of immunoglobulin light chains or amyloid.

Etiology

The exact initiating cause of multiple myeloma is not completely established. The disease arises
from post-germinal center plasma cells that have undergone immunoglobulin gene
rearrangement and somatic hypermutation. It is usually preceded by monoclonal gammopathy
of undetermined significance, a premalignant clonal plasma cell disorder with monoclonal
protein production but without end-organ damage.

Genetic abnormalities are central. Many cases show chromosomal translocations involving the
immunoglobulin heavy chain locus on chromosome 14q32. These translocations place
oncogenes under the influence of immunoglobulin enhancers. Common partner genes include
cyclin D1 gene, cyclin D3 gene, fibroblast growth factor receptor 3 gene, multiple myeloma
SET domain gene, and musculoaponeurotic fibrosarcoma oncogene homolog. Hyperdiploidy
with multiple trisomies is another major genetic pathway.

Cyclin D dysregulation is common and promotes plasma cell proliferation. Late disease may
show MYC oncogene alterations, tumor protein p53 gene abnormalities, chromosome 17p
deletion, or other high-risk genetic lesions.

The bone marrow microenvironment is crucial. Interleukin-6 produced by marrow stromal

cells, macrophages, and sometimes tumor cells supports plasma cell survival and proliferation.
Adhesion between myeloma cells and stromal cells promotes cytokine production, resistance
to apoptosis, and tumor expansion.

The etiologic formulation is therefore: clonal plasma cell evolution from a monoclonal
gammopathy precursor, driven by immunoglobulin heavy chain translocations or
hyperdiploidy, supported by marrow microenvironmental cytokines, and followed by genetic
progression.

Pathogenesis

The central pathogenic process is clonal expansion of malignant plasma cells within bone
marrow. These cells produce monoclonal immunoglobulin or light chains and interact with
marrow stromal cells, osteoclasts, osteoblasts, and immune cells.

Bone destruction is one of the most important pathological effects. Myeloma cells stimulate
osteoclast activity and suppress osteoblast function. They induce marrow stromal cells and
osteoblast-lineage cells to increase receptor activator of nuclear factor-kappa B ligand
expression. Receptor activator of nuclear factor-kappa B ligand stimulates osteoclast
differentiation and activation. At the same time, myeloma-derived factors inhibit osteoblasts,
preventing compensatory bone formation. The result is purely lytic bone destruction.

The skeletal lesions release calcium into the blood and weaken bone, causing hypercalcemia
and pathological fractures. Because osteoblast activity is inhibited, bone scans may
underestimate lesions compared with radiologic methods that detect lytic destruction.

Renal injury occurs through several mechanisms. Free light chains are filtered by glomeruli and
reabsorbed by proximal tubules. Excess light chains reach distal tubules and collecting ducts,
where they combine with Tamm-Horsfall protein to form obstructive casts. These casts incite
tubular injury and interstitial inflammation, producing myeloma cast nephropathy. Light chains
may also cause light chain deposition disease or immunoglobulin light chain amyloidosis.

Immune dysfunction results from suppression of normal immunoglobulin production. Although

monoclonal immunoglobulin is increased, functional polyclonal antibody production is
reduced. This predisposes to recurrent bacterial infections.

The major pathological sequence is:

clonal plasma cell transformation → marrow plasma cell expansion → monoclonal

immunoglobulin or light chain production → osteoclast activation and osteoblast inhibition →
lytic bone lesions, hypercalcemia, and fractures → light chain renal injury → marrow failure
and immune suppression.

The essential pathogenic concept is that multiple myeloma is not simply accumulation of
plasma cells; it is a plasma cell neoplasm with systemic effects mediated by monoclonal protein
production and bone marrow microenvironment-driven skeletal destruction.

Macroscopic Findings

Grossly, multiple myeloma primarily involves bone marrow and skeleton. The disease produces
multiple punched-out lytic lesions, especially in axial skeleton and proximal long bones.
Common sites include vertebrae, ribs, skull, pelvis, sternum, clavicles, scapulae, and proximal
femora or humeri.

The skull may show sharply circumscribed punched-out defects. Vertebrae may show lytic
destruction and compression fractures. Ribs and long bones may fracture through lytic lesions.
Lesions are often soft, red-brown, gray-red, or gelatinous because they are filled with plasma
cell tumor tissue.

Bone marrow may appear hypercellular and replaced by gray-red tumor. In diffuse marrow
involvement, the marrow may be extensively infiltrated without a sharply discrete mass.

Extramedullary plasmacytomas may occur in soft tissue or mucosal sites, but in multiple
myeloma the dominant gross disease is multifocal marrow and skeletal involvement.

The gross pathological impression is multifocal lytic skeletal destruction with marrow
replacement by plasma cell tumor, frequently associated with pathological fractures.

Histopathological Findings

Bone marrow biopsy shows increased clonal plasma cells. The infiltration pattern may be
interstitial, nodular, diffuse, or packed. Plasma cells may be mature appearing or show atypical
features. Mature plasma cells have eccentric nuclei, clumped “clock-face” chromatin,
basophilic cytoplasm, and a perinuclear hof corresponding to the Golgi zone.

Atypical plasma cells may be enlarged, binucleated, multinucleated, plasmablastic, or show

prominent nucleoli. Dutcher bodies may be present; these are intranuclear pseudoinclusions of
immunoglobulin. Russell bodies may be present; these are cytoplasmic immunoglobulin
inclusions.
Immunohistochemistry and flow cytometry demonstrate plasma cell phenotype and clonality.
Tumor cells express cluster of differentiation 138, cluster of differentiation 38, and usually
cytoplasmic immunoglobulin light chain restriction, either kappa or lambda. Aberrant
expression of cluster of differentiation 56 is common. Cyclin D1 may be expressed in cases
with t(11;14) involving the cyclin D1 gene.

The bone lesions show sheets of plasma cells replacing marrow and eroding trabecular bone.
Osteoclast activity is increased at sites of bone destruction, while osteoblast activity is
suppressed. Reactive new bone formation is minimal compared with metastatic osteoblastic
tumors.

Renal pathology may show myeloma cast nephropathy. Distal tubules and collecting ducts
contain fractured eosinophilic casts composed of light chains and Tamm-Horsfall protein. These
casts may incite a giant cell reaction and tubular injury. Interstitial inflammation and fibrosis
may develop. Other renal lesions include light chain deposition disease, amyloidosis,
hypercalcemia-related nephrocalcinosis, and infection-related injury.

Amyloid deposition, when present, is usually immunoglobulin light chain amyloid. Congo red
stain demonstrates apple-green birefringence under polarized light, and electron microscopy
shows nonbranching fibrils in amyloid deposits.

The concise histopathological formulation is:

clonal marrow plasma cell neoplasm with light chain restriction, marrow replacement, lytic
bone destruction due to osteoclast activation and osteoblast suppression, monoclonal protein
production, and possible renal cast nephropathy or light chain amyloidosis.

Differential Diagnosis

Monoclonal gammopathy of undetermined significance is a premalignant plasma cell disorder

with monoclonal protein but without the end-organ damage of myeloma. It has fewer clonal
plasma cells and lacks lytic bone lesions, anemia, renal failure, and hypercalcemia attributable
to plasma cell neoplasia.

Smoldering multiple myeloma has higher plasma cell burden or monoclonal protein than
monoclonal gammopathy of undetermined significance but lacks myeloma-defining end-organ
damage. It is distinguished by clinical-pathological criteria rather than morphology alone.
Solitary plasmacytoma is a localized plasma cell neoplasm in bone or soft tissue without
systemic marrow involvement or multiple lytic lesions. It may progress to multiple myeloma,
especially when osseous.

Lymphoplasmacytic lymphoma with Waldenström macroglobulinemia produces

immunoglobulin M monoclonal protein and marrow infiltration by lymphoplasmacytic cells.
Hyperviscosity is common. Multiple myeloma rarely produces immunoglobulin M and is
dominated by plasma cell marrow disease and lytic lesions.

Metastatic carcinoma to bone can produce lytic lesions and marrow replacement. Carcinoma
expresses cytokeratins and site-specific epithelial markers, whereas myeloma expresses plasma
cell markers and shows light chain restriction.

Primary bone lymphoma may cause destructive bone lesions but is composed of malignant
lymphoid cells expressing B-cell markers such as cluster of differentiation 20 rather than plasma
cell markers with cytoplasmic light chain restriction.

Reactive plasmacytosis may occur in infection, autoimmune disease, or chronic inflammation.

It is polyclonal, lacks destructive lytic bone lesions, and does not show a monoclonal serum or
urine protein pattern typical of multiple myeloma.

Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

Multiple
punched-out Clonal plasma cell
Plasma cell
lytic bone proliferation with
neoplasm with
Bone marrow lesions, light chain restriction,
Multiple myeloma monoclonal protein
and skeleton marrow osteolytic bone
and end-organ
replacement, destruction, possible
damage
pathologic cast nephropathy
fractures
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

No lytic
Monoclonal Bone marrow, Monoclonal protein
lesions
gammopathy of low-level Low-level clonal without myeloma-
attributable to
undetermined clonal plasma plasma cells defining organ
plasma cell
significance cells damage
neoplasm

No myeloma-
Increased clonal Asymptomatic
Smoldering multiple defining bone
Bone marrow plasma cells or intermediate plasma
myeloma or organ
monoclonal protein cell neoplasm
damage

Localized
Single bone Single lesion
Solitary mass or Localized clonal
or soft tissue without systemic
plasmacytoma single lytic plasma cell tumor
site myeloma
lesion

Marrow and Lymphoplasmacytic

Bone marrow, Waldenström
Lymphoplasmacytic lymphoid infiltrate with
lymph nodes, macroglobulinemia
lymphoma organ immunoglobulin M
spleen phenotype
infiltration monoclonal protein

Lytic,
sclerotic, or Epithelial lineage
Metastatic Skeleton, Cytokeratin-positive
mixed rather than plasma
carcinoma to bone often axial epithelial tumor cells
metastatic cell lineage
lesions

Cluster of
Malignant lymphoid differentiation 20-
Primary bone Destructive
Bone infiltrate, usually B- positive lymphoma
lymphoma bone mass
cell rather than plasma
cell tumor
 Gross / Key
Main Site / Distinguishing
Disease Structural Histopathological
Distribution Feature
Pattern Finding

Marrow or No tumor-
Reactive tissue in type lytic Polyclonal plasma Polyclonal reactive
plasmacytosis inflammatory bone cell increase process
states destruction
MARFAN SYNDROME

Marfan syndrome is an autosomal dominant connective tissue disorder caused by abnormalities

of fibrillin-1, a major structural glycoprotein of extracellular microfibrils. The disease affects
multiple organ systems, especially the cardiovascular, skeletal, and ocular systems. In
pathology, the most life-threatening lesion is weakening of the aortic media, leading to
progressive aortic root dilation, aneurysm formation, aortic regurgitation, and aortic dissection.

The pathological identity of Marfan syndrome is defective elastic tissue architecture and
dysregulated transforming growth factor-beta signaling due to abnormal fibrillin-1 microfibrils.
The aorta is particularly vulnerable because normal aortic media depends on intact elastic
lamellae and smooth muscle cell-matrix interactions to withstand pulsatile hemodynamic stress.

The most important cardiovascular lesion is cystic medial degeneration of the aorta. This term
refers to fragmentation and loss of elastic fibers, loss of medial smooth muscle cells, and
accumulation of basophilic mucoid extracellular matrix within the aortic media. The term
“cystic” is historical; the spaces are not true epithelial-lined cysts.

Etiology

Marfan syndrome is caused primarily by mutations in the fibrillin-1 gene, abbreviated FBN1.
The fibrillin-1 gene encodes fibrillin-1, a key component of extracellular microfibrils. These
microfibrils provide structural support for elastic fibers and also regulate the bioavailability of
transforming growth factor-beta.

The inheritance pattern is autosomal dominant. Many cases are familial, while others arise from
new mutations. Because heterozygous individuals are affected, abnormal fibrillin-1 may
interfere with normal microfibril assembly and function.

The disease is not caused by acquired inflammation, atherosclerosis, infection, or autoimmune

vascular injury. The primary abnormality is inherited extracellular matrix dysfunction.

Related Marfan-like syndromes may be caused by abnormalities in transforming growth factor-

beta signaling components, including transforming growth factor-beta receptor genes. These
conditions overlap with Marfan syndrome in causing aortic aneurysm and dissection,
emphasizing the central role of transforming growth factor-beta pathway dysregulation in aortic
wall disease.
The etiologic formulation is therefore: autosomal dominant fibrillin-1 gene mutation, defective
microfibril assembly, abnormal elastic tissue integrity, excessive transforming growth factor-
beta signaling, and progressive connective tissue weakness.

Pathogenesis

Fibrillin-1 is essential for the structural organization of elastic microfibrils. In the aorta, elastic
lamellae and smooth muscle cells form organized units that provide both strength and elasticity.
Mutant fibrillin-1 disrupts the assembly and stability of these microfibrils, weakening the
extracellular matrix.

Fibrillin-rich microfibrils also bind and sequester latent transforming growth factor-beta
complexes in the extracellular matrix. When microfibrils are abnormal, transforming growth
factor-beta becomes excessively available. Excess transforming growth factor-beta signaling
alters smooth muscle cell behavior, matrix remodeling, and elastic fiber maintenance.

In the aortic media, these abnormalities produce progressive degeneration of elastic lamellae.
Elastic fibers fragment and become disorganized. Smooth muscle cells are lost or reduced.
Basophilic mucoid matrix accumulates between lamellar units. This combination weakens the
wall and predisposes to dilation and dissection.

Aortic root dilation can stretch the aortic valve ring, producing aortic regurgitation. Dissection
occurs when blood enters the media through an intimal tear and separates the lamellar planes
of the aortic wall. Medial degeneration provides the structural vulnerability that permits this
catastrophic event.

The major pathological sequence is:

fibrillin-1 gene mutation → defective elastic microfibril architecture → increased transforming

growth factor-beta activity → degeneration of aortic medial elastic lamellae and smooth muscle
cells → cystic medial degeneration → aortic root dilation, aneurysm, aortic regurgitation, and
dissection.

The essential pathogenic concept is that Marfan syndrome is not simply a structural collagen
disorder. It is a fibrillin-1 microfibril disorder with both mechanical matrix failure and abnormal
growth factor signaling.

Macroscopic Findings
Gross findings are most important in the cardiovascular system. The ascending aorta and aortic
root may show dilation and aneurysmal enlargement. The aortic valve ring may be dilated,
producing aortic valve incompetence. The aortic wall may appear thinned or weakened.

Aortic dissection may occur, especially in the ascending aorta. Grossly, an intimal tear permits
blood to enter and split the media, creating a false lumen. The dissection may extend proximally
toward the aortic valve or distally along the aorta. Rupture into the pericardial cavity can
produce hemopericardium and cardiac tamponade.

The aorta may show aneurysmal enlargement without severe atherosclerosis. This point is
important because Marfan-related aortic disease is based on medial weakness rather than
primary intimal plaque formation.

Skeletal and ocular abnormalities are important clinically, but in pathology-oriented gross
description the central macroscopic lesion is dilation, aneurysm, or dissection of the ascending
aorta due to medial degeneration.

The classical gross pathological impression is an enlarged and weakened ascending aorta or
aortic root, sometimes with aortic valve ring dilation and aortic dissection.

Histopathological Findings

The characteristic aortic lesion is cystic medial degeneration. The aortic media shows
fragmentation and loss of elastic fibers. Elastic lamellae become disrupted, thinned, and
irregular. Elastic stains highlight breaks and disorganization of the medial elastic framework.

Medial smooth muscle cells are reduced in number or show degenerative change. Loss of
smooth muscle cells weakens the vessel wall and impairs normal matrix maintenance.

Basophilic mucoid extracellular matrix accumulates within the media. On routine hematoxylin
and eosin staining, this appears as pale basophilic pools or spaces between elastic lamellae.
These spaces are not true cysts; they are zones of myxoid matrix accumulation.

The intima may be relatively unremarkable unless atherosclerosis or dissection is

superimposed. This helps distinguish Marfan-associated aortic disease from primary
atherosclerotic aneurysm, which is intima-driven and plaque-associated.

In aortic dissection, blood dissects through the media, separating elastic lamellar planes. The
dissected media may show hemorrhage, elastic fragmentation, smooth muscle loss, and mucoid
matrix accumulation.
The concise histopathological formulation is:

cystic medial degeneration of the aorta with elastic fiber fragmentation and loss, depletion of
medial smooth muscle cells, basophilic mucoid extracellular matrix accumulation, and
structural weakening predisposing to aneurysm and dissection.

Differential Diagnosis

Loeys-Dietz syndrome is a Marfan-like inherited aortopathy caused by mutations affecting

transforming growth factor-beta signaling pathway genes, including transforming growth
factor-beta receptor genes. It may produce aggressive arterial aneurysms and dissections.
Craniofacial and arterial tortuosity features help distinguish it, while molecular testing confirms
the diagnosis.

Ehlers-Danlos syndrome, vascular type, is caused by collagen type III abnormalities, usually
involving the collagen type III alpha 1 chain gene. It predisposes to arterial rupture, organ
rupture, and fragile tissues. Histology may show vascular fragility but not the classic fibrillin-
1-based Marfan phenotype.

Hypertensive aortic dissection can show medial degeneration and aortic dissection, especially
in older individuals with long-standing hypertension. The underlying driver is pressure-related
medial injury and vascular remodeling rather than inherited fibrillin-1 microfibril abnormality.

Atherosclerotic abdominal aortic aneurysm usually involves the abdominal aorta and is driven
by intimal atheromatous plaque, inflammation, proteolytic matrix degradation, and medial
thinning. It differs from Marfan-related ascending aortic root disease with cystic medial
degeneration.

Syphilitic aortitis involves the ascending thoracic aorta and results from obliterative endarteritis
of the vasa vasorum, causing ischemic medial scarring and tree-bark intimal wrinkling. Marfan
syndrome lacks infectious vasa vasorum endarteritis.

Takayasu arteritis can affect the aorta and major branches, but it is a granulomatous
inflammatory large-vessel vasculitis with wall thickening and stenosis. Marfan syndrome is a
noninflammatory inherited medial degeneration.

Bicuspid aortic valve-associated aortopathy may produce ascending aortic dilation and medial
degeneration. It is associated with congenital valve malformation and altered aortic wall
biology. It lacks the systemic fibrillin-1 phenotype of Marfan syndrome.
Diagnostic Pathology Emphasis

In Marfan syndrome, the decisive pathological concept is not merely the presence of aortic
aneurysm or dissection, but the inherited medial weakness that predisposes the ascending aorta
and aortic root to these complications. The central lesion is cystic medial degeneration of the
aortic media, characterized by fragmentation and loss of elastic fibers, depletion of medial
smooth muscle cells, and accumulation of basophilic mucoid extracellular matrix between the
elastic lamellae. This abnormality reflects defective fibrillin-1 microfibril architecture and
increased transforming growth factor-beta signaling. Therefore, aortic root dilatation, aortic
regurgitation, aneurysm formation, and dissection should be interpreted as structural
consequences of medial degeneration rather than as primary atherosclerotic, inflammatory, or
infectious vascular disease. This distinction is especially important in separating Marfan
syndrome from atherosclerotic aneurysm, syphilitic aortitis, Takayasu arteritis, hypertensive
aortic dissection, and other inherited aortopathies.

Gross / Key
Distinguishing
Disease Primary Defect Structural Histopathological
Feature
Pattern Finding

Fibrillin-1 gene Ascending

Cystic medial Autosomal
mutation with aortic/root
degeneration with dominant
defective dilation,
elastic fiber fibrillin-1
Marfan microfibrils and aneurysm,
fragmentation, smooth microfibril
syndrome increased aortic valve
muscle cell loss, and disorder with
transforming ring dilation,
basophilic mucoid aortic medial
growth factor- aortic
matrix accumulation weakness
beta signaling dissection

Aggressive
Transforming Widespread
Medial degeneration syndromic
Loeys-Dietz growth factor- arterial
and aneurysmal aortopathy with
syndrome beta pathway aneurysms and
disease transforming
gene mutations tortuosity
growth factor-beta
 Gross / Key
Distinguishing
Disease Primary Defect Structural Histopathological
Feature
Pattern Finding

receptor pathway
defects

Connective tissue
Vascular Ehlers- Collagen type III-
Type III collagen Arterial and fragility with
Danlos related vascular
defect organ rupture abnormal collagen
syndrome fragility
support

Aortic
Pressure-related
Chronic pressure- dissection, Medial degeneration
Hypertensive disease rather than
related medial often in and hemorrhagic
aortic dissection inherited
injury hypertensive dissection
microfibril defect
setting

Intimal Abdominal
Atheromatous plaques
Atherosclerotic atherosclerosis aortic Intima-driven
with medial thinning
aneurysm and medial aneurysm plaque disease
and inflammation
weakening common

Ascending Obliterative
Treponemal vasa
Syphilitic aortic dilation, endarteritis of vasa Infectious vasa
vasorum
aortitis tree-bark vasorum with medial vasorum disease
endarteritis
intima scarring

Aortic and
Immune- Inflammatory
Takayasu branch vessel Granulomatous
mediated large- large-vessel
arteritis wall thickening transmural arteritis
vessel vasculitis vasculitis
and stenosis

Congenital valve-
Bicuspid aortic Ascending Medial degeneration Valve
associated aortic
valve- aortic dilation variable malformation-
wall abnormality
 Gross / Key
Distinguishing
Disease Primary Defect Structural Histopathological
Feature
Pattern Finding

associated with bicuspid associated

aortopathy valve aortopathy
CORE DIAGNOSTIC PATHOLOGY PATTERNS ACROSS THE DISEASE LIST

This section provides an integrated overview of the major diagnostic pathology patterns across
the disease list. It is not intended to replace the detailed disease chapters. Instead, it functions
as a bridge between disease-based learning and diagnostic histopathological reasoning. Each
disease is summarized according to its defining morphological signature, the most useful
ancillary diagnostic clue, and the principal differential diagnostic trap.

Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

Chronic Giant cell arteritis is

granulomatous large- Elastic tissue stains also granulomatous
vessel vasculitis may show but classically
involving the aorta, fragmentation and involves cranial
aortic arch, and disruption of elastic branches of the
major branches, with fibers; CD68 carotid artery;
TAKAYASU ARTERITIS
transmural highlights atherosclerosis is an
inflammation, macrophages and intimal plaque
medial injury, giant-cell-rich disease rather than
intimal hyperplasia, inflammation when transmural
adventitial fibrosis, needed. granulomatous
and luminal stenosis. arteritis.

Discontinuous Ulcerative colitis is

transmural chronic continuous, colon-
CD68 may highlight
active inflammation restricted, and
granulomas; acid-fast
with skip lesions, mucosal-
and fungal stains
deep fissuring ulcers, submucosal;
CROHN DISEASE help exclude
cobblestone mucosa, intestinal
infectious
thickened bowel tuberculosis may
granulomatous
wall, strictures, show caseating
enterocolitis.
creeping fat, and granulomas,
noncaseating necrotic lymph
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

granulomas when nodes, and acid-fast

present. bacilli.

Dementia with
Neurodegenerative Lewy bodies shows
disease with cortical Amyloid-β α-synuclein-
and hippocampal immunohistochemist positive Lewy
atrophy, extracellular ry highlights plaques; bodies; vascular
amyloid-β neuritic phospho-tau dementia shows
plaques, highlights tangles; infarcts and small-
ALZHEIMER DISEASE
intraneuronal neurofibrillary vessel ischemic
hyperphosphorylated tangles correspond injury;
tau neurofibrillary ultrastructurally to frontotemporal
tangles, neuronal paired helical lobar degeneration
loss, and synaptic filaments. has tau, TDP-43, or
loss. FUS-based
pathology.

Autoimmune
ANCA-associated
pulmonary-renal
Smooth linear IgG, crescentic
basement membrane
often with C3, along glomerulonephritis
disease with
GOODPASTURE the glomerular is pauci-immune;
necrotizing
SYNDROME basement membrane lupus nephritis
crescentic
by shows granular full-
glomerulonephritis
immunofluorescence. house immune
and pulmonary
complex deposition.
alveolar hemorrhage.

Highly aggressive CD20, CD10, BCL6 Diffuse large B-cell

BURKITT LYMPHOMA mature B-cell positivity; surface lymphoma is more
lymphoma with IgM; nearly 100% pleomorphic; B-
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

diffuse Ki-67; MYC lymphoblastic

monomorphic rearrangement, lymphoma
intermediate-sized classically t(8;14). expresses TdT;
cells, very high high-grade B-cell
proliferation, lymphoma with
abundant apoptosis, MYC and
and starry-sky BCL2/BCL6
appearance. rearrangements
requires molecular
separation.

Disordered bone
remodeling with Osteosarcoma
excessive Mosaic pattern of shows malignant
osteoclastic lamellar bone with osteoid produced by
resorption followed irregular cement pleomorphic tumor
PAGET DISEASE OF
by exuberant lines; serum alkaline cells; fibrous
BONE
osteoblastic bone phosphatase may be dysplasia shows
formation and increased in active irregular woven
enlarged disease. bone in bland
architecturally fibrous stroma.
abnormal bone.

High-grade Lymphoma is
Synaptophysin,
neuroendocrine leukocyte marker-
chromogranin,
carcinoma composed positive and
CD56, cytokeratin,
SMALL CELL LUNG of small cytokeratin-
and often TTF-1
CARCINOMA hyperchromatic cells negative; large cell
positivity; very high
with scant neuroendocrine
Ki-67; dense-core
cytoplasm, nuclear carcinoma has
neurosecretory
molding, numerous larger cells;
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

mitoses, apoptosis, granules may be seen basaloid squamous

necrosis, and crush ultrastructurally. carcinoma
artifact. expresses squamous
markers.

Primary
Focal segmental
podocytopathy with
glomerulosclerosis
nephrotic syndrome,
Electron microscopy shows focal and
essentially normal
shows diffuse segmental sclerosis;
MINIMAL CHANGE glomeruli by light
effacement of membranous
DISEASE microscopy, and
podocyte foot nephropathy shows
negative or
processes. subepithelial
nonspecific
deposits and
immunofluorescence
granular IgG/C3.
.

Graves disease
Chronic autoimmune Anti-thyroid
shows diffuse
thyroiditis with peroxidase and anti-
follicular
lymphoplasmacytic thyroglobulin
hyperplasia and
infiltration, germinal antibodies support
HASHIMOTO scalloped colloid;
centers, follicular diagnosis; lymphoid
THYROIDITIS primary thyroid
destruction, Hürthle infiltrate is
lymphoma shows
cell metaplasia, polyclonal in
monomorphic
colloid depletion, uncomplicated
clonal lymphoid
and variable fibrosis. disease.
proliferation.

Clonal Langerhans- CD1a, langerin, and Rosai-Dorfman

LANGERHANS CELL type dendritic cell S100 positivity; disease shows
HISTIOCYTOSIS proliferation with Birbeck granules emperipolesis and
grooved nuclei, pale with tennis-racket lacks
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

cytoplasm, configuration on CD1a/langerin;

eosinophil-rich electron microscopy. Erdheim-Chester
inflammation, and disease shows
destructive tissue foamy histiocytes
lesions. and osteosclerotic
lesions.

Small cell
Malignant small
osteosarcoma
round blue cell
Strong membranous produces malignant
sarcoma of bone or
CD99; NKX2.2 osteoid;
soft tissue,
supportive; EWSR1- lymphoblastic
EWING SARCOMA composed of
ETS fusion, most lymphoma
uniform primitive
commonly EWSR1- expresses TdT;
cells with scant
FLI1. rhabdomyosarcoma
glycogen-rich
expresses myogenin
cytoplasm.
and MyoD1.

Cystic fibrosis
Primary ciliary causes
dyskinesia with bronchiectasis
impaired through thick
mucociliary Electron microscopy dehydrated
KARTAGENER clearance, chronic shows dynein arm secretions;
SYNDROME sinus disease, defect in ciliary postinfectious and
bronchiectasis, situs axonemes. obstructive
inversus, and bronchiectasis lack
impaired sperm congenital ciliary
motility. dynein arm
abnormality.
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

Spinal muscular
atrophy is lower
Combined upper and motor neuron-
lower motor neuron predominant;
TDP-43-positive
degeneration with primary lateral
cytoplasmic
anterior horn cell sclerosis is upper
inclusions in many
AMYOTROPHIC loss, corticospinal motor neuron-
cases; muscle shows
LATERAL SCLEROSIS tract degeneration, predominant;
grouped small
anterior root atrophy, inclusion body
angulated fibers and
gliosis, and myositis is a
fiber type grouping.
neurogenic skeletal primary
muscle atrophy. inflammatory-
degenerative
myopathy.

Microscopic
Necrotizing
polyangiitis lacks
granulomatous
granulomas;
inflammation of Proteinase 3-ANCA
eosinophilic
respiratory tract with is classically
GRANULOMATOSIS granulomatosis with
necrotizing small- to associated; renal
WITH POLYANGIITIS polyangiitis is
medium-vessel immunofluorescence
eosinophil-rich;
vasculitis and pauci- is pauci-immune.
tuberculosis and
immune crescentic
fungal infection
glomerulonephritis.
must be excluded.

Invasive acinar Basal cell markers Benign prostatic

carcinoma, usually p63, high-molecular- hyperplasia retains
PROSTATIC
peripheral zone, with weight cytokeratin, basal cells; high-
ADENOCARCINOMA
small crowded and cytokeratin 5/6 grade prostatic
infiltrative glands are absent; AMACR intraepithelial
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

lacking basal cells, is often positive; neoplasia retains at

enlarged nuclei, PSA, PSAP, and least partial basal
prominent nucleoli, NKX3.1 support cells; urothelial
and frequent prostatic origin. carcinoma has
perineural invasion. urothelial marker
profile.

Minimal change
disease lacks
immune deposits;
Podocyte-facing Granular IgG and C3
lupus membranous
immune deposit along capillary walls;
nephritis often
disease with diffuse PLA2R positivity in
shows full-house
MEMBRANOUS capillary wall many primary cases;
immunofluorescenc
NEPHROPATHY thickening, little electron microscopy
e; diabetic
hypercellularity, and shows subepithelial
nephropathy shows
subepithelial deposits with spike-
mesangial
immune deposits. and-dome pattern.
expansion and
arteriolar
hyalinosis.

Invasive breast ER, PR, and HER2 Invasive lobular

carcinoma of no define major carcinoma shows
special type with biological groups; discohesive single-
malignant glands, myoepithelial file cells and E-
INVASIVE DUCTAL
nests, cords, or solid markers are absent cadherin loss;
CARCINOMA
aggregates around invasive ductal carcinoma in
infiltrating nests; GATA3 situ retains
desmoplastic stroma supports breast myoepithelial
and adipose tissue. origin. boundary.
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

Infiltrating diffuse
IDH-mutant
glioma with uniform
astrocytoma lacks
round cells,
Integrated diagnosis 1p/19q codeletion
perinuclear halos,
requires IDH and often shows
OLIGODENDROGLIOM fried-egg
mutation and 1p/19q ATRX loss; central
A appearance, chicken-
codeletion; ATRX is neurocytoma is
wire capillary
usually retained. intraventricular and
network, and
synaptophysin-
frequent
positive.
calcification.

Eczema lacks
Intraepidermal CK7, EMA, CEA, malignant Paget
spread of malignant GATA3, and often cells; melanoma
ductal carcinoma HER2 positivity; expresses
PAGET DISEASE OF cells into nipple- usually associated melanocytic
BREAST areola epidermis, with underlying markers; squamous
forming large pale ductal carcinoma in cell carcinoma in
Paget cells singly or situ or invasive situ shows
in clusters. ductal carcinoma. keratinocytic
atypia.

Chronic Polymyositis lacks

Electron microscopy
inflammatory- rimmed vacuoles;
shows cytoplasmic
degenerative dermatomyositis
tubulofilamentous
myopathy with shows
INCLUSION BODY inclusions; p62,
endomysial perifascicular
MYOSITIS TDP-43, beta-
inflammation, atrophy; immune-
amyloid precursor
necrotic and mediated
protein, and
regenerating fibers, necrotizing
phosphorylated tau
rimmed vacuoles, myopathy shows
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

abnormal protein may highlight prominent necrosis

aggregates, fibrosis, aggregates. with sparse
and fatty inflammation.
replacement.

Aggressive
Pulmonary
malignant Calretinin, CK5/6,
adenocarcinoma
mesothelial tumor WT-1, D2-40
expresses claudin-4,
with diffuse nodular positivity; BAP1 loss
Ber-EP4, MOC31,
pleural thickening or CDKN2A deletion
MALIGNANT TTF-1, and napsin
and rind-like supports malignancy;
MESOTHELIOMA A; reactive
encasement of lung; electron microscopy
mesothelial
epithelioid tumors may show long
hyperplasia lacks
may show slender nonbranching
destructive
tubulopapillary microvilli.
invasion.
pattern.

Autoimmune Bullous pemphigoid

Direct
intraepidermal is subepidermal
immunofluorescence
blistering with with linear IgG/C3;
shows intercellular
suprabasal pemphigus
IgG along
PEMPHIGUS acantholysis, foliaceus is
keratinocyte
VULGARIS intraepidermal subcorneal;
surfaces; antibodies
blister, acantholytic dermatitis
target desmoglein 3
keratinocytes, and herpetiformis shows
and often desmoglein
row-of-tombstones granular IgA in
1.
basal cells. dermal papillae.

ALPHA-1 SERPINA1-related PAS-D-positive Wilson disease

ANTITRYPSIN misfolded protein cytoplasmic shows copper
DEFICIENCY retention in globules, especially accumulation;
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

hepatocytes with in periportal hemochromatosis

reduced circulating hepatocytes; electron shows iron
antiprotease activity, microscopy shows deposition;
producing liver electron-dense alcoholic liver
disease and protein material disease shows
panacinar within dilated steatohepatitis and
emphysema. endoplasmic Mallory-Denk
reticulum cisternae. bodies.

Usual interstitial
Nonspecific
pneumonia pattern
Fibroblastic foci at interstitial
with patchy
the interface of pneumonia is
subpleural and basal-
preserved lung and temporally uniform;
predominant fibrosis,
IDIOPATHIC dense fibrosis; hypersensitivity
fibroblastic foci,
PULMONARY imaging correlates pneumonitis is
temporal
FIBROSIS with reticulation, bronchiolocentric
heterogeneity,
traction and granulomatous;
architectural
bronchiectasis, and asbestosis requires
distortion, and
honeycomb change. asbestos bodies and
honeycomb
exposure history.
remodeling.

Ependymoma
Highly malignant Synaptophysin
shows perivascular
embryonal cerebellar positivity; high Ki-
pseudorosettes and
tumor composed of 67; Homer-Wright
EMA dot-like
primitive small blue rosettes may be
MEDULLOBLASTOMA staining; pilocytic
cells with high present; molecular
astrocytoma shows
mitotic activity, groups include WNT,
Rosenthal fibers;
apoptosis, neuronal SHH, group 3, and
atypical
differentiation, and group 4.
teratoid/rhabdoid
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

CSF dissemination tumor shows

tendency. INI1/SMARCB1
loss.

Tobacco-associated Atherosclerosis is
segmental Internal elastic lipid plaque-driven;
thrombosing lamina is relatively polyarteritis nodosa
inflammatory preserved; chronic lacks vein-nerve
BUERGER DISEASE / disease of small- and lesions show bundle
THROMBOANGIITIS medium-sized organization, involvement;
OBLITERANS extremity arteries recanalization, and antiphospholipid
and veins with fibrotic encasement syndrome is
inflammatory of artery-vein-nerve thrombotic with
thrombi and bundles. minimal wall
microabscesses. inflammation.

Thin basement
Hereditary type IV
Type IV collagen membrane
collagen disorder
alpha-chain nephropathy shows
with progressive
expression may be uniform thinning;
glomerular basement
abnormal; electron IgA nephropathy
membrane
microscopy shows shows mesangial
ALPORT SYNDROME abnormality,
irregular thickening, IgA deposits;
hematuria,
thinning, splitting, diabetic
proteinuria,
and lamellation of nephropathy shows
glomerulosclerosis,
GBM with basket- GBM thickening
tubular atrophy, and
weave remodeling. with nodular
interstitial fibrosis.
sclerosis.

Malignant germ cell Alpha-fetoprotein Embryonal

YOLK SAC TUMOR
tumor with yolk sac and glypican-3 carcinoma is CD30
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

differentiation, soft positivity; SALL4 and OCT3/4

hemorrhagic yellow- supports germ cell positive; seminoma
white tumor, origin. is OCT3/4 and
microcystic-reticular CD117 positive but
pattern, hyaline AFP negative;
globules, and choriocarcinoma
Schiller-Duval produces human
bodies. chorionic
gonadotropin.

Amyloidosis is
Diabetic
Congo red-positive;
microangiopathic Electron microscopy
light chain
renal disease with shows diffuse GBM
deposition disease
GBM thickening, thickening and
shows monoclonal
diffuse mesangial mesangial matrix
light-chain deposits;
DIABETIC sclerosis, expansion;
hypertensive
NEPHROPATHY Kimmelstiel-Wilson immunofluorescence
nephrosclerosis
nodules, may show
lacks classic
afferent/efferent nonspecific linear
diabetic nodules
arteriolar hyalinosis, trapping of plasma
and efferent
tubular atrophy, and proteins.
arteriolar
interstitial fibrosis.
hyalinosis.

Autoimmune Hashimoto
receptor-stimulating Thyroid-stimulating thyroiditis is
hyperthyroidism hormone receptor- destructive with
GRAVES DISEASE with diffuse stimulating Hürthle cells; toxic
follicular epithelial immunoglobulins are multinodular goiter
hypertrophy and central; lymphoid is nodular; papillary
hyperplasia, tall carcinoma has true
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

crowded cells, infiltrates may be fibrovascular

papillary infoldings present. papillae and
without diagnostic nuclei.
fibrovascular cores,
scalloped colloid,
and increased
vascularity.

Follicular epithelial Follicular

carcinoma defined carcinoma is
Thyroglobulin, TTF-
by Orphan Annie eye defined by
1, and PAX8 support
nuclei, nuclear capsular/vascular
follicular origin;
grooves, nuclear invasion;
PAPILLARY THYROID BRAF, RET/PTC,
overlap, Hashimoto
CARCINOMA NTRK, or RAS
pseudoinclusions, thyroiditis may
alterations activate
papillary structures show reactive
MAP kinase
with fibrovascular atypia; medullary
signaling.
cores, and carcinoma is
psammoma bodies. calcitonin-positive.

Infiltrative Congo red shows

Hypertrophic
myocardial disease apple-green
cardiomyopathy
with extracellular birefringence;
shows myocyte
RESTRICTIVE amyloid deposition electron microscopy
disarray;
CARDIOMYOPATHY / causing stiff shows extracellular
hypertensive heart
CARDIAC noncompliant nonbranching fibrils;
disease shows
AMYLOIDOSIS ventricles, diastolic amyloid typing
pressure-overload
dysfunction, separates light-chain
hypertrophy;
ventricular wall from transthyretin
hemochromatosis
thickening, and amyloid.
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

waxy firm shows iron

myocardium. deposition.

Malignant bone- Ewing sarcoma

forming sarcoma lacks malignant
with destructive osteoid;
metaphyseal mass, SATB2 supports chondrosarcoma
cortical destruction, osteoblastic produces cartilage;
OSTEOSARCOMA soft tissue invasion, differentiation, but aneurysmal bone
periosteal elevation, malignant osteoid is cyst lacks
and malignant decisive. malignant
osteoid between pleomorphic
pleomorphic tumor osteoid-producing
cells. cells.

Acute medium- Polyarteritis nodosa

vessel vasculitis with is systemic
coronary artery medium-vessel
predilection, CD68 highlights vasculitis; Takayasu
transmural macrophage-rich arteritis is large-
necrotizing arteritis, inflammation; elastic vessel
KAWASAKI DISEASE
internal elastic stains show internal granulomatous
lamina elastic lamina vasculitis;
fragmentation, fragmentation. atherosclerotic
coronary aneurysm, coronary disease is
thrombosis, and intimal plaque-
myocardial ischemia. driven.

Chronic primary Anti-steroid 21- Secondary adrenal

ADDISON DISEASE adrenocortical hydroxylase insufficiency has
insufficiency due to antibodies support low ACTH drive
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

cortical destruction autoimmune and relatively

or severe adrenalitis; preserved
dysfunction; tuberculosis shows aldosterone;
autoimmune caseating congenital adrenal
adrenalitis shows granulomatous hyperplasia shows
small atrophic glands adrenalitis; cortical hyperplasia;
with lymphocytic metastasis shows Waterhouse-
cortical destruction tumor replacement. Friderichsen
and medullary syndrome is acute
preservation. hemorrhagic
adrenal failure.

Granulomatosis
with polyangiitis is
usually PR3-
Eosinophil-rich Myeloperoxidase-
ANCA-associated
necrotizing ANCA is present in a
and not eosinophil-
granulomatous subset; histology
CHURG-STRAUSS dominant;
inflammation with shows eosinophil-
SYNDROME / microscopic
necrotizing small- to rich tissue
EOSINOPHILIC polyangiitis lacks
medium-vessel inflammation,
GRANULOMATOSIS granulomas;
vasculitis involving extravascular
WITH POLYANGIITIS allergic
lung, upper airway, granulomas, and
bronchopulmonary
skin, nerves, and necrotizing
aspergillosis shows
heart. vasculitis.
fungal allergic
mucin without
systemic vasculitis.

Immune complex- Full-house granular Primary

LUPUS NEPHRITIS mediated renal immunofluorescence membranous
disease in systemic with IgG, IgA, IgM, nephropathy lacks
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

lupus erythematosus C3, and C1q; full-house pattern;

with class-dependent electron microscopy anti-GBM disease
mesangial, shows deposits shows linear IgG;
proliferative, according to class ANCA-associated
necrotizing, and may show glomerulonephritis
crescentic, tubuloreticular is pauci-immune.
membranous, or inclusions.
sclerosing
glomerular patterns.

CD138/CD38-
MGUS lacks
Clonal plasma cell positive clonal
myeloma-defining
neoplasm with plasma cells with
organ damage;
marrow replacement, kappa or lambda
solitary
monoclonal restriction; cast
plasmacytoma is
immunoglobulin/ligh nephropathy shows
MULTIPLE MYELOMA localized;
t-chain production, fractured
metastatic
lytic bone lesions, eosinophilic casts;
carcinoma is
anemia, renal injury, skeletal disease
cytokeratin-positive
hypercalcemia, and reflects RANKL-
and lacks plasma
immunodeficiency. mediated osteoclast
cell phenotype.
activation.

Autosomal dominant Atherosclerotic

fibrillin-1 microfibril Aortic cystic medial aneurysm is intimal
disorder with degeneration: elastic plaque-driven;
increased fiber fragmentation, syphilitic aortitis is
MARFAN SYNDROME
transforming growth medial smooth vasa vasorum
factor-beta signaling, muscle cell loss, and endarteritis;
causing aortic medial basophilic mucoid Takayasu arteritis is
weakness, aortic root granulomatous
 Defining
Key Ancillary / Main Differential
Disease Pathological
Special Finding Diagnostic Trap
Signature

dilation, aneurysm, extracellular matrix large-vessel

and dissection. accumulation. vasculitis; Loeys-
Dietz and vascular
Ehlers-Danlos are
other inherited
aortopathies.
Pattern-Based Diagnostic Framework

The diseases in this section are organized according to recurring diagnostic pathology
patterns, integrating anatomical distribution, gross morphology, histopathological
architecture, ancillary findings, and major differential diagnostic considerations.

Representative Diseases Diagnostic Logic

Pattern Group

First define the vessel size and distribution.

Takayasu arteritis, Kawasaki Large-vessel granulomatous disease
disease, Buerger disease, suggests Takayasu arteritis. Coronary-
Vascular
granulomatosis with predominant necrotizing arteritis suggests
inflammation
polyangiitis, eosinophilic Kawasaki disease. Tobacco-associated distal
and
granulomatosis with thromboinflammatory disease suggests
vasculopathy
polyangiitis, Marfan Buerger disease. Inherited noninflammatory
syndrome aortic medial degeneration suggests Marfan
syndrome.

Immunofluorescence and electron

microscopy are decisive. Linear IgG
Goodpasture syndrome, lupus indicates anti-GBM disease. Full-house
Renal immune nephritis, membranous granular staining indicates lupus nephritis.
and structural nephropathy, minimal change Subepithelial deposits indicate membranous
patterns disease, Alport syndrome, nephropathy. Diffuse foot process
diabetic nephropathy effacement with normal light microscopy
indicates minimal change disease. GBM
lamellation indicates Alport syndrome.

Determine lineage. Burkitt lymphoma is a

MYC-driven B-cell lymphoma with starry-
Small blue cell Burkitt lymphoma, Ewing
sky morphology. Ewing sarcoma is an
and primitive sarcoma, medulloblastoma,
EWSR1 fusion sarcoma with CD99
tumors small cell lung carcinoma
positivity. Medulloblastoma is a cerebellar
embryonal tumor with neuronal
 Representative Diseases Diagnostic Logic
Pattern Group

differentiation. Small cell lung carcinoma is

a high-grade neuroendocrine carcinoma with
nuclear molding.

Minimal change disease, Electron microscopy is especially valuable

Alport syndrome, Kartagener when it shows a distinctive structure: foot
syndrome, malignant process effacement, GBM lamellation,
Ultrastructural
mesothelioma, alpha-1 dynein arm defect, long slender microvilli,
diagnostic
antitrypsin deficiency, dilated endoplasmic reticulum with retained
signatures
inclusion body myositis, protein, tubulofilamentous inclusions, paired
Alzheimer disease, cardiac helical filaments, or nonbranching amyloid
amyloidosis fibrils.

Separate destructive autoimmunity,

stimulatory autoimmunity, and carcinoma.
Thyroid
Hashimoto thyroiditis, Graves Hashimoto thyroiditis destroys follicles and
autoimmune and
disease, papillary thyroid produces Hürthle cells. Graves disease
neoplastic
carcinoma stimulates follicles and produces scalloped
patterns
colloid. Papillary carcinoma is defined by
nuclear features and psammoma bodies.

Identify whether the lesion is a remodeling

disorder, malignant matrix-producing
Bone, skeletal, Paget disease of bone,
sarcoma, small round blue cell sarcoma, or
and connective osteosarcoma, Ewing
inherited connective tissue aortopathy.
tissue lesions sarcoma, Marfan syndrome
Malignant osteoid is decisive for
osteosarcoma.

Breast, Invasive ductal carcinoma, Determine epithelial lineage and invasion.

reproductive, Paget disease of breast, yolk Invasive ductal carcinoma lacks
and glandular sac tumor, prostatic myoepithelial layer. Paget disease of breast
tumors adenocarcinoma shows malignant ductal cells within nipple
 Representative Diseases Diagnostic Logic
Pattern Group

epidermis. Yolk sac tumor shows

AFP/glypican-3 and Schiller-Duval bodies.
Prostatic adenocarcinoma shows infiltrative
glands lacking basal cells.

Identify the protein and its compartment.

Amyloid-β and tau accumulate in brain.
Protein Alzheimer disease, inclusion TDP-43, tau, and amyloid-related proteins
aggregation and body myositis, cardiac accumulate in skeletal muscle in inclusion
deposition amyloidosis, multiple body myositis. Amyloid deposits
diseases myeloma extracellularly in myocardium. Monoclonal
immunoglobulin or light chains define
plasma cell neoplasia.